Autonomous Communities;Employee strata;Cohorts;ERTEs;Demographic Concepts;Periodo;Total National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.175.582 National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.136.561 National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.190.870 National Total;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" National Total;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" National Total;Total ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" National Total;Total ;Cohort January 1;Total;Survival in the first trimester;2022QI;1.110.581 National Total;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" National Total;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" National Total;Total ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" National Total;Total ;Cohort January 1;Total;Survival in the first trimester;2021QI;1.074.320 National Total;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" National Total;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" National Total;Total ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" National Total;Total ;Cohort January 1;Total;Survival in the first trimester;2020QI;1.050.404 National Total;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" National Total;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" National Total;Total ;Cohort January 1;Total;Survival in the second trimester;2022QII;1.062.357 National Total;Total ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" National Total;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" National Total;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" National Total;Total ;Cohort January 1;Total;Survival in the second trimester;2021QII;1.035.575 National Total;Total ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" National Total;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" National Total;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" National Total;Total ;Cohort January 1;Total;Survival in the second trimester;2020QII;1.014.398 National Total;Total ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.024.559 National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.003.536 National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;983.011 National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;994.419 National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;976.592 National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;952.502 National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" National Total;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 National Total;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,47 National Total;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,52 National Total;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;88,2 National Total;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;90,37 National Total;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;91,11 National Total;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;85,18 National Total;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,15 National Total;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,3 National Total;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;82,55 National Total;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,59 National Total;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,93 National Total;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;79,98 National Total;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;1.116.307 National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;972.382 National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;1.053.423 National Total;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;915.073 National Total;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;1.006.960 National Total;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;879.880 National Total;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;970.603 National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;850.920 National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;941.626 National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;827.437 National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;94,37 National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;94,11 National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;90,2 National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;90,49 National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;86,95 National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;87,51 National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;84,35 National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;85,09 National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;59.275 National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;164.179 National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;57.158 National Total;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;159.247 National Total;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;55.397 National Total;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;155.695 National Total;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;53.956 National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;152.616 National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;52.793 National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;149.155 National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;96,43 National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;97 National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;93,46 National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;94,83 National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;91,03 National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;92,96 National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;89,06 National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;90,85 National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.180.282 National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.137.018 National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.102.738 National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" National Total;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" National Total;Total ;Cohort April 1;Total;Survival in the first trimester;2022QII;1.119.786 National Total;Total ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" National Total;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" National Total;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" National Total;Total ;Cohort April 1;Total;Survival in the first trimester;2021QII;1.087.341 National Total;Total ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" National Total;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" National Total;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" National Total;Total ;Cohort April 1;Total;Survival in the first trimester;2020QII;1.059.378 National Total;Total ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" National Total;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" National Total;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.073.841 National Total;Total ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" National Total;Total ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" National Total;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" National Total;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.047.638 National Total;Total ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" National Total;Total ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" National Total;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" National Total;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.022.614 National Total;Total ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" National Total;Total ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.034.840 National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.013.467 National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;986.485 National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;976.815 National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;950.014 National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 National Total;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,87 National Total;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,63 National Total;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,07 National Total;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;90,98 National Total;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,14 National Total;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,73 National Total;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,68 National Total;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,13 National Total;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,46 National Total;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,91 National Total;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,15 National Total;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;1.122.675 National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;981.798 National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;852.306 National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;1.064.037 National Total;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;935.775 National Total;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;812.240 National Total;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;1.019.625 National Total;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;899.208 National Total;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;781.490 National Total;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;982.021 National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;868.703 National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;753.187 National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;835.962 National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;724.018 National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 National Total;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;94,78 National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;95,31 National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;95,3 National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;90,82 National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;91,59 National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;91,69 National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;87,47 National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;88,48 National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;88,37 National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;85,15 National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;84,95 National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;57.607 National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;155.220 National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;250.432 National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;55.749 National Total;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;151.566 National Total;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;247.138 National Total;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;54.216 National Total;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;148.430 National Total;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;241.124 National Total;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;52.819 National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;144.764 National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;233.298 National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;140.853 National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;225.996 National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 National Total;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;96,77 National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,65 National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,68 National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;94,11 National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;95,63 National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;96,28 National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;91,69 National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;93,26 National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;93,16 National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;90,74 National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;90,24 National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.200.910 National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.175.049 National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.141.253 National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" National Total;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.133.593 National Total;Total ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" National Total;Total ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" National Total;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" National Total;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.112.584 National Total;Total ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" National Total;Total ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" National Total;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" National Total;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.085.053 National Total;Total ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" National Total;Total ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" National Total;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.077.291 National Total;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" National Total;Total ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" National Total;Total ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" National Total;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.060.988 National Total;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" National Total;Total ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" National Total;Total ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" National Total;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.033.148 National Total;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" National Total;Total ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" National Total;Total ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;1.018.275 National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;991.293 National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;987.625 National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;966.184 National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" National Total;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;94,39 National Total;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;94,68 National Total;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,08 National Total;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,71 National Total;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;90,29 National Total;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,53 National Total;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;86,66 National Total;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,86 National Total;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,05 National Total;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,66 National Total;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;1.166.975 National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;1.123.921 National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;962.702 National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;1.100.667 National Total;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;1.062.703 National Total;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;910.591 National Total;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;1.045.250 National Total;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;1.012.815 National Total;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;865.189 National Total;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;971.426 National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;828.387 National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;941.834 National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;806.621 National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;94,32 National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;94,55 National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;94,59 National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;89,57 National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;90,11 National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;89,87 National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;86,43 National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;86,05 National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;83,8 National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;83,79 National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;33.935 National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;51.128 National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;178.551 National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;32.926 National Total;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;49.881 National Total;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;174.462 National Total;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;32.041 National Total;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;48.173 National Total;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;167.959 National Total;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;46.849 National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;162.906 National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;45.791 National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;159.563 National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;97,03 National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;97,56 National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;97,71 National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;94,42 National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;94,22 National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;94,07 National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;91,63 National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;91,24 National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;89,56 National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;89,37 National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.189.333 National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.173.766 National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.149.469 National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.121.025 National Total;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" National Total;Total ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" National Total;Total ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" National Total;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.108.131 National Total;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" National Total;Total ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" National Total;Total ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" National Total;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.080.193 National Total;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" National Total;Total ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" National Total;Total ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" National Total;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" National Total;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" National Total;Total ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" National Total;Total ;Cohort October 1;Total;Survival in the second trimester;2022QI;1.058.391 National Total;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" National Total;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" National Total;Total ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" National Total;Total ;Cohort October 1;Total;Survival in the second trimester;2021QI;1.031.022 National Total;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" National Total;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" National Total;Total ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" National Total;Total ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;1.020.827 National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;1.000.340 National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;988.984 National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;973.266 National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" National Total;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,26 National Total;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,41 National Total;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,97 National Total;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;90,17 National Total;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,7 National Total;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;86,97 National Total;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,03 National Total;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,26 National Total;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,67 National Total;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;1.160.407 National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;1.109.995 National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;962.114 National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;1.092.834 National Total;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;1.046.546 National Total;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;899.731 National Total;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;998.931 National Total;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;855.977 National Total;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;963.203 National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;828.952 National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;932.892 National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;805.210 National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;94,18 National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;94,28 National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;93,52 National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;89,99 National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;88,97 National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;86,78 National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;86,16 National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;84,04 National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;83,69 National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;28.926 National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;63.771 National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;187.355 National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;28.191 National Total;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;61.585 National Total;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;180.462 National Total;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;59.460 National Total;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;175.045 National Total;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;57.624 National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;171.388 National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;56.092 National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;168.056 National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;97,46 National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;96,57 National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;96,32 National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;93,24 National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;93,43 National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;90,36 National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;91,48 National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;87,96 National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;89,7 National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;874.114 National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;855.490 National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;886.684 National Total;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QII;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QI;812.905 National Total;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QII;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QI;796.794 National Total;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QI;756.210 National Total;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QII;769.343 National Total;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QI;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QII;761.641 National Total;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QI;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QII;723.750 National Total;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;734.959 National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;732.347 National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;695.670 National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;707.744 National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;708.023 National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;668.592 National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" National Total;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93 National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,14 National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;85,29 National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;88,01 National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;89,03 National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;81,62 National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;84,08 National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;85,61 National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;78,46 National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;80,97 National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;82,76 National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;75,4 National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;837.215 National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;768.170 National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;777.875 National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;713.559 National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;735.791 National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;681.184 National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;702.623 National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;654.274 National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;676.390 National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;632.648 National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;92,91 National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;92,89 National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;87,89 National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;88,68 National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;83,92 National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;85,17 National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;80,79 National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;82,36 National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;36.899 National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;87.320 National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;35.030 National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;83.235 National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;33.552 National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;80.457 National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;32.336 National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;78.073 National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;31.354 National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;75.375 National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;94,93 National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;95,32 National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;90,93 National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;92,14 National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;87,63 National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;89,41 National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;84,97 National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;86,32 National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;874.197 National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;854.310 National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;825.970 National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QII;818.113 National Total;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QI;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QII;808.026 National Total;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QI;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QII;785.210 National Total;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIII;775.542 National Total;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QII;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QI;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIII;771.127 National Total;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QII;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QI;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIII;751.083 National Total;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QII;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;740.395 National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;740.136 National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;718.066 National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;707.163 National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;685.318 National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 National Total;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,58 National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,58 National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,07 National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;88,71 National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;90,26 National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;90,93 National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;84,69 National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;86,64 National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;86,94 National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;82,78 National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;82,97 National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;838.776 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;769.732 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;676.830 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;784.297 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;726.460 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;638.724 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;743.050 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;692.118 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;609.668 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;709.047 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;664.072 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;583.024 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;634.180 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;556.127 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;93,5 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;94,38 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;94,37 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;88,59 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;89,92 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;90,08 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;84,53 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;86,27 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;86,14 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;82,39 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;82,17 National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;35.421 National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;84.578 National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;149.140 National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;33.816 National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;81.566 National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;146.486 National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;32.492 National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;79.009 National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;141.415 National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;31.348 National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;76.064 National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;135.042 National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;72.983 National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;129.191 National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 National Total;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;95,47 National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;96,44 National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,22 National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;91,73 National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;93,42 National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;94,82 National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;88,5 National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;89,93 National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;90,55 National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;86,29 National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;86,62 National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;883.149 National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;874.571 National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;853.778 National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIII;820.049 National Total;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QII;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QI;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIII;815.824 National Total;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QII;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QI;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIII;800.979 National Total;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIV;771.171 National Total;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QII;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QI;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIV;770.295 National Total;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QII;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QI;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIV;754.275 National Total;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;731.887 National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;716.603 National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;704.284 National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;694.215 National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" National Total;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;92,86 National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;93,28 National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;93,82 National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;87,32 National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;88,08 National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;88,35 National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;83,69 National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;83,93 National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;80,53 National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;81,31 National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;861.875 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;846.766 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;759.705 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;799.681 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;789.096 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;710.308 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;751.489 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;744.825 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;668.408 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;707.461 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;634.589 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;680.705 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;614.694 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;92,78 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;93,19 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;93,5 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;87,19 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;87,96 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;87,98 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;83,55 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;83,53 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;80,39 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;80,91 National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;21.274 National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;27.805 National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;94.073 National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;20.368 National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;26.728 National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;90.671 National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;19.682 National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;25.470 National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;85.867 National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;24.426 National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;82.014 National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;23.579 National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;79.521 National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;95,74 National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;96,13 National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;96,38 National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;92,52 National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;91,6 National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;91,28 National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;87,85 National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;87,18 National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;84,8 National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;84,53 National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;876.949 National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;873.692 National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;861.639 National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIV;814.659 National Total;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QII;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QI;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIV;813.113 National Total;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QII;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QI;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIV;796.865 National Total;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QII;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QI;767.484 National Total;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QII;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QI;751.794 National Total;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;733.651 National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;724.273 National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;704.836 National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;699.781 National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" National Total;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,9 National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,07 National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,48 National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;87,84 National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,25 National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;83,97 National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;84,06 National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;80,67 National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;81,22 National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;859.355 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;832.620 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;764.014 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;797.673 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;773.929 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;704.637 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;730.155 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;663.810 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;697.930 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;639.048 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;670.420 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;617.075 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;92,82 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;92,95 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;92,23 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;87,69 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;86,88 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;83,82 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;83,64 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;80,52 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;80,77 National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;17.594 National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;41.072 National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;97.625 National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;16.986 National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;39.184 National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;92.228 National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;37.329 National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;87.984 National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;35.721 National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;85.225 National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;34.416 National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;82.706 National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;96,54 National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;95,4 National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;94,47 National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;90,89 National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;90,12 National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;86,97 National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;87,3 National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;83,79 National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;84,72 National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;124.549 National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;116.998 National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;125.748 National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QI;122.442 National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QI;115.037 National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QI;119.746 National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QII;119.929 National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QII;113.082 National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QII;117.857 National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;118.092 National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;111.610 National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;116.016 National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;116.475 National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;110.232 National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;114.126 National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,31 National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,32 National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,23 National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,29 National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,65 National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,72 National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,82 National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,39 National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,26 National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,52 National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,22 National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,76 National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;116.252 National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;89.900 National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;114.291 National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;88.368 National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;111.916 National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;86.777 National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;110.189 National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;85.631 National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;108.663 National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;84.625 National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,31 National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,3 National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;96,27 National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;96,53 National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;94,78 National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;95,25 National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;93,47 National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;94,13 National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;8.297 National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;27.098 National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;8.151 National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;26.669 National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;8.013 National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;26.305 National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;7.903 National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;25.979 National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;7.812 National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;25.607 National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;98,24 National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,42 National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;96,58 National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;97,07 National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;95,25 National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;95,87 National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;94,15 National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;94,5 National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;125.746 National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;117.333 National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;113.956 National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QII;123.339 National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QII;115.449 National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QII;112.601 National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIII;121.490 National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIII;113.946 National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIII;111.102 National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;119.297 National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;112.122 National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;109.297 National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;110.064 National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;107.283 National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 National Total;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,09 National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,39 National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,81 National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,62 National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,11 National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,5 National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,87 National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,56 National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,91 National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,8 National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,14 National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;117.702 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;92.334 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;73.717 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;115.409 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;90.772 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;72.663 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;113.675 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;89.553 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;71.705 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;111.618 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;88.101 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;70.739 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;86.453 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;69.483 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,05 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,31 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,57 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;96,58 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;96,99 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;97,27 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;94,83 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;95,42 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;95,96 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;93,63 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;94,26 National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;8.044 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;24.999 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;40.239 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;7.930 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;24.677 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;39.938 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;7.815 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;24.393 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;39.397 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;7.679 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;24.021 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;38.558 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;23.611 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;37.800 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;98,58 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;98,71 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,25 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;97,15 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;97,58 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;97,91 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;95,46 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;96,09 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;95,82 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;94,45 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;93,94 National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;130.132 National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;124.765 National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;119.956 National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIII;127.777 National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIII;122.694 National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIII;117.978 National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIV;123.924 National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIV;119.394 National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIV;114.960 National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;116.989 National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;112.670 National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;115.333 National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;111.210 National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,19 National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,34 National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,35 National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,23 National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,7 National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,84 National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,77 National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,93 National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,44 National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,71 National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;125.390 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;116.697 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;90.074 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;123.085 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;114.694 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;88.484 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;119.321 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;111.607 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;86.341 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;109.334 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;84.652 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;107.792 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;83.598 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,16 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,28 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,23 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;95,16 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;95,64 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;95,86 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;93,69 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;93,98 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;92,37 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;92,81 National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;4.742 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;8.068 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;29.882 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;4.692 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;8.000 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;29.494 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;4.603 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;7.787 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;28.619 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;7.655 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;28.018 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;7.541 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;27.612 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;98,95 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,16 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,7 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;97,07 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;96,52 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;95,77 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;94,88 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;93,76 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;93,47 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;92,4 National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;127.463 National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;123.997 National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;119.747 National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIV;124.148 National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIV;121.155 National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIV;117.016 National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QI;118.849 National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QI;114.737 National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;116.838 National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;113.058 National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;115.212 National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;111.718 National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,4 National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,71 National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,72 National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,85 National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,82 National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,23 National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,41 National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,92 National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,3 National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;123.328 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;115.622 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;88.359 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;120.065 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;112.939 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;86.418 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;110.785 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;84.738 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;108.872 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;83.486 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;107.369 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;82.513 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;97,35 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;97,68 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;97,8 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;95,82 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;95,9 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;94,16 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;94,48 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;92,86 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;93,38 National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;4.135 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;8.375 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;31.388 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;4.083 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;8.216 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;30.598 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;8.064 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;29.999 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;7.966 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;29.572 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;7.843 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;29.205 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;98,74 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;98,1 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;97,48 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;96,29 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;95,57 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;95,12 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;94,21 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;93,65 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;93,05 National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;163.320 National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;151.266 National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;164.940 National Total;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QII;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QI;161.717 National Total;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QII;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QI;149.762 National Total;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QI;161.052 National Total;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QII;159.625 National Total;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QI;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QII;148.171 National Total;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QI;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QII;159.443 National Total;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;158.127 National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;146.961 National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;158.052 National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;156.876 National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;145.782 National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;156.571 National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" National Total;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,02 National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,01 National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;97,64 National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,74 National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,95 National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;96,67 National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;96,82 National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;97,15 National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;95,82 National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;96,05 National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;96,37 National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;94,93 National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;150.543 National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;106.288 National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;149.040 National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;105.181 National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;147.087 National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;103.991 National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;145.695 National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;103.131 National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;144.529 National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;102.326 National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99 National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,96 National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;97,7 National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;97,84 National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;96,78 National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;97,03 National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;96,01 National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;96,27 National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;12.777 National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;44.978 National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;12.677 National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;44.581 National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;12.538 National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;44.180 National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;12.432 National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;43.830 National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;12.347 National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;43.456 National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;99,22 National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,12 National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;98,13 National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,23 National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;97,3 National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;97,45 National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;96,63 National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;96,62 National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;166.450 National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;152.636 National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;150.040 National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QII;164.493 National Total;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QI;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QII;151.161 National Total;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QI;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QII;148.830 National Total;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIII;163.054 National Total;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QII;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QI;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIII;149.932 National Total;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QII;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QI;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIII;147.755 National Total;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QII;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;161.455 National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;148.639 National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;146.511 National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;147.097 National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;144.878 National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 National Total;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,82 National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,03 National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,19 National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;97,96 National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;98,23 National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,48 National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;97 National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;97,38 National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;97,65 National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;96,37 National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;96,56 National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;153.606 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;111.384 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;93.261 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;151.785 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;110.222 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;92.383 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;150.432 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;109.269 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;91.698 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;148.945 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;108.311 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;91.053 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;107.167 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;90.090 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,81 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,96 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,06 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;97,93 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;98,1 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,32 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;96,97 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;97,24 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;97,63 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;96,21 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;96,6 National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;12.844 National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;41.252 National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;56.779 National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;12.708 National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;40.939 National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;56.447 National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;12.622 National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;40.663 National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;56.057 National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;12.510 National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;40.328 National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;55.458 National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;39.930 National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;54.788 National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 National Total;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;98,94 National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,24 National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,42 National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;98,27 National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;98,57 National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,73 National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;97,4 National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;97,76 National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;97,67 National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;96,8 National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;96,49 National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;173.380 National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;162.690 National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;155.017 National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIII;171.583 National Total;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QII;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QI;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIII;161.089 National Total;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QII;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QI;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIII;153.646 National Total;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIV;168.075 National Total;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QII;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QI;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIV;158.391 National Total;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QII;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QI;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIV;151.519 National Total;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;156.573 National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;149.706 National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;155.225 National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;148.479 National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" National Total;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,96 National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,02 National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,12 National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,94 National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;97,36 National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97,74 National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;96,24 National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;96,57 National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;95,41 National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;95,78 National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;166.164 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;148.996 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;105.363 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;164.417 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;147.492 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;104.280 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;161.016 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;145.023 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;102.959 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;143.349 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;101.717 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;142.095 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;100.927 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,95 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,99 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,97 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;96,9 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;97,33 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;97,72 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;96,21 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;96,54 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;95,37 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;95,79 National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;7.216 National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;13.694 National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;49.654 National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;7.166 National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;13.597 National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;49.366 National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;7.059 National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;13.368 National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;48.560 National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;13.224 National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;47.989 National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;13.130 National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;47.552 National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;99,31 National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,29 National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,42 National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;97,82 National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;97,62 National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;97,8 National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;96,57 National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;96,65 National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;95,88 National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;95,77 National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;170.547 National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;162.696 National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;155.216 National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIV;167.898 National Total;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QII;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QI;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIV;160.551 National Total;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QII;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QI;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIV;153.508 National Total;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QII;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QI;158.833 National Total;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QII;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QI;151.765 National Total;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;157.160 National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;150.320 National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;155.826 National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;149.131 National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" National Total;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,45 National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,68 National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,9 National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;97,63 National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,78 National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;96,6 National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;96,85 National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;95,78 National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;96,08 National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;163.975 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;149.747 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;102.151 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;161.397 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;147.739 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;101.131 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;146.137 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;99.937 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;144.590 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;98.954 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;143.354 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;98.189 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;98,43 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;98,66 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;97,59 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;97,83 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;96,56 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;96,87 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;95,73 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;96,12 National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;6.572 National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;12.949 National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;53.065 National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;6.501 National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;12.812 National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;52.377 National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;12.696 National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;51.828 National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;12.570 National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;51.366 National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;12.472 National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;50.942 National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;98,92 National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;98,94 National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;98,7 National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;98,05 National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;97,67 National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;97,07 National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;96,8 National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;96,32 National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;96 National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.758 National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;8.219 National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;8.715 National Total;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QII;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QI;8.715 National Total;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QII;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QI;8.160 National Total;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QI;8.634 National Total;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QII;8.673 National Total;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QI;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QII;8.128 National Total;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QI;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QII;8.600 National Total;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.617 National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;8.088 National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;8.549 National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;8.576 National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;8.046 National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;8.509 National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" National Total;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,51 National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,28 National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;99,07 National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;99,03 National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;98,89 National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;98,68 National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;98,39 National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;98,41 National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;98,1 National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;97,92 National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;97,9 National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;97,64 National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;7.908 National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;5.257 National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;7.866 National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;5.213 National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;7.829 National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;5.187 National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;7.780 National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;5.161 National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;7.743 National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;5.129 National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,47 National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,16 National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;99 National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;98,67 National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;98,38 National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;98,17 National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;97,91 National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;97,57 National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;850 National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;2.962 National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;849 National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;2.947 National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;844 National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;2.941 National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;837 National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;2.927 National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;833 National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;2.917 National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;99,88 National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,49 National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;99,29 National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;99,29 National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;98,47 National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;98,82 National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;98 National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;98,48 National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;8.978 National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;8.170 National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;8.183 National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QII;8.942 National Total;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QI;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QII;8.148 National Total;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QI;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QII;8.155 National Total;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIII;8.878 National Total;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QII;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QI;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIII;8.094 National Total;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QII;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QI;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIII;8.119 National Total;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QII;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;8.830 National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;8.052 National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;8.078 National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;8.012 National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;8.025 National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 National Total;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;99,6 National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,73 National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,66 National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;98,89 National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;99,07 National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;99,22 National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;98,35 National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;98,56 National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;98,72 National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;98,07 National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;98,07 National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;8.143 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;5.493 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;5.426 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;8.108 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;5.475 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;5.402 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;8.050 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;5.435 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;5.375 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;8.004 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;5.402 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;5.344 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;5.377 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;5.309 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;99,57 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;99,67 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,56 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;98,86 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;98,94 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;99,06 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;98,29 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;98,34 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;98,49 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;97,89 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;97,84 National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;835 National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;2.677 National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;2.757 National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;834 National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;2.673 National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;2.753 National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;828 National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;2.659 National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;2.744 National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;826 National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;2.650 National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;2.734 National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;2.635 National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;2.716 National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 National Total;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;99,88 National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,85 National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,85 National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;99,16 National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;99,33 National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;99,53 National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;98,92 National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;98,99 National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;99,17 National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;98,43 National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;98,51 National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;9.297 National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;8.416 National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;8.063 National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIII;9.247 National Total;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QII;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QI;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIII;8.379 National Total;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QII;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QI;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIII;8.025 National Total;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIV;9.198 National Total;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QII;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QI;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIV;8.331 National Total;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QII;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QI;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIV;7.991 National Total;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;8.288 National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;7.932 National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;8.257 National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;7.907 National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" National Total;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,46 National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,56 National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,53 National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;98,94 National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;98,99 National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;99,11 National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;98,48 National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;98,38 National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;98,11 National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;98,07 National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;8.817 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;7.463 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;4.935 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;8.769 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;7.429 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;4.907 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;8.721 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;7.385 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;4.885 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;7.346 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;4.848 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;7.318 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;4.828 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,46 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99,54 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,43 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;98,91 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;98,95 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;98,99 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;98,43 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;98,24 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;98,06 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;97,83 National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;480 National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;953 National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;3.128 National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;478 National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;950 National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;3.118 National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;477 National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;946 National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;3.106 National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;942 National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;3.084 National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;939 National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;3.079 National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;99,58 National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,69 National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,68 National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;99,38 National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;99,27 National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;99,3 National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;98,85 National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;98,59 National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;98,53 National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;98,43 National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;9.311 National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;8.634 National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;8.288 National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIV;9.273 National Total;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QII;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QI;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIV;8.585 National Total;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QII;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QI;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIV;8.247 National Total;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QII;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QI;8.541 National Total;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QII;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QI;8.189 National Total;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;8.509 National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;8.164 National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.459 National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;8.128 National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" National Total;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,59 National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,43 National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,51 National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,92 National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;98,81 National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;98,55 National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;98,5 National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;97,97 National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;98,07 National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;8.889 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;7.774 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;4.950 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;8.854 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;7.726 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;4.920 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;7.683 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;4.881 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;7.654 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;4.861 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;7.608 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;4.840 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,61 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,38 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,39 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,83 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;98,61 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;98,46 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;98,2 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;97,86 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;97,78 National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;422 National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;860 National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;3.338 National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;419 National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;859 National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;3.327 National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;858 National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;3.308 National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;855 National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;3.303 National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;851 National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;3.288 National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;99,29 National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;99,88 National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,67 National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;99,77 National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;99,1 National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;99,42 National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;98,95 National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;98,95 National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;98,5 National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.841 National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.588 National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.783 National Total;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QII;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QI;4.802 National Total;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QII;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QI;4.567 National Total;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QII;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QI;4.762 National Total;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QII;4.787 National Total;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QI;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QII;4.553 National Total;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QI;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QII;4.748 National Total;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QI;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.764 National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.530 National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.724 National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.748 National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.509 National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.704 National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" National Total;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,19 National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,54 National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;99,56 National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;98,88 National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;99,24 National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;99,27 National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;98,41 National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;98,74 National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;98,77 National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;98,08 National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;98,28 National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;98,35 National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;4.389 National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;2.767 National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;4.351 National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;2.752 National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;4.337 National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;2.741 National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;4.316 National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;2.723 National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;4.301 National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;2.709 National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,13 National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,46 National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;98,82 National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;99,06 National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;98,34 National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;98,41 National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;97,99 National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;97,9 National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;452 National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;1.821 National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;451 National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;1.815 National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;450 National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;1.812 National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;448 National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;1.807 National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;447 National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;1.800 National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;99,78 National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,67 National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;99,56 National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;99,51 National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;99,12 National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;99,23 National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;98,89 National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;98,85 National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.911 National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.569 National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.589 National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QII;4.899 National Total;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QI;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QII;4.557 National Total;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QI;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QII;4.582 National Total;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QI;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIII;4.877 National Total;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QII;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QI;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIII;4.539 National Total;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QII;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QI;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.555 National Total;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QII;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QI;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;4.863 National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;4.518 National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.533 National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;4.479 National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;4.510 National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 National Total;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;99,76 National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,74 National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,85 National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;99,31 National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;99,34 National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;99,26 National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;99,02 National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;98,88 National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;98,78 National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;98,03 National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;98,28 National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;4.448 National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;2.855 National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;3.072 National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;4.438 National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;2.846 National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;3.068 National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;4.418 National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;2.833 National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;3.044 National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;4.407 National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;2.817 National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;3.027 National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;2.785 National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;3.009 National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 National Total;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;99,78 National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;99,68 National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,87 National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;99,33 National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;99,23 National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;99,09 National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;99,08 National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;98,67 National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;98,54 National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;97,55 National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;97,95 National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;463 National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;1.714 National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;1.517 National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;461 National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;1.711 National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;1.514 National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;459 National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;1.706 National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;1.511 National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;456 National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;1.701 National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;1.506 National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;1.694 National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;1.501 National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 National Total;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;99,57 National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,82 National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,8 National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;99,14 National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;99,53 National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;99,6 National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;98,49 National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;99,24 National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;99,27 National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;98,83 National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;98,95 National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.952 National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.607 National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.439 National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.937 National Total;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QII;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QI;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.598 National Total;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QII;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QI;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.425 National Total;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QII;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QI;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIV;4.923 National Total;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QII;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QI;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.577 National Total;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QII;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QI;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.403 National Total;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QII;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QI;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;4.538 National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;4.382 National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;4.526 National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;4.373 National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" National Total;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,7 National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,8 National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,68 National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;99,41 National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;99,35 National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;99,19 National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;98,5 National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;98,72 National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;98,24 National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;98,51 National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;4.729 National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;3.999 National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;2.625 National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;4.715 National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;3.992 National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;2.612 National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;4.703 National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;3.975 National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;2.596 National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;3.936 National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;2.581 National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;3.924 National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;2.574 National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,7 National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99,82 National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,5 National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;99,45 National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;99,4 National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;98,9 National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;98,42 National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;98,32 National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;98,12 National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;98,06 National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;223 National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;608 National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;1.814 National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;222 National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;606 National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;1.813 National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;220 National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;602 National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;1.807 National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;602 National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;1.801 National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;602 National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;1.799 National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;99,55 National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,67 National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,94 National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;98,65 National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;99,01 National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;99,61 National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;99,01 National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;99,28 National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;99,01 National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;99,17 National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.063 National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.747 National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.579 National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.047 National Total;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QII;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QI;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.727 National Total;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QII;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QI;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.557 National Total;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QII;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QI;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QII;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QI;4.684 National Total;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QII;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QI;4.537 National Total;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QII;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QI;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;4.669 National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;4.525 National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;4.651 National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.508 National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" National Total;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,68 National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,58 National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,52 National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,67 National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;99,08 National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;98,36 National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;98,82 National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;97,98 National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;98,45 National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" National Total;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;4.860 National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;4.232 National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;2.640 National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;4.845 National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;4.213 National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;2.625 National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;4.171 National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;2.611 National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;4.157 National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;2.603 National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;4.141 National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;2.593 National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,69 National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,55 National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,43 National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,56 National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;98,9 National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;98,23 National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;98,6 National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;97,85 National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;98,22 National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;203 National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;515 National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;1.939 National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;202 National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;514 National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;1.932 National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;513 National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;1.926 National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;512 National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;1.922 National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;510 National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;1.915 National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;99,51 National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;99,81 National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,64 National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;99,61 National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;99,33 National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;99,42 National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;99,12 National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;99,03 National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;98,76 National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" National Total;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;191.980 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;182.747 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;194.451 01 Andalucía;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the first trimester;2022QI;179.191 01 Andalucía;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the first trimester;2021QI;170.464 01 Andalucía;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the first trimester;2020QI;160.827 01 Andalucía;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the second trimester;2022QII;170.279 01 Andalucía;Total ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the second trimester;2021QII;163.254 01 Andalucía;Total ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the second trimester;2020QII;154.596 01 Andalucía;Total ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;163.289 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;157.326 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;149.229 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;157.605 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;152.453 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;143.626 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,34 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,28 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;82,71 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;88,7 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;89,33 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;79,5 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;85,06 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;86,09 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;76,74 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;82,09 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;83,42 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;73,86 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;182.880 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;160.033 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;170.430 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;148.500 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;161.821 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;141.800 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;155.076 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;136.328 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;149.583 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;131.964 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;93,19 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;92,79 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;88,48 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;88,61 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;84,8 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;85,19 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;81,79 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;82,46 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;9.100 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;22.714 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;8.761 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;21.964 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;8.458 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;21.454 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;8.213 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;20.998 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;8.022 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;20.489 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;96,27 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;96,7 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;92,95 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;94,45 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;90,25 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;92,45 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;88,15 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;90,2 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;193.805 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;183.937 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;170.456 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the first trimester;2022QII;181.965 01 Andalucía;Total ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the first trimester;2021QII;174.132 01 Andalucía;Total ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the first trimester;2020QII;162.695 01 Andalucía;Total ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIII;173.042 01 Andalucía;Total ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIII;166.433 01 Andalucía;Total ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIII;156.218 01 Andalucía;Total ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;165.252 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;159.659 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;149.414 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;153.267 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;143.259 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 01 Andalucía;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,89 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,67 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,45 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;89,29 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;90,48 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,65 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;85,27 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;86,8 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,66 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;83,33 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,04 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;184.968 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;163.833 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;137.494 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;173.445 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;154.546 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;130.126 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;164.796 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;147.291 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;124.463 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;157.280 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;141.030 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;118.883 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;135.171 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;113.745 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;93,77 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;94,33 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;94,64 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;89,09 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;89,9 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;90,52 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;85,03 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;86,08 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;86,46 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;82,51 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;82,73 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;8.837 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;20.104 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;32.962 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;8.520 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;19.586 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;32.569 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;8.246 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;19.142 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;31.755 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;7.972 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;18.629 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;30.531 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;18.096 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;29.514 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 01 Andalucía;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;96,41 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,42 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,81 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;93,31 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;95,21 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;96,34 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;90,21 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;92,66 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;92,62 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;90,01 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;89,54 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;198.387 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;192.438 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;184.439 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIII;184.680 01 Andalucía;Total ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIII;179.576 01 Andalucía;Total ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIII;172.836 01 Andalucía;Total ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIV;173.476 01 Andalucía;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIV;169.264 01 Andalucía;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIV;161.934 01 Andalucía;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;161.542 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;154.283 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;156.177 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;149.851 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,09 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;93,32 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;93,71 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;87,44 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;87,96 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;87,8 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;83,94 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;83,65 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;81,16 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;81,25 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;192.820 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;185.602 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;158.194 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;179.295 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;172.919 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;147.240 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;168.292 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;162.787 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;137.272 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;155.269 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;130.438 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;150.057 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;126.510 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;92,99 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;93,17 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;93,08 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;87,28 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;87,71 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;86,77 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;83,66 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;82,45 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;80,85 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;79,97 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;5.567 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;6.836 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;26.245 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;5.385 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;6.657 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;25.596 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;5.184 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;6.477 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;24.662 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;6.273 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;23.845 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;6.120 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;23.341 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;96,73 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;97,38 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;97,53 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;93,12 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;94,75 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;93,97 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;91,76 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;90,86 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;89,53 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;88,94 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;196.005 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;191.941 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;186.659 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIV;181.815 01 Andalucía;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIV;178.257 01 Andalucía;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIV;171.250 01 Andalucía;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the second trimester;2022QI;168.949 01 Andalucía;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the second trimester;2021QI;161.967 01 Andalucía;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;162.311 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;156.533 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;156.603 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;151.687 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,76 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,87 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;91,74 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;88,02 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;86,77 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;84,56 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;83,86 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;81,59 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;81,26 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;191.145 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;182.035 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;162.488 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;177.124 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;168.713 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;148.003 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;159.746 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;139.486 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;153.420 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;134.539 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;147.980 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;130.150 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;92,66 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;92,68 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;91,09 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;87,76 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;85,84 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;84,28 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;82,8 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;81,29 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;80,1 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;4.860 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;9.906 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;24.171 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;4.691 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;9.544 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;23.247 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;9.203 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;22.481 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;8.891 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;21.994 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;8.623 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;21.537 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;96,52 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;96,35 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;96,18 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;92,9 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;93,01 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;89,75 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;90,99 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;87,05 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;89,1 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;147.123 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;142.412 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;149.516 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QI;135.008 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QI;130.754 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QI;118.283 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QII;126.941 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QII;124.144 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QII;112.653 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;120.541 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;118.661 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;107.786 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;115.410 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;114.215 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;102.851 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;91,77 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;91,81 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;79,11 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;86,28 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;87,17 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;75,35 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;81,93 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;83,32 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;72,09 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;78,44 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;80,2 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;68,79 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;141.065 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;129.874 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;129.249 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;118.853 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;121.441 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;112.651 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;115.251 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;107.521 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;110.292 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;103.472 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;91,62 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;91,51 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;86,09 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;86,74 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;81,7 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;82,79 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;78,19 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;79,67 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;6.058 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;12.538 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;5.759 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;11.901 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;5.500 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;11.493 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;5.290 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;11.140 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;5.118 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;10.743 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;95,06 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;94,92 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;90,79 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;91,67 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;87,32 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;88,85 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;84,48 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;85,68 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;148.128 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;142.964 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;132.240 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QII;137.085 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QII;133.738 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QII;124.872 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIII;128.759 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIII;126.519 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIII;118.799 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;121.792 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;120.374 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;112.576 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;114.615 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;107.019 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 01 Andalucía;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,54 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,55 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;94,43 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;86,92 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;88,5 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,84 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;82,22 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;84,2 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;85,13 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;80,17 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;80,93 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;142.325 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;131.460 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;112.454 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;131.554 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;122.661 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;105.398 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;123.469 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;115.801 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;100.022 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;116.723 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;110.055 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;94.762 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;104.720 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;90.023 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;92,43 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;93,31 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;93,73 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;86,75 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;88,09 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;88,94 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;82,01 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;83,72 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;84,27 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;79,66 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;80,05 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;5.803 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;11.504 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;19.786 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;5.531 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;11.077 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;19.474 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;5.290 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;10.718 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;18.777 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;5.069 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;10.319 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;17.814 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;9.895 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;16.996 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;95,31 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;96,29 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,42 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;91,16 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;93,17 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;94,9 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;87,35 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;89,7 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;90,03 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;86,01 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;85,9 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;150.191 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;147.718 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;142.376 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIII;137.304 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIII;135.565 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIII;131.454 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIV;127.585 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIV;126.468 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIV;121.689 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;119.519 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;114.807 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;114.692 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;110.832 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,42 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,77 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,33 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;84,95 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;85,61 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;85,47 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;80,91 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;80,64 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;77,64 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;77,84 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;146.528 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;143.739 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;127.994 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;133.808 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;131.741 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;117.633 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;124.236 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;122.775 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;108.567 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;115.988 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;102.322 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;111.280 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;98.722 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;91,32 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;91,65 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;91,91 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;84,79 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;85,42 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;84,82 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;80,69 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;79,94 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;77,42 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;77,13 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;3.663 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;3.979 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;14.382 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;3.496 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;3.824 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;13.821 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;3.349 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;3.693 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;13.122 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;3.531 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;12.485 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;3.412 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;12.110 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;95,44 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;96,1 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;96,1 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;91,43 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;92,81 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;91,24 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;88,74 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;86,81 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;85,75 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;84,2 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;148.943 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;147.392 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;144.505 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIV;135.996 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIV;134.750 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIV;130.071 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QI;126.183 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QI;121.536 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;120.190 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;116.624 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;114.998 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;112.192 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,31 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,42 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;90,01 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;85,61 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;84,11 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;81,54 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;80,71 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;78,02 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;77,64 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;145.815 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;140.631 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;131.484 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;132.998 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;128.294 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;117.794 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;120.024 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;109.876 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;114.305 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;105.339 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;109.337 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;101.259 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;91,21 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;91,23 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;89,59 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;85,35 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;83,57 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;81,28 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;80,12 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;77,75 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;77,01 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;3.128 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;6.761 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;13.021 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;2.998 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;6.456 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;12.277 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;6.159 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;11.660 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;5.885 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;11.285 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;5.661 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;10.933 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;95,84 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;95,49 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;94,29 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;91,1 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;89,55 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;87,04 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;86,67 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;83,73 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;83,96 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;19.862 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;18.153 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;19.882 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QI;19.456 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QI;17.787 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QI;18.361 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QII;18.973 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QII;17.430 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QII;18.018 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;18.613 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;17.182 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;17.736 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;18.297 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;16.947 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;17.371 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,96 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,98 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,35 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,52 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,02 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,62 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,71 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,65 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,21 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,12 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,36 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,37 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;18.634 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;14.267 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;18.255 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;13.961 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;17.795 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;13.653 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;17.454 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;13.446 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;17.150 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;13.268 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;97,97 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;97,86 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;95,5 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;95,7 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;93,67 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;94,25 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;92,04 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;93 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;1.228 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;3.886 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;1.201 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;3.826 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;1.178 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;3.777 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;1.159 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;3.736 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;1.147 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;3.679 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;97,8 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,46 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;95,93 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;97,2 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;94,38 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;96,14 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;93,4 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;94,67 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;20.184 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;18.444 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;17.010 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QII;19.730 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QII;18.108 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QII;16.800 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIII;19.359 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIII;17.833 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIII;16.553 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;18.866 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;17.448 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;16.208 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;17.060 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;15.870 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,75 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,18 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,77 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,91 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,69 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,31 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,47 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,6 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,29 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,5 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,3 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;18.990 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;15.130 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;11.564 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;18.557 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;14.838 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;11.396 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;18.211 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;14.603 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;11.221 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;17.748 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;14.276 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;11.026 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;13.954 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;10.796 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;97,72 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,07 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,55 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;95,9 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;96,52 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;97,03 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;93,46 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;94,36 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;95,35 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;92,23 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;93,36 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;1.194 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;3.314 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;5.446 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;1.173 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;3.270 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;5.404 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;1.148 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;3.230 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;5.332 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;1.118 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;3.172 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;5.182 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;3.106 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;5.074 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;98,24 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;98,67 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,23 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;96,15 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;97,47 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;97,91 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;93,63 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;95,72 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;95,15 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;93,72 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;93,17 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;21.149 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;19.906 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;18.932 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIII;20.651 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIII;19.497 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIII;18.521 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIV;19.861 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIV;18.851 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIV;17.843 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;18.404 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;17.410 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;18.095 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;17.157 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,65 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,95 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,83 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,91 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,7 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,25 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,45 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,96 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,9 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,62 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;20.397 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;18.830 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;14.494 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;19.909 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;18.428 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;14.134 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;19.135 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;17.799 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;13.584 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;17.376 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;13.242 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;17.091 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;13.057 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;97,61 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;97,87 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;97,52 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;93,81 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;94,52 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;93,72 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;92,28 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;91,36 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;90,76 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;90,09 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;752 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;1.076 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;4.438 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;742 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;1.069 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;4.387 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;726 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;1.052 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;4.259 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;1.028 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;4.168 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;1.004 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;4.100 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;98,67 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,35 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,85 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;96,54 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;97,77 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;95,97 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;95,54 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;93,92 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;93,31 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;92,38 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;20.738 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;19.827 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;19.090 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIV;20.017 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIV;19.200 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIV;18.444 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QI;18.752 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QI;18.006 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;18.377 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;17.716 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;18.072 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;17.491 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,52 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,84 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,62 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,58 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,32 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,69 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,8 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,15 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,62 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;20.069 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;18.565 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;14.847 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;19.360 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;17.965 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;14.308 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;17.543 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;13.951 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;17.188 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;13.719 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;16.911 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;13.543 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;96,47 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;96,77 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;96,37 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;94,5 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;93,97 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;92,58 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;92,4 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;91,09 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;91,22 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;669 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;1.262 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;4.243 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;657 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;1.235 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;4.136 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;1.209 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;4.055 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;1.189 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;3.997 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;1.161 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;3.948 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;98,21 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;97,86 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;97,48 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;95,8 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;95,57 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;94,22 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;94,2 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;92 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;93,05 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;23.644 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;20.947 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;23.731 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QI;23.387 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QI;20.698 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QI;22.878 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QII;23.030 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QII;20.461 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QII;22.628 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;22.807 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;20.272 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;22.420 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;22.574 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;20.084 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;22.119 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,91 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,81 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,41 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,4 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,68 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,35 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;96,46 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,78 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,48 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;95,47 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;95,88 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;93,21 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;21.942 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;15.018 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;21.698 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;14.821 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;21.361 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;14.636 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;21.154 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;14.507 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;20.928 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;14.372 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,89 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,69 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;97,35 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;97,46 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;96,41 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;96,6 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;95,38 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;95,7 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;1.702 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;5.929 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;1.689 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;5.877 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;1.669 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;5.825 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;1.653 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;5.765 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;1.646 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;5.712 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;99,24 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,12 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;98,06 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,25 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;97,12 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;97,23 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;96,71 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;96,34 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;24.120 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;21.315 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;20.003 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QII;23.782 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QII;21.077 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QII;19.829 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIII;23.563 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIII;20.880 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIII;19.680 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;23.237 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;20.642 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;19.447 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;20.404 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;19.194 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 01 Andalucía;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,6 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,88 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,13 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;97,69 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,96 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,39 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;96,34 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;96,84 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;97,22 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;95,73 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;95,96 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;22.387 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;16.353 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;12.613 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;22.073 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;16.161 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;12.477 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;21.862 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;16.007 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;12.373 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;21.559 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;15.823 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;12.250 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;15.628 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;12.087 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,6 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,83 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,92 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;97,65 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;97,88 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,1 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;96,3 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;96,76 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;97,12 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;95,57 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;95,83 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;1.733 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;4.962 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;7.390 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;1.709 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;4.916 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;7.352 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;1.701 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;4.873 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;7.307 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;1.678 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;4.819 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;7.197 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;4.776 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;7.107 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;98,62 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,07 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,49 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;98,15 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;98,21 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,88 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;96,83 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;97,12 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;97,39 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;96,25 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;96,17 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;25.626 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;23.570 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;21.990 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIII;25.311 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIII;23.275 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIII;21.727 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIV;24.621 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIV;22.713 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIV;21.271 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;22.397 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;20.943 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;22.169 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;20.742 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,77 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,75 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,8 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,08 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,36 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,73 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,02 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,24 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;94,06 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,32 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;24.534 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;21.906 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;14.957 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;24.224 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;21.628 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;14.730 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;23.572 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;21.098 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;14.380 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;20.800 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;14.139 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;20.582 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;13.998 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,74 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,73 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,48 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;96,08 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;96,31 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;96,14 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;94,95 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;94,53 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;93,96 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;93,59 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;1.092 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;1.664 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;7.033 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;1.087 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;1.647 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;6.997 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;1.049 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;1.615 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;6.891 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;1.597 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;6.804 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;1.587 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;6.744 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;99,54 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;98,98 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,49 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;96,06 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;97,06 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;97,98 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;95,97 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;96,74 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;95,37 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;95,89 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;24.886 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;23.412 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;21.826 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIV;24.372 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIV;23.007 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIV;21.503 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QI;22.724 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QI;21.203 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;22.457 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;20.973 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;22.252 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;20.787 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,93 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,27 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,52 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;97,06 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,15 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,92 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;96,09 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;95,05 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;95,24 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;23.875 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;21.637 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;15.314 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;23.388 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;21.262 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;15.063 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;20.997 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;14.829 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;20.747 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;14.652 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;20.558 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;14.521 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;97,96 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;98,27 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;98,36 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;97,04 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;96,83 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;95,89 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;95,68 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;95,01 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;94,82 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;1.011 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;1.775 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;6.512 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;984 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;1.745 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;6.440 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;1.727 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;6.374 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;1.710 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;6.321 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;1.694 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;6.266 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;97,33 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;98,31 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;98,89 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;97,3 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;97,88 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;96,34 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;97,07 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;95,44 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;96,22 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;900 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;825 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;891 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QI;896 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QI;816 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QI;877 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QII;892 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QII;812 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QII;873 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;889 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;805 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;868 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;885 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;801 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;866 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,56 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,91 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;98,43 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;99,11 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;98,42 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;97,98 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;98,78 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;97,58 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;97,42 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;98,33 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;97,09 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;97,19 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;825 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;585 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;821 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;577 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;818 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;574 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;815 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;569 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;811 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;567 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,52 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,63 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;99,15 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;98,12 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;98,79 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;97,26 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;98,3 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;96,92 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;75 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;240 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;75 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;239 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;74 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;238 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;74 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;236 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;74 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;234 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,58 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;98,67 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;99,17 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;98,67 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;98,33 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;98,67 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;97,5 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;908 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;808 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;795 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QII;905 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QII;804 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QII;788 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIII;902 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIII;797 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIII;787 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;898 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;791 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;785 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;790 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;778 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 01 Andalucía;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;99,67 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,5 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,12 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;99,34 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;98,64 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,99 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;98,9 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;97,9 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;98,74 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;97,77 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;97,86 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;837 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;599 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;556 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;834 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;596 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;550 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;831 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;591 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;549 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;827 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;587 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;548 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;586 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;542 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;99,64 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;99,5 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,92 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;99,28 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;98,66 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,74 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;98,81 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;98 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;98,56 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;97,83 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;97,48 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;71 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;209 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;239 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;71 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;208 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;238 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;71 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;206 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;238 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;71 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;204 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;237 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;204 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;236 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,52 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,58 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;98,56 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;99,58 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;97,61 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;99,16 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;97,61 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;98,74 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;981 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;850 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;776 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIII;975 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIII;845 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIII;771 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIV;970 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIV;838 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIV;769 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;833 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;761 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;832 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;758 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,39 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,41 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,36 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;98,88 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;98,59 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;99,1 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;98 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;98,07 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;97,88 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;97,68 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;940 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;769 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;506 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;934 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;764 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;502 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;929 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;757 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;501 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;752 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;495 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;751 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;493 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,36 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99,35 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,21 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;98,83 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;98,44 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;99,01 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;97,79 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;97,83 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;97,66 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;97,43 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;41 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;81 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;270 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;41 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;81 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;269 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;41 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;81 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;268 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;81 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;266 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;81 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;265 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,63 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;99,26 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;98,52 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;98,15 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;989 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;890 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;840 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIV;982 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIV;880 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIV;834 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QI;877 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QI;824 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;875 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;822 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;871 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;819 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,29 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,88 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,29 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,54 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;98,1 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;98,31 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;97,86 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;97,87 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;97,5 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;954 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;812 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;574 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;947 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;802 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;569 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;799 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;561 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;798 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;560 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;794 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;558 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,27 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;98,77 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,13 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,4 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;97,74 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;98,28 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;97,56 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;97,78 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;97,21 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;35 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;78 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;266 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;35 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;78 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;265 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;78 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;263 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;77 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;262 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;77 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;261 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,62 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,87 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;98,72 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;98,5 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;98,72 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;98,12 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;451 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;410 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;431 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QI;444 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QI;409 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QI;428 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QII;443 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QII;407 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QII;424 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;439 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;406 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;419 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;439 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;406 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;419 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,45 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,76 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;99,3 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;98,23 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;99,27 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;98,38 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;97,34 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;99,02 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;97,22 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;97,34 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;99,02 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;97,22 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;414 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;289 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;407 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;288 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;406 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;286 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;402 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;285 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;402 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;285 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,31 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,65 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;98,07 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;98,96 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;97,1 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;98,62 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;97,1 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;98,62 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;37 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;121 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;37 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;121 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;37 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;121 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;37 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;121 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;37 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;121 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;100 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;465 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;406 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;408 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QII;463 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QII;405 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QII;406 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIII;459 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIII;404 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIII;399 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;459 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;404 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;398 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;398 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;398 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 01 Andalucía;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;99,57 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,75 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,51 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;98,71 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;99,51 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,79 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;98,71 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;99,51 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;97,55 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;98,03 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;97,55 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;429 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;291 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;307 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;427 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;290 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;305 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;423 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;289 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;298 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;423 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;289 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;297 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;283 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;297 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;99,53 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;99,66 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,35 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;98,6 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;99,31 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;97,07 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;98,6 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;99,31 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;96,74 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;97,25 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;96,74 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;36 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;115 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;101 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;36 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;115 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;101 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;36 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;115 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;101 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;36 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;115 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;101 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;115 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;101 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;100 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;440 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;394 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;365 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIII;439 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIII;394 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIII;363 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIV;439 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIV;394 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIV;362 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;389 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;362 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;389 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;362 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,77 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,45 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;99,77 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;100 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;99,18 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;98,73 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;99,18 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;98,73 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;99,18 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;421 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;358 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;243 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;420 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;358 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;241 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;420 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;358 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;240 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;353 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;240 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;353 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;240 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,76 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,18 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;99,76 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;100 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;98,77 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;98,6 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;98,77 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;98,6 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;98,77 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;19 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;36 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;122 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;19 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;36 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;122 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;19 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;36 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;122 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;36 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;122 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;36 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;122 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;100 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;100 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;449 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;420 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;398 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIV;448 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIV;420 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIV;398 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QI;413 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QI;398 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;412 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;398 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;410 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;398 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,78 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;100 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;100 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,33 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;100 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;98,1 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;100 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;97,62 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;100 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;432 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;390 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;269 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;431 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;390 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;269 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;383 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;269 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;382 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;269 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;380 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;269 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,77 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;100 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,21 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;100 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;97,95 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;100 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;97,44 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;100 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;17 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;30 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;129 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;17 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;30 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;129 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;30 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;129 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;30 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;129 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;30 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;129 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;100 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 01 Andalucía;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;32.517 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;31.714 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;33.323 02 Aragón;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the first trimester;2022QI;30.921 02 Aragón;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the first trimester;2021QI;30.281 02 Aragón;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the first trimester;2020QI;30.202 02 Aragón;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the second trimester;2022QII;29.638 02 Aragón;Total ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the second trimester;2021QII;29.290 02 Aragón;Total ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the second trimester;2020QII;29.231 02 Aragón;Total ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;28.656 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;28.527 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;28.410 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;27.914 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;27.851 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;27.662 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,09 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,48 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;90,63 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,15 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,36 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;87,72 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,13 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,95 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,26 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;85,84 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87,82 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,01 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;31.562 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;28.602 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;29.993 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;27.268 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;28.740 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;26.338 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;27.784 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;25.632 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;27.051 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;25.024 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;95,03 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;95,34 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;91,06 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;92,08 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;88,03 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;89,62 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;85,71 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;87,49 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;955 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;3.112 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;928 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;3.013 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;898 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;2.952 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;872 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;2.895 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;863 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;2.827 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;97,17 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;96,82 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;94,03 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;94,86 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;91,31 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;93,03 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;90,37 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;90,84 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;32.386 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;31.738 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;31.357 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the first trimester;2022QII;30.833 02 Aragón;Total ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the first trimester;2021QII;30.488 02 Aragón;Total ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the first trimester;2020QII;30.222 02 Aragón;Total ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIII;29.661 02 Aragón;Total ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIII;29.548 02 Aragón;Total ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIII;29.291 02 Aragón;Total ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;28.767 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;28.703 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;28.434 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;27.776 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;27.540 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 02 Aragón;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,2 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,06 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,38 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,59 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,1 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,41 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,83 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,44 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,68 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,52 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87,83 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;31.460 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;28.795 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;26.296 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;29.946 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;27.600 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;25.255 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;28.800 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;26.726 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;24.434 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;27.923 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;25.950 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;23.707 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;25.088 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;22.939 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 02 Aragón;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;95,19 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;95,85 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;96,04 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;91,54 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;92,81 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;92,92 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;88,76 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;90,12 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;90,15 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;87,13 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;87,23 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;926 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;2.943 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;5.061 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;887 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;2.888 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;4.967 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;861 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;2.822 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;4.857 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;844 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;2.753 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;4.727 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;2.688 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;4.601 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 02 Aragón;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;95,79 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;98,13 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,14 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;92,98 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;95,89 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;95,97 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;91,14 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;93,54 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;93,4 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;91,34 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;90,91 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;32.595 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;32.406 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;31.952 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIII;30.887 02 Aragón;Total ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIII;30.934 02 Aragón;Total ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIII;30.578 02 Aragón;Total ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIV;29.699 02 Aragón;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIV;29.757 02 Aragón;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIV;29.383 02 Aragón;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;28.711 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;28.390 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;27.990 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;27.794 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;94,76 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,46 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,7 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,12 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,83 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,96 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,6 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,85 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,37 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;86,99 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;32.023 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;31.562 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;28.457 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;30.337 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;30.108 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;27.155 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;29.161 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;28.956 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;26.050 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;27.928 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;25.151 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;27.222 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;24.613 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;94,74 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;95,39 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;95,42 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;91,06 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;91,74 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;91,54 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;88,49 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;88,38 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;86,25 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;86,49 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;572 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;844 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;3.495 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;550 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;826 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;3.423 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;538 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;801 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;3.333 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;783 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;3.239 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;768 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;3.181 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;96,15 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;97,87 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;97,94 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;94,06 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;94,91 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;95,36 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;92,77 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;92,68 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;91 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;91,02 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;32.270 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;32.378 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;31.981 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIV;30.801 02 Aragón;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIV;30.894 02 Aragón;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIV;30.395 02 Aragón;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the second trimester;2022QI;29.673 02 Aragón;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the second trimester;2021QI;29.261 02 Aragón;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;28.711 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;28.490 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;27.904 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;27.842 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,45 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,42 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,04 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,65 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,49 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,67 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,08 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,18 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,06 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;31.801 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;31.393 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;28.819 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;30.341 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;29.931 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;27.326 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;28.733 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;26.292 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;27.796 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;25.571 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;27.006 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;24.978 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;95,41 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;95,34 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;94,82 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;91,53 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;91,23 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;88,54 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;88,73 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;86,03 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;86,67 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;469 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;985 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;3.162 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;460 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;963 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;3.069 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;940 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;2.969 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;915 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;2.919 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;898 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;2.864 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;98,08 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;97,77 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;97,06 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;95,43 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;93,9 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;92,89 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;92,31 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;91,17 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;90,58 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;23.867 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;23.661 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;24.619 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QI;22.370 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QI;22.301 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QI;21.748 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QII;21.229 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QII;21.411 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QII;20.891 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;20.332 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;20.725 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;20.156 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;19.659 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;20.107 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;19.489 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,73 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,25 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;88,34 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;88,95 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;90,49 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,86 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;85,19 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;87,59 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;81,87 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;82,37 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,98 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;79,16 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;23.328 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;22.084 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;21.851 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;20.807 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;20.735 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;19.964 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;19.860 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;19.323 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;19.195 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;18.760 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;93,67 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;94,22 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;88,88 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;90,4 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;85,13 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;87,5 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;82,28 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;84,95 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;539 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;1.577 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;519 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;1.494 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;494 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;1.447 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;472 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;1.402 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;464 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;1.347 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;96,29 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;94,74 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;91,65 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;91,76 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;87,57 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;88,9 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;86,09 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;85,42 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;23.699 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;23.589 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;23.272 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QII;22.283 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QII;22.441 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QII;22.232 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIII;21.185 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIII;21.577 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIII;21.363 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;20.374 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;20.804 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;20.574 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;19.963 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;19.768 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 02 Aragón;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,03 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,13 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,53 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;89,39 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;91,47 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,8 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;85,97 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,19 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,41 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;84,63 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,94 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;23.195 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;22.123 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;20.462 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;21.814 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;21.016 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;19.488 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;20.739 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;20.204 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;18.718 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;19.943 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;19.488 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;18.035 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;18.692 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;17.325 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;94,05 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;95 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;95,24 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;89,41 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;91,33 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;91,48 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;85,98 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;88,09 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;88,14 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;84,49 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;84,67 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;504 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;1.466 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;2.810 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;469 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;1.425 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;2.744 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;446 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;1.373 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;2.645 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;431 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;1.316 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;2.539 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;1.271 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;2.443 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;93,06 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,2 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;97,65 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;88,49 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;93,66 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;94,13 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;85,52 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;89,77 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;90,36 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;86,7 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;86,94 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;23.815 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;23.900 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;23.754 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIII;22.186 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIII;22.507 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIII;22.445 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIV;21.124 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIV;21.425 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIV;21.333 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;20.486 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;20.431 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;19.826 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;19.887 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,16 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;94,17 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,49 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;88,7 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;89,64 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,81 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;85,72 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,01 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;82,95 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;83,72 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;23.471 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;23.469 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;22.033 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;21.862 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;22.091 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;20.783 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;20.810 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;21.031 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;19.738 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;20.106 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;18.908 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;19.460 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;18.411 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;93,14 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;94,13 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;94,33 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;88,66 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;89,61 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;89,58 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;85,67 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;85,82 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;82,92 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;83,56 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;344 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;431 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;1.721 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;324 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;416 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;1.662 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;314 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;394 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;1.595 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;380 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;1.523 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;366 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;1.476 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;94,19 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;96,52 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;96,57 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;91,28 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;91,42 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;92,68 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;88,17 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;88,5 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;84,92 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;85,76 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;23.555 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;23.887 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;23.788 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIV;22.182 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIV;22.486 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIV;22.278 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QI;21.363 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QI;21.228 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;20.490 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;20.536 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;19.751 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;19.961 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,17 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,13 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,65 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;89,43 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,24 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;85,78 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;86,33 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;82,69 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;83,91 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;23.283 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;23.308 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;22.288 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;21.918 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;21.925 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;20.853 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;20.819 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;19.879 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;19.969 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;19.221 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;19.246 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;18.688 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;94,14 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;94,07 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;93,56 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;89,32 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;89,19 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;85,67 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;86,24 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;82,57 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;83,85 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;272 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;579 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;1.500 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;264 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;561 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;1.425 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;544 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;1.349 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;521 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;1.315 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;505 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;1.273 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;97,06 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;96,89 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;95 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;93,96 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;89,93 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;89,98 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;87,67 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;87,22 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;84,87 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.517 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.272 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.525 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QI;3.464 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QI;3.232 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QI;3.408 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QII;3.385 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QII;3.176 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QII;3.353 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.335 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.132 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.309 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.301 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.106 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.261 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,49 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,78 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,68 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,25 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,07 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,12 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,83 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,72 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;93,87 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,86 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,93 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,51 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;3.378 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;2.761 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;3.329 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;2.729 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;3.253 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;2.678 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;3.205 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;2.638 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;3.172 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;2.617 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,55 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,84 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;96,3 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;96,99 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;94,88 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;95,55 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;93,9 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;94,78 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;139 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;511 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;135 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;503 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;132 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;498 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;130 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;494 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;129 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;489 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;97,12 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,43 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;94,96 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;97,46 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;93,53 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;96,67 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;92,81 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;95,69 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.505 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.320 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.307 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QII;3.431 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QII;3.264 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QII;3.257 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.391 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.219 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.228 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.343 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.181 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.183 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;3.138 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;3.133 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,89 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,31 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,49 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,75 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,96 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,61 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,38 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,81 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,25 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,52 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,74 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;3.374 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;2.860 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;2.482 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;3.303 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;2.810 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;2.444 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;3.264 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;2.772 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;2.417 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;3.216 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;2.739 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;2.386 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;2.703 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;2.350 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;97,9 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,25 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,47 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;96,74 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;96,92 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;97,38 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;95,32 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;95,77 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;96,13 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;94,51 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;94,68 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;131 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;460 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;825 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;128 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;454 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;813 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;127 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;447 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;811 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;127 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;442 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;797 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;435 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;783 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;97,71 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;98,7 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,55 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;96,95 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;97,17 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,3 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;96,95 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;96,09 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;96,61 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;94,57 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;94,91 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.495 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.474 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.350 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.445 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.427 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.317 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.371 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.375 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.263 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;3.317 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;3.206 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;3.279 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;3.171 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,57 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,65 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,01 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,45 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;97,15 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97,4 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,48 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,7 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;94,39 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,66 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;3.429 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;3.345 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;2.767 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;3.380 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;3.299 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;2.738 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;3.306 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;3.250 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;2.697 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;3.193 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;2.652 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;3.156 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;2.622 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,57 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,62 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,95 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;96,41 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;97,16 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;97,47 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;95,46 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;95,84 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;94,35 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;94,76 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;66 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;129 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;583 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;65 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;128 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;579 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;65 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;125 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;566 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;124 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;554 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;123 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;549 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;98,48 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,22 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,31 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;98,48 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;96,9 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;97,08 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;96,12 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;95,03 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;95,35 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;94,17 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.457 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.421 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.306 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.404 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.380 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.257 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QI;3.325 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QI;3.211 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;3.278 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;3.162 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.240 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.125 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,47 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,8 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,52 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;97,19 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,13 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,82 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,64 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;94,71 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,53 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;3.403 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;3.280 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;2.784 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;3.350 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;3.241 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;2.744 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;3.189 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;2.712 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;3.143 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;2.671 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;3.106 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;2.639 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;98,44 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;98,81 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;98,56 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;97,23 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;97,41 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;95,82 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;95,94 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;94,7 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;94,79 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;54 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;141 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;522 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;54 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;139 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;513 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;136 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;499 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;135 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;491 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;134 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;486 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;98,58 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;98,28 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;96,45 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;95,59 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;95,74 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;94,06 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;95,04 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;93,1 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.758 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.429 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.808 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QI;4.714 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QI;4.397 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QI;4.684 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QII;4.652 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QII;4.353 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QII;4.625 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.620 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.321 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.585 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.585 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.291 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.553 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,08 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,28 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;97,42 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,77 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;98,28 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;96,19 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;97,1 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;97,56 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;95,36 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;96,36 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;96,88 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;94,7 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;4.514 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;3.506 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;4.473 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;3.481 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;4.413 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;3.446 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;4.383 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;3.422 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;4.348 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;3.399 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,09 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,29 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;97,76 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;98,29 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;97,1 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;97,6 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;96,32 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;96,95 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;244 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;923 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;241 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;916 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;239 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;907 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;237 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;899 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;237 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;892 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;98,77 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,24 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;97,95 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,27 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;97,13 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;97,4 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;97,13 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;96,64 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.802 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.480 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.435 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QII;4.740 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QII;4.434 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QII;4.390 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIII;4.709 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIII;4.404 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.359 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;4.674 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;4.373 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.337 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;4.332 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;4.300 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 02 Aragón;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,71 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,97 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,99 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;98,06 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;98,3 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,29 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;97,33 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;97,61 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;97,79 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;96,7 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;96,96 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;4.545 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;3.561 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;3.124 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;4.484 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;3.523 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;3.095 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;4.455 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;3.500 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;3.073 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;4.422 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;3.476 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;3.061 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;3.447 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;3.039 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,66 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,93 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,07 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;98,02 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;98,29 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,37 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;97,29 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;97,61 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;97,98 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;96,8 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;97,28 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;257 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;919 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;1.311 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;256 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;911 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;1.295 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;254 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;904 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;1.286 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;252 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;897 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;1.276 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;885 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;1.261 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;99,61 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,13 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,78 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;98,83 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;98,37 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,09 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;98,05 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;97,61 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;97,33 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;96,3 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;96,19 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.899 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.672 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.501 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.873 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.641 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.471 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIV;4.821 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.601 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.444 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;4.555 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;4.411 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;4.533 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;4.394 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,47 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,34 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,33 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;98,41 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;98,48 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;98,73 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;97,5 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;98 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;97,02 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;97,62 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;4.749 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;4.421 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;3.425 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;4.724 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;4.392 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;3.404 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;4.674 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;4.352 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;3.387 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;4.308 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;3.363 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;4.286 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;3.352 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,47 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99,34 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,39 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;98,42 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;98,44 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;98,89 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;97,44 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;98,19 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;96,95 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;97,87 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;150 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;251 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;1.076 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;149 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;249 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;1.067 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;147 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;249 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;1.057 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;247 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;1.048 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;247 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;1.042 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;99,33 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,2 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,16 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;98 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;99,2 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;98,23 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;98,41 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;97,4 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;98,41 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;96,84 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.865 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.702 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.536 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIV;4.822 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.663 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.510 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QI;4.624 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QI;4.473 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;4.582 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;4.443 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;4.554 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.409 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,12 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,17 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,43 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,34 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;98,61 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;97,45 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;97,95 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;96,85 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;97,2 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;4.733 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;4.473 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;3.501 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;4.691 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;4.436 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;3.484 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;4.400 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;3.456 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;4.359 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;3.434 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;4.331 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;3.408 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,11 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,17 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,51 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,37 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;98,71 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;97,45 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;98,09 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;96,83 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;97,34 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;132 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;229 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;1.035 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;131 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;227 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;1.026 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;224 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;1.017 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;223 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;1.009 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;223 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;1.001 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;99,24 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;99,13 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,13 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;97,82 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,26 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;97,38 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;97,49 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;97,38 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;96,71 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;252 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;237 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;256 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QI;251 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QI;236 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QI;247 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QII;250 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QII;235 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QII;247 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;247 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;235 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;245 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;247 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;235 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;244 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,6 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,58 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,48 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;99,21 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;99,16 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;96,48 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;98,02 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;99,16 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;95,7 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;98,02 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;99,16 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;95,31 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;232 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;175 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;231 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;175 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;230 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;174 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;227 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;174 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;227 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;174 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,57 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;100 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;99,14 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;99,43 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;97,84 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;99,43 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;97,84 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;99,43 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;20 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;62 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;20 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;61 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;20 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;61 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;20 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;61 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;20 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;61 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,39 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,39 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;98,39 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;98,39 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;254 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;235 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;227 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QII;253 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QII;235 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QII;227 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIII;250 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIII;235 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIII;225 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;250 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;234 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;224 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;233 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;223 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 02 Aragón;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;99,61 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;98,43 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;100 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;99,12 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;98,43 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;99,57 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;98,68 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;99,15 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;98,24 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;234 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;174 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;156 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;233 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;174 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;156 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;230 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;174 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;154 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;230 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;173 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;153 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;173 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;153 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;99,57 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;98,29 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;100 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,72 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;98,29 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;99,43 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;98,08 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;99,43 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;98,08 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;20 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;61 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;71 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;20 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;61 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;71 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;20 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;61 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;71 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;20 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;61 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;71 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;60 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;70 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;98,36 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;98,59 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;264 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;244 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;233 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIII;261 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIII;244 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIII;231 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIV;261 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIV;243 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIV;229 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;241 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;228 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;240 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;228 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,86 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,14 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;98,86 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;99,59 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;98,28 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;98,77 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;97,85 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;98,36 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;97,85 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;256 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;223 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;164 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;253 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;223 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;162 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;253 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;222 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;160 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;221 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;160 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;220 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;160 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,83 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,78 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;98,83 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;99,55 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;97,56 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;99,1 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;97,56 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;98,65 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;97,56 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;8 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;21 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;69 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;8 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;21 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;69 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;8 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;21 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;69 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;20 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;68 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;20 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;68 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;95,24 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;98,55 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;95,24 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;98,55 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;260 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;248 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;237 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIV;260 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIV;247 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIV;236 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QI;244 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QI;235 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;244 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;235 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;242 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;234 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,6 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,58 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,39 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;99,16 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;98,39 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;99,16 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;97,58 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;98,73 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;253 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;228 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;174 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;253 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;227 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;173 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;224 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;173 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;224 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;173 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;222 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;172 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,56 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,43 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,25 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;99,43 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;98,25 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;99,43 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;97,37 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;98,85 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;7 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;20 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;63 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;7 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;20 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;63 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;20 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;62 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;20 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;62 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;20 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;62 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,41 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;98,41 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;98,41 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;123 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;115 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;115 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QI;122 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QI;115 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QI;115 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QII;122 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QII;115 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QII;115 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;122 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;114 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;115 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;122 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;112 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;115 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,19 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;100 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;100 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;99,19 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;100 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;100 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;99,19 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;99,13 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;100 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;99,19 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;97,39 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;100 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;110 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;76 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;109 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;76 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;109 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;76 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;109 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;75 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;109 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;74 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,09 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;100 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;99,09 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;100 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;99,09 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;98,68 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;99,09 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;97,37 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;13 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;39 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;13 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;39 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;13 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;39 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;13 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;39 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;13 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;38 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;97,44 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;126 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;114 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;116 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QII;126 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QII;114 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QII;116 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIII;126 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIII;113 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIII;116 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;126 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;111 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;116 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;110 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;116 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 02 Aragón;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;100 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;100 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;99,12 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;100 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;100 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;97,37 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;100 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;96,49 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;100 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;112 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;77 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;72 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;112 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;77 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;72 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;112 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;76 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;72 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;112 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;74 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;72 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;73 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;72 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;100 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;98,7 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;100 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;100 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;96,1 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;100 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;94,81 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;100 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;14 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;37 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;44 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;14 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;37 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;44 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;14 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;37 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;44 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;14 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;37 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;44 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;37 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;44 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;100 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;122 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;116 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;114 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIII;122 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIII;115 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIII;114 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIV;122 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIV;113 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIV;114 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;112 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;114 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;112 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;114 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;100 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,14 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;100 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;100 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;97,41 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;100 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;96,55 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;100 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;96,55 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;100 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;118 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;104 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;68 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;118 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;103 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;68 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;118 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;101 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;68 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;100 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;68 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;100 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;68 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;100 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99,04 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;100 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;97,12 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;100 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;96,15 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;100 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;96,15 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;100 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;4 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;12 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;46 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;4 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;12 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;46 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;4 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;12 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;46 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;12 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;46 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;12 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;46 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;100 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;100 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;133 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;120 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;114 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIV;133 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIV;118 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIV;114 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QI;117 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QI;114 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;117 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;114 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;117 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;113 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,33 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;100 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;97,5 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;100 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;97,5 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;100 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;97,5 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;99,12 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;129 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;104 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;72 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;129 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;102 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;72 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;101 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;72 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;101 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;72 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;101 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;71 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;98,08 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;97,12 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;100 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;97,12 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;100 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;97,12 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;98,61 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;4 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;16 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;42 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;4 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;16 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;42 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;16 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;42 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;16 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;42 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;16 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;42 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;100 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 02 Aragón;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;24.026 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;23.402 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;24.500 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the first trimester;2022QI;22.763 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the first trimester;2021QI;22.239 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the first trimester;2020QI;22.090 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the second trimester;2022QII;21.761 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the second trimester;2021QII;21.463 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the second trimester;2020QII;21.448 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;21.033 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;20.878 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;20.840 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;20.386 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;20.309 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;20.228 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,74 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,03 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;90,16 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;90,57 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;91,71 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;87,54 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,54 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,21 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,06 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,85 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,78 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,56 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;22.873 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;20.307 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;21.649 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;19.229 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;20.696 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;18.508 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;19.997 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;17.981 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;19.380 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;17.480 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;94,65 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;94,69 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;90,48 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;91,14 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;87,43 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;88,55 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;84,73 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;86,08 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;1.153 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;3.095 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;1.114 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;3.010 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;1.065 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;2.955 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;1.036 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;2.897 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;1.006 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;2.829 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;96,62 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;97,25 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;92,37 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;95,48 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;89,85 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;93,6 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;87,25 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;91,41 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;23.955 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;23.336 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;22.988 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the first trimester;2022QII;22.724 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the first trimester;2021QII;22.342 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the first trimester;2020QII;22.216 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIII;21.869 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIII;21.636 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIII;21.523 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;21.052 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;20.948 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;20.826 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;20.214 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;20.109 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 03 Asturias, Principado de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,86 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,74 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,64 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,29 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,72 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,63 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,88 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,77 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,6 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,62 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87,48 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;22.824 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;20.233 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;18.009 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;21.629 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;19.291 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;17.316 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;20.806 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;18.645 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;16.729 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;20.021 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;18.029 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;16.154 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;17.372 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;15.577 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;94,76 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;95,34 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;96,15 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;91,16 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;92,15 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;92,89 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;87,72 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;89,11 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;89,7 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;85,86 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;86,5 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;1.131 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;3.103 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;4.979 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;1.095 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;3.051 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;4.900 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;1.063 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;2.991 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;4.794 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;1.031 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;2.919 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;4.672 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;2.842 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;4.532 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;96,82 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;98,32 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,41 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;93,99 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;96,39 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;96,28 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;91,16 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;94,07 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;93,83 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;91,59 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;91,02 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;24.276 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;24.075 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;23.579 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIII;22.946 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIII;22.894 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIII;22.528 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIV;21.779 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIV;21.832 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIV;21.530 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;20.986 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;20.733 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;20.359 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;20.238 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;94,52 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,09 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,54 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,71 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;90,68 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,31 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,17 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,93 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,56 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,83 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;23.538 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;23.209 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;20.656 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;22.229 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;22.044 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;19.664 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;21.086 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;21.008 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;18.730 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;20.191 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;18.014 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;19.586 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;17.563 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;94,44 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;94,98 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;95,2 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;89,58 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;90,52 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;90,68 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;87 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;87,21 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;84,39 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;85,03 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;738 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;866 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;2.923 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;717 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;850 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;2.864 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;693 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;824 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;2.800 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;795 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;2.719 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;773 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;2.675 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;97,15 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;98,15 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;97,98 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;93,9 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;95,15 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;95,79 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;91,8 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;93,02 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;89,26 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;91,52 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;24.015 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;24.078 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;23.870 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIV;22.595 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIV;22.721 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIV;22.416 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the second trimester;2022QI;21.732 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the second trimester;2021QI;21.488 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;20.957 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;20.868 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;20.344 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;20.368 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,09 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,36 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,91 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;90,26 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,02 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,04 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,42 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,49 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,33 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;23.341 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;22.849 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;20.721 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;21.943 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;21.542 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;19.342 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;20.606 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;18.494 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;19.868 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;17.927 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;19.276 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;17.483 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;94,01 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;94,28 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;93,34 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;90,18 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;89,25 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;86,95 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;86,52 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;84,36 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;84,37 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;674 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;1.229 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;3.149 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;652 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;1.179 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;3.074 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;1.126 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;2.994 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;1.089 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;2.941 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;1.068 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;2.885 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;96,74 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;95,93 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;97,62 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;91,62 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;95,08 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;88,61 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;93,39 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;86,9 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;91,62 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;18.671 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;18.410 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;19.043 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QI;17.485 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QI;17.295 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QI;16.755 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QII;16.560 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QII;16.582 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QII;16.162 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;15.893 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;16.045 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;15.597 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;15.290 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;15.513 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;15.029 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,65 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,94 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,99 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;88,69 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;90,07 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,87 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;85,12 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;87,15 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;81,9 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;81,89 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,26 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;78,92 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;17.874 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;16.628 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;16.725 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;15.587 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;15.841 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;14.922 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;15.200 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;14.432 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;14.623 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;13.955 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;93,57 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;93,74 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;88,63 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;89,74 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;85,04 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;86,79 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;81,81 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;83,92 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;797 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;1.782 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;760 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;1.708 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;719 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;1.660 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;693 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;1.613 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;667 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;1.558 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;95,36 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;95,85 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;90,21 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;93,15 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;86,95 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;90,52 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;83,69 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;87,43 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;18.561 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;18.319 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;17.995 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QII;17.411 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QII;17.395 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QII;17.266 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIII;16.618 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIII;16.733 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIII;16.608 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;15.861 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;16.084 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;15.948 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;15.424 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;15.277 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,8 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,96 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,95 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;89,53 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;91,34 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,29 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;85,45 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;87,8 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,62 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;84,2 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,9 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;17.765 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;16.528 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;14.857 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;16.648 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;15.652 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;14.191 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;15.885 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;15.043 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;13.628 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;15.158 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;14.455 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;13.073 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;13.859 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;12.520 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;93,71 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;94,7 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;95,52 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;89,42 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;91,02 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;91,73 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;85,33 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;87,46 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;87,99 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;83,85 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;84,27 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;796 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;1.791 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;3.138 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;763 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;1.743 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;3.075 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;733 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;1.690 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;2.980 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;703 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;1.629 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;2.875 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;1.565 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;2.757 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;95,85 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,32 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;97,99 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;92,09 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;94,36 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;94,96 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;88,32 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;90,95 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;91,62 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;87,38 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;87,86 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;18.646 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;18.737 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;18.439 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIII;17.381 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIII;17.608 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIII;17.433 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIV;16.325 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIV;16.641 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIV;16.499 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;15.879 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;15.754 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;15.291 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;15.303 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,22 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;93,97 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,54 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;87,55 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;88,81 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,48 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;84,75 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;85,44 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;81,61 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;82,99 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;18.121 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;18.213 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;16.881 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;16.876 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;17.100 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;15.927 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;15.843 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;16.154 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;15.046 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;15.417 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;14.368 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;14.849 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;13.952 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;93,13 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;93,89 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;94,35 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;87,43 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;88,69 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;89,13 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;84,65 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;85,11 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;81,53 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;82,65 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;525 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;524 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;1.558 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;505 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;508 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;1.506 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;482 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;487 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;1.453 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;462 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;1.386 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;442 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;1.351 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;96,19 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;96,95 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;96,66 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;91,81 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;92,94 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;93,26 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;88,17 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;88,96 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;84,35 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;86,71 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;18.491 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;18.705 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;18.644 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIV;17.137 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIV;17.402 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIV;17.240 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QI;16.490 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QI;16.366 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;15.773 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;15.802 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;15.215 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;15.346 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,68 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,03 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,47 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;88,16 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,78 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;84,33 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;84,76 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;81,34 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;82,31 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;18.027 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;17.857 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;16.948 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;16.695 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;16.600 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;15.610 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;15.735 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;14.801 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;15.051 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;14.279 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;14.512 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;13.869 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;92,61 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;92,96 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;92,11 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;88,12 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;87,33 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;84,29 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;84,25 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;81,27 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;81,83 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;464 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;848 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;1.696 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;442 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;802 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;1.630 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;755 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;1.565 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;722 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;1.523 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;703 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;1.477 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;95,26 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;94,58 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;96,11 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;89,03 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;92,28 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;85,14 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;89,8 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;82,9 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;87,09 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.285 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.133 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.390 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QI;2.238 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QI;2.103 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QI;2.309 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QII;2.193 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QII;2.068 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QII;2.283 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.163 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.038 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.258 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.137 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.015 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.229 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,94 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,59 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,61 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,97 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,95 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,52 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,66 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,55 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,48 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,52 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,47 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;93,26 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;2.146 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;1.601 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;2.100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;1.576 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;2.058 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;1.545 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;2.030 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;1.523 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;2.005 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;1.508 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;97,86 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,44 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;95,9 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;96,5 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;94,59 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;95,13 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;93,43 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;94,19 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;139 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;532 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;138 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;527 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;135 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;523 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;133 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;515 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;132 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;507 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;99,28 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,06 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;97,12 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,31 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;95,68 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;96,8 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;94,96 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;95,3 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.288 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.156 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.139 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QII;2.239 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QII;2.114 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QII;2.114 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.210 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.084 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.092 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.173 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.058 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.069 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;2.007 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;2.045 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,86 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,05 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,83 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,59 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,66 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,8 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,97 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,45 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,73 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,09 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;95,61 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;2.159 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;1.636 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;1.325 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;2.110 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;1.595 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;1.309 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;2.081 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;1.570 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;1.292 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;2.045 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;1.550 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;1.278 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;1.505 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;1.264 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;97,73 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;97,49 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,79 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;96,39 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;95,97 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;97,51 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;94,72 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;94,74 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;96,45 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;91,99 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;95,4 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;129 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;520 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;814 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;129 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;519 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;805 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;129 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;514 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;800 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;128 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;508 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;791 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;502 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;781 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,81 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,89 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;98,85 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,28 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;99,22 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;97,69 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;97,17 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;96,54 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;95,95 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.412 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.321 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.252 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.372 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.287 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.219 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.304 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.218 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.172 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;2.162 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;2.140 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;2.138 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;2.114 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,34 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,54 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,53 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,52 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,56 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,45 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,15 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,03 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,12 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,87 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;2.318 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;2.189 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;1.707 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;2.278 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;2.155 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;1.678 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;2.211 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;2.090 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;1.637 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;2.038 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;1.612 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;2.014 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;1.591 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,27 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,45 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,3 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;95,38 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;95,48 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;95,9 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;93,1 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;94,43 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;92,01 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;93,2 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;94 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;132 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;545 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;94 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;132 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;541 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;93 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;128 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;535 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;124 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;528 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;124 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;523 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,27 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;98,94 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;96,97 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;98,17 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;93,94 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;96,88 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;93,94 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;95,96 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.315 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.299 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.268 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.275 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.261 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.237 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QI;2.214 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QI;2.206 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;2.182 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;2.172 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.156 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.145 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,27 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,35 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,63 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,3 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,27 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,91 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,77 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,78 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,58 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;2.219 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;2.133 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;1.720 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;2.179 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;2.098 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;1.693 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;2.055 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;1.668 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;2.023 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;1.640 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;1.998 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;1.617 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;98,2 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;98,36 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;98,43 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;96,34 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;96,98 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;94,84 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;95,35 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;93,67 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;94,01 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;96 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;166 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;548 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;96 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;163 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;544 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;159 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;538 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;159 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;532 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;158 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;528 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;98,19 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,27 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;95,78 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,18 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;95,78 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;97,08 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;95,18 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;96,35 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.874 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.669 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.874 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QI;2.844 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QI;2.651 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QI;2.834 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QII;2.812 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QII;2.623 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QII;2.812 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.782 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.607 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.794 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.765 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.593 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.779 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,96 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,33 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;98,61 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,84 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;98,28 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;97,84 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;96,8 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;97,68 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;97,22 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;96,21 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;97,15 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;96,69 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;2.675 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;1.953 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;2.646 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;1.941 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;2.619 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;1.916 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;2.590 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;1.903 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;2.576 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;1.894 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,92 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,39 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;97,91 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;98,11 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;96,82 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;97,44 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;96,3 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;96,98 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;199 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;716 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;198 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;710 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;193 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;707 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;192 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;704 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;189 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;699 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;99,5 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,16 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;96,98 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,74 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;96,48 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;98,32 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;94,97 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;97,63 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.900 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.665 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.669 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QII;2.868 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QII;2.637 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QII;2.651 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.836 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.625 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.638 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.814 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.612 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.624 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;2.589 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;2.602 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,9 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,95 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,33 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;97,79 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;98,5 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,84 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;97,03 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;98,01 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;98,31 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;97,15 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;97,49 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;2.714 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;1.935 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;1.693 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;2.685 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;1.910 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;1.682 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;2.655 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;1.900 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;1.675 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;2.634 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;1.892 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;1.669 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;1.876 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;1.659 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,93 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,71 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,35 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;97,83 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;98,19 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,94 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;97,05 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;97,78 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;98,58 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;96,95 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;97,99 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;186 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;730 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;976 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;183 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;727 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;969 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;181 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;725 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;963 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;180 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;720 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;955 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;713 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;943 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;98,39 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,59 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,28 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;97,31 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;99,32 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,67 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;96,77 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;98,63 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;97,85 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;97,67 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;96,62 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.009 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.823 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.701 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.985 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.807 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.689 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.943 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.781 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.672 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;2.753 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;2.652 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;2.738 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;2.634 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,2 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,43 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,56 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;97,81 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;98,51 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;98,93 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;97,52 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;98,19 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;96,99 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;97,52 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;2.903 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;2.627 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;1.940 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;2.880 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;2.611 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;1.931 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;2.838 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;2.586 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;1.919 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;2.558 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;1.906 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;2.545 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;1.892 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,21 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99,39 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,54 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;97,76 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;98,44 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;98,92 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;97,37 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;98,25 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;96,88 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;97,53 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;106 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;196 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;761 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;105 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;196 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;758 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;105 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;195 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;753 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;195 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;746 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;193 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;742 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;99,06 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,61 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;99,06 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;99,49 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;98,95 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;99,49 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;98,03 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;98,47 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;97,5 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.003 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.881 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.767 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.978 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.865 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.748 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QI;2.835 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QI;2.725 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;2.809 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;2.703 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.781 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.688 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,17 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,44 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,31 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,4 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;98,48 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;97,5 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;97,69 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;96,53 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;97,14 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;2.901 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;2.681 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;1.930 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;2.876 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;2.666 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;1.916 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;2.638 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;1.902 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;2.616 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;1.885 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;2.589 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;1.876 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,14 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,44 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,27 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,4 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;98,55 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;97,58 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;97,67 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;96,57 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;97,2 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;102 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;200 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;837 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;102 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;199 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;832 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;197 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;823 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;193 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;818 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;192 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;812 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;99,5 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,4 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;98,5 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,33 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;96,5 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;97,73 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;96 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;97,01 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;134 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;128 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;127 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QI;134 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QI;128 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QI;127 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QII;134 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QII;128 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QII;126 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;133 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;127 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;126 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;133 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;127 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;126 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;99,21 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;99,25 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;99,22 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;99,21 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;99,25 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;99,22 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;99,21 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;120 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;89 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;120 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;89 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;120 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;89 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;119 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;88 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;119 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;88 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;99,17 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;98,88 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;99,17 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;98,88 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;14 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;39 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;14 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;39 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;14 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;39 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;14 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;39 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;14 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;39 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;142 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;134 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;123 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QII;142 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QII;134 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QII;123 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIII;141 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIII;133 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIII;123 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;141 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;133 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;123 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;133 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;123 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;99,3 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;99,25 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;99,3 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;99,25 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;99,25 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;127 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;95 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;90 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;127 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;95 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;90 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;126 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;94 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;90 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;126 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;94 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;90 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;94 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;90 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;99,21 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;98,95 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;99,21 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;98,95 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;98,95 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;15 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;39 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;33 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;15 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;39 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;33 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;15 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;39 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;33 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;15 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;39 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;33 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;39 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;33 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;100 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;147 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;133 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;130 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIII;146 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIII;132 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIII;130 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIV;146 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIV;132 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIV;130 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;132 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;130 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;132 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;130 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,32 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,25 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;99,32 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;99,25 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;99,25 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;99,25 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;138 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;125 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;87 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;137 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;124 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;87 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;137 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;124 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;87 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;124 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;87 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;124 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;87 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,28 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99,2 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;99,28 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;99,2 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;99,2 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;99,2 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;9 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;8 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;43 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;9 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;8 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;43 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;9 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;8 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;43 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;8 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;43 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;8 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;43 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;100 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;139 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;131 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;130 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIV;139 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIV;131 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIV;130 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QI;131 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QI;130 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;131 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;130 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;130 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;129 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;99,24 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;99,23 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;131 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;122 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;88 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;131 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;122 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;88 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;122 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;88 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;122 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;88 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;121 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;87 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;99,18 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;98,86 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;8 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;9 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;42 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;8 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;9 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;42 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;9 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;42 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;9 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;42 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;9 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;42 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;100 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;62 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;62 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;66 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QI;62 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QI;62 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QI;65 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QII;62 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QII;62 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QII;65 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;62 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;61 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;65 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;61 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;61 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;65 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;98,48 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;98,48 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;98,39 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;98,48 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;98,39 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;98,39 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;98,48 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;58 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;36 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;58 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;36 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;58 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;36 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;58 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;35 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;57 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;35 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;97,22 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;98,28 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;97,22 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;4 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;26 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;4 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;26 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;4 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;26 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;4 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;26 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;4 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;26 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;100 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;64 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;62 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;62 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QII;64 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QII;62 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QII;62 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIII;64 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIII;61 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIII;62 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;63 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;61 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;62 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;61 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;62 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;98,39 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;98,44 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;98,39 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;98,39 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;59 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;39 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;44 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;59 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;39 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;44 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;59 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;38 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;44 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;58 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;38 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;44 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;38 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;44 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;97,44 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;98,31 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;97,44 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;97,44 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;5 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;23 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;18 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;5 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;23 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;18 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;5 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;23 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;18 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;5 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;23 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;18 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;23 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;18 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;100 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;62 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;61 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;57 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIII;62 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIII;60 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIII;57 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIV;61 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIV;60 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIV;57 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;60 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;57 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;60 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;57 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,36 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;98,39 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;98,36 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;98,36 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;98,36 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;58 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;55 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;41 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;58 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;54 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;41 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;57 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;54 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;41 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;54 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;41 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;54 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;41 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,18 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;98,28 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;98,18 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;98,18 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;98,18 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;4 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;6 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;16 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;4 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;6 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;16 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;4 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;6 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;16 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;6 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;16 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;6 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;16 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;100 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;67 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;62 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;61 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIV;66 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIV;62 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIV;61 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QI;62 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QI;61 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;62 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;61 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;62 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;60 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,51 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;98,36 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;63 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;56 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;35 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;62 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;56 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;35 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;56 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;35 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;56 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;35 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;56 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;34 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;98,41 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;97,14 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;4 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;6 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;26 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;4 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;6 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;26 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;6 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;26 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;6 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;26 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;6 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;26 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;100 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 03 Asturias, Principado de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;33.288 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;32.023 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;34.322 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the first trimester;2022QI;31.182 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the first trimester;2021QI;29.995 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the first trimester;2020QI;30.573 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the second trimester;2022QII;29.863 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the second trimester;2021QII;28.916 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the second trimester;2020QII;29.544 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;28.832 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;28.086 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;28.523 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;27.653 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;27.084 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;26.886 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,67 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,67 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;89,08 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;89,71 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;90,3 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;86,08 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;86,61 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;87,71 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;83,1 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,07 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,58 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;78,33 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;31.816 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;25.693 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;29.774 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;23.922 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;28.499 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;22.965 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;27.501 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;22.227 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;26.375 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;21.438 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;93,58 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;93,11 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;89,57 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;89,38 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;86,44 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;86,51 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;82,9 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;83,44 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;1.472 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;6.330 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;1.408 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;6.073 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;1.364 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;5.951 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;1.331 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;5.859 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;1.278 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;5.646 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;95,65 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;95,94 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;92,66 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;94,01 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;90,42 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;92,56 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;86,82 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;89,19 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;35.038 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;32.278 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;33.451 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the first trimester;2022QII;33.330 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the first trimester;2021QII;30.906 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the first trimester;2020QII;32.101 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIII;31.994 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIII;29.829 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIII;30.758 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;29.161 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;28.166 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;28.059 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;27.037 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;26.834 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 04 Balears, Illes;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,13 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,75 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,96 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,31 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,41 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,95 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;83,23 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;87,26 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;83,88 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;83,76 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;80,22 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;33.535 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;25.544 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;24.206 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;31.868 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;24.307 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;23.005 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;30.569 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;23.343 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;21.931 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;27.887 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;22.050 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;20.290 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;21.098 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;19.372 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;95,03 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;95,16 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;95,04 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;91,16 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;91,38 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;90,6 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;83,16 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;86,32 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;83,82 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;82,59 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;80,03 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;1.503 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;6.734 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;9.245 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;1.462 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;6.599 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;9.096 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;1.425 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;6.486 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;8.827 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;1.274 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;6.116 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;7.769 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;5.939 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;7.462 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;97,27 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;98 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,39 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;94,81 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;96,32 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;95,48 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;84,76 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;90,82 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;84,03 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;88,19 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;80,71 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;40.810 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;38.501 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;36.918 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIII;38.310 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIII;36.338 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIII;34.742 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIV;30.997 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIV;30.207 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIV;29.248 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;28.680 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;27.807 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;27.816 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;27.078 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,87 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;94,38 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,11 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;75,95 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;78,46 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;79,22 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;74,49 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;75,32 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;72,25 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;73,35 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;40.203 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;36.567 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;27.196 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;37.721 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;34.465 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;25.322 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;30.470 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;28.833 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;21.749 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;27.356 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;20.608 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;26.515 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;20.012 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;93,83 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;94,25 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;93,11 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;75,79 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;78,85 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;79,97 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;74,81 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;75,78 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;72,51 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;73,58 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;607 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;1.934 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;9.722 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;589 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;1.873 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;9.420 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;527 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;1.374 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;7.499 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;1.324 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;7.199 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;1.301 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;7.066 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;97,03 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;96,85 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;96,89 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;86,82 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;71,04 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;77,13 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;68,46 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;74,05 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;67,27 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;72,68 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;40.038 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;38.595 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;36.940 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIV;32.235 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIV;31.600 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIV;30.588 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the second trimester;2022QI;29.856 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the second trimester;2021QI;28.879 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;28.793 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;28.001 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;27.917 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;27.299 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;80,51 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;81,88 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;82,8 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;77,36 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;78,18 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;74,6 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;75,8 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;72,33 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;73,9 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;39.560 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;36.755 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;28.303 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;31.805 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;30.098 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;23.825 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;28.421 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;22.399 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;27.392 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;21.639 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;26.547 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;21.032 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;80,4 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;81,89 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;84,18 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;77,33 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;79,14 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;74,53 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;76,45 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;72,23 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;74,31 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;478 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;1.840 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;8.637 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;430 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;1.502 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;6.763 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;1.435 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;6.480 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;1.401 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;6.362 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;1.370 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;6.267 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;89,96 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;81,63 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;78,3 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;77,99 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;75,03 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;76,14 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;73,66 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;74,46 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;72,56 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;25.327 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;24.640 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;25.805 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QI;23.334 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QI;22.715 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QI;22.292 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QII;22.117 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QII;21.717 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QII;21.357 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;21.166 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;20.960 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;20.428 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;20.080 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;20.037 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;18.957 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,13 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;92,19 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;86,39 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,33 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;88,14 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;82,76 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;83,57 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;85,06 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;79,16 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;79,28 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;81,32 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;73,46 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;24.362 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;20.938 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;22.423 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;19.235 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;21.243 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;18.332 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;20.319 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;17.649 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;19.278 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;16.910 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;92,04 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;91,87 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;87,2 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;87,55 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;83,4 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;84,29 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;79,13 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;80,76 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;965 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;3.702 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;911 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;3.480 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;874 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;3.385 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;847 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;3.311 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;802 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;3.127 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;94,4 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;94 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;90,57 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;91,44 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;87,77 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;89,44 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;83,11 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;84,47 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;25.945 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;24.661 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;25.034 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QII;24.351 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QII;23.373 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QII;23.760 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIII;23.107 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIII;22.370 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIII;22.509 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;20.689 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;20.851 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;20.136 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;19.817 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;19.044 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,86 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,78 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;94,91 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;89,06 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;90,71 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,91 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;79,74 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;84,55 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;80,43 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;80,36 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;76,07 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;25.018 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;20.668 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;19.546 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;23.460 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;19.490 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;18.398 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;22.246 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;18.583 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;17.384 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;19.948 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;17.387 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;15.846 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;16.503 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;14.996 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;93,77 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;94,3 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;94,13 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;88,92 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;89,91 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;88,94 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;79,73 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;84,13 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;81,07 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;79,85 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;76,72 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;927 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;3.993 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;5.488 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;891 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;3.883 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;5.362 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;861 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;3.787 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;5.125 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;741 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;3.464 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;4.290 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;3.314 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;4.048 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;96,12 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,25 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;97,7 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;92,88 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;94,84 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;93,39 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;79,94 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;86,75 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;78,17 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;83 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;73,76 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;29.272 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;28.195 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;27.189 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIII;26.911 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIII;26.169 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIII;25.133 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIV;21.374 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIV;21.266 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIV;20.633 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;19.906 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;19.359 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;19.123 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;18.730 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,93 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;92,81 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,44 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;73,02 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;75,42 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;75,89 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;70,6 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;71,2 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;67,82 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;68,89 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;28.926 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;27.174 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;22.277 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;26.580 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;25.202 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;20.475 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;21.082 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;20.602 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;17.219 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;19.282 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;16.162 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;18.517 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;15.616 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;91,89 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;92,74 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;91,91 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;72,88 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;75,82 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;77,29 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;70,96 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;72,55 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;68,14 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;70,1 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;346 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;1.021 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;4.912 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;331 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;967 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;4.658 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;292 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;664 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;3.414 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;624 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;3.197 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;606 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;3.114 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;95,66 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;94,71 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;94,83 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;84,39 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;65,03 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;69,5 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;61,12 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;65,09 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;59,35 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;63,4 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;28.950 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;28.385 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;27.501 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIV;22.691 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIV;22.581 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIV;22.073 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QI;21.009 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QI;20.528 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;20.040 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;19.752 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;19.250 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;19.123 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;78,38 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;79,55 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;80,26 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;74,01 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;74,64 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;70,6 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;71,82 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;67,82 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;69,54 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;28.686 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;27.256 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;23.160 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;22.456 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;21.697 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;18.996 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;20.179 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;17.653 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;19.238 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;16.951 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;18.475 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;16.394 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;78,28 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;79,6 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;82,02 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;74,04 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;76,22 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;70,58 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;73,19 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;67,78 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;70,79 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;264 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;1.129 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;4.341 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;235 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;884 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;3.077 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;830 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;2.875 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;802 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;2.801 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;775 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;2.729 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;89,02 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;78,3 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;70,88 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;73,52 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;66,23 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;71,04 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;64,52 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;68,64 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;62,87 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.450 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.291 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.760 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QI;3.379 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QI;3.222 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QI;3.605 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QII;3.330 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QII;3.191 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QII;3.554 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.288 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.149 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.494 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.234 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.105 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.391 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,94 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,9 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,88 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,52 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,96 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,52 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,3 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,69 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,93 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,74 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,35 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,19 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;3.256 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;2.329 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;3.192 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;2.281 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;3.147 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;2.259 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;3.107 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;2.226 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;3.056 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;2.198 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,03 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;97,94 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;96,65 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;96,99 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;95,42 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;95,58 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;93,86 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;94,38 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;194 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;962 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;187 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;941 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;183 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;932 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;181 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;923 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;178 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;907 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;96,39 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;97,82 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;94,33 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;96,88 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;93,3 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;95,95 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;91,75 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;94,28 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.887 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.355 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.663 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QII;3.826 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QII;3.312 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QII;3.623 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.776 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.274 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.563 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.514 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.177 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.360 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;3.123 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;3.278 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,43 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,72 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,91 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;97,14 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,59 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,27 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,4 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,69 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,73 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,08 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,49 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;3.681 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;2.352 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;2.264 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;3.621 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;2.319 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;2.233 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;3.574 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;2.290 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;2.191 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;3.330 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;2.223 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;2.122 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;2.183 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;2.079 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,37 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,6 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,63 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;97,09 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;97,36 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;96,78 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;90,46 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;94,52 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;93,73 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;92,81 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;91,83 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;206 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;1.003 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;1.399 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;205 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;993 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;1.390 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;202 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;984 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;1.372 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;184 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;954 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;1.238 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;940 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;1.199 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;99,51 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,36 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;98,06 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;98,11 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,07 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;89,32 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;95,11 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;88,49 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;93,72 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;85,7 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.657 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.298 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.164 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.577 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.221 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.083 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.749 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.572 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.517 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;3.480 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;3.424 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;3.433 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;3.379 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,28 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,21 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,05 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;80,5 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;83,11 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;84,46 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;80,97 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;82,23 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;79,87 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;81,15 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;4.570 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;3.986 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;2.505 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;4.490 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;3.911 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;2.453 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;3.673 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;3.355 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;2.226 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;3.266 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;2.174 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;3.222 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;2.149 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,25 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,12 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;97,92 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;80,37 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;84,17 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;88,86 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;81,94 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;86,79 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;80,83 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;85,79 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;87 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;312 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;1.659 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;87 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;310 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;1.630 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;76 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;217 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;1.291 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;214 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;1.250 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;211 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;1.230 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,36 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,25 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;87,36 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;69,55 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;77,82 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;68,59 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;75,35 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;67,63 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;74,14 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.487 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.248 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.009 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.746 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.622 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.483 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QI;3.525 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QI;3.385 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;3.476 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;3.338 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.427 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.301 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;83,49 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;85,26 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;86,88 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;82,98 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;84,44 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;81,83 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;83,26 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;80,67 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;82,34 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;4.426 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;3.991 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;2.581 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;3.691 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;3.411 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;2.373 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;3.321 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;2.317 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;3.274 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;2.288 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;3.226 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;2.259 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;83,39 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;85,47 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;91,94 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;83,21 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;89,77 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;82,03 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;88,65 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;80,83 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;87,52 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;61 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;257 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;1.428 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;55 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;211 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;1.110 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;204 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;1.068 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;202 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;1.050 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;201 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;1.042 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;90,16 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;82,1 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;77,73 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;79,38 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;74,79 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;78,6 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;73,53 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;78,21 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;72,97 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.252 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.854 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.492 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QI;4.211 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QI;3.821 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QI;4.412 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QII;4.159 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QII;3.771 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QII;4.369 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.124 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.743 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.338 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.089 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.708 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.276 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,04 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,14 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;98,22 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,81 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,85 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;97,26 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;96,99 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;97,12 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;96,57 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;96,17 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;96,21 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;95,19 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;3.963 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;2.331 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;3.925 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;2.311 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;3.876 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;2.279 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;3.845 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;2.257 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;3.814 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;2.235 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,04 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,14 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;97,8 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;97,77 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;97,02 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;96,83 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;96,24 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;95,88 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;289 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;1.523 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;286 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;1.510 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;283 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;1.492 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;279 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;1.486 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;275 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;1.473 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;98,96 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,15 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;97,92 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;97,96 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;96,54 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;97,57 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;95,16 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;96,72 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.907 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.020 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.480 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QII;4.854 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QII;3.979 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QII;4.444 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIII;4.815 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.946 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.413 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;4.667 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.899 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.291 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;3.859 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;4.241 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,92 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,98 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,2 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;98,13 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;98,16 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,5 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,11 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;96,99 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,78 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;96 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,67 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;4.561 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;2.419 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;2.280 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;4.512 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;2.393 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;2.258 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;4.476 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;2.365 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;2.241 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;4.341 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;2.335 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;2.208 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;2.308 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;2.183 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,93 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,93 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,04 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;98,14 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;97,77 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,29 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;95,18 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;96,53 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;96,84 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;95,41 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;95,75 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;346 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;1.601 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;2.200 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;342 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;1.586 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;2.186 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;339 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;1.581 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;2.172 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;326 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;1.564 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;2.083 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;1.551 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;2.058 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;98,84 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,06 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,36 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;97,98 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;98,75 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,73 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;94,22 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;97,69 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;94,68 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;96,88 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;93,55 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.444 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.656 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.228 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.387 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.600 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.190 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.447 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.024 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.765 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;4.950 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;4.692 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;4.917 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;4.637 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,12 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,01 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,27 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;84,53 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;88,83 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,14 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,52 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89,75 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,93 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,7 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;6.292 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;5.101 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;2.329 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;6.237 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;5.050 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;2.310 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;5.309 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;4.576 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;2.220 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;4.509 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;2.188 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;4.478 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;2.163 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,13 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,18 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;84,38 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;89,71 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;95,32 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;88,39 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;93,95 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;87,79 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;92,87 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;152 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;555 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;2.899 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;150 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;550 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;2.880 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;138 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;448 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;2.545 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;441 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;2.504 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;439 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;2.474 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;98,68 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,1 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,34 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;90,79 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;80,72 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;87,79 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;79,46 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;86,37 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;79,1 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;85,34 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.174 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;5.597 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;5.108 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.376 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIV;5.034 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.713 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QI;4.960 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QI;4.648 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;4.916 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;4.593 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;4.881 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.560 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;87,07 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;89,94 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,27 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;88,62 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,99 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,83 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,92 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,21 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,27 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;6.039 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;5.169 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;2.469 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;5.254 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;4.653 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;2.363 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;4.585 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;2.336 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;4.545 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;2.307 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;4.512 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;2.286 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;87 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;90,02 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;95,71 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;88,7 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;94,61 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;87,93 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;93,44 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;87,29 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;92,59 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;135 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;428 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;2.639 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;122 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;381 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;2.350 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;375 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;2.312 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;371 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;2.286 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;369 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;2.274 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;90,37 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;89,02 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;89,05 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;87,62 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;87,61 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;86,68 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;86,62 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;86,21 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;86,17 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;188 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;171 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;184 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QI;188 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QI;170 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QI;183 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QII;187 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QII;170 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QII;183 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;184 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;167 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;182 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;180 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;167 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;181 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;100 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,42 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;99,46 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;99,47 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;99,42 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;99,46 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;97,87 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;97,66 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;98,91 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;95,74 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;97,66 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;98,37 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;171 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;69 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;171 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;69 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;170 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;69 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;167 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;69 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;164 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;69 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;100 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;100 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;99,42 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;100 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;97,66 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;100 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;95,91 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;100 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;17 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;102 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;17 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;101 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;17 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;101 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;17 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;98 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;16 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;98 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,02 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;99,02 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;96,08 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;94,12 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;96,08 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;213 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;175 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;194 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QII;213 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QII;175 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QII;194 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIII;210 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIII;172 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIII;193 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;206 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;172 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;192 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;172 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;191 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;98,59 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;98,29 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;99,48 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;96,71 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;98,29 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;98,97 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;98,29 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;98,45 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;198 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;75 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;85 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;198 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;75 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;85 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;196 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;75 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;84 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;192 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;75 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;83 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;75 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;83 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;98,99 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,82 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;96,97 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;97,65 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;97,65 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;15 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;109 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;15 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;109 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;14 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;97 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;109 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;14 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;97 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;109 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;97 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;108 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;93,33 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;97 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;93,33 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;97 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;97 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;99,08 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;303 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;249 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;234 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIII;301 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIII;246 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIII;233 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIV;293 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIV;243 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIV;230 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;243 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;229 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;242 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;229 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,34 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,8 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,57 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,7 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;97,59 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;98,29 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;97,59 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;97,86 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;97,19 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;97,86 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;288 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;225 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;59 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;287 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;222 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;58 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;279 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;220 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;58 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;220 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;58 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;219 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;58 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,65 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,67 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,31 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;96,88 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;97,78 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;98,31 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;97,78 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;98,31 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;97,33 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;98,31 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;15 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;24 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;175 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;14 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;24 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;175 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;14 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;23 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;172 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;23 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;171 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;23 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;171 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;93,33 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;93,33 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;95,83 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;98,29 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;95,83 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;97,71 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;95,83 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;97,71 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;296 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;261 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;223 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIV;292 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIV;260 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIV;220 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QI;260 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QI;219 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;259 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;219 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;257 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;217 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,65 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,62 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,65 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;99,62 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;98,21 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;99,23 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;98,21 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;98,47 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;97,31 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;284 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;247 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;68 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;280 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;246 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;68 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;246 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;68 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;245 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;68 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;244 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;68 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;98,59 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,6 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;99,6 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;100 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;99,19 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;100 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;98,79 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;100 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;12 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;14 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;155 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;12 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;14 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;152 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;14 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;151 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;14 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;151 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;13 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;149 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;98,06 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;97,42 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;97,42 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;92,86 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;96,13 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;71 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;67 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;81 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QI;70 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QI;67 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QI;81 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QII;70 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QII;67 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QII;81 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;70 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;67 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;81 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;70 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;67 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;81 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,59 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;100 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;100 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;98,59 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;100 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;100 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;98,59 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;100 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;100 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;98,59 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;100 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;100 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;64 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;26 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;63 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;26 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;63 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;26 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;63 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;26 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;63 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;26 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,44 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;100 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;98,44 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;100 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;98,44 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;100 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;98,44 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;100 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;7 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;41 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;7 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;41 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;7 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;41 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;7 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;41 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;7 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;41 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;100 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;86 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;67 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;80 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QII;86 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QII;67 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QII;80 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIII;86 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIII;67 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIII;80 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;85 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;67 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;80 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;66 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;80 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;98,84 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;100 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;100 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;98,51 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;100 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;77 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;30 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;31 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;77 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;30 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;31 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;77 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;30 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;31 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;76 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;30 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;31 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;29 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;31 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;98,7 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;100 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;100 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;96,67 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;100 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;9 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;37 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;49 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;9 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;37 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;49 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;9 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;37 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;49 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;9 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;37 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;49 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;37 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;49 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;100 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;134 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;103 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;103 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIII;134 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIII;102 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIII;103 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIV;134 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIV;102 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIV;103 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;101 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;103 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;101 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;103 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;100 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,03 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;100 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;100 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;99,03 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;100 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;98,06 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;100 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;98,06 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;100 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;127 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;81 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;26 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;127 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;80 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;26 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;127 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;80 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;26 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;79 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;26 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;79 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;26 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;100 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,77 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;100 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;98,77 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;100 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;97,53 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;100 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;97,53 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;100 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;7 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;22 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;77 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;7 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;22 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;77 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;7 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;22 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;77 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;22 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;77 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;22 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;77 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;100 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;100 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;131 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;104 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;99 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIV;130 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIV;103 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIV;99 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QI;102 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QI;99 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;102 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;99 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;102 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;98 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,24 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,04 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;100 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,08 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;100 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;98,08 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;100 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;98,08 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;98,99 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;125 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;92 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;25 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;124 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;91 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;25 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;90 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;25 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;90 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;25 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;90 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;25 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,2 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;98,91 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;97,83 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;100 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;97,83 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;100 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;97,83 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;100 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;6 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;12 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;74 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;6 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;12 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;74 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;12 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;74 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;12 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;74 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;12 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;73 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;98,65 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 04 Balears, Illes;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;53.706 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;51.837 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;55.634 05 Canarias;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the first trimester;2022QI;50.651 05 Canarias;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the first trimester;2021QI;48.683 05 Canarias;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the first trimester;2020QI;47.879 05 Canarias;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the second trimester;2022QII;48.261 05 Canarias;Total ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the second trimester;2021QII;46.930 05 Canarias;Total ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the second trimester;2020QII;45.984 05 Canarias;Total ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;46.373 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;45.390 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;44.574 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;45.022 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;44.077 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;43.228 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,31 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,92 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;86,06 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;89,86 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;90,53 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;82,65 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;86,35 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;87,56 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;80,12 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,83 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,03 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;77,7 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;51.142 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;41.525 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;48.184 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;38.720 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;45.879 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;37.197 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;44.059 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;35.854 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;42.769 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;34.809 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;94,22 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;93,25 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;89,71 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;89,58 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;86,15 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;86,34 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;83,63 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;83,83 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;2.564 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;10.312 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;2.467 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;9.963 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;2.382 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;9.733 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;2.314 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;9.536 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;2.253 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;9.268 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;96,22 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;96,62 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;92,9 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;94,39 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;90,25 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;92,47 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;87,87 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;89,88 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;53.693 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;51.119 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;50.177 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the first trimester;2022QII;50.731 05 Canarias;Total ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the first trimester;2021QII;48.900 05 Canarias;Total ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the first trimester;2020QII;47.968 05 Canarias;Total ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIII;48.478 05 Canarias;Total ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIII;47.072 05 Canarias;Total ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIII;46.342 05 Canarias;Total ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;46.944 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;45.606 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;44.826 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;43.885 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;42.999 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 05 Canarias;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,48 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,66 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,6 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;90,29 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,08 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,36 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,43 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,22 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,34 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,85 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,69 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;51.194 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;44.183 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;37.174 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;48.328 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;42.156 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;35.128 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;46.148 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;40.483 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;33.767 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;44.663 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;39.219 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;32.571 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;37.700 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;31.172 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 05 Canarias;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;94,4 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;95,41 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;94,5 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;90,14 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;91,63 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;90,83 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;87,24 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;88,76 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;87,62 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;85,33 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;83,85 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;2.499 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;6.936 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;13.003 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;2.403 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;6.744 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;12.840 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;2.330 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;6.589 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;12.575 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;2.281 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;6.387 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;12.255 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;6.185 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;11.827 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 05 Canarias;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;96,16 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,23 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,75 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;93,24 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;95 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;96,71 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;91,28 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;92,08 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;94,25 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;89,17 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;90,96 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;53.722 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;51.769 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;50.704 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIII;50.873 05 Canarias;Total ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIII;49.336 05 Canarias;Total ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIII;48.544 05 Canarias;Total ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIV;49.051 05 Canarias;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIV;47.578 05 Canarias;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIV;46.665 05 Canarias;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;45.634 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;44.619 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;44.085 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;43.416 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;94,7 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,3 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,74 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,31 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,9 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,03 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,15 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,16 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,63 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;52.529 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;49.265 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;39.524 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;49.716 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;46.906 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;37.578 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;47.919 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;45.225 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;35.968 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;43.355 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;34.282 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;41.867 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;33.299 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;94,64 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;95,21 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;95,08 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;91,22 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;91,8 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;91 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;88 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;86,74 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;84,98 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;84,25 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;1.193 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;2.504 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;11.180 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;1.157 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;2.430 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;10.966 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;1.132 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;2.353 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;10.697 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;2.279 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;10.337 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;2.218 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;10.117 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;96,98 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;97,04 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,09 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;94,89 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;93,97 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;95,68 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;91,01 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;92,46 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;88,58 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;90,49 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;53.852 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;52.577 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;51.791 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIV;51.498 05 Canarias;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIV;50.226 05 Canarias;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIV;49.248 05 Canarias;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the second trimester;2022QI;47.913 05 Canarias;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the second trimester;2021QI;46.763 05 Canarias;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;46.034 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;45.322 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;44.406 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;43.988 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,63 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,53 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,09 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,13 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,29 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,56 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,51 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,46 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,93 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;53.044 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;49.237 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;40.950 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;50.707 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;47.008 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;38.676 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;44.811 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;36.543 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;43.066 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;35.328 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;41.542 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;34.195 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;95,59 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;95,47 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;94,45 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;91,01 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;89,24 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;87,47 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;86,27 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;84,37 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;83,5 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;808 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;3.340 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;10.841 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;791 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;3.218 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;10.572 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;3.102 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;10.220 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;2.968 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;9.994 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;2.864 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;9.793 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;97,9 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;96,35 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;97,52 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;92,87 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;94,27 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;88,86 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;92,19 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;85,75 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;90,33 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;39.633 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;38.733 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;40.891 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QI;36.790 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QI;35.773 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QI;33.756 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QII;34.622 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QII;34.167 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QII;32.041 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;32.940 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;32.761 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;30.784 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;31.744 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;31.598 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;29.609 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,83 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;92,36 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;82,55 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,36 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;88,21 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;78,36 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;83,11 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;84,58 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;75,28 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;80,09 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;81,58 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;72,41 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;37.964 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;33.358 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;35.206 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;30.677 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;33.111 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;29.252 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;31.483 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;27.999 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;30.339 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;27.049 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;92,74 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;91,96 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;87,22 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;87,69 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;82,93 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;83,93 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;79,92 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;81,09 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;1.669 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;5.375 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;1.584 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;5.096 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;1.511 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;4.915 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;1.457 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;4.762 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;1.405 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;4.549 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;94,91 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;94,81 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;90,53 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;91,44 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;87,3 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;88,6 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;84,18 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;84,63 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;39.587 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;38.261 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;37.291 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QII;36.836 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QII;36.181 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QII;35.182 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIII;34.773 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIII;34.489 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIII;33.660 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;33.399 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;33.166 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;32.292 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;31.642 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;30.665 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 05 Canarias;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,05 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,56 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;94,34 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;87,84 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;90,14 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;90,26 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;84,37 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;86,68 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;86,59 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;82,7 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;82,23 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;37.992 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;34.306 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;30.007 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;35.328 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;32.383 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;28.035 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;33.328 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;30.824 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;26.742 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;31.997 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;29.677 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;25.633 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;28.309 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;24.342 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;92,99 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;94,39 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;93,43 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;87,72 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;89,85 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;89,12 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;84,22 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;86,51 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;85,42 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;82,52 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;81,12 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;1.595 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;3.955 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;7.284 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;1.508 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;3.798 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;7.147 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;1.445 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;3.665 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;6.918 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;1.402 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;3.489 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;6.659 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;3.333 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;6.323 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;94,55 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;96,03 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,12 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;90,6 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;92,67 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;94,98 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;87,9 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;88,22 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;91,42 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;84,27 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;86,81 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;39.506 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;38.538 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;37.659 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIII;36.831 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIII;36.217 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIII;35.597 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIV;35.162 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIV;34.610 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIV;33.879 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;32.876 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;32.032 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;31.500 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;30.957 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,23 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;93,98 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,52 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;89,81 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,96 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;85,31 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;85,06 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;81,74 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;82,2 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;38.678 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;37.039 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;31.945 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;36.036 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;34.788 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;30.073 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;34.390 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;33.246 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;28.565 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;31.573 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;26.991 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;30.247 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;26.083 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;93,17 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;93,92 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;94,14 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;88,91 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;89,76 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;89,42 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;85,24 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;84,49 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;81,66 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;81,65 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;828 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;1.499 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;5.714 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;795 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;1.429 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;5.524 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;772 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;1.364 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;5.314 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;1.303 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;5.041 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;1.253 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;4.874 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;96,01 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;95,33 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;96,67 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;93,24 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;90,99 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;93 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;86,92 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;88,22 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;83,59 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;85,3 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;39.491 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;38.879 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;38.546 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIV;37.270 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIV;36.657 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIV;36.142 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QI;34.561 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QI;33.866 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;32.872 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;32.571 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;31.437 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;31.380 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,38 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,28 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,76 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;88,89 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,86 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;84,55 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;84,5 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;80,86 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;81,41 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;38.963 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;36.487 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;32.915 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;36.759 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;34.381 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;30.734 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;32.394 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;28.731 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;30.826 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;27.607 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;29.479 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;26.565 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;94,34 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;94,23 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;93,37 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;88,78 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;87,29 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;84,48 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;83,87 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;80,79 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;80,71 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;528 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;2.392 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;5.631 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;511 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;2.276 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;5.408 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;2.167 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;5.135 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;2.046 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;4.964 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;1.958 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;4.815 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;96,78 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;95,15 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;96,04 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;90,59 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;91,19 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;85,54 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;88,15 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;81,86 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;85,51 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.183 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;5.820 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.439 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QI;6.062 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QI;5.692 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QI;6.034 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QII;5.926 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QII;5.603 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QII;5.925 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.805 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;5.516 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.830 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.713 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.425 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.735 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,04 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,8 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,71 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,84 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,27 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,02 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,89 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,78 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,54 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,4 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,21 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,07 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;5.832 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;4.096 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;5.718 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;4.007 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;5.590 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;3.941 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;5.476 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;3.880 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;5.390 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;3.821 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,05 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;97,83 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;95,85 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;96,22 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;93,9 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;94,73 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;92,42 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;93,29 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;351 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;1.724 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;344 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;1.685 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;336 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;1.662 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;329 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;1.636 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;323 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;1.604 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;98,01 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;97,74 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;95,73 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;96,4 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;93,73 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;94,9 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;92,02 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;93,04 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;6.130 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;5.705 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;5.598 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QII;5.999 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QII;5.617 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QII;5.533 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.890 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.523 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.463 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.796 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.433 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.370 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;5.316 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;5.253 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,86 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,46 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,84 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,08 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,81 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,59 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,55 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,23 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,93 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,18 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,84 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;5.774 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;4.675 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;3.427 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;5.647 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;4.608 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;3.373 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;5.544 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;4.531 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;3.328 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;5.454 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;4.456 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;3.273 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;4.365 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;3.204 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;97,8 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,57 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,42 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;96,02 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;96,92 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;97,11 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;94,46 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;95,32 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;95,51 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;93,37 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;93,49 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;356 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;1.030 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;2.171 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;352 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;1.009 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;2.160 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;346 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;992 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;2.135 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;342 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;977 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;2.097 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;951 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;2.049 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;98,88 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,96 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,49 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;97,19 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;96,31 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,34 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;96,07 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;94,85 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;96,59 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;92,33 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;94,38 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.167 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.870 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.708 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.068 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.794 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.648 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.976 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.704 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.549 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;5.575 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;5.431 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;5.470 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;5.346 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,39 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,71 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,95 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,9 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;97,17 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97,21 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,97 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,15 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,19 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,66 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;6.025 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;5.502 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;3.774 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;5.928 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;5.429 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;3.729 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;5.838 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;5.347 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;3.662 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;5.225 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;3.594 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;5.126 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;3.541 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,39 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,67 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,81 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;96,9 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;97,18 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;97,03 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;94,97 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;95,23 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;93,17 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;93,83 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;142 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;368 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;1.934 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;140 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;365 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;1.919 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;138 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;357 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;1.887 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;350 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;1.837 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;344 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;1.805 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;98,59 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,18 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,22 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;97,18 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;97,01 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;97,57 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;95,11 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;94,98 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;93,48 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;93,33 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.132 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.015 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;5.823 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.054 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIV;5.947 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIV;5.733 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QI;5.815 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QI;5.599 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;5.701 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;5.505 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.588 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.416 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,73 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,87 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,45 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,67 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,15 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,78 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,54 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,9 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,01 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;6.032 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;5.633 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;4.004 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;5.954 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;5.568 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;3.941 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;5.439 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;3.853 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;5.331 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;3.791 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;5.226 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;3.732 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;98,71 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;98,85 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;98,43 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;96,56 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;96,23 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;94,64 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;94,68 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;92,77 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;93,21 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;382 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;1.819 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;100 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;379 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;1.792 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;376 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;1.746 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;370 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;1.714 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;362 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;1.684 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;99,21 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;98,52 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;98,43 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;95,99 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;96,86 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;94,23 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;94,76 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;92,58 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;7.331 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.769 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;7.716 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QI;7.242 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QI;6.706 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QI;7.503 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QII;7.157 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QII;6.648 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QII;7.434 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;7.074 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.602 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;7.376 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;7.015 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.543 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;7.303 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,79 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,07 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;97,24 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,63 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;98,21 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;96,35 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;96,49 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;97,53 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;95,59 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;95,69 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;96,66 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;94,65 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;6.824 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;3.866 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;6.740 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;3.833 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;6.659 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;3.801 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;6.583 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;3.773 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;6.527 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;3.737 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,77 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,15 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;97,58 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;98,32 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;96,47 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;97,59 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;95,65 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;96,66 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;507 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;2.903 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;502 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;2.873 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;498 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;2.847 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;491 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;2.829 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;488 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;2.806 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;99,01 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,97 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;98,22 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,07 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;96,84 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;97,45 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;96,25 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;96,66 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.392 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.651 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.765 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QII;7.313 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QII;6.601 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QII;6.731 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIII;7.236 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.561 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.697 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;7.174 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.508 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;6.644 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;6.431 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;6.564 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 05 Canarias;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,93 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,25 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,5 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;97,89 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;98,65 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,99 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;97,05 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;97,85 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;98,21 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;96,69 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;97,03 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;6.877 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;4.919 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;3.519 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;6.803 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;4.883 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;3.499 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;6.730 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;4.848 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;3.476 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;6.669 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;4.806 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;3.444 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;4.747 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;3.407 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,92 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;99,27 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,43 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;97,86 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;98,56 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,78 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;96,98 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;97,7 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;97,87 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;96,5 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;96,82 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;515 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;1.732 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;3.246 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;510 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;1.718 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;3.232 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;506 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;1.713 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;3.221 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;505 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;1.702 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;3.200 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;1.684 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;3.157 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;99,03 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,19 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,57 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;98,25 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;98,9 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;99,23 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;98,06 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;98,27 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;98,58 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;97,23 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;97,26 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;7.477 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.874 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.830 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIII;7.403 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.838 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.792 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIV;7.346 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.777 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.731 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;6.699 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;6.653 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;6.631 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;6.610 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,01 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,48 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,44 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;98,25 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;98,59 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;98,55 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;97,45 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;97,41 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;96,46 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;96,78 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;7.270 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;6.310 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;3.623 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;7.197 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;6.275 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;3.594 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;7.140 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;6.218 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;3.559 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;6.146 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;3.517 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;6.083 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;3.495 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99,45 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,2 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;98,21 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;98,54 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;98,23 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;97,4 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;97,07 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;96,4 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;96,47 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;207 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;564 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;3.207 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;206 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;563 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;3.198 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;206 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;559 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;3.172 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;553 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;3.136 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;548 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;3.115 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;99,52 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,82 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,72 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;99,52 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;99,11 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;98,91 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;98,05 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;97,79 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;97,16 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;97,13 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;7.630 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;7.151 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.905 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.577 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIV;7.091 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.857 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QI;7.009 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QI;6.785 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;6.933 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;6.733 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.855 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.679 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,31 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,16 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,3 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,01 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;98,26 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;96,95 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;97,51 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;95,86 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;96,73 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;7.463 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;6.628 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;3.834 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;7.410 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;6.571 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;3.804 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;6.493 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;3.764 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;6.424 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;3.735 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;6.354 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;3.703 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,29 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,14 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,22 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;97,96 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;98,17 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;96,92 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;97,42 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;95,87 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;96,58 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;167 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;523 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;3.071 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;167 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;520 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;3.053 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;516 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;3.021 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;509 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;2.998 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;501 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;2.976 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;99,43 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,41 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;98,66 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,37 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;97,32 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;97,62 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;95,79 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;96,91 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;383 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;372 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;424 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QI;382 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QI;370 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QI;422 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QII;382 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QII;370 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QII;420 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;380 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;369 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;420 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;377 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;369 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;418 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,74 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,46 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;99,53 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;99,74 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;99,46 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;99,06 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;99,22 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;99,19 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;99,06 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;98,43 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;99,19 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;98,58 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;358 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;153 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;357 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;152 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;357 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;152 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;355 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;151 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;352 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;151 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,72 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,35 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;99,72 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;99,35 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;99,16 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;98,69 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;98,32 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;98,69 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;25 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;219 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;25 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;218 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;25 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;218 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;25 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;218 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;25 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;218 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,54 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;99,54 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;99,54 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;99,54 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;409 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;361 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;371 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QII;408 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QII;361 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QII;370 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIII;404 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIII;359 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIII;370 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;401 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;359 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;369 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;357 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;367 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 05 Canarias;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;99,76 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,73 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;98,78 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;99,45 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;99,73 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;98,04 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;99,45 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;99,46 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;98,89 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;98,92 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;386 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;214 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;162 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;385 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;214 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;162 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;381 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;212 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;162 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;378 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;212 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;162 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;212 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;161 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;99,74 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;98,7 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;99,07 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;100 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;97,93 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;99,07 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;100 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;99,07 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;99,38 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;23 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;147 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;209 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;23 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;147 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;208 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;23 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;147 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;208 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;23 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;147 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;207 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;145 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;206 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,52 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;99,52 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;99,04 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;98,64 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;98,56 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;393 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;343 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;356 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIII;392 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIII;343 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIII;356 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIV;388 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIV;343 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIV;356 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;341 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;354 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;341 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;354 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,75 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;100 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;98,73 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;100 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;100 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;99,42 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;99,44 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;99,42 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;99,44 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;382 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;302 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;134 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;381 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;302 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;134 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;377 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;302 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;134 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;300 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;133 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;300 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;133 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,74 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;98,69 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;100 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;100 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;99,34 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;99,25 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;99,34 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;99,25 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;11 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;41 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;222 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;11 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;41 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;222 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;11 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;41 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;222 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;41 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;221 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;41 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;221 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;99,55 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;99,55 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;413 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;371 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;370 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIV;411 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIV;370 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIV;370 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QI;368 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QI;368 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;368 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;368 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;366 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;368 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,52 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,73 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;100 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;99,19 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;99,46 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;99,19 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;99,46 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;98,65 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;99,46 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;406 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;350 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;148 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;404 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;349 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;148 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;347 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;147 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;347 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;147 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;345 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;147 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,51 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,71 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;99,14 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;99,32 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;99,14 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;99,32 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;98,57 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;99,32 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;7 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;21 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;222 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;7 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;21 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;222 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;21 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;221 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;21 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;221 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;21 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;221 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;99,55 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;99,55 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;99,55 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;176 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;143 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;164 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QI;175 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QI;142 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QI;164 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QII;174 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QII;142 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QII;164 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;174 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;142 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;164 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;173 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;142 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;163 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,43 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,3 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;100 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;98,86 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;99,3 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;100 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;98,86 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;99,3 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;100 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;98,3 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;99,3 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;99,39 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;164 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;52 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;163 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;51 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;162 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;51 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;162 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;51 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;161 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;51 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,39 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,08 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;98,78 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;98,08 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;98,78 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;98,08 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;98,17 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;98,08 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;12 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;91 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;12 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;91 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;12 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;91 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;12 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;91 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;12 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;91 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;100 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;175 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;141 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;152 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QII;175 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QII;140 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QII;152 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIII;175 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIII;140 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIII;152 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;174 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;140 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;151 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;139 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;150 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 05 Canarias;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;100 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,29 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;100 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;99,29 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;100 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;99,43 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;99,29 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;99,34 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;98,58 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;98,68 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;165 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;69 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;59 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;165 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;68 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;59 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;165 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;68 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;59 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;165 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;68 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;59 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;67 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;58 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,55 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;100 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;98,55 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;100 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;100 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;98,55 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;100 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;97,1 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;98,31 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;10 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;72 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;93 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;10 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;72 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;93 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;10 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;72 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;93 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;9 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;72 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;92 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;72 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;92 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;90 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;98,92 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;98,92 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;179 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;144 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;151 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIII;179 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIII;144 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIII;151 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIV;179 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIV;144 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIV;150 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;143 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;149 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;143 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;149 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;100 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;100 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;100 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;100 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;99,34 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;99,31 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;98,68 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;99,31 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;98,68 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;174 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;112 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;48 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;174 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;112 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;48 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;174 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;112 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;48 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;111 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;47 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;111 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;47 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;100 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;100 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;100 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;100 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;99,11 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;97,92 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;99,11 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;97,92 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;5 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;32 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;103 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;5 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;32 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;103 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;5 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;32 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;102 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;32 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;102 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;32 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;102 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;99,03 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;99,03 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;99,03 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;186 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;161 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;147 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIV;186 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIV;161 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIV;146 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QI;160 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QI;145 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;160 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;145 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;160 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;145 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;100 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,32 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;99,38 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;98,64 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;99,38 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;98,64 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;99,38 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;98,64 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;180 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;139 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;49 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;180 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;139 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;49 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;138 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;48 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;138 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;48 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;138 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;48 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;100 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;99,28 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;97,96 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;99,28 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;97,96 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;99,28 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;97,96 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;6 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;22 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;98 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;6 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;22 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;97 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;22 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;97 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;22 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;97 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;22 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;97 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;98,98 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,98 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;98,98 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;98,98 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 05 Canarias;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;14.388 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;13.790 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;14.505 06 Cantabria;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the first trimester;2022QI;13.710 06 Cantabria;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the first trimester;2021QI;13.171 06 Cantabria;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the first trimester;2020QI;13.081 06 Cantabria;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the second trimester;2022QII;13.152 06 Cantabria;Total ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the second trimester;2021QII;12.767 06 Cantabria;Total ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the second trimester;2020QII;12.713 06 Cantabria;Total ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;12.771 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;12.442 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;12.360 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;12.441 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;12.152 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;11.979 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,29 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,51 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;90,18 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,41 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,58 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;87,65 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,76 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,22 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,21 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,47 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,12 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,59 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;13.915 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;12.529 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;13.252 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;11.940 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;12.701 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;11.550 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;12.329 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;11.249 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;12.003 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;10.985 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;95,24 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;95,3 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;91,28 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;92,19 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;88,6 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;89,78 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;86,26 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;87,68 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;473 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;1.261 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;458 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;1.231 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;451 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;1.217 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;442 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;1.193 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;438 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;1.167 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;96,83 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;97,62 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;95,35 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;96,51 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;93,45 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;94,61 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;92,6 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;92,55 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;14.469 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;13.963 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;13.608 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the first trimester;2022QII;13.796 06 Cantabria;Total ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the first trimester;2021QII;13.422 06 Cantabria;Total ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the first trimester;2020QII;13.172 06 Cantabria;Total ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIII;13.321 06 Cantabria;Total ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIII;13.008 06 Cantabria;Total ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIII;12.761 06 Cantabria;Total ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;12.855 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;12.615 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;12.305 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;12.236 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;11.939 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 06 Cantabria;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,35 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,13 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,8 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,07 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,16 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,78 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,85 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,35 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,42 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,63 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87,74 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;13.987 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;12.643 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;11.340 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;13.323 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;12.117 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;10.936 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;12.857 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;11.726 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;10.578 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;12.402 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;11.359 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;10.186 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;11.008 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;9.870 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;95,25 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;95,84 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;96,44 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;91,92 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;92,75 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;93,28 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;88,67 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;89,84 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;89,82 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;87,07 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;87,04 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;482 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;1.320 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;2.268 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;473 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;1.305 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;2.236 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;464 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;1.282 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;2.183 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;453 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;1.256 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;2.119 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;1.228 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;2.069 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 06 Cantabria;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;98,13 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;98,86 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,59 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;96,27 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;97,12 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;96,25 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;93,98 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;95,15 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;93,43 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;93,03 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;91,23 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;14.857 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;14.635 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;14.192 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIII;14.036 06 Cantabria;Total ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIII;13.845 06 Cantabria;Total ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIII;13.494 06 Cantabria;Total ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIV;13.341 06 Cantabria;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIV;13.165 06 Cantabria;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIV;12.787 06 Cantabria;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;12.714 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;12.371 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;12.378 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;12.125 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;94,47 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;94,6 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,08 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,8 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;89,96 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,1 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;86,87 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,17 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,58 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,44 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;14.691 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;14.282 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;12.831 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;13.875 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;13.500 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;12.164 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;13.186 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;12.830 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;11.487 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;12.386 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;11.100 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;12.053 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;10.870 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;94,45 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;94,52 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;94,8 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;89,76 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;89,83 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;89,53 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;86,72 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;86,51 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;84,39 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;84,72 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;166 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;353 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;1.361 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;161 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;345 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;1.330 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;155 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;335 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;1.300 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;328 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;1.271 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;325 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;1.255 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;96,99 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;97,73 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;97,72 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;93,37 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;94,9 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;95,52 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;92,92 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;93,39 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;92,07 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;92,21 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;14.642 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;14.554 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;14.226 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIV;13.774 06 Cantabria;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIV;13.682 06 Cantabria;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIV;13.253 06 Cantabria;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the second trimester;2022QI;13.159 06 Cantabria;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the second trimester;2021QI;12.767 06 Cantabria;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;12.738 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;12.460 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;12.428 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;12.168 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,07 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,01 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,16 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;90,42 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,74 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,52 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,59 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,39 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,53 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;14.524 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;14.030 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;12.884 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;13.659 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;13.171 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;11.944 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;12.669 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;11.490 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;12.259 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;11.196 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;11.957 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;10.923 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;94,04 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;93,88 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;92,7 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;90,3 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;89,18 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;87,38 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;86,9 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;85,22 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;84,78 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;118 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;524 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;1.342 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;115 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;511 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;1.309 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;490 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;1.277 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;479 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;1.264 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;471 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;1.245 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;97,46 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;97,52 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;97,54 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;93,51 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;95,16 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;91,41 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;94,19 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;89,89 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;92,77 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;11.091 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;10.731 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;11.173 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QI;10.449 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QI;10.131 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QI;9.834 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QII;9.950 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QII;9.768 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QII;9.499 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;9.592 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;9.468 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;9.176 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;9.283 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;9.197 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;8.829 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,21 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,41 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;88,02 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;89,71 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;91,03 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;85,02 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;86,48 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,23 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;82,13 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,7 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,7 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;79,02 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;10.777 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;10.043 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;10.149 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;9.467 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;9.655 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;9.115 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;9.306 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;8.833 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;9.001 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;8.587 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;94,17 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;94,26 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;89,59 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;90,76 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;86,35 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;87,95 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;83,52 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;85,5 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;314 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;688 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;300 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;664 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;295 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;653 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;286 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;635 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;282 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;610 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;95,54 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;96,51 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;93,95 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;94,91 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;91,08 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;92,3 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;89,81 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;88,66 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;11.123 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;10.864 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;10.570 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QII;10.505 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QII;10.366 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QII;10.163 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIII;10.052 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIII;9.972 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIII;9.779 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;9.622 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;9.598 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;9.351 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;9.257 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;9.005 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 06 Cantabria;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,44 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,42 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,15 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;90,37 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;91,79 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,52 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,51 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,35 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,47 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,21 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,19 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;10.797 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;10.147 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;9.202 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;10.187 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;9.661 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;8.819 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;9.742 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;9.287 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;8.482 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;9.323 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;8.938 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;8.110 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;8.618 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;7.808 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;94,35 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;95,21 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;95,84 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;90,23 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;91,52 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;92,18 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;86,35 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;88,09 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;88,13 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;84,93 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;84,85 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;326 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;717 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;1.368 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;318 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;705 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;1.344 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;310 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;685 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;1.297 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;299 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;660 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;1.241 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;639 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;1.197 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;97,55 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;98,33 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,25 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;95,09 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;95,54 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;94,81 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;91,72 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;92,05 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;90,72 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;89,12 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;87,5 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;11.244 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;11.191 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;10.938 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIII;10.459 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIII;10.444 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIII;10.274 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIV;9.862 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIV;9.835 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIV;9.636 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;9.436 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;9.247 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;9.134 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;9.027 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,02 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;93,32 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;93,93 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;87,71 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;87,88 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;88,1 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;84,32 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;84,54 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;81,62 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;82,53 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;11.112 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;11.015 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;10.254 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;10.331 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;10.276 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;9.617 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;9.739 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;9.676 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;9.003 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;9.282 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;8.639 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;8.983 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;8.431 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;92,97 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;93,29 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;93,79 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;87,64 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;87,84 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;87,8 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;84,27 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;84,25 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;81,55 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;82,22 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;132 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;176 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;684 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;128 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;168 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;657 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;123 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;159 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;633 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;154 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;608 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;151 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;596 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;96,97 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;95,45 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;96,05 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;93,18 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;90,34 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;92,54 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;87,5 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;88,89 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;85,8 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;87,13 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;11.122 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;11.150 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;11.006 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIV;10.327 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIV;10.333 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIV;10.087 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QI;9.859 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QI;9.626 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;9.476 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;9.346 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;9.187 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;9.081 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,85 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,67 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;91,65 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;88,42 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,46 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;84,99 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;84,92 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;82,39 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;82,51 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;11.018 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;10.796 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;10.354 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;10.226 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;9.991 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;9.462 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;9.536 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;9.027 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;9.164 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;8.757 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;8.881 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;8.504 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;92,81 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;92,54 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;91,38 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;88,33 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;87,18 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;84,88 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;84,58 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;82,26 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;82,13 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;104 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;354 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;652 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;101 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;342 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;625 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;323 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;599 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;312 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;589 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;306 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;577 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;97,12 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;96,61 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;95,86 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;91,24 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;91,87 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;88,14 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;90,34 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;86,44 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;88,5 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.391 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.310 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.363 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QI;1.366 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QI;1.298 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QI;1.318 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QII;1.339 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QII;1.272 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QII;1.294 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.326 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.260 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.275 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.310 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.249 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.254 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,2 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,08 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,7 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,26 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,1 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,94 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,33 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,18 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;93,54 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;94,18 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;95,34 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;1.321 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;1.094 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;1.297 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;1.086 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;1.271 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;1.061 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;1.258 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;1.053 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;1.242 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;1.042 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,18 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,27 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;96,21 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;96,98 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;95,23 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;96,25 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;94,02 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;95,25 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;70 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;216 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;69 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;212 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;68 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;211 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;68 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;207 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;68 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;207 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;98,57 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,15 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;97,14 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;97,69 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;97,14 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;95,83 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;97,14 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;95,83 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.374 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.299 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.246 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QII;1.352 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QII;1.276 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QII;1.227 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.336 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.270 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.208 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.314 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.258 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.194 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;1.231 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;1.181 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,4 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,23 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,48 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;97,23 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,77 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,95 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,63 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;96,84 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,83 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,77 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,78 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;1.314 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;1.078 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;887 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;1.292 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;1.056 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;873 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;1.276 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;1.051 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;858 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;1.254 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;1.039 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;848 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;1.016 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;839 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,33 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;97,96 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,42 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;97,11 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;97,5 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;96,73 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;95,43 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;96,38 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;95,6 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;94,25 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;94,59 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;60 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;221 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;359 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;60 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;220 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;354 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;60 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;219 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;350 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;60 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;219 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;346 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;215 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;342 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,55 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,61 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;99,1 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;97,49 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;99,1 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;96,38 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;97,29 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;95,26 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.485 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.448 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.360 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.464 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.426 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.337 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.407 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.381 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.296 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;1.348 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;1.277 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;1.333 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;1.264 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,59 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,48 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,31 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,75 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,37 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,29 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,09 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,9 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,06 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,94 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;1.470 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;1.384 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;1.122 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;1.450 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;1.362 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;1.102 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;1.394 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;1.318 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;1.063 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;1.287 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;1.047 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;1.272 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;1.036 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,64 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,41 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,22 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;94,83 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;95,23 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;94,74 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;92,99 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;93,32 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;91,91 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;92,34 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;15 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;64 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;238 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;14 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;64 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;235 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;13 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;63 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;233 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;61 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;230 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;61 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;228 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;93,33 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,74 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;86,67 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;98,44 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;97,9 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;95,31 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;96,64 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;95,31 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;95,8 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.464 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.452 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.339 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.419 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.415 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.305 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QI;1.384 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QI;1.289 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;1.366 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;1.274 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.357 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.262 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,93 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,45 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,46 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,32 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,27 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,08 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,15 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,46 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,25 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;1.455 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;1.387 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;1.093 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;1.410 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;1.350 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;1.065 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;1.321 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;1.053 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;1.303 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;1.039 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;1.295 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;1.031 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;96,91 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;97,33 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;97,44 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;95,24 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;96,34 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;93,94 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;95,06 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;93,37 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;94,33 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;9 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;65 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;246 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;9 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;65 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;240 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;63 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;236 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;63 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;235 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;62 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;231 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;97,56 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;96,92 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;95,93 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;96,92 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;95,53 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;95,38 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;93,9 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.781 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.629 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.837 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QI;1.770 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QI;1.622 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QI;1.798 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QII;1.738 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QII;1.607 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QII;1.789 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.728 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.594 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.781 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.723 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.587 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.769 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,38 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,57 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;97,88 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,59 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;98,65 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;97,39 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;97,02 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;97,85 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;96,95 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;96,74 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;97,42 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;96,3 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;1.701 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;1.305 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;1.690 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;1.300 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;1.659 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;1.287 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;1.649 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;1.276 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;1.644 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;1.270 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,35 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,62 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;97,53 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;98,62 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;96,94 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;97,78 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;96,65 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;97,32 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;80 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;324 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;80 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;322 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;79 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;320 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;79 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;318 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;79 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;317 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,38 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;98,75 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,77 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;98,75 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;98,15 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;98,75 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;97,84 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.840 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.679 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.673 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QII;1.807 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QII;1.659 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QII;1.663 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.801 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.645 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.657 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.787 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.639 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.644 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;1.628 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;1.637 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 06 Cantabria;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,21 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,81 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,4 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;97,88 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,97 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;99,04 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;97,12 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;97,62 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;98,27 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;96,96 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;97,85 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;1.752 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;1.328 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;1.163 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;1.720 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;1.310 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;1.156 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;1.715 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;1.298 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;1.151 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;1.701 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;1.293 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;1.142 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;1.285 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;1.137 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,17 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,64 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,4 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;97,89 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;97,74 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,97 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;97,09 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;97,36 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;98,19 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;96,76 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;97,76 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;88 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;351 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;510 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;87 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;349 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;507 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;86 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;347 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;506 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;86 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;346 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;502 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;343 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;500 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;98,86 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,43 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,41 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;97,73 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;98,86 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;99,22 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;97,73 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;98,58 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;98,43 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;97,72 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;98,04 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.005 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.874 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.776 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.990 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.853 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.766 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.949 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.828 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.739 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;1.809 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;1.731 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;1.790 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;1.718 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,25 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,88 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,44 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;97,21 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;97,55 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97,92 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;96,53 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;97,47 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;95,52 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;96,73 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;1.986 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;1.772 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;1.371 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;1.971 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;1.751 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;1.362 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;1.930 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;1.726 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;1.339 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;1.707 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;1.332 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;1.688 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;1.321 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,24 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,81 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,34 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;97,18 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;97,4 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;97,67 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;96,33 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;97,16 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;95,26 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;96,35 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;19 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;102 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;405 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;19 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;102 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;404 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;19 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;102 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;400 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;102 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;399 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;102 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;397 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,75 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;98,77 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;98,52 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;98,02 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.925 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.827 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.759 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.897 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.810 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.740 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QI;1.792 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QI;1.731 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;1.772 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;1.719 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.760 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.704 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,55 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,07 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,92 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,08 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;98,41 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;96,99 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;97,73 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;96,33 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;96,87 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;1.920 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;1.734 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;1.354 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;1.892 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;1.718 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;1.335 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;1.700 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;1.328 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;1.680 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;1.318 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;1.669 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;1.306 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;98,54 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,08 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;98,6 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,04 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;98,08 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;96,89 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;97,34 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;96,25 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;96,45 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;5 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;93 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;405 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;5 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;92 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;405 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;92 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;403 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;92 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;401 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;91 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;398 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;98,92 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;98,92 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;99,51 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;98,92 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;99,01 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;97,85 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;98,27 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;82 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;78 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;84 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QI;82 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QI;78 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QI;84 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QII;82 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QII;78 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QII;84 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;82 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;78 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;82 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;82 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;78 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;81 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;100 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;100 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;100 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;100 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;100 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;100 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;100 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;100 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;97,62 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;100 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;100 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;96,43 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;76 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;55 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;76 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;55 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;76 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;55 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;76 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;55 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;76 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;55 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;100 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;100 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;100 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;100 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;100 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;100 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;100 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;100 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;6 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;23 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;6 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;23 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;6 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;23 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;6 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;23 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;6 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;23 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;100 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;89 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;79 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;77 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QII;89 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QII;79 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QII;77 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIII;89 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIII;79 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIII;76 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;89 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;79 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;75 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;79 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;75 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 06 Cantabria;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;100 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;100 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;100 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,7 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;100 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;100 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;97,4 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;100 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;97,4 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;84 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;57 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;57 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;84 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;57 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;57 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;84 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;57 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;56 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;84 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;57 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;55 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;57 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;55 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;100 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;100 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,25 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;100 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;100 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;96,49 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;100 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;96,49 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;5 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;22 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;20 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;5 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;22 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;20 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;5 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;22 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;20 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;5 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;22 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;20 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;22 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;20 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;100 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;79 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;80 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;78 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIII;79 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIII;80 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIII;77 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIV;79 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIV;80 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIV;76 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;80 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;76 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;80 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;76 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;100 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,72 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;100 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;100 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97,44 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;100 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;97,44 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;100 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;97,44 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;79 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;74 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;56 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;79 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;74 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;55 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;79 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;74 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;54 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;74 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;54 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;74 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;54 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;100 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,21 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;100 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;100 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;96,43 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;100 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;96,43 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;100 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;96,43 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;0 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;6 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;22 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;0 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;6 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;22 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;0 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;6 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;22 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;6 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;22 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;6 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;22 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;0 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;0 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;0 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;100 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;100 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;88 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;82 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;78 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIV;88 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIV;82 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIV;77 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QI;82 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QI;77 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;82 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;77 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;82 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;77 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;100 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,72 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;100 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;98,72 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;100 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;98,72 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;100 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;98,72 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;88 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;75 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;54 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;88 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;75 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;53 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;75 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;53 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;75 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;53 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;75 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;53 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;100 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;98,15 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;100 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;98,15 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;100 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;98,15 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;100 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;98,15 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;0 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;7 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;24 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;0 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;7 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;24 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;7 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;24 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;7 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;24 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;7 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;24 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;0 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;0 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;100 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;43 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;42 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;48 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QI;43 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QI;42 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QI;47 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QII;43 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QII;42 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QII;47 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;43 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;42 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;46 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;43 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;41 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;46 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;100 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;100 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;97,92 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;100 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;100 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;97,92 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;100 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;100 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;95,83 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;100 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;97,62 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;95,83 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;40 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;32 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;40 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;32 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;40 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;32 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;40 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;32 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;40 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;31 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;100 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;100 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;100 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;100 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;100 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;100 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;100 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;96,88 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;3 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;10 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;3 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;10 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;3 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;10 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;3 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;10 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;3 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;10 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;100 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;43 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;42 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;42 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QII;43 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QII;42 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QII;42 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIII;43 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIII;42 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIII;41 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;43 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;41 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;41 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;41 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;41 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 06 Cantabria;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;100 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;100 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;100 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,62 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;100 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;97,62 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;97,62 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;97,62 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;97,62 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;40 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;33 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;31 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;40 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;33 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;31 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;40 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;33 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;31 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;40 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;32 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;31 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;32 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;31 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;100 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;100 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;100 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;100 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;96,97 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;100 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;96,97 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;100 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;3 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;9 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;11 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;3 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;9 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;11 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;3 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;9 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;10 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;3 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;9 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;10 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;9 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;10 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;90,91 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;90,91 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;90,91 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;44 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;42 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;40 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIII;44 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIII;42 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIII;40 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIV;44 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIV;41 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIV;40 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;41 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;40 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;41 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;40 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;100 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;100 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;100 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;97,62 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;100 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;97,62 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;100 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;97,62 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;100 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;44 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;37 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;28 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;44 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;37 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;28 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;44 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;36 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;28 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;36 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;28 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;36 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;28 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;100 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;100 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;97,3 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;100 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;97,3 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;100 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;97,3 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;100 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;0 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;5 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;12 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;0 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;5 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;12 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;0 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;5 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;12 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;5 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;12 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;5 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;12 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;0 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;0 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;0 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;100 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;100 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;43 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;43 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;44 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIV;43 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIV;42 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIV;44 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QI;42 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QI;44 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;42 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;44 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;42 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;44 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,67 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;100 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;97,67 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;100 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;97,67 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;100 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;97,67 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;100 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;43 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;38 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;29 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;43 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;37 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;29 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;37 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;29 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;37 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;29 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;37 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;29 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;97,37 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;97,37 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;100 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;97,37 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;100 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;97,37 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;100 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;0 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;5 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;15 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;0 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;5 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;15 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;5 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;15 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;5 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;15 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;5 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;15 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;0 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;0 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;100 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 06 Cantabria;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;55.901 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;54.487 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;57.537 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the first trimester;2022QI;53.306 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the first trimester;2021QI;52.076 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the first trimester;2020QI;52.081 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the second trimester;2022QII;51.361 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the second trimester;2021QII;50.488 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the second trimester;2020QII;50.435 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;49.854 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;49.235 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;49.080 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;48.490 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;48.129 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;47.764 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,36 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,58 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;90,52 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,88 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,66 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;87,66 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,18 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,36 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,3 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,74 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,33 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,01 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;53.590 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;47.544 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;51.076 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;45.286 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;49.173 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;43.851 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;47.725 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;42.715 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;46.409 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;41.706 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;95,31 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;95,25 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;91,76 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;92,23 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;89,06 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;89,84 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;86,6 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;87,72 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;2.311 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;6.943 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;2.230 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;6.790 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;2.188 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;6.637 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;2.129 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;6.520 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;2.081 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;6.423 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;96,5 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;97,8 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;94,68 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;95,59 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;92,12 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;93,91 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;90,05 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;92,51 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;55.838 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;54.554 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;53.930 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the first trimester;2022QII;53.399 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the first trimester;2021QII;52.515 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the first trimester;2020QII;52.020 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIII;51.579 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIII;50.959 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIII;50.483 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;49.933 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;49.546 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;49.009 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;48.140 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;47.510 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 07 Castilla y León;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,63 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,26 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,46 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,37 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,41 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,61 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,42 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,82 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,88 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,24 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;88,1 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;53.637 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;47.825 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;42.206 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;51.254 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;45.937 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;40.463 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;49.489 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;44.499 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;39.176 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;47.892 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;43.187 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;37.984 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;41.901 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;36.731 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;95,56 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;96,05 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;95,87 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;92,27 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;93,05 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;92,82 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;89,29 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;90,3 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;90 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;87,61 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;87,03 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;2.201 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;6.729 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;11.724 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;2.145 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;6.578 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;11.557 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;2.090 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;6.460 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;11.307 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;2.041 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;6.359 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;11.025 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;6.239 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;10.779 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;97,46 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,76 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,58 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;94,96 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;96 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;96,44 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;92,73 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;94,5 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;94,04 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;92,72 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;91,94 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;56.702 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;56.024 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;55.021 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIII;53.778 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIII;53.390 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIII;52.673 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIV;51.563 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIV;51.387 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIV;50.615 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;49.745 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;48.961 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;48.533 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;47.921 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;94,84 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,3 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,73 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,94 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,72 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,99 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,79 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,99 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,63 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,1 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;55.665 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;54.120 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;47.264 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;52.773 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;51.534 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;45.068 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;50.588 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;49.569 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;43.187 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;47.954 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;41.683 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;46.773 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;40.782 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;94,8 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;95,22 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;95,35 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;90,88 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;91,59 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;91,37 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;88,61 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;88,19 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;86,42 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;86,29 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;1.037 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;1.904 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;7.757 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;1.005 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;1.856 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;7.605 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;975 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;1.818 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;7.428 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;1.791 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;7.278 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;1.760 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;7.139 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;96,91 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;97,48 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,04 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;94,02 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;95,48 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;95,76 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;94,07 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;93,82 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;92,44 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;92,03 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;55.874 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;55.865 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;55.370 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIV;53.106 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIV;53.194 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIV;52.464 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the second trimester;2022QI;51.267 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the second trimester;2021QI;50.546 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;49.797 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;49.287 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;48.542 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;48.206 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,05 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,22 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,75 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,77 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,29 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,14 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,01 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,89 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,06 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;54.972 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;53.399 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;47.715 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;52.230 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;50.779 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;44.998 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;48.924 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;43.224 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;47.514 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;42.117 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;46.314 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;41.158 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;95,01 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;95,09 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;94,31 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;91,62 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;90,59 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;88,98 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;88,27 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;86,73 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;86,26 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;902 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;2.466 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;7.655 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;876 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;2.415 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;7.466 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;2.343 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;7.322 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;2.283 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;7.170 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;2.228 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;7.048 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;97,12 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;97,93 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;97,53 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;95,01 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;95,65 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;92,58 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;93,66 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;90,35 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;92,07 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;42.812 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;42.319 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;44.225 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QI;40.342 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QI;40.024 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QI;39.027 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QII;38.555 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QII;38.557 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QII;37.535 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;37.176 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;37.396 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;36.303 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;35.907 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;36.360 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;35.104 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,23 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,58 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;88,25 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;90,06 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;91,11 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,87 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;86,84 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,37 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;82,09 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,87 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,92 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;79,38 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;41.301 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;38.384 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;38.904 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;36.220 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;37.147 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;34.877 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;35.819 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;33.806 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;34.593 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;32.857 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;94,2 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;94,36 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;89,94 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;90,86 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;86,73 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;88,07 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;83,76 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;85,6 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;1.511 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;3.935 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;1.438 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;3.804 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;1.408 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;3.680 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;1.357 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;3.590 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;1.314 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;3.503 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;95,17 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;96,67 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;93,18 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;93,52 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;89,81 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;91,23 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;86,96 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;89,02 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;42.598 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;42.205 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;41.664 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QII;40.322 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QII;40.293 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QII;39.870 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIII;38.624 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIII;38.828 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIII;38.431 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;37.084 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;37.491 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;37.044 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;36.203 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;35.674 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,66 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,47 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,69 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;90,67 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,24 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,06 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,83 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,91 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,78 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,62 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;41.215 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;38.410 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;34.377 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;38.983 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;36.622 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;32.720 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;37.332 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;35.254 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;31.492 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;35.833 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;34.011 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;30.347 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;32.810 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;29.184 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;94,58 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;95,34 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;95,18 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;90,58 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;91,78 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;91,61 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;86,94 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;88,55 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;88,28 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;85,42 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;84,89 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;1.383 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;3.795 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;7.287 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;1.339 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;3.671 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;7.150 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;1.292 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;3.574 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;6.939 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;1.251 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;3.480 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;6.697 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;3.393 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;6.490 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;96,82 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;96,73 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,12 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;93,42 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;94,18 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;95,22 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;90,46 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;91,7 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;91,9 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;89,41 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;89,06 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;43.052 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;43.120 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;42.635 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIII;40.286 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIII;40.607 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIII;40.391 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIV;38.231 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIV;38.714 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIV;38.446 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;37.198 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;36.927 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;36.076 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;35.984 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,58 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;94,17 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,74 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;88,8 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;89,78 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,17 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;86,27 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,61 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;83,66 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,4 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;42.333 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;42.050 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;38.340 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;39.592 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;39.581 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;36.224 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;37.563 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;37.723 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;34.423 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;36.228 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;33.028 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;35.127 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;32.192 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;93,53 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;94,13 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;94,48 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;88,73 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;89,71 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;89,78 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;86,15 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;86,15 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;83,54 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;83,96 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;719 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;1.070 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;4.295 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;694 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;1.026 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;4.167 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;668 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;991 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;4.023 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;970 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;3.899 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;949 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;3.792 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;96,52 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;95,89 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;97,02 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;92,91 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;92,62 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;93,67 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;90,65 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;90,78 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;88,69 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;88,29 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;42.422 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;42.888 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;42.826 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIV;39.802 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIV;40.308 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIV;40.027 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QI;38.516 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QI;38.243 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;37.158 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;37.087 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;36.011 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;36.095 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,82 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,98 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,46 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;89,81 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,3 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;86,64 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;86,6 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;83,97 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,28 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;41.791 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;41.250 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;38.646 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;39.193 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;38.717 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;36.004 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;36.985 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;34.339 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;35.680 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;33.304 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;34.579 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;32.405 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;93,78 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;93,86 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;93,16 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;89,66 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;88,86 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;86,5 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;86,18 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;83,83 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;83,85 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;631 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;1.638 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;4.180 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;609 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;1.591 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;4.023 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;1.531 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;3.904 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;1.478 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;3.783 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;1.432 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;3.690 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;96,51 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;97,13 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;96,24 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;93,47 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;93,4 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;90,23 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;90,5 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;87,42 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;88,28 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;5.586 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;5.252 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;5.778 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QI;5.526 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QI;5.183 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QI;5.621 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QII;5.433 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QII;5.116 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QII;5.527 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.359 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;5.067 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.455 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.306 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.027 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.392 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,93 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,69 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;97,28 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,26 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,41 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,66 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,94 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,48 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,41 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;94,99 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;95,72 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;93,32 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;5.260 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;4.121 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;5.204 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;4.064 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;5.119 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;4.011 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;5.050 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;3.981 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;5.000 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;3.947 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,94 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,62 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;97,32 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;97,33 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;96,01 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;96,6 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;95,06 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;95,78 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;326 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;1.131 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;322 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;1.119 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;314 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;1.105 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;309 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;1.086 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;306 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;1.080 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;98,77 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,94 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;96,32 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;97,7 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;94,79 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;96,02 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;93,87 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;95,49 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;5.696 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;5.368 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;5.310 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QII;5.598 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QII;5.300 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QII;5.238 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.527 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.247 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.177 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.461 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.200 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.125 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;5.136 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;5.040 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,28 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,73 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,64 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;97,03 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,75 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,5 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,87 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;96,87 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,52 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;95,68 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,92 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;5.381 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;4.260 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;3.456 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;5.288 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;4.205 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;3.402 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;5.220 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;4.166 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;3.368 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;5.157 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;4.123 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;3.340 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;4.075 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;3.284 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,27 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,71 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,44 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;97,01 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;97,79 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;97,45 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;95,84 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;96,78 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;96,64 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;95,66 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;95,02 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;315 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;1.108 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;1.854 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;310 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;1.095 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;1.836 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;307 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;1.081 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;1.809 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;304 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;1.077 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;1.785 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;1.061 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;1.756 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;98,41 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;98,83 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,03 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;97,46 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;97,56 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;97,57 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;96,51 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;97,2 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;96,28 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;95,76 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;94,71 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5.914 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.587 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.381 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.812 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.507 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.318 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.717 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.445 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.253 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;5.383 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;5.161 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;5.332 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;5.108 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,28 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,57 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,83 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,67 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;97,46 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97,62 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;96,35 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,91 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;95,44 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,93 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;5.790 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;5.290 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;4.082 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;5.691 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;5.212 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;4.036 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;5.597 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;5.151 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;3.990 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;5.091 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;3.916 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;5.044 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;3.877 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,29 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,53 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,87 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;96,67 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;97,37 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;97,75 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;96,24 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;95,93 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;95,35 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;94,98 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;124 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;297 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;1.299 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;121 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;295 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;1.282 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;120 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;294 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;1.263 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;292 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;1.245 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;288 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;1.231 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;97,58 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,33 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,69 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;96,77 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;98,99 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;97,23 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;98,32 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;95,84 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;96,97 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;94,77 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.746 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;5.589 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;5.465 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.658 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIV;5.539 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIV;5.405 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QI;5.472 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QI;5.322 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;5.413 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;5.264 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.353 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.221 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,47 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,11 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,9 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;97,91 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,38 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;96,85 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;96,32 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;95,78 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;95,54 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;5.649 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;5.253 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;4.148 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;5.562 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;5.206 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;4.099 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;5.145 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;4.031 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;5.089 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;3.988 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;5.036 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;3.962 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;98,46 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,11 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;98,82 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;97,94 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;97,18 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;96,88 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;96,14 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;95,87 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;95,52 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;97 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;336 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;1.317 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;96 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;333 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;1.306 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;327 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;1.291 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;324 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;1.276 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;317 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;1.259 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;98,97 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;99,11 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,16 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;97,32 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,03 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;96,43 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;96,89 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;94,35 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;95,6 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;7.027 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.451 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;7.069 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QI;6.965 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QI;6.407 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QI;6.972 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QII;6.902 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QII;6.355 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QII;6.913 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.849 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.315 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.864 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.809 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.289 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.811 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,12 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,32 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;98,63 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;98,22 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;98,51 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;97,79 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;97,47 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;97,89 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;97,1 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;96,9 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;97,49 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;96,35 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;6.588 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;4.727 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;6.530 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;4.692 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;6.471 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;4.655 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;6.421 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;4.622 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;6.383 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;4.598 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,12 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,26 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;98,22 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;98,48 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;97,47 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;97,78 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;96,89 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;97,27 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;439 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;1.724 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;435 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;1.715 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;431 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;1.700 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;428 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;1.693 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;426 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;1.691 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;99,09 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,48 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;98,18 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,61 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;97,49 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;98,2 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;97,04 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;98,09 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.064 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.536 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.512 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QII;7.001 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QII;6.478 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QII;6.469 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.951 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.443 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.434 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;6.913 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.415 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;6.400 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;6.364 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;6.359 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;99,11 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,11 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,34 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;98,4 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;98,58 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,8 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;97,86 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;98,15 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;98,28 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;97,37 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;97,65 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;6.600 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;4.848 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;4.097 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;6.544 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;4.804 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;4.066 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;6.499 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;4.775 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;4.042 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;6.465 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;4.749 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;4.023 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;4.715 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;3.991 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;99,15 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;99,09 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,24 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;98,47 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;98,49 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,66 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;97,95 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;97,96 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;98,19 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;97,26 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;97,41 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;464 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;1.688 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;2.415 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;457 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;1.674 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;2.403 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;452 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;1.668 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;2.392 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;448 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;1.666 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;2.377 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;1.649 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;2.368 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;98,49 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,17 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,5 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;97,41 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;98,82 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;99,05 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;96,55 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;98,7 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;98,43 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;97,69 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;98,05 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;7.257 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.862 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.566 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIII;7.202 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.823 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.527 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIV;7.139 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.776 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.480 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;6.715 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;6.440 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;6.677 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;6.399 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,24 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,43 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,41 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;98,37 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;98,75 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;98,69 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;97,86 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;98,08 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;97,3 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;97,46 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;7.079 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;6.374 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;4.562 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;7.028 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;6.337 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;4.529 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;6.967 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;6.292 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;4.495 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;6.235 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;4.462 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;6.203 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;4.439 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,28 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99,42 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,28 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;98,42 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;98,71 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;98,53 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;97,82 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;97,81 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;97,32 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;97,3 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;178 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;488 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;2.004 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;174 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;486 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;1.998 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;172 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;484 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;1.985 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;480 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;1.978 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;474 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;1.960 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;97,75 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,59 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,7 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;96,63 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;99,18 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;99,05 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;98,36 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;98,7 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;97,13 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;97,8 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;7.216 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.925 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.626 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.158 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.884 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.580 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QI;6.819 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QI;6.532 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;6.767 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;6.490 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.720 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.447 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,2 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,41 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,31 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,47 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;98,58 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;97,72 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;97,95 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;97,04 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;97,3 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;7.055 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;6.473 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;4.629 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;6.999 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;6.433 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;4.603 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;6.374 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;4.564 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;6.326 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;4.538 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;6.281 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;4.506 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,21 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,38 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,44 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,47 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;98,6 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;97,73 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;98,03 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;97,03 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;97,34 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;161 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;452 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;1.997 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;159 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;451 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;1.977 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;445 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;1.968 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;441 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;1.952 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;439 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;1.941 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;98,76 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;99,78 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;98,45 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,55 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;97,57 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;97,75 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;97,12 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;97,2 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;312 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;310 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;312 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QI;309 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QI;308 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QI;308 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QII;307 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QII;307 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QII;308 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;307 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;304 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;307 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;307 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;300 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;306 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,04 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,35 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;98,72 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;98,4 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;99,03 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;98,72 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;98,4 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;98,06 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;98,4 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;98,4 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;96,77 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;98,08 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;291 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;213 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;288 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;212 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;286 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;211 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;286 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;209 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;286 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;207 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,97 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,53 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;98,28 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;99,06 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;98,28 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;98,12 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;98,28 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;97,18 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;21 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;97 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;21 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;96 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;21 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;96 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;21 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;95 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;21 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;93 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,97 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,97 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;97,94 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;95,88 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;313 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;289 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;296 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QII;311 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QII;288 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QII;295 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIII;311 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIII;285 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIII;294 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;311 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;284 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;293 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;281 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;291 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;99,36 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,65 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,66 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;99,36 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;98,62 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;99,32 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;99,36 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;98,27 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;98,99 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;97,23 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;98,31 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;292 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;205 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;181 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;290 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;204 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;180 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;290 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;202 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;180 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;290 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;202 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;180 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;199 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;179 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;99,32 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;99,51 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,45 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;99,32 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;98,54 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;99,45 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;99,32 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;98,54 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;99,45 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;97,07 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;98,9 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;21 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;84 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;115 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;21 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;84 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;115 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;21 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;83 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;114 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;21 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;82 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;113 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;82 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;112 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;98,81 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;99,13 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;97,62 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;98,26 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;97,62 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;97,39 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;318 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;305 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;295 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIII;318 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIII;303 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIII;294 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIV;318 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIV;302 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIV;293 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;299 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;291 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;298 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;289 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;100 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,34 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,66 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;100 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;99,02 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;99,32 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;98,03 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;98,64 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;97,7 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;97,97 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;311 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;276 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;187 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;311 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;274 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;187 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;311 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;273 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;187 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;270 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;186 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;269 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;184 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;100 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99,28 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;100 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;98,91 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;100 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;97,83 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;99,47 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;97,46 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;98,4 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;7 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;29 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;108 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;7 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;29 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;107 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;7 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;29 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;106 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;29 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;105 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;29 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;105 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,07 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;98,15 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;97,22 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;97,22 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;327 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;308 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;299 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIV;326 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIV;308 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIV;298 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QI;305 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QI;296 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;304 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;294 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;304 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;291 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,69 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;100 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,67 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;99,03 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;99 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;98,7 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;98,33 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;98,7 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;97,32 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;321 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;284 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;197 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;321 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;284 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;197 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;281 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;196 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;280 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;194 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;280 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;192 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;100 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,94 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;99,49 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;98,59 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;98,48 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;98,59 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;97,46 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;6 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;24 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;102 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;5 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;24 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;101 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;24 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;100 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;24 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;100 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;24 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;99 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;83,33 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,02 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,04 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;98,04 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;97,06 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;164 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;155 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;153 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QI;164 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QI;154 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QI;153 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QII;164 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QII;153 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QII;152 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;163 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;153 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;151 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;161 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;153 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;151 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;100 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,35 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;100 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;100 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;98,71 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;99,35 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;99,39 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;98,71 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;98,69 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;98,17 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;98,71 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;98,69 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;150 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;99 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;150 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;98 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;150 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;97 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;149 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;97 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;147 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;97 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;100 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,99 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;100 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;97,98 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;99,33 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;97,98 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;98 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;97,98 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;14 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;56 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;14 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;56 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;14 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;56 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;14 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;56 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;14 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;56 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;100 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;167 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;156 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;148 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QII;167 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QII;156 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QII;148 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIII;166 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIII;156 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIII;147 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;164 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;156 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;147 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;156 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;146 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 07 Castilla y León;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;100 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;99,4 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;100 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;99,32 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;98,2 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;100 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;99,32 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;100 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;98,65 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;149 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;102 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;95 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;149 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;102 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;95 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;148 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;102 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;94 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;147 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;102 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;94 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;102 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;93 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;99,33 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;100 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,95 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;98,66 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;100 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;98,95 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;100 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;97,89 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;18 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;54 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;53 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;18 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;54 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;53 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;18 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;54 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;53 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;17 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;54 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;53 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;54 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;53 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;94,44 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;100 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;161 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;150 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;144 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIII;160 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIII;150 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIII;143 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIV;158 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIV;150 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIV;143 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;150 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;142 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;150 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;141 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,38 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,31 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;98,14 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;100 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;99,31 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;100 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;98,61 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;100 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;97,92 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;152 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;130 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;93 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;151 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;130 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;92 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;150 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;130 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;92 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;130 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;91 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;130 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;90 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,34 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,92 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;98,68 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;100 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;98,92 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;100 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;97,85 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;100 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;96,77 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;9 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;20 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;51 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;9 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;20 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;51 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;8 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;20 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;51 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;20 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;51 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;20 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;51 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;88,89 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;100 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;100 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;163 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;155 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;154 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIV;162 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIV;155 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIV;154 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QI;155 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QI;153 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;155 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;152 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;154 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;152 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,39 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;100 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;100 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;100 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;99,35 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;100 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;98,7 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;99,35 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;98,7 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;156 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;139 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;95 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;155 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;139 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;95 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;139 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;94 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;139 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;93 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;138 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;93 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,36 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;100 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;100 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;98,95 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;100 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;97,89 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;99,28 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;97,89 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;7 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;16 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;59 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;7 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;16 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;59 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;16 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;59 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;16 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;59 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;16 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;59 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;100 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 07 Castilla y León;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;46.037 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;44.347 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;46.329 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the first trimester;2022QI;43.385 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the first trimester;2021QI;41.879 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the first trimester;2020QI;40.060 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the second trimester;2022QII;41.425 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the second trimester;2021QII;40.387 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the second trimester;2020QII;38.804 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;39.925 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;39.070 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;37.668 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;38.784 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;38.045 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;36.630 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,24 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,43 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;86,47 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;89,98 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;91,07 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;83,76 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;86,72 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,1 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;81,31 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,25 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,79 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;79,06 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;43.834 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;39.282 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;41.257 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;36.942 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;39.371 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;35.540 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;37.922 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;34.323 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;36.819 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;33.375 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;94,12 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;94,04 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;89,82 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;90,47 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;86,51 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;87,38 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;84 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;84,96 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;2.203 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;5.065 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;2.128 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;4.937 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;2.054 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;4.847 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;2.003 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;4.747 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;1.965 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;4.670 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;96,6 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;97,47 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;93,24 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;95,7 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;90,92 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;93,72 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;89,2 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;92,2 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;46.024 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;44.593 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;41.915 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the first trimester;2022QII;43.534 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the first trimester;2021QII;42.510 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the first trimester;2020QII;40.375 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIII;41.669 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIII;40.809 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIII;39.048 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;40.280 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;39.466 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;37.851 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;38.056 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;36.568 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,59 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,33 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,33 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;90,54 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;91,51 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,16 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,52 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,5 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,3 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,34 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87,24 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;43.856 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;39.749 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;32.703 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;41.455 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;37.765 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;31.250 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;39.642 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;36.167 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;30.113 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;38.299 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;34.907 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;29.129 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;33.613 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;28.083 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;94,53 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;95,01 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;95,56 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;90,39 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;90,99 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;92,08 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;87,33 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;87,82 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;89,07 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;84,56 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;85,87 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;2.168 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;4.844 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;9.212 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;2.079 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;4.745 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;9.125 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;2.027 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;4.642 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;8.935 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;1.981 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;4.559 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;8.722 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;4.443 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;8.485 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;95,89 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,96 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,06 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;93,5 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;95,83 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;96,99 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;91,37 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;94,12 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;94,68 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;91,72 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;92,11 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;46.371 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;45.956 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;44.240 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIII;43.547 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIII;43.134 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIII;41.894 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIV;41.732 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIV;41.305 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIV;40.047 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;39.656 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;38.521 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;38.488 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;37.623 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,91 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;93,86 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,7 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;89,88 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,52 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;86,29 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,07 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;83,75 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,04 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;45.548 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;44.207 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;38.447 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;42.753 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;41.429 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;36.215 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;40.954 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;39.634 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;34.496 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;38.026 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;33.106 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;36.900 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;32.293 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;93,86 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;93,72 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;94,19 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;89,91 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;89,66 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;89,72 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;86,02 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;86,11 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;83,47 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;83,99 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;823 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;1.749 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;5.793 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;794 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;1.705 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;5.679 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;778 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;1.671 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;5.551 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;1.630 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;5.415 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;1.588 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;5.330 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;96,48 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;97,48 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,03 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;94,53 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;95,54 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;95,82 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;93,2 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;93,47 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;90,79 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;92,01 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;45.739 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;45.619 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;44.509 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIV;43.329 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIV;43.151 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIV;41.924 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the second trimester;2022QI;41.224 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the second trimester;2021QI;40.057 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;39.770 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;38.924 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;38.540 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;37.849 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,73 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,59 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,19 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;90,37 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,18 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,45 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,48 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,04 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;45.032 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;43.252 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;38.829 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;42.635 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;40.852 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;36.382 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;39.006 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;34.647 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;37.636 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;33.606 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;36.463 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;32.631 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;94,68 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;94,45 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;93,7 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;90,18 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;89,23 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;87,02 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;86,55 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;84,3 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;84,04 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;707 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;2.367 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;5.680 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;694 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;2.299 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;5.542 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;2.218 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;5.410 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;2.134 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;5.318 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;2.077 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;5.218 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;98,16 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;97,13 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;97,57 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;93,71 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;95,25 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;90,16 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;93,63 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;87,75 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;91,87 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;35.182 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;34.345 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;35.538 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QI;32.667 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QI;31.999 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QI;29.693 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QII;30.903 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QII;30.624 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QII;28.570 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;29.513 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;29.404 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;27.549 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;28.455 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;28.475 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;26.621 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,85 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,17 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;83,55 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,84 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;89,17 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;80,39 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;83,89 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;85,61 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;77,52 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;80,88 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;82,91 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;74,91 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;33.761 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;31.563 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;31.314 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;29.320 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;29.614 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;28.019 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;28.269 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;26.876 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;27.245 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;26.005 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;92,75 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;92,89 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;87,72 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;88,77 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;83,73 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;85,15 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;80,7 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;82,39 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;1.421 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;2.782 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;1.353 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;2.679 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;1.289 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;2.605 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;1.244 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;2.528 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;1.210 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;2.470 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;95,21 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;96,3 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;90,71 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;93,64 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;87,54 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;90,87 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;85,15 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;88,79 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;35.130 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;34.504 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;32.473 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QII;32.819 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QII;32.551 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QII;31.021 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIII;31.076 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIII;30.954 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIII;29.776 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;29.778 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;29.722 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;28.659 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;28.428 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;27.490 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,42 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,34 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,53 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;88,46 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;89,71 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,69 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;84,77 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;86,14 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,25 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;82,39 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,65 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;33.766 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;31.736 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;26.745 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;31.534 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;29.865 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;25.367 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;29.837 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;28.351 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;24.282 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;28.577 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;27.182 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;23.349 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;25.990 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;22.367 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;93,39 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;94,1 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;94,85 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;88,36 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;89,33 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;90,79 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;84,63 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;85,65 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;87,3 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;81,89 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;83,63 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;1.364 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;2.768 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;5.728 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;1.285 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;2.686 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;5.654 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;1.239 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;2.603 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;5.494 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;1.201 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;2.540 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;5.310 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;2.438 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;5.123 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;94,21 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,04 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,71 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;90,84 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;94,04 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;95,91 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;88,05 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;91,76 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;92,7 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;88,08 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;89,44 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;35.233 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;35.316 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;34.193 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIII;32.573 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIII;32.636 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIII;31.955 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIV;30.887 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIV;30.946 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIV;30.235 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;29.428 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;28.863 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;28.364 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;28.051 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;92,45 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;92,41 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;93,45 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;87,66 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;87,63 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;88,42 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;83,33 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;84,41 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;80,31 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;82,04 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;34.628 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;34.290 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;31.123 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;31.994 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;31.648 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;28.978 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;30.321 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;29.986 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;27.361 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;28.501 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;26.084 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;27.474 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;25.334 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;92,39 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;92,3 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;93,11 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;87,56 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;87,45 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;87,91 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;83,12 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;83,81 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;80,12 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;81,4 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;605 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;1.026 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;3.070 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;579 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;988 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;2.977 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;566 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;960 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;2.874 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;927 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;2.779 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;890 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;2.717 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;95,7 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;96,3 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;96,97 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;93,55 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;93,57 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;93,62 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;90,35 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;90,52 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;86,74 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;88,5 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;34.744 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;34.960 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;34.334 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIV;32.455 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIV;32.620 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIV;31.872 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QI;30.839 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QI;30.146 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;29.525 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;29.107 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;28.381 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;28.114 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,41 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,31 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,83 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;88,21 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,8 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;84,45 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;84,78 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;81,18 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;81,88 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;34.234 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;33.377 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;31.258 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;31.956 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;31.098 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;28.912 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;29.390 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;27.286 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;28.148 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;26.321 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;27.057 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;25.407 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;93,35 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;93,17 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;92,49 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;88,05 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;87,29 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;84,33 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;84,21 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;81,06 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;81,28 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;510 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;1.583 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;3.076 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;499 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;1.522 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;2.960 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;1.449 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;2.860 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;1.377 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;2.786 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;1.324 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;2.707 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;97,84 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;96,15 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;96,23 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;91,54 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;92,98 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;86,99 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;90,57 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;83,64 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;88 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.809 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.400 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.745 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QI;4.723 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QI;4.340 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QI;4.496 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QII;4.616 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QII;4.285 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QII;4.431 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.554 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.227 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.369 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.504 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.171 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.302 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,21 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,64 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,75 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,99 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,39 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,38 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,7 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,07 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,08 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,66 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,8 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,66 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;4.486 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;3.517 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;4.404 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;3.468 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;4.305 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;3.419 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;4.246 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;3.374 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;4.198 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;3.325 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,17 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,61 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;95,97 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;97,21 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;94,65 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;95,93 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;93,58 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;94,54 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;323 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;883 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;319 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;872 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;311 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;866 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;308 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;853 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;306 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;846 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;98,76 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,75 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;96,28 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,07 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;95,36 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;96,6 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;94,74 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;95,81 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.745 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.427 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.119 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QII;4.650 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QII;4.368 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QII;4.076 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIII;4.578 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIII;4.310 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.032 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;4.526 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;4.244 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.981 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;4.171 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;3.924 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,67 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,96 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,48 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,36 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,89 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,38 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,87 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,65 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,22 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;95,27 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;4.410 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;3.625 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;2.587 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;4.319 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;3.571 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;2.549 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;4.250 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;3.525 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;2.518 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;4.204 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;3.468 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;2.486 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;3.404 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;2.453 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;97,94 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,51 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,53 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;96,37 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;97,24 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;97,33 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;95,33 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;95,67 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;96,1 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;93,9 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;94,82 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;335 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;802 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;1.532 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;331 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;797 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;1.527 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;328 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;785 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;1.514 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;322 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;776 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;1.495 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;767 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;1.471 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;98,81 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,38 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,67 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;97,91 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;97,88 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,83 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;96,12 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;96,76 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;97,58 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;95,64 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;96,02 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.846 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.701 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.436 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.754 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.625 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.384 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIV;4.675 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.548 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.296 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;4.473 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;4.215 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;4.420 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;4.168 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,1 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,38 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,83 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,47 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,75 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,84 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,15 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,02 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;94,02 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,96 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;4.744 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;4.403 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;3.395 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;4.654 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;4.329 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;3.353 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;4.578 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;4.254 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;3.282 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;4.184 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;3.221 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;4.134 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;3.183 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,1 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,32 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,76 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;96,5 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;96,62 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;96,67 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;95,03 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;94,87 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;93,89 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;93,76 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;102 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;298 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;1.041 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;296 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;1.031 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;97 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;294 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;1.014 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;289 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;994 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;286 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;985 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;98,04 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,33 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,04 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;95,1 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;98,66 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;97,41 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;96,98 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;95,49 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;95,97 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;94,62 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.753 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.658 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.405 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIV;4.677 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.585 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.328 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QI;4.497 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QI;4.253 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;4.422 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;4.209 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;4.376 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.168 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,4 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,43 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,25 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,54 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,55 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,93 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,55 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,95 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,62 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;4.663 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;4.332 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;3.407 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;4.589 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;4.262 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;3.344 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;4.179 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;3.287 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;4.110 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;3.251 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;4.066 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;3.222 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;98,41 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;98,38 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;98,15 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;96,47 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;96,48 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;94,88 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;95,42 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;93,86 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;94,57 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;90 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;326 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;998 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;88 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;323 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;984 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;318 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;966 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;312 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;958 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;310 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;946 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;97,78 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;99,08 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;98,6 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;97,55 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;96,79 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;95,71 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;95,99 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;95,09 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;94,79 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;5.739 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;5.324 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;5.752 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QI;5.689 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QI;5.264 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QI;5.579 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QII;5.600 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QII;5.203 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QII;5.511 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.553 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;5.165 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.459 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.520 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.125 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.416 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,13 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,87 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,99 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,58 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,73 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,81 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;96,76 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;97,01 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,91 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;96,18 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;96,26 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;94,16 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;5.314 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;4.015 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;5.267 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;3.969 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;5.180 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;3.918 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;5.135 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;3.889 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;5.104 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;3.861 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,12 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,85 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;97,48 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;97,58 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;96,63 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;96,86 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;96,05 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;96,16 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;425 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;1.309 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;422 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;1.295 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;420 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;1.285 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;418 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;1.276 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;416 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;1.264 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;99,29 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,93 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;98,82 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,17 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;98,35 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;97,48 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;97,88 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;96,56 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;5.839 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;5.381 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;5.049 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QII;5.755 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QII;5.311 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QII;5.004 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.706 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.266 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.967 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.667 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.221 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.938 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;5.179 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;4.882 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,56 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,7 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,11 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;97,72 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,86 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,38 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;97,05 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;97,03 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;97,8 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;96,25 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;96,69 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;5.404 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;4.191 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;3.170 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;5.326 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;4.133 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;3.133 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;5.279 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;4.095 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;3.113 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;5.242 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;4.061 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;3.094 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;4.024 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;3.064 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,56 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,62 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,83 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;97,69 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;97,71 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,2 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;97 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;96,9 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;97,6 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;96,02 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;96,66 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;435 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;1.190 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;1.879 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;429 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;1.178 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;1.871 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;427 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;1.171 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;1.854 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;425 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;1.160 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;1.844 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;1.155 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;1.818 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;98,62 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;98,99 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,57 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;98,16 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;98,4 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,67 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;97,7 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;97,48 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;98,14 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;97,06 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;96,75 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5.973 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.646 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.333 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.903 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.580 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.278 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.853 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.519 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.239 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;5.465 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;5.167 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;5.414 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;5.129 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,83 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,83 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,97 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;97,99 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;97,75 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;98,24 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;96,79 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;96,89 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;95,89 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;96,17 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;5.866 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;5.254 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;3.746 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;5.797 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;5.192 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;3.702 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;5.747 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;5.134 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;3.671 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;5.083 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;3.620 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;5.034 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;3.596 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,82 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,82 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,83 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;97,97 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;97,72 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;98 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;96,75 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;96,64 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;95,81 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;96 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;107 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;392 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;1.587 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;106 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;388 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;1.576 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;106 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;385 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;1.568 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;382 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;1.547 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;380 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;1.533 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;99,07 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;98,98 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,31 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;99,07 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;98,21 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;98,8 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;97,45 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;97,48 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;96,94 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;96,6 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.914 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;5.692 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;5.486 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.869 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIV;5.637 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIV;5.440 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QI;5.581 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QI;5.375 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;5.516 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;5.326 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.477 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.286 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,24 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,03 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,16 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,05 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,98 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;96,91 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;97,08 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;96,22 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;96,35 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;5.817 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;5.271 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;3.973 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;5.772 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;5.220 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;3.935 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;5.167 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;3.884 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;5.108 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;3.845 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;5.070 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;3.813 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,23 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,03 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,04 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,03 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;97,76 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;96,91 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;96,78 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;96,19 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;95,97 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;97 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;421 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;1.513 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;97 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;417 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;1.505 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;414 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;1.491 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;408 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;1.481 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;407 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;1.473 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;99,05 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,47 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;98,34 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,55 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;96,91 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;97,88 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;96,67 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;97,36 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;213 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;190 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;206 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QI;212 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QI;188 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QI;204 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QII;212 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QII;187 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QII;204 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;211 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;187 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;203 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;211 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;187 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;203 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,53 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,95 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;99,03 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;99,53 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;98,42 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;99,03 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;99,06 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;98,42 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;98,54 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;99,06 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;98,42 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;98,54 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;190 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;130 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;189 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;128 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;189 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;127 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;189 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;127 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;189 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;127 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,47 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,46 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;99,47 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;97,69 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;99,47 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;97,69 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;99,47 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;97,69 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;23 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;60 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;23 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;60 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;23 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;60 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;22 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;60 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;22 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;60 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;95,65 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;95,65 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;215 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;188 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;188 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QII;215 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QII;187 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QII;188 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIII;214 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIII;187 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIII;187 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;214 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;187 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;187 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;186 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;186 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,47 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;99,53 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;99,47 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;99,47 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;99,53 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;99,47 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;99,47 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;98,94 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;98,94 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;192 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;136 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;140 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;192 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;135 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;140 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;192 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;135 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;139 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;192 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;135 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;139 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;134 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;138 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;99,26 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;99,26 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;99,29 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;99,26 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;99,29 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;98,53 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;98,57 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;23 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;52 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;48 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;23 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;52 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;48 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;22 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;52 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;48 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;22 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;52 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;48 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;52 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;48 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;95,65 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;95,65 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;100 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;224 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;201 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;190 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIII;222 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIII;201 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIII;189 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIV;222 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIV;200 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIV;189 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;199 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;188 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;199 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;187 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,11 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,47 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;99,11 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;99,5 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;99,47 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;99 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;98,95 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;99 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;98,42 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;219 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;179 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;129 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;217 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;179 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;128 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;217 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;179 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;128 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;178 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;127 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;178 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;126 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,09 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,22 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;99,09 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;99,22 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;99,44 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;98,45 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;99,44 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;97,67 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;5 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;22 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;61 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;5 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;22 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;61 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;5 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;21 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;61 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;21 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;61 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;21 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;61 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;95,45 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;95,45 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;100 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;95,45 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;100 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;231 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;212 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;195 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIV;231 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIV;212 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIV;195 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QI;211 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QI;194 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;211 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;193 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;210 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;193 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;99,53 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;99,49 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;99,53 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;98,97 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;99,06 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;98,97 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;225 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;190 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;136 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;225 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;190 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;136 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;189 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;135 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;189 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;134 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;189 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;134 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;99,47 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;99,26 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;99,47 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;98,53 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;99,47 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;98,53 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;6 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;22 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;59 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;6 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;22 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;59 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;22 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;59 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;22 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;59 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;21 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;59 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;95,45 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;100 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;94 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;88 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;88 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QI;94 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QI;88 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QI;88 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QII;94 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QII;88 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QII;88 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;94 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;87 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;88 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;94 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;87 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;88 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;98,86 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;98,86 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;83 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;57 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;83 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;57 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;83 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;57 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;83 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;57 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;83 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;57 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;11 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;31 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;11 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;31 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;11 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;31 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;11 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;30 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;11 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;30 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;96,77 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;96,77 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;95 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;93 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;86 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QII;95 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QII;93 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QII;86 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIII;95 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIII;92 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIII;86 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;95 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;92 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;86 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;92 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;86 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;98,92 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;98,92 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;98,92 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;84 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;61 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;61 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;84 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;61 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;61 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;84 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;61 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;61 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;84 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;61 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;61 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;61 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;61 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;11 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;32 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;25 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;11 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;32 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;25 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;11 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;31 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;25 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;11 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;31 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;25 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;31 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;25 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;96,88 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;96,88 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;96,88 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;100 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;95 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;92 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;88 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIII;95 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIII;92 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIII;88 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIV;95 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIV;92 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIV;88 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;91 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;88 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;91 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;88 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;98,91 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;98,91 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;91 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;81 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;54 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;91 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;81 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;54 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;91 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;81 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;54 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;80 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;54 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;80 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;54 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;98,77 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;98,77 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;4 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;11 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;34 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;4 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;11 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;34 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;4 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;11 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;34 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;11 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;34 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;11 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;34 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;100 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;97 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;97 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;89 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIV;97 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIV;97 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIV;89 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QI;96 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QI;89 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;96 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;89 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;96 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;88 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,97 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;98,97 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;98,97 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;98,88 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;93 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;82 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;55 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;93 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;82 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;55 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;81 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;55 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;81 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;55 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;81 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;55 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,78 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;98,78 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;98,78 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;4 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;15 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;34 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;4 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;15 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;34 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;15 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;34 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;15 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;34 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;15 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;33 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;97,06 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 08 Castilla - La Mancha;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;210.756 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;204.413 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;212.589 09 Cataluña;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the first trimester;2022QI;199.652 09 Cataluña;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the first trimester;2021QI;194.794 09 Cataluña;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the first trimester;2020QI;192.100 09 Cataluña;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the second trimester;2022QII;191.518 09 Cataluña;Total ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the second trimester;2021QII;188.188 09 Cataluña;Total ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the second trimester;2020QII;185.869 09 Cataluña;Total ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;185.103 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;182.565 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;180.325 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;179.836 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;177.784 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;175.055 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,73 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,29 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;90,36 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;90,87 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,06 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;87,43 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,83 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,31 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;84,82 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;85,33 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,97 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,34 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;199.994 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;171.115 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;189.268 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;162.417 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;181.440 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;156.570 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;175.267 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;151.564 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;170.205 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;147.419 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;94,64 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;94,92 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;90,72 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;91,5 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;87,64 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;88,57 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;85,11 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;86,15 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;10.762 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;33.298 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;10.384 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;32.377 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;10.078 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;31.618 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;9.836 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;31.001 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;9.631 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;30.365 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;96,49 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;97,23 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;93,64 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;94,95 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;91,4 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;93,1 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;89,49 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;91,19 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;211.480 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;205.464 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;201.461 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the first trimester;2022QII;201.606 09 Cataluña;Total ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the first trimester;2021QII;197.276 09 Cataluña;Total ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the first trimester;2020QII;194.050 09 Cataluña;Total ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIII;193.942 09 Cataluña;Total ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIII;190.404 09 Cataluña;Total ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIII;187.595 09 Cataluña;Total ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;187.428 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;184.474 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;181.517 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;177.657 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;175.269 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 09 Cataluña;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,33 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,01 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,32 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,71 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,67 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,12 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,63 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,78 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,1 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,47 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;201.049 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;175.694 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;152.088 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;191.485 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;168.237 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;145.272 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;184.067 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;161.936 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;139.992 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;177.772 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;156.626 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;135.286 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;150.562 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;130.331 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;95,24 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;95,76 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;95,52 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;91,55 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;92,17 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;92,05 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;88,42 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;89,15 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;88,95 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;85,7 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;85,69 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;10.431 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;29.770 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;49.373 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;10.121 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;29.039 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;48.778 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;9.875 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;28.468 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;47.603 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;9.656 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;27.848 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;46.231 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;27.095 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;44.938 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 09 Cataluña;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;97,03 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,54 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,79 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;94,67 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;95,63 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;96,42 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;92,57 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;93,54 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;93,64 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;91,01 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;91,02 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;215.003 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;211.262 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;205.171 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIII;203.931 09 Cataluña;Total ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIII;200.710 09 Cataluña;Total ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIII;195.970 09 Cataluña;Total ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIV;194.740 09 Cataluña;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIV;192.383 09 Cataluña;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIV;187.821 09 Cataluña;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;184.555 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;180.932 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;179.007 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;176.441 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;94,85 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,01 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,52 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,58 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,06 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,54 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,36 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,19 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,73 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;86 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;208.994 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;201.554 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;174.843 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;198.081 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;191.227 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;166.343 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;189.026 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;183.164 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;159.085 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;175.574 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;152.971 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;170.236 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;149.100 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;94,78 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;94,88 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;95,14 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;90,45 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;90,88 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;90,99 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;87,11 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;87,49 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;84,46 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;85,28 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;6.009 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;9.708 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;30.328 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;5.850 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;9.483 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;29.627 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;5.714 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;9.219 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;28.736 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;8.981 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;27.961 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;8.771 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;27.341 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;97,35 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;97,68 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;97,69 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;95,09 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;94,96 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;94,75 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;92,51 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;92,2 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;90,35 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;90,15 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;212.896 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;210.168 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;206.008 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIV;202.148 09 Cataluña;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIV;200.060 09 Cataluña;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIV;195.418 09 Cataluña;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the second trimester;2022QI;191.190 09 Cataluña;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the second trimester;2021QI;187.554 09 Cataluña;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;184.609 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;182.097 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;179.088 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;177.230 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,95 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,19 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,86 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;90,97 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,04 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,84 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,39 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,21 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,03 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;207.964 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;198.776 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;165.747 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;197.327 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;188.987 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;156.271 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;180.466 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;149.497 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;174.216 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;144.870 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;168.949 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;140.730 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;94,89 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;95,08 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;94,28 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;90,79 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;90,2 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;87,64 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;87,4 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;84,99 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;84,91 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;4.932 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;11.392 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;40.261 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;4.821 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;11.073 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;39.147 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;10.724 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;38.057 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;10.393 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;37.227 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;10.139 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;36.500 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;97,75 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;97,2 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;97,23 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;94,14 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;94,53 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;91,23 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;92,46 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;89 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;90,66 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;153.330 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;150.076 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;154.734 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QI;142.917 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QI;141.041 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QI;135.666 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QII;135.521 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QII;135.100 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QII;129.981 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;129.698 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;129.954 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;125.040 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;124.990 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;125.704 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;120.359 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,21 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,98 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,68 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;88,39 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;90,02 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;84,59 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;86,59 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;80,81 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;81,52 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;83,76 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;77,78 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;147.134 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;132.973 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;137.053 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;124.701 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;129.910 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;119.339 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;124.288 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;114.673 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;119.750 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;110.897 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;93,15 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;93,78 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;88,29 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;89,75 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;84,47 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;86,24 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;81,39 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;83,4 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;6.196 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;17.103 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;5.864 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;16.340 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;5.611 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;15.761 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;5.410 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;15.281 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;5.240 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;14.807 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;94,64 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;95,54 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;90,56 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;92,15 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;87,31 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;89,35 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;84,57 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;86,58 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;153.013 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;150.520 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;147.023 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QII;143.814 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QII;142.925 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QII;140.029 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIII;136.720 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIII;136.541 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIII;134.076 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;130.885 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;131.260 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;128.548 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;125.158 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;122.977 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 09 Cataluña;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,99 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,95 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,24 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;89,35 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;90,71 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,19 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;85,54 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;87,2 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,43 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;83,15 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;83,64 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;147.080 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;135.208 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;118.770 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;138.145 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;128.203 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;112.250 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;131.260 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;122.280 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;107.265 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;125.590 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;117.468 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;102.840 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;111.962 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;98.310 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;93,93 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;94,82 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;94,51 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;89,24 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;90,44 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;90,31 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;85,39 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;86,88 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;86,59 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;82,81 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;82,77 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;5.933 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;15.312 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;28.253 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;5.669 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;14.722 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;27.779 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;5.460 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;14.261 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;26.811 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;5.295 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;13.792 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;25.708 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;13.196 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;24.667 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;95,55 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;96,15 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,32 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;92,03 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;93,14 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;94,9 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;89,25 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;90,07 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;90,99 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;86,18 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;87,31 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;154.283 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;153.505 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;149.789 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIII;143.969 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIII;143.675 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIII;141.239 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIV;136.101 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIV;136.460 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIV;133.928 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;129.460 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;127.741 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;124.456 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;123.777 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,31 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;93,6 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,29 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;88,22 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;88,9 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,41 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;84,34 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;85,28 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;81,08 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;82,63 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;150.743 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;148.550 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;134.008 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;140.569 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;138.908 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;126.034 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;132.791 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;131.876 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;119.395 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;125.064 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;113.806 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;120.237 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;110.308 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;93,25 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;93,51 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;94,05 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;88,09 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;88,78 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;89,1 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;84,19 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;84,92 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;80,94 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;82,31 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;3.540 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;4.955 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;15.781 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;3.400 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;4.767 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;15.205 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;3.310 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;4.584 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;14.533 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;4.396 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;13.935 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;4.219 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;13.469 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;96,05 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;96,21 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;96,35 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;93,5 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;92,51 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;92,09 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;88,72 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;88,3 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;85,15 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;85,35 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;153.640 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;153.068 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;150.891 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIV;143.820 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIV;143.769 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIV;140.991 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QI;135.653 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QI;133.806 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;129.715 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;128.969 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;124.728 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;124.566 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,61 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,92 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,44 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;88,62 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;88,68 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;84,74 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;85,47 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;81,49 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;82,55 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;150.860 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;146.248 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;130.297 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;141.125 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;137.224 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;121.295 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;129.412 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;114.970 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;123.764 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;110.751 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;118.996 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;106.892 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;93,55 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;93,83 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;93,09 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;88,49 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;88,24 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;84,63 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;85 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;81,37 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;82,04 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;2.780 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;6.820 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;20.594 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;2.695 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;6.545 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;19.696 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;6.241 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;18.836 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;5.951 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;18.218 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;5.732 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;17.674 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;96,94 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;95,97 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;95,64 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;91,51 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;91,46 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;87,26 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;88,46 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;84,05 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;85,82 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;22.724 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;21.635 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;22.853 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QI;22.346 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QI;21.322 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QI;22.032 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QII;21.956 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QII;20.968 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QII;21.754 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;21.653 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;20.726 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;21.427 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;21.352 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;20.460 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;21.137 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,34 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,55 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,41 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,62 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,92 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,19 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,29 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,8 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;93,76 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,96 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,57 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,49 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;21.192 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;16.314 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;20.845 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;16.073 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;20.475 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;15.804 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;20.192 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;15.618 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;19.905 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;15.421 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,36 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,52 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;96,62 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;96,87 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;95,28 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;95,73 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;93,93 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;94,53 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;1.532 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;5.321 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;1.501 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;5.249 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;1.481 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;5.164 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;1.461 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;5.108 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;1.447 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;5.039 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;97,98 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,65 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;96,67 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;97,05 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;95,37 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;96 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;94,45 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;94,7 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;23.017 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;21.858 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;21.467 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QII;22.631 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QII;21.537 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QII;21.258 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIII;22.344 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIII;21.304 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIII;20.970 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;21.985 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;20.947 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;20.662 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;20.553 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;20.299 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,32 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,53 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,03 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;97,08 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,47 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,68 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,52 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,83 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,25 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,03 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,56 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;21.528 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;17.144 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;13.462 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;21.161 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;16.889 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;13.303 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;20.889 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;16.701 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;13.127 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;20.555 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;16.418 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;12.964 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;16.105 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;12.722 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,3 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,51 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,82 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;97,03 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;97,42 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;97,51 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;95,48 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;95,77 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;96,3 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;93,94 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;94,5 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;1.489 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;4.714 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;8.005 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;1.470 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;4.648 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;7.955 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;1.455 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;4.603 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;7.843 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;1.430 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;4.529 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;7.698 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;4.448 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;7.577 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;98,72 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;98,6 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,38 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;97,72 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;97,65 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;97,98 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;96,04 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;96,08 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;96,16 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;94,36 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;94,65 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;23.870 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;22.954 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;22.031 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIII;23.469 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIII;22.555 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIII;21.653 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIV;22.808 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIV;21.957 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIV;21.187 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;21.491 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;20.804 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;21.203 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;20.539 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,32 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,26 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,28 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,55 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,66 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,17 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,63 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,43 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,37 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,23 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;22.986 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;21.466 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;17.224 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;22.591 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;21.085 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;16.910 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;21.949 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;20.523 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;16.547 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;20.077 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;16.251 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;19.808 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;16.048 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,28 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,23 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,18 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;95,49 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;95,61 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;96,07 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;93,53 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;94,35 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;92,28 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;93,17 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;884 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;1.488 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;4.807 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;878 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;1.470 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;4.743 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;859 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;1.434 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;4.640 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;1.414 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;4.553 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;1.395 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;4.491 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;99,32 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;98,79 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,67 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;97,17 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;96,37 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;96,53 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;95,03 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;94,72 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;93,75 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;93,43 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;23.169 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;22.643 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;21.904 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIV;22.655 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIV;22.181 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIV;21.498 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QI;21.764 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QI;21.124 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;21.423 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;20.802 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;21.165 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;20.563 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,78 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,96 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,15 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,12 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,44 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,61 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,97 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,47 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,88 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;22.405 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;21.113 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;15.379 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;21.903 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;20.676 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;15.071 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;20.281 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;14.801 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;19.955 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;14.574 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;19.717 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;14.411 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;97,76 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;97,93 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;98 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;96,06 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;96,24 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;94,52 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;94,77 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;93,39 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;93,71 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;764 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;1.530 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;6.525 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;752 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;1.505 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;6.427 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;1.483 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;6.323 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;1.468 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;6.228 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;1.448 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;6.152 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;98,43 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;98,37 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;98,5 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;96,93 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;96,9 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;95,95 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;95,45 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;94,64 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;94,28 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;31.764 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;29.887 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;32.044 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QI;31.462 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QI;29.631 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QI;31.460 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QII;31.124 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QII;29.331 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QII;31.206 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;30.847 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;29.105 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;30.942 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;30.598 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;28.851 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;30.658 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,05 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,14 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;98,18 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,99 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;98,14 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;97,38 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;97,11 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;97,38 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;96,56 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;96,33 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;96,53 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;95,67 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;29.051 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;20.201 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;28.764 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;20.026 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;28.456 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;19.818 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;28.198 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;19.669 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;27.968 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;19.503 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,01 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,13 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;97,95 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;98,1 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;97,06 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;97,37 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;96,27 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;96,54 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;2.713 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;9.686 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;2.698 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;9.605 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;2.668 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;9.513 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;2.649 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;9.436 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;2.630 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;9.348 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;99,45 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,16 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;98,34 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,21 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;97,64 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;97,42 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;96,94 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;96,51 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;32.457 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;30.280 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;30.130 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QII;32.174 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QII;30.015 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QII;29.931 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIII;31.903 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIII;29.770 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIII;29.725 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;31.590 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;29.489 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;29.494 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;29.181 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;29.198 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 09 Cataluña;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;99,13 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,12 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,34 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;98,29 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;98,32 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,66 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;97,33 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;97,39 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;97,89 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;96,37 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;96,91 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;29.781 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;21.607 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;18.093 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;29.525 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;21.415 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;17.962 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;29.274 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;21.231 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;17.849 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;28.989 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;21.023 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;17.739 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;20.788 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;17.566 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;99,14 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;99,11 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,28 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;98,3 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;98,26 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,65 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;97,34 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;97,3 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;98,04 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;96,21 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;97,09 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;2.676 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;8.673 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;12.037 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;2.649 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;8.600 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;11.969 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;2.629 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;8.539 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;11.876 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;2.601 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;8.466 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;11.755 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;8.393 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;11.632 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;98,99 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,16 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,44 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;98,24 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;98,45 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,66 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;97,2 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;97,61 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;97,66 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;96,77 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;96,64 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;33.738 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;31.937 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;30.572 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIII;33.388 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIII;31.618 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIII;30.303 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIV;32.736 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIV;31.115 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIV;29.942 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;30.763 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;29.641 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;30.517 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;29.388 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,96 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,12 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;97,03 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;97,43 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97,94 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;96,32 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;96,95 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;95,55 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;96,13 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;32.345 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;29.070 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;21.944 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;32.008 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;28.769 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;21.735 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;31.382 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;28.307 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;21.487 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;27.985 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;21.268 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;27.752 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;21.105 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,96 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,96 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,05 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;97,02 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;97,38 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;97,92 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;96,27 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;96,92 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;95,47 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;96,18 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;1.393 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;2.867 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;8.628 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;1.380 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;2.849 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;8.568 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;1.354 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;2.808 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;8.455 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;2.778 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;8.373 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;2.765 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;8.283 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;99,07 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,37 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,3 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;97,2 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;97,94 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;97,99 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;96,9 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;97,04 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;96,44 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;96 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;32.965 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;31.555 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;30.391 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIV;32.557 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIV;31.218 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIV;30.116 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QI;30.894 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QI;29.828 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;30.600 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;29.540 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;30.335 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;29.324 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,76 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,93 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,1 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;97,91 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;98,15 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;96,97 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;97,2 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;96,13 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;96,49 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;31.740 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;28.863 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;18.577 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;31.345 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;28.544 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;18.417 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;28.242 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;18.248 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;27.973 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;18.074 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;27.721 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;17.960 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;98,76 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;98,89 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,14 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;97,85 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;98,23 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;96,92 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;97,29 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;96,04 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;96,68 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;1.225 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;2.692 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;11.814 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;1.212 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;2.674 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;11.699 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;2.652 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;11.580 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;2.627 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;11.466 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;2.614 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;11.364 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;98,94 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;99,33 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,03 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;98,51 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,02 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;97,59 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;97,05 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;97,1 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;96,19 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.936 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.861 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.966 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QI;1.928 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QI;1.846 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QI;1.953 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QII;1.918 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QII;1.839 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QII;1.943 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.909 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.834 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.934 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.903 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.827 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.919 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,59 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,19 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;99,34 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;99,07 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;98,82 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;98,83 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;98,61 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;98,55 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;98,37 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;98,3 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;98,17 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;97,61 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;1.723 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;1.104 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;1.715 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;1.094 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;1.708 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;1.090 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;1.701 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;1.088 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;1.696 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;1.083 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,54 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,09 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;99,13 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;98,73 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;98,72 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;98,55 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;98,43 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;98,1 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;213 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;757 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;213 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;752 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;210 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;749 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;208 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;746 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;207 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;744 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,34 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;98,59 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,94 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;97,65 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;98,55 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;97,18 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;98,28 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.972 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.847 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.883 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QII;1.967 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QII;1.845 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QII;1.877 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.958 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.837 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.872 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.952 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.829 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.861 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;1.820 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;1.845 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 09 Cataluña;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;99,75 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,89 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,68 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;99,29 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;99,46 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;99,42 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;98,99 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;99,03 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;98,83 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;98,54 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;97,98 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;1.758 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;1.184 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;1.162 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;1.753 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;1.183 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;1.157 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;1.746 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;1.178 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;1.154 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;1.740 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;1.171 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;1.146 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;1.165 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;1.137 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;99,72 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;99,92 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,57 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;99,32 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;99,49 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;99,31 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;98,98 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;98,9 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;98,62 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;98,4 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;97,85 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;214 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;663 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;721 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;214 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;662 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;720 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;212 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;659 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;718 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;212 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;658 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;715 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;655 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;708 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,85 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,86 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;99,07 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;99,4 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;99,58 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;99,07 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;99,25 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;99,17 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;98,79 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;98,2 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.075 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.893 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.849 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.072 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.890 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.848 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.064 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.883 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.838 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;1.876 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;1.822 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;1.866 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;1.816 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,86 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,84 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,95 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;99,47 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;99,47 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;99,41 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;99,1 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;98,54 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;98,57 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;98,22 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;1.945 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;1.638 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;1.136 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;1.942 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;1.635 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;1.136 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;1.934 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;1.629 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;1.129 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;1.622 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;1.120 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;1.613 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;1.116 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,85 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99,82 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;99,43 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;99,45 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;99,38 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;99,02 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;98,59 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;98,47 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;98,24 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;130 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;255 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;713 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;130 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;255 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;712 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;130 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;254 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;709 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;254 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;702 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;253 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;700 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,86 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;99,61 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;99,44 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;99,61 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;98,46 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;99,22 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;98,18 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.071 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.908 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.874 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.067 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.901 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.865 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QI;1.892 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QI;1.850 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;1.884 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;1.844 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.878 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.838 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,81 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,63 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,52 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;99,16 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;98,72 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;98,74 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;98,4 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;98,43 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;98,08 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;1.961 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;1.678 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;1.004 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;1.957 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;1.671 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;998 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;1.662 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;989 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;1.655 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;985 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;1.650 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;982 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,8 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,58 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,4 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;99,05 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;98,51 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;98,63 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;98,11 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;98,33 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;97,81 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;110 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;230 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;870 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;110 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;230 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;867 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;230 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;861 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;229 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;859 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;228 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;856 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,66 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,97 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;99,57 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;98,74 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;99,13 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;98,39 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.002 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;954 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;992 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QI;999 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QI;954 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QI;989 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QII;999 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QII;950 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QII;985 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;996 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;946 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;982 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;993 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;942 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;982 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,7 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;100 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;99,7 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;99,7 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;99,58 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;99,29 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;99,4 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;99,16 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;98,99 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;99,1 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;98,74 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;98,99 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;894 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;523 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;891 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;523 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;891 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;519 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;888 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;516 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;886 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;515 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,66 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;100 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;99,66 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;99,24 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;99,33 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;98,66 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;99,11 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;98,47 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;108 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;431 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;108 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;431 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;108 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;431 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;108 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;430 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;107 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;427 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;99,77 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;99,07 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;99,07 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.021 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;959 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;958 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QII;1.020 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QII;954 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QII;955 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.017 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIII;952 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIII;952 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.016 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;949 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;952 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;945 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;950 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 09 Cataluña;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;99,9 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,48 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,69 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;99,61 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;99,27 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;99,37 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;99,51 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;98,96 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;99,37 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;98,54 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;99,16 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;902 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;551 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;601 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;901 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;547 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;600 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;898 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;546 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;597 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;898 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;546 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;597 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;542 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;596 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;99,89 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;99,27 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,83 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;99,56 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;99,09 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;99,33 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;99,56 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;99,09 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;99,33 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;98,37 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;99,17 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;119 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;408 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;357 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;119 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;407 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;355 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;119 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;406 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;355 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;118 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;403 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;355 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;403 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;354 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,75 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,44 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;99,51 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;99,44 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;99,16 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;98,77 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;99,44 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;98,77 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;99,16 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.037 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;973 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;930 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.033 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIII;972 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIII;927 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.031 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIV;968 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIV;926 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;965 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;924 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;965 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;921 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,61 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,9 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,68 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;99,42 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;99,49 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;99,57 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;99,18 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;99,35 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;99,18 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;99,03 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;975 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;830 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;531 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;971 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;830 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;528 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;970 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;829 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;527 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;826 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;526 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;826 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;523 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,59 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,44 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;99,49 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;99,88 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;99,25 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;99,52 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;99,06 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;99,52 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;98,49 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;62 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;143 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;399 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;62 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;142 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;399 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;61 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;139 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;399 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;139 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;398 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;139 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;398 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,3 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;98,39 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;97,2 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;97,2 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;99,75 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;97,2 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;99,75 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.051 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;994 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;948 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.049 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIV;991 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIV;948 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QI;987 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QI;946 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;987 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;942 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;982 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;939 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,81 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,7 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;100 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;99,3 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;99,79 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;99,3 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;99,37 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;98,79 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;99,05 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;998 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;874 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;490 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;997 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;872 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;490 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;869 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;489 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;869 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;486 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;865 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;485 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,9 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,77 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;99,43 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;99,8 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;99,43 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;99,18 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;98,97 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;98,98 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;53 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;120 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;458 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;52 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;119 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;458 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;118 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;457 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;118 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;456 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;117 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;454 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;98,11 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;99,17 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;98,33 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;99,78 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;98,33 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;99,56 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;97,5 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;99,13 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 09 Cataluña;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;133.340 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;129.397 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;134.876 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the first trimester;2022QI;125.822 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the first trimester;2021QI;120.901 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the first trimester;2020QI;118.187 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the second trimester;2022QII;120.202 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the second trimester;2021QII;116.198 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the second trimester;2020QII;113.889 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;115.685 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;112.309 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;110.057 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;112.194 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;109.256 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;106.515 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,36 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,43 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,63 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;90,15 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;89,8 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,44 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;86,76 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;86,79 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;81,6 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,14 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,43 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;78,97 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;126.143 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;112.564 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;118.902 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;104.713 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;113.492 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;100.400 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;109.152 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;96.823 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;105.811 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;94.139 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;94,26 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;93,03 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;89,97 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;89,19 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;86,53 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;86,02 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;83,88 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;83,63 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;7.197 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;16.833 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;6.920 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;16.188 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;6.710 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;15.798 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;6.533 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;15.486 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;6.383 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;15.117 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;96,15 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;96,17 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;93,23 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;93,85 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;90,77 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;92 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;88,69 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;89,81 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;134.131 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;128.108 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;124.612 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the first trimester;2022QII;127.091 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the first trimester;2021QII;122.222 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the first trimester;2020QII;119.441 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIII;121.499 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIII;117.389 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIII;114.892 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;116.993 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;113.530 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;110.682 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;109.424 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;105.864 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,75 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,41 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,85 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;90,58 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;91,63 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,2 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,22 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,62 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,82 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,42 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,95 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;127.070 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;110.413 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;95.248 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;120.251 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;104.992 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;90.446 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;114.860 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;100.537 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;86.709 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;110.518 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;97.113 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;83.503 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;93.454 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;79.809 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;94,63 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;95,09 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;94,96 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;90,39 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;91,06 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;91,03 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;86,97 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;87,95 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;87,67 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;84,64 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;83,79 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;7.061 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;17.695 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;29.364 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;6.840 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;17.230 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;28.995 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;6.639 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;16.852 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;28.183 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;6.475 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;16.417 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;27.179 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;15.970 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;26.055 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;96,87 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,37 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,74 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;94,02 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;95,24 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;95,98 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;91,7 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;92,78 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;92,56 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;90,25 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;88,73 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;136.522 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;132.932 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;129.201 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIII;128.233 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIII;125.180 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIII;122.101 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIV;122.151 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIV;119.651 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIV;116.435 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;114.800 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;110.764 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;111.331 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;107.803 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,93 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;94,17 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,5 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,47 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;90,01 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,12 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;86,36 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;85,73 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;83,75 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;83,44 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;131.932 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;127.054 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;110.351 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;123.786 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;119.472 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;103.703 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;117.814 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;114.102 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;98.609 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;109.420 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;93.612 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;106.068 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;91.059 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;93,83 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;94,03 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;93,98 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;89,3 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;89,81 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;89,36 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;86,12 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;84,83 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;83,48 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;82,52 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;4.590 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;5.878 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;18.850 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;4.447 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;5.708 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;18.398 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;4.337 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;5.549 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;17.826 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;5.380 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;17.152 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;5.263 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;16.744 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;96,88 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;97,11 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;97,6 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;94,49 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;94,4 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;94,57 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;91,53 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;90,99 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;89,54 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;88,83 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;134.639 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;132.330 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;129.724 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIV;127.267 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIV;125.221 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIV;122.171 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the second trimester;2022QI;119.525 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the second trimester;2021QI;115.428 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;115.235 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;111.791 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;111.467 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;108.635 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,52 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,63 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,18 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;90,32 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;88,98 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,08 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;86,18 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,23 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;83,74 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;130.809 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;124.802 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;109.263 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;123.523 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;117.934 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;102.373 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;112.498 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;96.387 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;108.405 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;93.202 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;104.846 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;90.404 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;94,43 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;94,5 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;93,69 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;90,14 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;88,22 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;86,86 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;85,3 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;84,01 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;82,74 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;3.830 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;7.528 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;20.461 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;3.744 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;7.287 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;19.798 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;7.027 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;19.041 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;6.830 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;18.589 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;6.621 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;18.231 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;97,75 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;96,8 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;96,76 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;93,34 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;93,06 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;90,73 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;90,85 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;87,95 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;89,1 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;99.946 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;98.226 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;101.315 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QI;92.882 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QI;90.209 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QI;85.896 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QII;87.826 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QII;85.974 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QII;82.100 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;83.731 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;82.429 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;78.714 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;80.551 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;79.654 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;75.605 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,93 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;91,84 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;84,78 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,87 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;87,53 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;81,03 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;83,78 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;83,92 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;77,69 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;80,59 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;81,09 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;74,62 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;95.416 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;89.171 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;88.593 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;81.700 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;83.719 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;77.762 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;79.777 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;74.464 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;76.726 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;71.994 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;92,85 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;91,62 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;87,74 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;87,21 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;83,61 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;83,51 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;80,41 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;80,74 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;4.530 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;9.055 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;4.289 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;8.509 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;4.107 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;8.212 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;3.954 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;7.965 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;3.825 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;7.660 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;94,68 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;93,97 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;90,66 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;90,69 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;87,28 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;87,96 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;84,44 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;84,59 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;100.248 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;97.310 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;94.453 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QII;93.756 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QII;91.842 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QII;89.680 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIII;88.594 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIII;87.391 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIII;85.473 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;84.530 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;83.883 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;81.650 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;80.172 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;77.284 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,52 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,38 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;94,95 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;88,37 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;89,81 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;90,49 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;84,32 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;86,2 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;86,45 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;82,39 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;81,82 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;95.814 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;87.095 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;75.918 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;89.514 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;82.013 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;71.444 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;84.521 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;77.882 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;67.938 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;80.601 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;74.743 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;64.936 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;71.394 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;61.506 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;93,42 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;94,16 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;94,11 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;88,21 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;89,42 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;89,49 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;84,12 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;85,82 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;85,53 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;81,97 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;81,02 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;4.434 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;10.215 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;18.535 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;4.242 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;9.829 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;18.236 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;4.073 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;9.509 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;17.535 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;3.929 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;9.140 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;16.714 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;8.778 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;15.778 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;95,67 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;96,22 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,39 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;91,86 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;93,09 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;94,6 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;88,61 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;89,48 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;90,18 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;85,93 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;85,13 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;101.104 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;99.719 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;97.709 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIII;93.412 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIII;92.490 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIII;91.083 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIV;88.137 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIV;87.639 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIV;86.030 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;83.289 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;80.897 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;80.151 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;78.252 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;92,39 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;92,75 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;93,22 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;87,17 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;87,89 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;88,05 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;83,52 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;82,79 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;80,38 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;80,09 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;98.218 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;96.415 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;87.681 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;90.653 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;89.328 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;81.432 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;85.468 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;84.606 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;76.818 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;80.391 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;72.208 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;77.351 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;69.866 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;92,3 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;92,65 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;92,87 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;87,02 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;87,75 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;87,61 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;83,38 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;82,35 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;80,23 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;79,68 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;2.886 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;3.304 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;10.028 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;2.759 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;3.162 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;9.651 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;2.669 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;3.033 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;9.212 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;2.898 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;8.689 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;2.800 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;8.386 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;95,6 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;95,7 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;96,24 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;92,48 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;91,8 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;91,86 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;87,71 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;86,65 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;84,75 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;83,63 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100.182 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;99.354 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;98.310 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIV;93.414 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIV;92.746 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIV;91.235 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QI;87.523 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QI;85.051 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;83.660 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;81.799 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;80.234 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;78.931 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,24 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,35 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,8 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;88,09 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;86,51 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;84,2 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;83,21 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;80,76 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;80,29 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;97.871 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;94.434 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;87.347 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;91.179 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;88.040 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;80.817 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;83.027 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;75.246 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;79.340 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;72.332 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;76.096 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;69.742 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;93,16 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;93,23 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;92,52 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;87,92 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;86,15 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;84,02 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;82,81 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;80,58 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;79,84 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;2.311 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;4.920 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;10.963 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;2.235 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;4.706 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;10.418 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;4.496 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;9.805 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;4.320 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;9.467 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;4.138 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;9.189 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;96,71 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;95,65 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;95,03 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;91,38 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;89,44 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;87,8 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;86,35 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;84,11 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;83,82 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;14.037 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;13.288 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;14.166 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QI;13.793 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QI;13.010 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QI;13.425 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QII;13.509 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QII;12.774 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QII;13.178 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;13.277 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;12.595 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;12.933 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;13.105 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;12.438 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;12.674 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,26 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,91 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,77 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,24 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,13 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,03 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,59 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,78 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,3 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,36 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,6 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,47 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;13.020 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;10.495 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;12.796 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;10.275 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;12.523 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;10.085 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;12.303 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;9.932 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;12.142 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;9.816 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,28 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;97,9 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;96,18 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;96,09 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;94,49 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;94,64 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;93,26 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;93,53 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;1.017 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;2.793 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;997 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;2.735 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;986 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;2.689 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;974 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;2.663 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;963 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;2.622 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;98,03 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;97,92 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;96,95 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;96,28 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;95,77 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;95,35 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;94,69 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;93,88 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;14.072 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;12.950 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;12.773 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QII;13.799 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QII;12.731 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QII;12.586 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIII;13.555 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIII;12.533 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIII;12.401 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;13.295 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;12.326 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;12.166 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;12.115 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;11.905 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,06 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,31 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,54 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,33 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,78 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,09 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,48 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,18 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,25 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,55 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,2 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;13.098 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;10.157 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;8.226 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;12.839 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;9.979 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;8.078 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;12.613 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;9.807 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;7.956 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;12.365 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;9.641 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;7.832 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;9.473 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;7.677 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,02 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,25 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,2 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;96,3 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;96,55 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;96,72 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;94,4 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;94,92 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;95,21 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;93,27 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;93,33 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;974 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;2.793 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;4.547 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;960 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;2.752 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;4.508 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;942 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;2.726 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;4.445 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;930 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;2.685 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;4.334 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;2.642 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;4.228 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;98,56 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;98,53 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,14 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;96,71 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;97,6 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;97,76 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;95,48 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;96,13 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;95,32 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;94,59 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;92,98 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;14.791 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;14.101 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;13.632 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIII;14.450 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIII;13.813 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIII;13.360 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIV;14.021 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIV;13.439 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIV;13.007 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;13.164 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;12.690 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;12.980 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;12.524 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,69 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,96 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,79 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,31 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,42 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,36 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,09 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,05 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,87 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;14.127 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;13.180 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;10.433 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;13.792 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;12.905 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;10.202 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;13.378 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;12.544 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;9.924 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;12.286 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;9.692 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;12.110 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;9.582 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;97,63 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;97,91 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;97,79 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;94,7 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;95,17 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;95,12 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;93,22 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;92,9 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;91,88 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;91,84 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;664 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;921 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;3.199 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;658 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;908 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;3.158 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;643 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;895 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;3.083 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;878 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;2.998 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;870 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;2.942 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;99,1 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;98,59 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,72 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;96,84 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;97,18 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;96,37 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;95,33 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;93,72 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;94,46 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;91,97 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;14.373 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;13.951 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;13.504 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIV;14.013 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIV;13.664 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIV;13.202 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QI;13.412 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QI;12.873 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;13.187 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;12.671 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;12.980 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;12.521 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,5 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,94 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,76 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,14 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,33 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,52 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,83 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,04 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,72 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;13.798 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;12.945 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;10.088 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;13.444 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;12.676 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;9.855 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;12.454 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;9.609 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;12.241 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;9.462 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;12.049 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;9.344 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;97,43 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;97,92 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;97,69 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;96,21 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;95,25 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;94,56 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;93,79 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;93,08 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;92,62 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;575 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;1.006 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;3.416 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;569 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;988 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;3.347 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;958 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;3.264 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;946 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;3.209 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;931 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;3.177 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;98,96 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;98,21 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;97,98 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;95,23 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;95,55 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;94,04 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;93,94 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;92,54 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;93 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;18.113 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;16.741 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;18.212 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QI;17.912 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QI;16.555 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QI;17.693 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QII;17.643 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QII;16.331 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QII;17.444 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;17.464 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;16.177 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;17.255 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;17.331 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;16.063 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;17.086 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,89 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,89 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;97,15 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,41 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,55 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,78 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;96,42 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,63 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,75 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;95,68 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;95,95 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;93,82 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;16.580 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;12.159 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;16.395 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;12.011 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;16.143 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;11.833 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;15.976 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;11.717 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;15.852 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;11.625 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,88 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,78 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;97,36 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;97,32 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;96,36 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;96,36 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;95,61 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;95,61 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;1.533 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;4.582 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;1.517 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;4.544 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;1.500 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;4.498 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;1.488 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;4.460 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;1.479 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;4.438 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;98,96 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,17 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;97,85 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,17 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;97,06 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;97,34 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;96,48 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;96,86 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;18.549 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;16.711 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;16.280 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QII;18.283 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QII;16.520 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QII;16.075 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIII;18.111 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIII;16.353 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIII;15.932 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;17.938 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;16.219 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;15.796 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;16.039 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;15.616 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,57 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,86 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,74 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;97,64 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,86 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,86 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;96,71 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;97,06 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;97,03 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;95,98 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;95,92 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;17.031 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;12.394 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;10.320 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;16.779 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;12.240 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;10.145 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;16.621 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;12.103 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;10.049 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;16.455 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;11.993 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;9.984 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;11.854 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;9.886 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,52 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,76 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,3 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;97,59 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;97,65 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;97,37 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;96,62 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;96,76 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;96,74 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;95,64 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;95,79 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;1.518 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;4.317 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;5.960 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;1.504 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;4.280 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;5.930 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;1.490 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;4.250 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;5.883 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;1.483 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;4.226 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;5.812 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;4.185 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;5.730 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;99,08 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,14 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,5 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;98,16 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;98,45 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,71 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;97,69 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;97,89 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;97,52 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;96,94 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;96,14 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;19.356 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;17.971 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;16.804 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIII;19.106 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIII;17.743 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIII;16.610 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIV;18.734 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIV;17.445 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIV;16.359 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;17.225 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;16.148 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;17.084 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;16.000 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,71 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,73 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,85 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,79 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;97,07 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97,35 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,85 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;96,1 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;95,06 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;95,22 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;18.380 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;16.447 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;11.621 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;18.140 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;16.233 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;11.460 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;17.772 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;15.952 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;11.267 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;15.749 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;11.119 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;15.619 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;11.020 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,69 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,7 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,61 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;96,69 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;96,99 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;96,95 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;95,76 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;95,68 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;94,97 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;94,83 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;976 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;1.524 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;5.183 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;966 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;1.510 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;5.150 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;962 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;1.493 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;5.092 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;1.476 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;5.029 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;1.465 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;4.980 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;98,98 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,08 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,36 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;98,57 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;97,97 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;98,24 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;96,85 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;97,03 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;96,13 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;96,08 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;18.817 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;17.848 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;16.807 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIV;18.581 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIV;17.642 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIV;16.649 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QI;17.428 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QI;16.430 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;17.236 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;16.253 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;17.109 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;16.122 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,75 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,85 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,06 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;97,65 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,76 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;96,57 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;96,7 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;95,86 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;95,92 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;17.932 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;16.389 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;11.172 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;17.699 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;16.192 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;11.062 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;15.998 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;10.901 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;15.815 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;10.782 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;15.700 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;10.698 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;98,7 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;98,8 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,02 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;97,61 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;97,57 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;96,5 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;96,51 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;95,8 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;95,76 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;885 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;1.459 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;5.635 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;882 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;1.450 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;5.587 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;1.430 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;5.529 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;1.421 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;5.471 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;1.409 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;5.424 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;99,66 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;99,38 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,15 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;98,01 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,12 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;97,4 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;97,09 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;96,57 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;96,26 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;842 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;753 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;788 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QI;836 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QI;746 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QI;782 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QII;829 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QII;741 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QII;778 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;825 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;737 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;772 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;820 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;731 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;770 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,29 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,07 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;99,24 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;98,46 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;98,41 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;98,73 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;97,98 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;97,88 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;97,97 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;97,39 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;97,08 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;97,72 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;763 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;494 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;757 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;488 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;750 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;483 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;746 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;480 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;742 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;475 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,21 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,79 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;98,3 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;97,77 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;97,77 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;97,17 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;97,25 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;96,15 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;79 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;259 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;79 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;258 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;79 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;258 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;79 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;257 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;78 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;256 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,61 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;99,61 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;99,23 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;98,73 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;98,84 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;852 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;757 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;740 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QII;846 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QII;752 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QII;735 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIII;839 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIII;739 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIII;726 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;830 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;732 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;715 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;729 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;711 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;99,3 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,34 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,32 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;98,47 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,62 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,11 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;97,42 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;96,7 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,62 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;96,3 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;96,08 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;761 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;517 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;519 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;755 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;512 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;514 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;748 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;501 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;506 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;740 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;495 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;495 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;492 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;491 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;99,21 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;99,03 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,04 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;98,29 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;96,91 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;97,5 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;97,24 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;95,74 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;95,38 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;95,16 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;94,61 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;91 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;240 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;221 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;91 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;240 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;221 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;91 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;238 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;220 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;90 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;237 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;220 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;237 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;220 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;99,17 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;99,55 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;98,9 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;98,75 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;99,55 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;98,75 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;99,55 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;875 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;768 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;717 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIII;870 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIII;761 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIII;709 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIV;864 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIV;757 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIV;704 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;754 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;698 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;751 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;697 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,43 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,09 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,88 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;98,74 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;98,57 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;98,19 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;98,18 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;97,35 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;97,79 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;97,21 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;827 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;683 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;416 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;822 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;677 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;409 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;817 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;673 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;404 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;670 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;400 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;667 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;399 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,4 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99,12 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,32 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;98,79 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;98,54 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;97,12 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;98,1 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;96,15 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;97,66 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;95,91 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;48 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;85 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;301 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;48 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;84 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;300 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;47 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;84 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;300 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;84 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;298 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;84 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;298 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;98,82 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,67 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;97,92 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;98,82 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;99,67 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;98,82 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;99 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;98,82 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;99 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;854 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;787 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;737 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIV;848 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIV;782 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIV;725 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QI;778 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QI;718 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;772 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;715 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;767 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;711 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,3 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,36 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,37 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,86 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,42 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;98,09 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;97,01 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;97,46 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;96,47 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;812 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;695 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;438 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;807 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;690 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;427 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;686 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;422 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;680 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;419 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;675 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;416 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,38 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,28 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;97,49 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,71 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;96,35 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;97,84 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;95,66 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;97,12 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;94,98 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;42 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;92 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;299 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;41 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;92 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;298 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;92 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;296 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;92 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;296 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;92 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;295 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;97,62 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,67 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;99 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;99 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;98,66 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;402 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;389 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;395 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QI;399 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QI;381 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QI;391 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QII;395 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QII;378 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QII;389 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;388 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;371 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;383 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;387 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;370 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;380 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,25 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,94 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;98,99 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;98,26 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,17 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;98,48 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;96,52 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,37 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;96,96 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;96,27 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;95,12 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;96,2 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;364 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;245 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;361 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;239 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;357 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;237 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;350 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;230 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;349 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;229 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,18 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;97,55 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;98,08 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;96,73 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;96,15 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;93,88 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;95,88 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;93,47 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;38 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;144 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;38 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;142 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;38 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;141 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;38 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;141 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;38 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;141 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,61 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;97,92 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;97,92 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;97,92 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;410 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;380 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;366 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QII;407 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QII;377 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QII;365 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIII;400 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIII;373 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIII;360 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;400 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;370 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;355 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;369 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;348 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;99,27 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,21 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,73 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;97,56 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;98,16 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,36 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;97,56 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;97,37 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,99 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;97,11 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;95,08 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;366 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;250 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;265 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;364 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;248 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;265 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;357 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;244 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;260 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;357 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;241 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;256 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;241 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;249 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;99,45 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;99,2 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;97,54 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;97,6 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,11 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;97,54 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;96,4 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;96,6 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;96,4 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;93,96 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;44 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;130 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;101 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;43 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;129 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;100 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;43 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;129 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;100 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;43 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;129 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;99 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;128 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;99 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;97,73 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,23 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,01 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;97,73 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;99,23 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;99,01 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;97,73 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;99,23 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;98,02 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;98,46 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;98,02 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;396 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;373 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;339 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIII;395 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIII;373 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIII;339 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIV;395 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIV;371 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIV;335 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;368 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;331 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;365 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;330 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,75 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;100 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;99,75 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;99,46 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;98,82 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;98,66 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;97,64 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;97,86 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;97,35 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;380 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;329 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;200 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;379 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;329 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;200 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;379 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;327 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;196 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;324 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;193 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;321 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;192 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,74 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;99,74 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;99,39 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;98 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;98,48 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;96,5 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;97,57 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;96 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;16 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;44 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;139 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;16 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;44 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;139 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;16 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;44 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;139 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;44 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;138 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;44 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;138 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;99,28 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;99,28 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;413 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;390 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;366 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIV;411 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIV;387 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIV;360 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QI;384 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QI;356 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;380 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;353 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;377 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;350 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,52 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,23 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,36 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,46 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,27 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;97,44 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;96,45 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;96,67 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;95,63 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;396 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;339 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;218 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;394 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;336 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;212 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;333 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;209 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;329 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;207 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;326 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;204 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,49 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,12 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;97,25 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,23 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;95,87 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;97,05 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;94,95 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;96,17 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;93,58 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;17 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;51 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;148 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;17 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;51 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;148 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;51 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;147 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;51 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;146 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;51 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;146 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;99,32 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;98,65 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;98,65 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 10 Comunitat Valenciana;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;23.571 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;22.784 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;23.696 11 Extremadura;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the first trimester;2022QI;22.001 11 Extremadura;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the first trimester;2021QI;21.290 11 Extremadura;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the first trimester;2020QI;20.160 11 Extremadura;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the second trimester;2022QII;20.938 11 Extremadura;Total ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the second trimester;2021QII;20.407 11 Extremadura;Total ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the second trimester;2020QII;19.427 11 Extremadura;Total ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;20.145 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;19.722 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;18.876 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;19.555 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;19.179 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;18.325 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,34 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,44 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;85,08 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;88,83 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;89,57 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;81,98 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;85,47 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;86,56 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;79,66 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;82,96 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,18 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;77,33 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;22.826 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;20.933 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;21.282 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;19.491 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;20.243 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;18.642 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;19.472 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;17.992 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;18.892 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;17.486 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;93,24 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;93,11 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;88,68 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;89,06 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;85,31 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;85,95 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;82,77 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;83,53 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;745 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;1.851 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;719 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;1.799 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;695 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;1.765 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;673 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;1.730 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;663 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;1.693 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;96,51 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;97,19 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;93,29 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;95,35 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;90,34 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;93,46 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;88,99 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;91,46 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;23.483 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;22.686 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;21.189 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the first trimester;2022QII;22.116 11 Extremadura;Total ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the first trimester;2021QII;21.481 11 Extremadura;Total ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the first trimester;2020QII;20.268 11 Extremadura;Total ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIII;21.132 11 Extremadura;Total ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIII;20.595 11 Extremadura;Total ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIII;19.601 11 Extremadura;Total ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;20.415 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;19.919 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;18.965 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;19.124 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;18.239 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 11 Extremadura;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,18 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,69 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,65 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;89,99 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;90,78 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,51 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,94 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;87,8 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,5 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;84,3 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,08 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;22.758 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;21.196 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;17.387 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;21.421 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;20.030 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;16.517 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;20.471 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;19.175 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;15.928 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;19.771 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;18.529 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;15.381 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;17.772 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;14.757 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;94,13 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;94,5 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;95 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;89,95 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;90,47 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;91,61 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;86,87 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;87,42 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;88,46 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;83,85 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;84,87 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;725 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;1.490 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;3.802 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;695 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;1.451 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;3.751 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;661 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;1.420 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;3.673 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;644 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;1.390 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;3.584 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;1.352 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;3.482 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 11 Extremadura;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;95,86 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,38 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,66 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;91,17 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;95,3 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;96,61 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;88,83 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;93,29 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;94,27 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;90,74 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;91,58 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;23.914 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;23.240 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;22.484 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIII;22.380 11 Extremadura;Total ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIII;21.751 11 Extremadura;Total ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIII;21.302 11 Extremadura;Total ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIV;21.384 11 Extremadura;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIV;20.822 11 Extremadura;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIV;20.335 11 Extremadura;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;19.919 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;19.422 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;19.301 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;18.897 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,59 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;93,59 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,74 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,42 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;89,6 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,44 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;85,71 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,38 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;83,05 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,05 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;23.408 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;22.713 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;20.139 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;21.900 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;21.240 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;19.005 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;20.917 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;20.319 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;18.091 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;19.429 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;17.236 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;18.822 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;16.744 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;93,56 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;93,51 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;94,37 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;89,36 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;89,46 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;89,83 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;85,54 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;85,59 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;82,87 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;83,14 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;506 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;527 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;2.345 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;480 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;511 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;2.297 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;467 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;503 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;2.244 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;490 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;2.186 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;479 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;2.153 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;94,86 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;96,96 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;97,95 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;92,29 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;95,45 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;95,69 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;92,98 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;93,22 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;90,89 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;91,81 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;24.055 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;23.235 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;22.926 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIV;22.692 11 Extremadura;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIV;21.917 11 Extremadura;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIV;21.487 11 Extremadura;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the second trimester;2022QI;20.817 11 Extremadura;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the second trimester;2021QI;20.391 11 Extremadura;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;20.014 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;19.697 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;19.366 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;19.122 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,33 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,33 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,72 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;89,59 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;88,94 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;86,14 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;85,92 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;83,35 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;83,41 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;23.594 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;22.431 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;20.618 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;22.244 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;21.138 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;19.234 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;20.064 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;18.197 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;19.284 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;17.542 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;18.665 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;17.004 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;94,28 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;94,24 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;93,29 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;89,45 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;88,26 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;85,97 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;85,08 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;83,21 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;82,47 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;461 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;804 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;2.308 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;448 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;779 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;2.253 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;753 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;2.194 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;730 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;2.155 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;701 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;2.118 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;97,18 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;96,89 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;97,62 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;93,66 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;95,06 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;90,8 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;93,37 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;87,19 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;91,77 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;18.450 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;18.089 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;18.673 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QI;16.943 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QI;16.674 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QI;15.316 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QII;15.971 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QII;15.854 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QII;14.642 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;15.242 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;15.219 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;14.138 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;14.703 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;14.708 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;13.639 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;91,83 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;92,18 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;82,02 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;86,56 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;87,64 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;78,41 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;82,61 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;84,13 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;75,71 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;79,69 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;81,31 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;73,04 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;17.962 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;17.057 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;16.479 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;15.684 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;15.528 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;14.891 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;14.820 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;14.278 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;14.290 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;13.798 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;91,74 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;91,95 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;86,45 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;87,3 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;82,51 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;83,71 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;79,56 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;80,89 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;488 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;1.032 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;464 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;990 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;443 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;963 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;422 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;941 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;413 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;910 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;95,08 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;95,93 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;90,78 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;93,31 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;86,48 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;91,18 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;84,63 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;88,18 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;18.365 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;17.946 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;16.828 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QII;17.094 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QII;16.801 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QII;15.951 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIII;16.171 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIII;15.967 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIII;15.321 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;15.510 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;15.329 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;14.724 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;14.594 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;14.058 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 11 Extremadura;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,08 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,62 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;94,79 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;88,05 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;88,97 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,04 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;84,45 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;85,42 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,5 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;81,32 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;83,54 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;17.867 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;17.091 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;14.408 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;16.624 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;15.981 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;13.574 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;15.730 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;15.169 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;13.012 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;15.085 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;14.556 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;12.493 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;13.851 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;11.904 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;93,04 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;93,51 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;94,21 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;88,04 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;88,75 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;90,31 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;84,43 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;85,17 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;86,71 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;81,04 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;82,62 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;498 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;855 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;2.420 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;470 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;820 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;2.377 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;441 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;798 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;2.309 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;425 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;773 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;2.231 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;743 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;2.154 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;94,38 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;95,91 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,22 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;88,55 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;93,33 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;95,41 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;85,34 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;90,41 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;92,19 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;86,9 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;89,01 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;18.583 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;18.213 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;17.769 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIII;17.140 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIII;16.798 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIII;16.642 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIV;16.226 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIV;15.921 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIV;15.745 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;15.085 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;14.902 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;14.524 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;14.421 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;92,23 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;92,23 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;93,66 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;87,32 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;87,42 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;88,61 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;82,83 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;83,87 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;79,75 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;81,16 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;18.226 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;17.903 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;16.428 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;16.806 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;16.499 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;15.340 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;15.904 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;15.630 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;14.486 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;14.804 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;13.683 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;14.249 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;13.232 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;92,21 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;92,16 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;93,38 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;87,26 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;87,3 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;88,18 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;82,69 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;83,29 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;79,59 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;80,55 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;357 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;310 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;1.341 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;334 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;299 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;1.302 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;322 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;291 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;1.259 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;281 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;1.219 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;275 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;1.189 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;93,56 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;96,45 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;97,09 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;90,2 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;93,87 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;93,89 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;90,65 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;90,9 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;88,71 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;88,67 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;18.740 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;18.178 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;18.114 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIV;17.471 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIV;16.911 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIV;16.748 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QI;15.878 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QI;15.723 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;15.159 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;15.084 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;14.561 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;14.554 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,23 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,03 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,46 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;87,35 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;86,8 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;83,39 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;83,27 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;80,1 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;80,35 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;18.426 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;17.598 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;16.822 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;17.169 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;16.355 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;15.502 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;15.347 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;14.519 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;14.647 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;13.913 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;14.074 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;13.408 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;93,18 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;92,94 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;92,15 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;87,21 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;86,31 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;83,23 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;82,71 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;79,97 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;79,71 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;314 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;580 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;1.292 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;302 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;556 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;1.246 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;531 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;1.204 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;512 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;1.171 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;487 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;1.146 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;96,18 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;95,86 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;96,44 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;91,55 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;93,19 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;88,28 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;90,63 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;83,97 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;88,7 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.351 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.174 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.336 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QI;2.312 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QI;2.128 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QI;2.227 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QII;2.261 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QII;2.085 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QII;2.190 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.233 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.062 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.165 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.203 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.046 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.134 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,34 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,88 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,33 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,17 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,91 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,75 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,98 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,85 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,68 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,7 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,11 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,35 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;2.233 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;1.852 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;2.195 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;1.810 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;2.146 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;1.770 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;2.119 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;1.755 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;2.090 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;1.742 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,3 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;97,73 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;96,1 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;95,57 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;94,89 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;94,76 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;93,6 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;94,06 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;118 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;322 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;117 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;318 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;115 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;315 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;114 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;307 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;113 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;304 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;99,15 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,76 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;97,46 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;97,83 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;96,61 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;95,34 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;95,76 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;94,41 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.329 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.207 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.019 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QII;2.277 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QII;2.172 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QII;1.992 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.253 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.147 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.972 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.219 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.123 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.952 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;2.081 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;1.918 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,77 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,41 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,66 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,74 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,28 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,67 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,28 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;96,19 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,68 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,29 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;95 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;2.234 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;1.956 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;1.425 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;2.184 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;1.923 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;1.401 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;2.164 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;1.903 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;1.386 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;2.130 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;1.882 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;1.374 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;1.843 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;1.357 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;97,76 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,31 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,32 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;96,87 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;97,29 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;97,26 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;95,34 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;96,22 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;96,42 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;94,22 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;95,23 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;95 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;251 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;594 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;93 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;249 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;591 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;89 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;244 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;586 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;89 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;241 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;578 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;238 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;561 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;97,89 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,2 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,49 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;93,68 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;97,21 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,65 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;93,68 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;96,02 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;97,31 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;94,82 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;94,44 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.462 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.333 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.196 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.420 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.297 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.165 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.373 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.266 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.124 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;2.226 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;2.086 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;2.196 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;2.057 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,29 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,46 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,59 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,39 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;97,13 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,72 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,41 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,99 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;94,13 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,67 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;2.406 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;2.244 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;1.800 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;2.366 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;2.209 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;1.774 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;2.320 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;2.178 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;1.737 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;2.139 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;1.709 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;2.114 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;1.681 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,34 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,44 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,56 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;96,43 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;97,06 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;96,5 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;95,32 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;94,94 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;94,21 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;93,39 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;56 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;89 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;396 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;54 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;88 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;391 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;53 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;88 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;387 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;87 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;377 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;82 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;376 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;96,43 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;98,88 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,74 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;94,64 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;98,88 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;97,73 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;97,75 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;95,2 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;92,13 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;94,95 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.437 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.307 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.208 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.381 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.278 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.165 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QI;2.232 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QI;2.126 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;2.184 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;2.093 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.160 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.070 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,7 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,74 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,05 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,75 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,29 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,67 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,79 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,63 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,75 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;2.377 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;2.208 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;1.813 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;2.322 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;2.179 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;1.777 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;2.134 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;1.746 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;2.087 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;1.715 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;2.065 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;1.699 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;97,69 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;98,69 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;98,01 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;96,65 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;96,3 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;94,52 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;94,59 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;93,52 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;93,71 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;60 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;99 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;395 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;59 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;99 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;388 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;98 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;380 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;97 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;378 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;95 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;371 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;98,33 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;98,23 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;98,99 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;96,2 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;97,98 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;95,7 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;95,96 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;93,92 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.616 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.383 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.535 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QI;2.592 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QI;2.352 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QI;2.465 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QII;2.553 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QII;2.332 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QII;2.443 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.517 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.305 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.422 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.496 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.289 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.403 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,08 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,7 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;97,24 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,59 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,86 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;96,37 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;96,22 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,73 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;95,54 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;95,41 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;96,06 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;94,79 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;2.492 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;1.921 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;2.469 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;1.896 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;2.431 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;1.880 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;2.395 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;1.858 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;2.374 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;1.845 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,08 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,7 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;97,55 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;97,87 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;96,11 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;96,72 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;95,26 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;96,04 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;124 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;462 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;123 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;456 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;122 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;452 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;122 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;447 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;122 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;444 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;99,19 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,7 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;98,39 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;97,84 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;98,39 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;96,75 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;98,39 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;96,1 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.637 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.400 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.207 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QII;2.594 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QII;2.375 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QII;2.190 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.557 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.348 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.174 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.535 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.334 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.155 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;2.316 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;2.131 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 11 Extremadura;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,37 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,96 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,23 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,97 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,83 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,5 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;96,13 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;97,25 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;97,64 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;96,5 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;96,56 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;2.515 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;2.047 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;1.459 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;2.472 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;2.024 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;1.447 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;2.436 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;2.001 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;1.436 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;2.415 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;1.989 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;1.420 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;1.976 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;1.404 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,29 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,88 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,18 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;96,86 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;97,75 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,42 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;96,02 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;97,17 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;97,33 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;96,53 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;96,23 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;122 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;353 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;748 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;122 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;351 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;743 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;121 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;347 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;738 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;120 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;345 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;735 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;340 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;727 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,43 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,33 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;99,18 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;98,3 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,66 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;98,36 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;97,73 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;98,26 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;96,32 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;97,19 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.709 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.554 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.388 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.661 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.517 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.365 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.626 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.496 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.336 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;2.469 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;2.306 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;2.442 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;2.291 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,23 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,55 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,04 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,94 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;97,73 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97,82 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;96,67 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;96,57 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;95,61 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;95,94 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;2.625 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;2.439 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;1.815 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;2.578 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;2.406 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;1.796 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;2.543 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;2.385 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;1.773 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;2.360 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;1.751 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;2.333 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;1.738 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,21 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,65 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,95 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;96,88 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;97,79 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;97,69 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;96,76 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;96,47 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;95,65 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;95,76 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;84 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;115 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;573 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;83 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;111 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;569 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;83 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;111 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;563 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;109 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;555 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;109 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;553 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;98,81 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;96,52 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,3 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;98,81 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;96,52 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;98,25 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;94,78 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;96,86 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;94,78 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;96,51 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.714 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.599 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.464 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.676 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.577 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.435 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QI;2.556 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QI;2.405 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;2.520 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;2.383 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.494 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.361 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,6 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,15 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,82 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,35 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,61 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;96,96 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;96,71 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;95,96 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;95,82 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;2.638 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;2.485 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;1.879 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;2.600 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;2.464 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;1.852 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;2.443 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;1.831 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;2.410 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;1.813 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;2.386 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;1.796 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;98,56 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,15 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;98,56 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,31 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;97,45 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;96,98 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;96,49 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;96,02 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;95,58 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;76 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;114 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;585 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;76 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;113 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;583 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;113 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;574 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;110 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;570 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;108 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;565 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;99,12 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,66 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;99,12 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,12 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;96,49 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;97,44 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;94,74 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;96,58 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;115 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;103 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;117 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QI;115 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QI;101 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QI;117 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QII;114 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QII;101 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QII;117 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;114 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;101 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;116 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;114 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;101 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;114 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;100 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,06 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;100 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;99,13 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;98,06 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;100 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;99,13 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;98,06 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;99,15 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;99,13 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;98,06 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;97,44 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;106 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;80 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;106 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;78 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;105 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;78 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;105 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;78 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;105 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;78 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;100 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;97,5 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;99,06 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;97,5 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;99,06 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;97,5 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;99,06 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;97,5 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;9 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;23 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;9 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;23 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;9 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;23 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;9 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;23 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;9 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;23 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;100 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;113 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;96 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;102 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QII;112 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QII;96 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QII;102 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIII;112 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIII;96 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIII;101 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;112 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;96 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;101 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;96 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;99 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 11 Extremadura;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;99,12 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;99,12 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;100 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;99,02 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;99,12 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;100 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;99,02 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;100 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;97,06 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;106 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;77 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;73 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;105 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;77 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;73 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;105 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;77 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;72 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;105 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;77 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;72 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;77 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;70 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;99,06 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;99,06 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;100 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,63 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;99,06 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;100 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;98,63 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;100 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;95,89 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;7 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;19 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;29 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;7 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;19 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;29 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;7 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;19 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;29 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;7 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;19 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;29 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;19 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;29 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;100 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;122 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;102 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;96 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIII;121 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIII;101 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIII;95 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIV;121 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIV;101 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIV;95 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;101 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;93 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;101 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;93 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,18 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,02 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,96 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;99,18 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;99,02 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;98,96 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;99,02 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;96,88 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;99,02 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;96,88 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;115 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;93 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;74 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;114 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;92 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;73 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;114 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;92 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;73 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;92 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;71 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;92 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;71 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,13 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,92 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,65 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;99,13 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;98,92 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;98,65 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;98,92 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;95,95 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;98,92 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;95,95 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;7 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;9 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;22 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;7 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;9 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;22 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;7 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;9 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;22 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;9 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;22 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;9 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;22 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;100 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;100 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;126 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;109 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;103 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIV;126 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIV;109 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIV;102 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QI;109 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QI;100 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;109 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;100 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;109 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;100 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;100 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,03 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;100 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,09 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;100 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;97,09 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;100 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;97,09 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;117 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;102 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;79 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;117 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;102 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;78 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;102 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;76 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;102 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;76 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;102 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;76 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;100 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;98,73 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;100 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;96,2 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;100 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;96,2 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;100 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;96,2 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;9 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;7 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;24 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;9 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;7 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;24 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;7 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;24 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;7 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;24 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;7 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;24 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;100 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;39 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;35 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;35 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QI;39 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QI;35 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QI;35 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QII;39 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QII;35 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QII;35 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;39 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;35 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;35 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;39 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;35 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;35 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;100 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;100 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;100 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;100 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;100 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;100 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;100 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;100 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;100 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;100 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;100 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;100 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;33 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;23 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;33 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;23 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;33 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;23 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;33 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;23 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;33 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;23 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;100 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;100 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;100 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;100 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;100 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;100 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;100 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;100 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;6 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;12 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;6 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;12 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;6 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;12 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;6 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;12 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;6 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;12 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;100 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;39 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;37 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;33 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QII;39 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QII;37 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QII;33 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIII;39 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIII;37 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIII;33 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;39 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;37 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;33 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;37 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;33 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 11 Extremadura;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;100 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;100 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;100 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;100 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;100 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;100 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;100 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;100 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;100 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;36 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;25 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;22 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;36 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;25 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;22 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;36 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;25 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;22 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;36 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;25 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;22 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;25 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;22 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;100 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;100 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;100 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;100 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;100 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;100 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;100 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;100 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;3 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;12 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;11 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;3 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;12 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;11 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;3 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;12 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;11 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;3 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;12 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;11 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;12 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;11 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;100 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;38 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;38 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;35 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIII;38 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIII;38 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIII;35 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIV;38 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIV;38 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIV;35 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;38 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;35 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;38 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;35 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;100 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;100 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;100 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;100 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;100 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;100 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;100 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;100 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;100 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;36 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;34 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;22 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;36 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;34 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;22 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;36 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;34 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;22 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;34 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;22 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;34 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;22 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;100 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;100 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;100 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;100 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;100 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;100 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;100 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;100 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;2 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;4 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;13 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;2 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;4 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;13 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;2 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;4 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;13 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;4 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;13 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;4 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;13 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;100 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;100 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;38 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;42 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;37 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIV;38 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIV;42 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIV;37 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QI;42 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QI;37 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;42 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;37 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;42 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;37 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;100 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;100 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;100 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;100 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;100 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;100 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;100 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;100 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;36 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;38 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;25 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;36 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;38 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;25 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;38 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;25 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;38 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;25 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;38 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;25 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;100 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;100 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;100 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;100 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;100 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;100 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;100 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;2 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;4 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;12 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;2 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;4 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;12 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;4 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;12 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;4 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;12 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;4 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;12 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;100 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 11 Extremadura;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;71.690 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;70.002 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;73.097 12 Galicia;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the first trimester;2022QI;68.126 12 Galicia;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the first trimester;2021QI;66.633 12 Galicia;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the first trimester;2020QI;66.505 12 Galicia;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the second trimester;2022QII;65.517 12 Galicia;Total ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the second trimester;2021QII;64.607 12 Galicia;Total ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the second trimester;2020QII;64.491 12 Galicia;Total ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;63.429 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;62.840 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;62.652 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;61.705 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;61.372 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;60.891 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,03 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,19 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;90,98 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,39 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,29 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;88,23 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,48 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,77 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,71 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,07 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87,67 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,3 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;68.198 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;61.488 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;64.761 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;58.318 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;62.276 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;56.441 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;60.266 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;54.807 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;58.604 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;53.486 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;94,96 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;94,84 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;91,32 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;91,79 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;88,37 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;89,13 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;85,93 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;86,99 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;3.492 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;8.514 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;3.365 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;8.315 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;3.241 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;8.166 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;3.163 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;8.033 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;3.101 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;7.886 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;96,36 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;97,66 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;92,81 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;95,91 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;90,58 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;94,35 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;88,8 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;92,62 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;71.312 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;69.683 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;69.240 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the first trimester;2022QII;68.153 12 Galicia;Total ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the first trimester;2021QII;67.163 12 Galicia;Total ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the first trimester;2020QII;66.866 12 Galicia;Total ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIII;65.726 12 Galicia;Total ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIII;65.046 12 Galicia;Total ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIII;64.749 12 Galicia;Total ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;63.590 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;63.232 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;62.762 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;61.168 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;60.672 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 12 Galicia;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,57 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,38 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,57 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,17 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,35 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,51 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,17 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,74 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,64 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,78 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87,63 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;67.928 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;60.845 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;55.259 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;64.882 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;58.500 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;53.060 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;62.540 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;56.539 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;51.260 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;60.474 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;54.897 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;49.613 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;53.041 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;47.889 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 12 Galicia;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;95,52 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;96,15 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;96,02 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;92,07 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;92,92 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;92,76 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;89,03 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;90,22 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;89,78 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;87,17 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;86,66 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;3.384 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;8.838 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;13.981 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;3.271 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;8.663 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;13.806 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;3.186 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;8.507 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;13.489 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;3.116 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;8.335 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;13.149 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;8.127 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;12.783 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 12 Galicia;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;96,66 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;98,02 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,75 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;94,15 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;96,25 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;96,48 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;92,08 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;94,31 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;94,05 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;91,96 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;91,43 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;72.346 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;71.848 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;70.278 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIII;68.747 12 Galicia;Total ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIII;68.398 12 Galicia;Total ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIII;67.253 12 Galicia;Total ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIV;65.688 12 Galicia;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIV;65.732 12 Galicia;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIV;64.614 12 Galicia;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;63.345 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;62.316 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;61.614 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;60.937 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,03 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,2 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,7 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,8 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,49 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,94 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,17 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,67 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,76 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;86,71 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;70.243 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;69.161 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;59.711 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;66.705 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;65.766 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;56.898 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;63.690 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;63.157 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;54.493 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;60.837 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;52.444 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;59.162 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;51.226 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;94,96 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;95,09 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;95,29 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;90,67 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;91,32 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;91,26 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;87,96 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;87,83 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;85,54 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;85,79 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;2.103 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;2.687 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;10.567 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;2.042 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;2.632 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;10.355 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;1.998 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;2.575 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;10.121 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;2.508 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;9.872 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;2.452 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;9.711 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;97,1 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;97,95 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;97,99 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;95,01 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;95,83 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;95,78 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;93,34 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;93,42 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;91,25 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;91,9 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;71.639 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;71.807 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;70.889 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIV;67.870 12 Galicia;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIV;68.304 12 Galicia;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIV;67.202 12 Galicia;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the second trimester;2022QI;65.549 12 Galicia;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the second trimester;2021QI;64.505 12 Galicia;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;63.407 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;62.843 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;61.602 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;61.335 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,74 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,12 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,8 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,28 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,99 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,3 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,65 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,79 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,52 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;69.759 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;68.096 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;62.213 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;66.030 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;64.698 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;58.726 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;62.094 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;56.230 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;60.073 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;54.699 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;58.349 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;53.325 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;94,65 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;95,01 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;94,4 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;91,19 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;90,38 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;88,22 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;87,92 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;85,69 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;85,71 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;1.880 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;3.711 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;8.676 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;1.840 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;3.606 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;8.476 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;3.455 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;8.275 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;3.334 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;8.144 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;3.253 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;8.010 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;97,87 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;97,17 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;97,69 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;93,1 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;95,38 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;89,84 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;93,87 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;87,66 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;92,32 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;55.675 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;55.065 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;56.985 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QI;52.268 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QI;51.848 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QI;50.725 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QII;49.889 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QII;50.016 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QII;48.848 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;47.922 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;48.363 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;47.155 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;46.322 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;46.997 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;45.552 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,88 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,16 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;89,01 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;89,61 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;90,83 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;85,72 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;86,07 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;87,83 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;82,75 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,2 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,35 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;79,94 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;53.302 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;50.190 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;50.015 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;47.138 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;47.745 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;45.425 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;45.846 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;43.884 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;44.304 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;42.632 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;93,83 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;93,92 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;89,57 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;90,51 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;86,01 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;87,44 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;83,12 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;84,94 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;2.373 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;4.875 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;2.253 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;4.710 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;2.144 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;4.591 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;2.076 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;4.479 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;2.018 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;4.365 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;94,94 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;96,62 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;90,35 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;94,17 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;87,48 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;91,88 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;85,04 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;89,54 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;55.177 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;54.716 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;54.333 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QII;52.222 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QII;52.390 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QII;52.067 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIII;49.916 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIII;50.387 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIII;50.064 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;47.921 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;48.684 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;48.202 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;46.766 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;46.270 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 12 Galicia;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,64 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,75 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,83 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;90,47 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,09 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,14 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,85 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,98 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,72 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,47 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,16 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;52.878 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;49.421 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;45.370 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;50.024 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;47.238 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;43.254 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;47.794 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;45.373 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;41.524 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;45.859 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;43.815 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;39.954 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;42.073 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;38.331 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;94,6 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;95,58 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;95,34 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;90,39 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;91,81 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;91,52 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;86,73 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;88,66 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;88,06 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;85,13 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;84,49 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;2.299 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;5.295 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;8.963 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;2.198 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;5.152 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;8.813 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;2.122 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;5.014 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;8.540 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;2.062 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;4.869 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;8.248 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;4.693 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;7.939 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;95,61 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,3 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,33 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;92,3 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;94,69 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;95,28 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;89,69 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;91,95 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;92,02 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;88,63 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;88,58 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;55.637 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;55.980 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;55.058 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIII;52.198 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIII;52.701 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIII;52.181 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIV;49.399 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIV;50.245 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIV;49.710 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;48.035 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;47.587 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;46.446 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;46.331 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,82 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;94,14 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,77 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;88,79 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;89,76 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,29 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;85,81 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,43 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;82,97 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,15 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;54.156 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;54.429 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;49.078 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;50.773 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;51.200 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;46.373 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;48.010 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;48.791 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;44.095 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;46.638 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;42.171 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;45.092 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;41.034 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;93,75 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;94,07 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;94,49 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;88,65 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;89,64 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;89,85 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;85,69 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;85,93 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;82,85 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;83,61 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;1.481 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;1.551 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;5.980 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;1.425 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;1.501 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;5.808 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;1.389 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;1.454 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;5.615 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;1.397 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;5.416 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;1.354 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;5.297 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;96,22 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;96,78 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;97,12 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;93,79 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;93,75 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;93,9 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;90,07 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;90,57 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;87,3 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;88,58 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;55.049 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;55.849 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;55.524 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIV;51.502 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIV;52.515 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIV;51.971 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QI;49.928 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QI;49.447 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;47.982 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;47.948 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;46.295 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;46.552 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,56 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,03 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,6 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;89,4 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,06 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;85,91 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;86,36 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;82,89 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;83,84 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;53.729 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;53.215 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;50.742 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;50.219 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;49.976 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;47.360 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;47.531 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;44.999 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;45.691 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;43.598 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;44.073 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;42.307 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;93,47 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;93,91 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;93,33 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;89,32 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;88,68 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;85,86 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;85,92 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;82,82 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;83,38 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;1.320 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;2.634 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;4.782 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;1.283 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;2.539 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;4.611 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;2.397 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;4.448 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;2.291 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;4.350 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;2.222 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;4.245 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;97,2 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;96,39 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;96,42 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;91 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;93,02 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;86,98 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;90,97 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;84,36 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;88,77 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;7.189 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.664 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;7.242 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QI;7.099 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QI;6.593 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QI;7.028 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QII;6.969 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QII;6.480 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QII;6.947 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.901 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.419 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.858 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.830 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.361 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.758 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,75 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,93 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;97,05 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,94 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,24 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,93 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,99 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,32 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,7 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;95,01 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;95,45 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;93,32 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;6.730 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;5.299 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;6.643 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;5.241 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;6.518 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;5.144 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;6.454 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;5.095 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;6.386 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;5.053 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,71 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,91 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;96,85 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;97,07 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;95,9 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;96,15 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;94,89 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;95,36 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;459 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;1.365 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;456 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;1.352 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;451 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;1.336 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;447 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;1.324 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;444 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;1.308 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;99,35 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,05 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;98,26 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;97,88 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;97,39 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;97 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;96,73 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;95,82 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.214 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.652 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.613 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QII;7.092 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QII;6.535 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QII;6.546 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIII;7.023 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.469 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.480 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;6.947 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.406 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;6.398 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;6.323 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;6.319 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,31 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,24 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,99 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;97,35 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,25 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,99 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;96,3 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;96,3 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,75 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;95,05 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;95,55 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;6.781 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;5.329 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;4.484 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;6.667 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;5.230 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;4.434 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;6.604 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;5.173 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;4.397 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;6.536 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;5.121 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;4.346 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;5.051 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;4.294 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,32 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,14 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,88 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;97,39 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;97,07 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,06 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;96,39 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;96,1 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;96,92 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;94,78 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;95,76 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;433 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;1.323 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;2.129 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;425 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;1.305 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;2.112 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;419 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;1.296 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;2.083 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;411 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;1.285 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;2.052 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;1.272 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;2.025 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;98,15 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;98,64 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,2 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;96,77 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;97,96 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;97,84 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;94,92 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;97,13 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;96,38 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;96,15 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;95,12 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;7.473 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;7.155 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.848 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIII;7.374 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIII;7.047 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.751 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIV;7.213 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.906 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.641 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;6.798 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;6.557 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;6.714 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;6.493 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,68 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,49 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,58 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,52 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,52 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,98 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,01 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,75 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,84 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,82 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;7.192 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;6.751 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;5.074 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;7.096 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;6.645 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;5.005 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;6.940 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;6.508 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;4.921 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;6.405 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;4.862 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;6.330 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;4.818 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,67 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,43 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,64 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;96,5 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;96,4 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;96,98 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;94,87 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;95,82 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;93,76 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;94,95 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;281 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;404 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;1.774 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;278 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;402 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;1.746 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;273 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;398 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;1.720 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;393 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;1.695 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;384 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;1.675 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;98,93 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,5 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,42 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;97,15 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;98,51 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;96,96 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;97,28 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;95,55 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;95,05 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;94,42 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;7.423 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;7.142 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.889 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.281 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIV;7.033 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.799 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QI;6.931 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QI;6.719 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;6.817 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;6.634 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.746 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.580 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,09 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,47 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,69 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;97,05 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,53 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,45 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;96,3 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;94,46 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;95,51 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;7.194 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;6.720 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;5.478 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;7.054 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;6.617 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;5.403 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;6.519 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;5.341 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;6.413 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;5.275 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;6.352 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;5.236 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;98,05 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;98,47 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;98,63 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;97,01 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;97,5 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;95,43 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;96,29 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;94,52 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;95,58 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;229 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;422 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;1.411 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;227 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;416 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;1.396 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;412 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;1.378 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;404 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;1.359 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;394 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;1.344 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;99,13 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;98,58 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;98,94 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;97,63 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;97,66 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;95,73 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;96,31 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;93,36 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;95,25 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.263 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;7.756 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;8.295 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QI;8.198 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QI;7.679 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QI;8.178 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QII;8.101 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QII;7.598 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QII;8.123 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.053 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;7.545 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;8.069 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;8.001 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;7.502 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;8.014 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,21 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,01 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;98,59 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;98,04 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,96 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;97,93 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;97,46 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;97,28 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;97,28 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;96,83 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;96,73 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;96,61 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;7.660 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;5.647 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;7.599 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;5.589 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;7.510 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;5.522 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;7.466 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;5.478 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;7.415 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;5.452 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,2 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,97 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;98,04 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;97,79 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;97,47 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;97,01 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;96,8 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;96,55 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;603 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;2.109 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;599 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;2.090 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;591 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;2.076 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;587 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;2.067 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;586 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;2.050 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;99,34 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,1 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;98,01 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,44 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;97,35 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;98,01 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;97,18 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;97,2 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;8.337 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;7.785 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;7.748 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QII;8.257 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QII;7.708 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QII;7.707 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIII;8.210 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIII;7.660 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIII;7.662 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;8.145 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;7.613 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;7.621 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;7.553 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;7.545 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 12 Galicia;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;99,04 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,01 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,47 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;98,48 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;98,39 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,89 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;97,7 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;97,79 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;98,36 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;97,02 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;97,38 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;7.735 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;5.719 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;5.040 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;7.657 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;5.656 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;5.007 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;7.612 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;5.617 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;4.976 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;7.549 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;5.586 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;4.951 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;5.544 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;4.903 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,99 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,9 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,35 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;98,41 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;98,22 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,73 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;97,6 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;97,67 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;98,23 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;96,94 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;97,28 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;602 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;2.066 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;2.708 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;600 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;2.052 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;2.700 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;598 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;2.043 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;2.686 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;596 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;2.027 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;2.670 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;2.009 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;2.642 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;99,67 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,32 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,7 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;99,34 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;98,89 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;99,19 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;99 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;98,11 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;98,6 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;97,24 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;97,56 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;8.643 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;8.170 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;7.833 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIII;8.587 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIII;8.107 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIII;7.785 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIV;8.488 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIV;8.039 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIV;7.729 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;7.973 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;7.641 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;7.919 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;7.582 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,35 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,23 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,39 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;98,21 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;98,4 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;98,67 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;97,59 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;97,55 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;96,93 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;96,8 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;8.337 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;7.497 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;5.216 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;8.282 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;7.437 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;5.178 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;8.186 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;7.375 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;5.136 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;7.314 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;5.071 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;7.263 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;5.034 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,34 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99,2 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,27 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;98,19 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;98,37 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;98,47 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;97,56 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;97,22 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;96,88 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;96,51 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;306 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;673 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;2.617 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;305 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;670 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;2.607 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;302 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;664 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;2.593 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;659 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;2.570 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;656 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;2.548 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;99,67 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,55 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,62 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;98,69 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;98,66 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;99,08 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;97,92 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;98,2 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;97,47 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;97,36 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;8.572 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;8.263 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;7.927 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIV;8.492 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIV;8.204 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIV;7.885 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QI;8.141 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QI;7.795 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;8.063 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;7.717 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.020 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;7.659 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,07 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,29 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,47 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,52 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;98,33 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;97,58 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;97,35 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;97,06 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;96,62 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;8.271 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;7.658 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;5.639 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;8.192 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;7.603 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;5.611 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;7.544 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;5.539 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;7.472 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;5.475 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;7.430 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;5.431 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,04 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,28 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,5 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,51 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;98,23 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;97,57 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;97,09 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;97,02 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;96,31 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;301 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;605 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;2.288 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;300 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;601 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;2.274 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;597 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;2.256 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;591 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;2.242 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;590 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;2.228 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;99,67 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;99,34 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,39 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;98,68 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,6 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;97,69 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;97,99 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;97,52 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;97,38 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;357 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;321 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;376 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QI;356 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QI;318 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QI;375 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QII;355 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QII;318 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QII;374 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;351 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;318 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;372 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;350 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;318 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;370 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,72 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,07 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;99,73 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;99,44 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;99,07 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;99,47 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;98,32 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;99,07 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;98,94 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;98,04 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;99,07 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;98,4 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;321 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;218 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;320 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;217 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;320 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;217 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;317 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;217 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;316 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;217 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,69 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,54 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;99,69 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;99,54 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;98,75 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;99,54 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;98,44 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;99,54 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;36 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;103 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;36 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;101 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;35 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;101 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;34 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;101 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;34 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;101 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,06 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;97,22 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,06 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;94,44 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;98,06 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;94,44 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;98,06 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;381 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;334 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;355 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QII;380 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QII;334 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QII;355 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIII;376 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIII;334 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIII;353 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;376 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;334 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;352 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;331 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;350 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 12 Galicia;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;99,74 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;98,69 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;100 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;99,44 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;98,69 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;100 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;99,15 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;99,1 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;98,59 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;349 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;242 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;231 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;349 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;242 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;231 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;345 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;242 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;230 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;345 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;242 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;230 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;240 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;230 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;98,85 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;100 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;99,57 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;98,85 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;100 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;99,57 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;99,17 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;99,57 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;32 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;92 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;124 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;31 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;92 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;124 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;31 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;92 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;123 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;31 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;92 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;122 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;91 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;120 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;96,88 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;96,88 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;99,19 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;96,88 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;98,39 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;98,91 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;96,77 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;390 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;343 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;347 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIII;386 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIII;343 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIII;345 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIV;386 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIV;343 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIV;344 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;341 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;342 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;339 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;342 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,97 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,42 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;98,97 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;100 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;99,14 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;99,42 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;98,56 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;98,83 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;98,56 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;365 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;310 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;215 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;361 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;310 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;215 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;361 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;310 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;215 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;308 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;215 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;307 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;215 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,9 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;98,9 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;100 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;100 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;99,35 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;100 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;99,03 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;100 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;25 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;33 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;132 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;25 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;33 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;130 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;25 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;33 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;129 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;33 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;127 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;32 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;127 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,48 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;97,73 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;96,21 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;96,97 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;96,21 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;388 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;346 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;347 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIV;388 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIV;346 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIV;346 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QI;344 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QI;344 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;342 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;344 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;339 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;344 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;100 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,71 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;99,42 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;99,14 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;98,84 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;99,14 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;97,98 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;99,14 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;367 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;317 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;220 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;367 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;317 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;219 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;316 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;219 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;314 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;219 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;311 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;219 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;100 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,55 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;99,68 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;99,55 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;99,05 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;99,55 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;98,11 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;99,55 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;21 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;29 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;127 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;21 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;29 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;127 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;28 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;125 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;28 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;125 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;28 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;125 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;96,55 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,43 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;96,55 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;98,43 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;96,55 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;98,43 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;206 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;196 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;199 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QI;205 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QI;195 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QI;199 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QII;203 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QII;195 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QII;199 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;202 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;195 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;198 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;202 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;194 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;197 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,51 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,49 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;100 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;98,54 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;99,49 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;100 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;98,06 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;99,49 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;99,5 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;98,06 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;98,98 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;98,99 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;185 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;134 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;184 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;133 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;183 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;133 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;183 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;133 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;183 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;132 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,46 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,25 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;98,92 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;99,25 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;98,92 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;99,25 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;98,92 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;98,51 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;21 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;62 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;21 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;62 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;20 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;62 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;19 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;62 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;19 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;62 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;95,24 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;90,48 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;90,48 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;100 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;203 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;196 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;191 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QII;202 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QII;196 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QII;191 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIII;201 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIII;196 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIII;190 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;201 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;195 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;189 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;195 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;188 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 12 Galicia;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;99,51 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;99,01 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;100 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;99,48 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;99,01 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;99,49 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;98,95 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;99,49 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;98,43 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;185 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;134 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;134 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;185 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;134 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;134 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;185 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;134 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;133 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;185 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;133 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;132 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;133 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;131 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;100 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;100 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;99,25 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;100 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;99,25 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;98,51 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;99,25 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;97,76 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;18 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;62 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;57 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;17 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;62 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;57 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;16 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;62 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;57 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;16 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;62 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;57 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;62 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;57 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;94,44 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;88,89 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;88,89 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;100 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;203 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;200 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;192 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIII;202 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIII;200 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIII;191 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIV;202 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIV;199 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIV;190 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;198 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;189 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;196 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;189 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,51 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,48 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;99,51 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;99,5 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;98,96 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;99 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;98,44 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;98 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;98,44 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;193 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;174 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;128 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;193 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;174 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;127 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;193 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;173 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;126 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;172 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;125 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;170 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;125 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;100 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,22 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;100 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;99,43 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;98,44 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;98,85 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;97,66 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;97,7 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;97,66 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;10 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;26 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;64 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;9 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;26 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;64 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;9 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;26 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;64 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;26 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;64 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;26 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;64 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;90 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;90 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;100 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;100 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;207 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;207 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;202 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIV;207 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIV;206 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIV;201 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QI;205 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QI;200 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;203 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;200 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;202 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;200 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,52 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,5 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;99,03 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;99,01 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;98,07 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;99,01 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;97,58 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;99,01 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;198 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;186 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;134 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;198 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;185 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;133 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;184 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;132 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;183 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;132 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;183 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;132 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,46 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,25 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,92 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;98,51 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;98,39 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;98,51 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;98,39 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;98,51 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;9 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;21 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;68 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;9 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;21 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;68 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;21 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;68 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;20 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;68 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;19 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;68 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;95,24 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;90,48 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;100 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 12 Galicia;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;170.250 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;164.017 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;170.238 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the first trimester;2022QI;161.452 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the first trimester;2021QI;155.700 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the first trimester;2020QI;151.697 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the second trimester;2022QII;154.760 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the second trimester;2021QII;150.224 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the second trimester;2020QII;146.492 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;149.129 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;145.583 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;141.850 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;145.093 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;141.735 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;137.729 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,83 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,93 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;89,11 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;90,9 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;91,59 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;86,05 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,59 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,76 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;83,32 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;85,22 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,41 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;80,9 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;158.529 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;132.874 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;150.133 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;125.468 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;143.757 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;120.699 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;138.408 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;116.680 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;134.584 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;113.515 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;94,7 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;94,43 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;90,68 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;90,84 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;87,31 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;87,81 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;84,9 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;85,43 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;11.721 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;31.143 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;11.319 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;30.232 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;11.003 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;29.525 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;10.721 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;28.903 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;10.509 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;28.220 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;96,57 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;97,07 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;93,87 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;94,8 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;91,47 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;92,81 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;89,66 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;90,61 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;170.804 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;164.129 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;158.930 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the first trimester;2022QII;162.475 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the first trimester;2021QII;157.281 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the first trimester;2020QII;152.732 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIII;155.903 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIII;151.746 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIII;147.454 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;151.244 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;147.340 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;142.867 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;141.862 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;137.564 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,12 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,83 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,1 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,28 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,46 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,78 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,55 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,77 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,89 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,43 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,56 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;159.474 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;133.437 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;117.168 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;151.487 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;127.315 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;111.514 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;145.201 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;122.422 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;107.264 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;140.740 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;118.715 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;103.704 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;114.048 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;99.625 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;94,99 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;95,41 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;95,17 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;91,05 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;91,75 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;91,55 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;88,25 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;88,97 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;88,51 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;85,47 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;85,03 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;11.330 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;30.692 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;41.762 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;10.988 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;29.966 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;41.218 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;10.702 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;29.324 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;40.190 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;10.504 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;28.625 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;39.163 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;27.814 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;37.939 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;96,98 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,63 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,7 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;94,46 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;95,54 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;96,24 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;92,71 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;93,27 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;93,78 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;90,62 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;90,85 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;171.468 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;166.953 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;161.758 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIII;162.948 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIII;159.383 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIII;154.718 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIV;157.368 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIV;153.937 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIV;149.134 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;147.776 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;143.251 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;143.241 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;139.472 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,03 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,47 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,65 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,78 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,2 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,2 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,51 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,56 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,8 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;86,22 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;165.039 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;155.931 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;127.803 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;156.695 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;148.597 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;121.548 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;151.242 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;143.395 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;116.788 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;137.526 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;111.877 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;133.230 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;108.781 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;94,94 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;95,3 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;95,11 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;91,64 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;91,96 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;91,38 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;88,2 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;87,54 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;85,44 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;85,12 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;6.429 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;11.022 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;33.955 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;6.253 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;10.786 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;33.170 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;6.126 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;10.542 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;32.346 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;10.250 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;31.374 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;10.011 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;30.691 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;97,26 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;97,86 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;97,69 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;95,29 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;95,65 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;95,26 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;93 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;92,4 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;90,83 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;90,39 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;170.560 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;167.679 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;163.090 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIV;163.715 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIV;160.773 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIV;155.882 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the second trimester;2022QI;153.765 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the second trimester;2021QI;149.146 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;148.375 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;144.677 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;143.492 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;140.621 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,99 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,88 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,58 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,7 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,45 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,49 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,71 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,58 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,22 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;164.924 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;155.357 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;127.459 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;158.189 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;148.794 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;121.162 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;142.196 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;115.456 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;137.121 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;111.733 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;132.517 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;108.375 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;95,92 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;95,78 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;95,06 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;91,53 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;90,58 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;88,26 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;87,66 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;85,3 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;85,03 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;5.636 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;12.322 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;35.631 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;5.526 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;11.979 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;34.720 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;11.569 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;33.690 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;11.254 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;32.944 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;10.975 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;32.246 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;98,05 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;97,22 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;97,44 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;93,89 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;94,55 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;91,33 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;92,46 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;89,07 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;90,5 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;121.043 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;117.693 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;120.832 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QI;112.854 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QI;109.964 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QI;103.903 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QII;106.894 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QII;105.040 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QII;99.281 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;101.885 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;100.912 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;95.236 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;98.339 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;97.552 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;91.640 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,23 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,43 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;85,99 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;88,31 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;89,25 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;82,16 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;84,17 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;85,74 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;78,82 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;81,24 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;82,89 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;75,84 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;114.042 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;101.727 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;106.200 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;94.718 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;100.498 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;90.340 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;95.716 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;86.668 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;92.333 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;83.805 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;93,12 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;93,11 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;88,12 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;88,81 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;83,93 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;85,2 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;80,96 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;82,38 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;7.001 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;15.966 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;6.654 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;15.246 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;6.396 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;14.700 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;6.169 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;14.244 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;6.006 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;13.747 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;95,04 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;95,49 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;91,36 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;92,07 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;88,12 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;89,21 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;85,79 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;86,1 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;121.161 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;117.632 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;113.654 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QII;113.491 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QII;111.257 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QII;107.837 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIII;107.518 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIII;106.219 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIII;103.023 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;103.323 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;102.310 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;98.856 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;97.503 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;94.207 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,67 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,58 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;94,88 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;88,74 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;90,3 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;90,65 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;85,28 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;86,97 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;86,98 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;82,89 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;82,89 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;114.442 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;101.897 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;89.748 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;107.060 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;96.130 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;84.364 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;101.327 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;91.577 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;80.379 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;97.292 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;88.192 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;77.049 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;83.982 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;73.321 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;93,55 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;94,34 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;94 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;88,54 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;89,87 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;89,56 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;85,01 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;86,55 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;85,85 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;82,42 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;81,7 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;6.719 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;15.735 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;23.906 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;6.431 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;15.127 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;23.473 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;6.191 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;14.642 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;22.644 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;6.031 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;14.118 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;21.807 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;13.521 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;20.886 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;95,71 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;96,14 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,19 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;92,14 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;93,05 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;94,72 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;89,76 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;89,72 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;91,22 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;85,93 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;87,37 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;121.576 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;119.145 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;115.709 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIII;113.656 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIII;112.099 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIII;109.159 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIV;108.560 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIV;107.172 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIV;104.037 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;101.721 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;98.856 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;97.767 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;95.554 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,49 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;94,09 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,34 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,29 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;89,95 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,91 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;85,38 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;85,44 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;82,06 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;82,58 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;117.778 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;113.369 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;98.174 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;110.016 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;106.522 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;92.249 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;105.029 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;101.800 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;87.779 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;96.569 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;83.301 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;92.794 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;80.505 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;93,41 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;93,96 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;93,96 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;89,18 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;89,8 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;89,41 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;85,18 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;84,85 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;81,85 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;82 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;3.798 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;5.776 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;17.535 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;3.640 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;5.577 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;16.910 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;3.531 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;5.372 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;16.258 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;5.152 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;15.555 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;4.973 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;15.049 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;95,84 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;96,55 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;96,44 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;92,97 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;93,01 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;92,72 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;89,2 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;88,71 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;86,1 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;85,82 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;121.037 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;119.617 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;116.940 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIV;114.588 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIV;113.140 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIV;110.141 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QI;106.797 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QI;104.068 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;102.037 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;100.111 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;97.738 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;96.554 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,67 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,59 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,19 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;89,28 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;88,99 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;85,3 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;85,61 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;81,71 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;82,57 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;117.795 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;112.031 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;98.600 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;111.446 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;105.867 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;92.565 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;99.880 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;87.268 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;95.388 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;83.875 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;91.318 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;80.825 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;94,61 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;94,5 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;93,88 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;89,15 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;88,51 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;85,14 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;85,07 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;81,51 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;81,97 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;3.242 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;7.586 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;18.340 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;3.142 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;7.273 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;17.576 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;6.917 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;16.800 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;6.649 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;16.236 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;6.420 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;15.729 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;96,92 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;95,87 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;95,83 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;91,18 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;91,6 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;87,65 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;88,53 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;84,63 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;85,76 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;18.535 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;17.573 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;18.507 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QI;18.218 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QI;17.267 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QI;17.600 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QII;17.840 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QII;16.982 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QII;17.309 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;17.547 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;16.728 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;16.992 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;17.295 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;16.504 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;16.725 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,29 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,26 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,1 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,25 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,64 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,53 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,67 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,19 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,81 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,31 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,92 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,37 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;16.845 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;12.435 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;16.560 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;12.228 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;16.211 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;12.017 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;15.943 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;11.838 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;15.715 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;11.696 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,31 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,34 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;96,24 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;96,64 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;94,65 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;95,2 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;93,29 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;94,06 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;1.690 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;5.138 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;1.658 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;5.039 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;1.629 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;4.965 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;1.604 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;4.890 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;1.580 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;4.808 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;98,11 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,07 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;96,39 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;96,63 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;94,91 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;95,17 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;93,49 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;93,58 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;18.672 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;17.561 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;16.862 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QII;18.337 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QII;17.299 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QII;16.676 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIII;18.039 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIII;17.041 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIII;16.426 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;17.817 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;16.799 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;16.213 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;16.469 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;15.906 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,21 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,51 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,9 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,61 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,04 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,41 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,42 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,66 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,15 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,78 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,33 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;17.059 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;12.447 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;10.032 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;16.746 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;12.252 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;9.892 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;16.473 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;12.074 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;9.762 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;16.272 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;11.915 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;9.647 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;11.679 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;9.490 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,17 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,43 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,6 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;96,56 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;97 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;97,31 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;95,39 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;95,73 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;96,16 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;93,83 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;94,6 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;1.613 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;5.114 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;6.830 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;1.591 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;5.047 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;6.784 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;1.566 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;4.967 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;6.664 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;1.545 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;4.884 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;6.566 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;4.790 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;6.416 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;98,64 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;98,69 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,33 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;97,09 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;97,13 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;97,57 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;95,78 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;95,5 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;96,13 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;93,66 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;93,94 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;18.584 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;18.033 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;17.445 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIII;18.304 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIII;17.778 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIII;17.178 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIV;18.074 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIV;17.531 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIV;16.937 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;17.176 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;16.598 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;16.882 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;16.360 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,49 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,59 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,47 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;97,26 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;97,22 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97,09 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,25 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,14 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,62 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,78 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;17.629 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;16.207 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;11.842 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;17.358 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;15.967 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;11.667 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;17.137 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;15.742 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;11.510 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;15.423 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;11.291 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;15.156 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;11.135 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,46 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,52 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,52 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;97,21 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;97,13 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;97,2 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;95,16 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;95,35 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;93,52 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;94,03 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;955 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;1.826 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;5.603 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;946 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;1.811 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;5.511 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;937 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;1.789 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;5.427 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;1.753 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;5.307 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;1.726 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;5.225 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;99,06 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,18 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,36 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;98,12 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;97,97 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;96,86 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;96 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;94,72 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;94,52 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;93,25 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;18.303 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;18.045 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;17.367 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIV;18.113 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIV;17.828 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIV;17.142 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QI;17.499 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QI;16.805 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;17.181 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;16.554 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;16.908 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;16.318 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,96 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,8 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,7 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,97 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,76 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,21 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,32 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,7 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,96 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;17.460 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;16.388 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;11.476 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;17.274 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;16.189 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;11.326 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;15.891 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;11.110 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;15.588 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;10.943 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;15.335 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;10.788 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;98,93 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;98,79 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;98,69 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;96,97 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;96,81 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;95,12 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;95,36 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;93,57 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;94 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;843 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;1.657 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;5.891 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;839 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;1.639 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;5.816 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;1.608 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;5.695 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;1.593 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;5.611 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;1.573 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;5.530 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;99,53 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;98,91 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;98,73 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;97,04 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;96,67 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;96,14 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;95,25 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;94,93 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;93,87 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;27.058 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;25.345 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;27.356 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QI;26.799 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QI;25.078 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QI;26.679 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QII;26.462 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QII;24.821 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QII;26.397 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;26.159 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;24.579 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;26.132 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;25.939 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;24.338 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;25.891 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,04 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,95 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;97,53 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,8 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,93 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;96,49 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;96,68 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,98 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;95,53 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;95,86 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;96,03 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;94,64 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;24.374 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;16.604 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;24.136 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;16.424 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;23.828 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;16.250 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;23.552 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;16.093 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;23.357 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;15.952 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,02 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,92 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;97,76 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;97,87 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;96,63 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;96,92 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;95,83 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;96,07 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;2.684 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;8.741 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;2.663 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;8.654 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;2.634 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;8.571 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;2.607 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;8.486 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;2.582 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;8.386 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;99,22 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;98,14 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,06 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;97,13 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;97,08 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;96,2 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;95,94 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;27.304 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;25.525 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;25.028 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QII;26.994 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QII;25.321 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QII;24.838 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIII;26.721 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIII;25.098 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIII;24.632 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;26.503 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;24.864 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;24.441 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;24.561 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;24.114 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,86 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,2 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,24 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;97,86 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;98,33 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,42 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;97,07 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;97,41 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;97,65 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;96,22 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;96,35 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;24.646 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;16.926 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;15.036 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;24.368 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;16.770 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;14.911 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;24.115 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;16.619 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;14.782 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;23.914 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;16.473 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;14.677 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;16.276 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;14.496 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,87 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;99,08 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,17 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;97,85 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;98,19 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,31 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;97,03 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;97,32 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;97,61 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;96,16 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;96,41 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;2.658 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;8.599 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;9.992 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;2.626 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;8.551 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;9.927 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;2.606 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;8.479 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;9.850 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;2.589 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;8.391 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;9.764 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;8.285 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;9.618 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;98,8 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,44 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,35 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;98,04 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;98,6 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,58 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;97,4 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;97,58 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;97,72 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;96,35 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;96,26 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;27.618 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;26.350 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;25.308 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIII;27.318 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIII;26.094 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIII;25.090 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIV;27.086 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIV;25.845 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIV;24.884 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;25.525 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;24.542 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;25.255 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;24.315 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,91 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,03 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,14 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;98,07 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;98,08 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;98,32 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;96,87 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;96,97 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;95,84 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;96,08 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;26.099 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;23.369 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;15.803 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;25.808 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;23.132 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;15.652 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;25.585 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;22.899 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;15.526 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;22.612 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;15.325 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;22.374 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;15.189 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,89 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,99 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,04 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;98,03 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;97,99 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;98,25 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;96,76 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;96,98 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;95,74 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;96,11 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;1.519 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;2.981 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;9.505 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;1.510 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;2.962 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;9.438 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;1.501 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;2.946 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;9.358 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;2.913 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;9.217 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;2.881 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;9.126 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;99,41 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,36 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,3 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;98,82 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;98,83 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;98,45 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;97,72 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;96,97 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;96,65 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;96,01 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;27.488 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;26.502 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;25.386 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIV;27.298 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIV;26.311 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIV;25.215 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QI;26.008 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QI;24.907 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;25.713 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;24.656 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;25.428 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;24.411 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,31 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,28 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,33 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,14 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;98,11 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;97,02 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;97,12 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;95,95 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;96,16 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;26.079 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;23.787 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;15.375 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;25.895 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;23.608 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;15.268 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;23.328 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;15.087 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;23.064 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;14.930 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;22.808 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;14.787 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,29 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,25 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,3 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,07 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;98,13 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;96,96 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;97,11 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;95,88 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;96,18 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;1.409 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;2.715 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;10.011 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;1.403 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;2.703 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;9.947 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;2.680 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;9.820 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;2.649 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;9.726 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;2.620 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;9.624 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;99,57 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;99,56 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,36 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;98,71 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,09 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;97,57 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;97,15 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;96,5 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;96,13 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.048 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.904 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.980 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QI;2.034 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QI;1.898 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QI;1.958 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QII;2.024 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QII;1.891 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QII;1.951 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.004 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.881 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.937 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.993 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.867 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.929 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,32 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,68 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;98,89 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;98,83 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;99,32 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;98,54 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;97,85 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;98,79 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;97,83 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;97,31 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;98,06 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;97,42 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;1.845 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;1.221 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;1.832 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;1.216 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;1.822 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;1.211 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;1.804 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;1.204 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;1.793 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;1.192 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,3 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,59 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;98,75 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;99,18 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;97,78 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;98,61 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;97,18 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;97,62 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;203 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;683 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;202 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;682 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;202 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;680 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;200 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;677 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;200 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;675 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;99,51 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,85 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;99,51 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;99,56 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;98,52 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;99,12 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;98,52 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;98,83 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.100 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.921 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.877 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QII;2.091 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QII;1.916 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QII;1.873 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.068 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.907 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.866 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.051 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.895 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.859 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;1.880 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;1.850 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;99,57 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,74 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,79 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;98,48 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;99,27 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;99,41 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;97,67 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;98,65 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;99,04 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;97,87 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;98,56 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;1.891 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;1.265 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;1.311 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;1.882 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;1.262 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;1.307 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;1.859 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;1.255 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;1.302 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;1.842 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;1.245 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;1.298 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;1.238 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;1.292 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;99,52 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;99,76 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,69 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;98,31 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;99,21 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;99,31 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;97,41 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;98,42 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;99,01 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;97,87 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;98,55 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;209 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;656 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;566 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;209 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;654 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;566 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;209 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;652 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;564 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;209 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;650 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;561 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;642 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;558 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,7 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;99,39 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;99,65 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;99,09 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;99,12 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;97,87 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;98,59 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.108 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.932 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.842 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.093 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.923 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.838 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.078 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.909 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.832 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;1.895 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;1.822 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;1.885 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;1.813 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,29 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,53 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,78 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;98,58 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;98,81 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;99,46 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;98,08 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;98,91 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;97,57 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;98,43 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;2.003 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;1.697 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;1.130 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;1.988 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;1.690 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;1.127 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;1.973 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;1.676 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;1.124 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;1.665 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;1.118 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;1.656 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;1.111 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,25 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99,59 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,73 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;98,5 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;98,76 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;99,47 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;98,11 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;98,94 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;97,58 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;98,32 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;105 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;235 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;712 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;105 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;233 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;711 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;105 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;233 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;708 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;230 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;704 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;229 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;702 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,15 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,86 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;99,15 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;99,44 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;97,87 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;98,88 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;97,45 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;98,6 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.110 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.989 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.904 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.100 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.976 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.900 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QI;1.964 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QI;1.892 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;1.954 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;1.885 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.934 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.874 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,53 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,35 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,79 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,74 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;99,37 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;98,24 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;99 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;97,23 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;98,42 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;2.016 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;1.786 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;1.145 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;2.006 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;1.773 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;1.143 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;1.761 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;1.137 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;1.752 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;1.132 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;1.733 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;1.126 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,5 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,27 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,83 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,6 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;99,3 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;98,1 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;98,86 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;97,03 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;98,34 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;94 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;203 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;759 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;94 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;203 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;757 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;203 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;755 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;202 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;753 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;201 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;748 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,74 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;99,47 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;99,51 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;99,21 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;99,01 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;98,55 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.566 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.502 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.563 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QI;1.547 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QI;1.493 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QI;1.557 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QII;1.540 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QII;1.490 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QII;1.554 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.534 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.483 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.553 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.527 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.474 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.544 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,79 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,4 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;99,62 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;98,34 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;99,2 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;99,42 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;97,96 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;98,74 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;99,36 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;97,51 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;98,14 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;98,78 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;1.423 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;887 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;1.405 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;882 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;1.398 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;881 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;1.393 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;877 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;1.386 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;870 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,74 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,44 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;98,24 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;99,32 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;97,89 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;98,87 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;97,4 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;98,08 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;143 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;615 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;142 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;611 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;142 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;609 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;141 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;606 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;141 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;604 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;99,3 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,35 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;99,3 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;99,02 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;98,6 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;98,54 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;98,6 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;98,21 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.567 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.490 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.509 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QII;1.562 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QII;1.488 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QII;1.508 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.557 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.481 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.507 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.550 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.472 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.498 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;1.449 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;1.487 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;99,68 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,87 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,93 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;99,36 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;99,4 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;99,87 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;98,92 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;98,79 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;99,27 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;97,25 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;98,54 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;1.436 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;902 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;1.041 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;1.431 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;901 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;1.040 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;1.427 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;897 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;1.039 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;1.420 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;890 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;1.033 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;873 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;1.026 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;99,65 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;99,89 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,9 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;99,37 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;99,45 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;99,81 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;98,89 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;98,67 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;99,23 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;96,78 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;98,56 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;131 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;588 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;468 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;131 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;587 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;468 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;130 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;584 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;468 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;130 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;582 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;465 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;576 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;461 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,83 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;99,24 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;99,32 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;99,24 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;98,98 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;99,36 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;97,96 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;98,5 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.582 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.493 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.454 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.577 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.489 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.453 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.570 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.480 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.444 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;1.459 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;1.433 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;1.452 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;1.430 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,68 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,73 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,93 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;99,24 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;99,13 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;99,31 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;97,72 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;98,56 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;97,25 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;98,35 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;1.530 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;1.289 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;854 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;1.525 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;1.286 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;853 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;1.518 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;1.278 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;849 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;1.257 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;842 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;1.250 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;841 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,67 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99,77 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,88 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;99,22 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;99,15 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;99,41 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;97,52 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;98,59 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;96,97 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;98,48 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;52 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;204 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;600 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;52 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;203 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;600 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;52 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;202 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;595 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;202 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;591 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;202 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;589 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,51 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;99,02 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;99,17 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;99,02 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;98,5 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;99,02 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;98,17 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.622 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.526 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.493 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.616 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.518 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.484 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QI;1.497 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QI;1.474 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;1.490 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;1.471 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.484 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.464 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,63 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,48 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,4 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,1 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;98,73 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;97,64 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;98,53 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;97,25 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;98,06 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;1.574 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;1.365 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;863 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;1.568 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;1.357 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;860 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;1.336 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;854 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;1.329 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;853 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;1.323 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;849 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,62 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,41 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,65 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;97,88 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;98,96 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;97,36 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;98,84 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;96,92 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;98,38 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;48 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;161 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;630 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;48 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;161 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;624 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;161 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;620 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;161 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;618 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;161 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;615 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,05 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,41 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;98,1 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;97,62 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 13 Madrid, Comunidad de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;35.351 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;33.961 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;35.373 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the first trimester;2022QI;33.397 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the first trimester;2021QI;32.056 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the first trimester;2020QI;30.905 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the second trimester;2022QII;31.869 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the second trimester;2021QII;30.916 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the second trimester;2020QII;29.808 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;30.682 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;29.945 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;28.853 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;29.801 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;29.199 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;28.031 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,47 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,39 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,37 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;90,15 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;91,03 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,27 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;86,79 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,17 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;81,57 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,3 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,98 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;79,24 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;34.007 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;31.017 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;32.104 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;29.196 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;30.617 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;28.119 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;29.465 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;27.212 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;28.616 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;26.523 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;94,4 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;94,13 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;90,03 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;90,66 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;86,64 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;87,73 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;84,15 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;85,51 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;1.344 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;2.944 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;1.293 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;2.860 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;1.252 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;2.797 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;1.217 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;2.733 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;1.185 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;2.676 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;96,21 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;97,15 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;93,15 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;95,01 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;90,55 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;92,83 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;88,17 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;90,9 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;35.420 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;34.026 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;32.456 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the first trimester;2022QII;33.491 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the first trimester;2021QII;32.541 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the first trimester;2020QII;31.083 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIII;32.056 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIII;31.307 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIII;29.977 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;30.966 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;30.345 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;29.024 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;29.304 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;27.940 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 14 Murcia, Región de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,55 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,64 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,77 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;90,5 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,01 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,36 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,43 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,18 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,43 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,12 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,09 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;34.106 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;31.055 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;26.779 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;32.228 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;29.637 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;25.491 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;30.839 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;28.474 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;24.523 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;29.775 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;27.569 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;23.748 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;26.612 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;22.840 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;94,49 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;95,43 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;95,19 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;90,42 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;91,69 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;91,58 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;87,3 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;88,77 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;88,68 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;85,69 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;85,29 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;1.314 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;2.971 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;5.677 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;1.263 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;2.904 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;5.592 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;1.217 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;2.833 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;5.454 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;1.191 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;2.776 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;5.276 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;2.692 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;5.100 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;96,12 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,74 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,5 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;92,62 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;95,36 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;96,07 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;90,64 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;93,44 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;92,94 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;90,61 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;89,84 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;35.662 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;34.995 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;34.000 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIII;33.598 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIII;33.068 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIII;32.134 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIV;32.137 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIV;31.747 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIV;30.753 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;30.525 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;29.500 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;29.552 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;28.763 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;94,21 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;94,49 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,51 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,12 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;90,72 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,45 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,23 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,76 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,45 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,6 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;34.543 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;33.917 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;30.804 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;32.519 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;32.022 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;29.011 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;31.082 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;30.723 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;27.733 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;29.527 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;26.568 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;28.575 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;25.884 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;94,14 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;94,41 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;94,18 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;89,98 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;90,58 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;90,03 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;87,06 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;86,25 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;84,25 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;84,03 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;1.119 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;1.078 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;3.196 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;1.079 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;1.046 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;3.123 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;1.055 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;1.024 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;3.020 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;998 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;2.932 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;977 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;2.879 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;96,43 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;97,03 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;97,72 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;94,28 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;94,99 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;94,49 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;92,58 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;91,74 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;90,63 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;90,08 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;35.285 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;34.897 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;33.910 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIV;33.473 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIV;33.168 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIV;32.111 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the second trimester;2022QI;31.730 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the second trimester;2021QI;30.657 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;30.557 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;29.773 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;29.587 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;28.971 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,86 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,05 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,69 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;90,92 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,41 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,56 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,8 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,78 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,43 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;34.279 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;33.478 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;30.534 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;32.487 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;31.777 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;28.849 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;30.386 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;27.494 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;29.246 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;26.674 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;28.313 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;25.943 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;94,77 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;94,92 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;94,48 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;90,76 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;90,04 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;87,36 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;87,36 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;84,57 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;84,96 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;1.006 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;1.419 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;3.376 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;986 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;1.391 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;3.262 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;1.344 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;3.163 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;1.311 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;3.099 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;1.274 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;3.028 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;98,01 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;98,03 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;96,62 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;94,71 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;93,69 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;92,39 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;91,8 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;89,78 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;89,69 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;25.693 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;24.981 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;25.774 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QI;23.861 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QI;23.224 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QI;21.650 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QII;22.479 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QII;22.184 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QII;20.659 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;21.404 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;21.293 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;19.818 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;20.623 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;20.630 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;19.096 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,87 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;92,97 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;84 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,49 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;88,8 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;80,15 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;83,31 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;85,24 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;76,89 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;80,27 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;82,58 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;74,09 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;24.900 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;23.533 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;23.112 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;21.847 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;21.766 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;20.858 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;20.720 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;20.016 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;19.965 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;19.398 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;92,82 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;92,84 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;87,41 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;88,63 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;83,21 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;85,06 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;80,18 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;82,43 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;793 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;1.448 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;749 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;1.377 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;713 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;1.326 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;684 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;1.277 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;658 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;1.232 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;94,45 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;95,1 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;89,91 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;91,57 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;86,25 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;88,19 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;82,98 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;85,08 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;25.695 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;24.982 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;23.866 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QII;23.911 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QII;23.606 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QII;22.576 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIII;22.589 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIII;22.450 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIII;21.558 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;21.615 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;21.590 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;20.676 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;20.661 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;19.741 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,06 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,49 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;94,59 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;87,91 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;89,86 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;90,33 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;84,12 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;86,42 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;86,63 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;82,7 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;82,72 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;24.926 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;23.433 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;20.503 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;23.188 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;22.115 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;19.288 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;21.908 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;21.023 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;18.390 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;20.955 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;20.211 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;17.657 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;19.353 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;16.863 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;93,03 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;94,38 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;94,07 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;87,89 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;89,72 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;89,69 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;84,07 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;86,25 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;86,12 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;82,59 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;82,25 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;769 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;1.549 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;3.363 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;723 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;1.491 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;3.288 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;681 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;1.427 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;3.168 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;660 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;1.379 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;3.019 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;1.308 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;2.878 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;94,02 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;96,26 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;97,77 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;88,56 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;92,12 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;94,2 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;85,83 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;89,03 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;89,77 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;84,44 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;85,58 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;25.562 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;25.380 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;24.897 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIII;23.666 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIII;23.570 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIII;23.158 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIV;22.409 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIV;22.414 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIV;21.899 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;21.315 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;20.806 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;20.448 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;20.142 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;92,58 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;92,87 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;93,02 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;87,67 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;88,31 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;87,96 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;83,98 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;83,57 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;80,57 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;80,9 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;24.946 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;24.843 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;23.338 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;23.086 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;23.062 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;21.667 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;21.848 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;21.925 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;20.494 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;20.847 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;19.473 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;19.995 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;18.850 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;92,54 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;92,83 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;92,84 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;87,58 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;88,25 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;87,81 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;83,91 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;83,44 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;80,49 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;80,77 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;616 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;537 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;1.559 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;580 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;508 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;1.491 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;561 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;489 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;1.405 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;468 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;1.333 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;453 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;1.292 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;94,16 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;94,6 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;95,64 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;91,07 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;91,06 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;90,12 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;87,15 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;85,5 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;84,36 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;82,87 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;25.491 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;25.462 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;24.886 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIV;23.824 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIV;23.846 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIV;23.181 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QI;22.525 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QI;21.883 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;21.471 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;21.083 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;20.604 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;20.354 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,46 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,65 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,15 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;88,47 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,93 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;84,33 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;84,72 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;80,92 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;81,79 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;24.965 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;24.592 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;23.231 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;23.314 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;22.999 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;21.627 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;21.722 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;20.408 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;20.697 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;19.660 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;19.864 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;18.983 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;93,39 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;93,52 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;93,1 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;88,33 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;87,85 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;84,16 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;84,63 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;80,77 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;81,71 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;526 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;870 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;1.655 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;510 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;847 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;1.554 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;803 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;1.475 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;774 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;1.423 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;740 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;1.371 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;96,96 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;97,36 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;93,9 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;92,3 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;89,12 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;88,97 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;85,98 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;85,06 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;82,84 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.038 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.819 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.060 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QI;3.981 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QI;3.750 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QI;3.849 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QII;3.907 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QII;3.693 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QII;3.793 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.854 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.642 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.729 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.798 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.600 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.668 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,59 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,19 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,8 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,76 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,7 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,42 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,44 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,37 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,85 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;94,06 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,27 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,34 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;3.824 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;3.282 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;3.769 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;3.219 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;3.698 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;3.168 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;3.647 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;3.127 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;3.594 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;3.092 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,56 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,08 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;96,71 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;96,53 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;95,37 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;95,28 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;93,99 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;94,21 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;214 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;537 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;212 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;531 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;209 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;525 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;207 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;515 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;204 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;508 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;99,07 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,88 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;97,66 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;97,77 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;96,73 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;95,9 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;95,33 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;94,6 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.039 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.836 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.614 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QII;3.967 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QII;3.766 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QII;3.576 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.907 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.720 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.529 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.838 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.665 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.485 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;3.605 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;3.403 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,22 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,18 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,95 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,73 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,98 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,65 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,02 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,54 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,43 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,98 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,16 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;3.827 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;3.328 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;2.690 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;3.758 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;3.264 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;2.656 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;3.701 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;3.221 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;2.617 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;3.633 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;3.171 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;2.592 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;3.117 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;2.527 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,2 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,08 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,74 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;96,71 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;96,78 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;97,29 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;94,93 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;95,28 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;96,36 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;93,66 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;93,94 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;212 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;508 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;924 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;209 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;502 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;920 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;206 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;499 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;912 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;205 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;494 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;893 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;488 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;876 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;98,58 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;98,82 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,57 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;97,17 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;98,23 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,7 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;96,7 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;97,24 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;96,65 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;96,06 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;94,81 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.201 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.083 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.889 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.105 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.015 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.821 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.984 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.915 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.741 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;3.851 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;3.659 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;3.798 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;3.610 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,71 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,33 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,25 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,83 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,89 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,19 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,32 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,09 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,02 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,83 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;4.022 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;3.895 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;3.310 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;3.929 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;3.829 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;3.247 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;3.809 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;3.731 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;3.175 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;3.667 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;3.100 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;3.618 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;3.055 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;97,69 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,31 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,1 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;94,7 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;95,79 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;95,92 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;94,15 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;93,66 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;92,89 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;92,3 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;179 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;188 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;579 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;176 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;186 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;574 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;175 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;184 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;566 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;184 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;559 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;180 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;555 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;98,32 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;98,94 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,14 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;97,77 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;97,87 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;97,75 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;97,87 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;96,55 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;95,74 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;95,85 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.087 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.981 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.878 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.991 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.921 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.818 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QI;3.852 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QI;3.733 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;3.793 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;3.681 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.740 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.640 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,65 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,49 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,45 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,76 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,26 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,28 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,92 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,95 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,86 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;3.913 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;3.773 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;3.247 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;3.819 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;3.716 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;3.195 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;3.650 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;3.122 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;3.594 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;3.075 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;3.542 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;3.044 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;97,6 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;98,49 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;98,4 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;96,74 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;96,15 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;95,26 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;94,7 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;93,88 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;93,75 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;174 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;208 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;631 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;172 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;205 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;623 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;202 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;611 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;199 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;606 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;198 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;596 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;98,85 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;98,56 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;98,73 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;97,12 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;96,83 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;95,67 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;96,04 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;95,19 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;94,45 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;5.313 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.847 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;5.231 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QI;5.250 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QI;4.773 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QI;5.101 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QII;5.181 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QII;4.732 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QII;5.053 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.126 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.707 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.006 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.086 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.668 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.969 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,81 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,47 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;97,51 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,52 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,63 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;96,6 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;96,48 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;97,11 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;95,7 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;95,73 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;96,31 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;94,99 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;4.999 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;3.965 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;4.941 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;3.897 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;4.874 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;3.862 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;4.823 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;3.842 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;4.786 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;3.808 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,84 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,28 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;97,5 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;97,4 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;96,48 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;96,9 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;95,74 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;96,04 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;314 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;882 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;309 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;876 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;307 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;870 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;303 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;865 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;300 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;860 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;98,41 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,32 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;97,77 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,64 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;96,5 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;98,07 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;95,54 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;97,51 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;5.366 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.901 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.681 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QII;5.298 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QII;4.862 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QII;4.638 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.249 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIII;4.836 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.600 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.206 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;4.791 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.575 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;4.739 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;4.512 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,73 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,2 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,08 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;97,82 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;98,67 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,27 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;97,02 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;97,76 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;97,74 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;96,69 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;96,39 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;5.056 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;4.059 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;3.359 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;4.990 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;4.023 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;3.322 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;4.941 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;4.001 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;3.294 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;4.902 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;3.960 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;3.279 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;3.915 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;3.233 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,69 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;99,11 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,9 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;97,73 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;98,57 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,06 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;96,95 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;97,56 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;97,62 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;96,45 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;96,25 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;310 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;842 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;1.322 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;308 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;839 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;1.316 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;308 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;835 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;1.306 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;304 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;831 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;1.296 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;824 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;1.279 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;99,35 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,64 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,55 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;99,35 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;99,17 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,79 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;98,06 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;98,69 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;98,03 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;97,86 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;96,75 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5.561 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.213 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.916 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.495 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.169 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.865 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.416 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.107 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.824 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;5.050 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;4.751 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;4.998 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;4.727 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,81 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,16 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,96 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;97,39 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;97,97 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;98,13 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;96,87 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;96,64 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;95,88 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;96,16 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;5.259 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;4.885 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;3.930 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;5.193 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;4.842 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;3.879 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;5.118 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;4.781 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;3.847 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;4.729 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;3.782 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;4.679 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;3.766 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,75 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99,12 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,7 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;97,32 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;97,87 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;97,89 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;96,81 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;96,23 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;95,78 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;95,83 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;302 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;328 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;986 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;302 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;327 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;986 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;298 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;326 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;977 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;321 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;969 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;319 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;961 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;99,7 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;98,68 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;99,39 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;99,09 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;97,87 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;98,28 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;97,26 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;97,46 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.385 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;5.153 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.845 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.340 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIV;5.105 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.812 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QI;5.059 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QI;4.745 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;5.001 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;4.715 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;4.953 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.686 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,16 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,07 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,32 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,18 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,94 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;97,05 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;97,32 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;96,12 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;96,72 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;5.096 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;4.830 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;3.833 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;5.053 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;4.784 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;3.805 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;4.738 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;3.745 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;4.681 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;3.722 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;4.635 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;3.701 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,16 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,05 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,27 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,1 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;97,7 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;96,92 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;97,1 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;95,96 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;96,56 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;289 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;323 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;1.012 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;287 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;321 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;1.007 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;321 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;1.000 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;320 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;993 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;318 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;985 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;99,31 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;99,38 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,51 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;99,38 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,81 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;99,07 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;98,12 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;98,45 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;97,33 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;206 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;217 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;215 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QI;204 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QI;212 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QI;213 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QII;201 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QII;210 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QII;211 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;198 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;206 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;209 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;195 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;205 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;207 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,03 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,7 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;99,07 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,57 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,77 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;98,14 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;96,12 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,93 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;97,21 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;94,66 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,47 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;96,28 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;188 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;162 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;186 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;158 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;183 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;156 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;180 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;152 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;177 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;151 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,94 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;97,53 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;97,34 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;96,3 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;95,74 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;93,83 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;94,15 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;93,21 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;18 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;55 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;18 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;54 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;18 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;54 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;18 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;54 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;18 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;54 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,18 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,18 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;98,18 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;98,18 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;217 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;207 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;201 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QII;212 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QII;207 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QII;199 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIII;209 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIII;201 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIII;199 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;206 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;200 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;197 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;200 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;193 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,7 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,31 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,1 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;99 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,93 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;96,62 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;98,01 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;96,62 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;96,02 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;199 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;156 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;156 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;194 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;156 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;154 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;192 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;150 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;154 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;189 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;149 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;152 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;149 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;149 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;97,49 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,72 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;96,48 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;96,15 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,72 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;94,97 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;95,51 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;97,44 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;95,51 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;95,51 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;18 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;51 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;45 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;18 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;51 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;45 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;17 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;51 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;45 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;17 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;51 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;45 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;51 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;44 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;94,44 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;94,44 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;97,78 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;229 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;228 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;203 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIII;225 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIII;223 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIII;199 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIV;223 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIV;221 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIV;198 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;219 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;193 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;218 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;193 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,25 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,81 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,03 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;97,38 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,93 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97,54 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;96,05 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,07 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;95,61 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;95,07 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;213 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;212 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;151 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;210 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;207 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;147 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;208 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;205 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;146 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;203 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;142 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;202 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;142 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,59 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;97,64 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;97,35 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;97,65 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;96,7 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;96,69 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;95,75 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;94,04 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;95,28 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;94,04 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;16 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;16 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;52 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;15 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;16 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;52 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;15 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;16 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;52 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;16 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;51 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;16 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;51 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;93,75 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;93,75 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;98,08 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;98,08 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;217 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;210 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;208 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIV;215 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIV;205 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIV;207 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QI;203 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QI;203 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;202 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;201 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;200 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;198 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,08 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,62 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,52 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,67 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,6 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;96,19 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;96,63 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;95,24 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;95,19 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;206 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;200 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;150 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;204 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;195 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;149 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;193 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;146 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;192 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;144 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;190 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;142 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,03 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;97,5 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,33 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;96,5 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;97,33 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;96 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;96 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;95 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;94,67 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;11 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;10 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;58 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;11 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;10 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;58 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;10 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;57 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;10 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;57 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;10 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;56 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,28 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;98,28 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;96,55 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;101 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;97 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;93 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QI;101 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QI;97 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QI;92 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QII;101 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QII;97 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QII;92 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;97 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;91 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;99 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;96 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;91 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;98,92 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;98,92 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;99,01 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;97,85 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;98,02 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;98,97 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;97,85 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;96 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;75 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;96 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;75 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;96 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;75 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;95 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;75 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;94 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;74 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;98,96 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;97,92 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;98,67 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;5 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;22 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;5 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;22 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;5 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;22 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;5 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;22 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;5 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;22 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;100 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;103 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;94 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QII;103 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QII;94 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIII;102 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIII;91 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;101 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;99 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;91 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;99 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;91 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;99,03 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,81 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;98,06 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;99 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,81 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;99 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;96,81 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;98 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;79 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;71 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;98 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;79 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;71 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;97 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;79 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;68 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;96 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;78 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;68 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;78 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;68 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;98,98 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;95,77 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;97,96 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;98,73 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;95,77 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;98,73 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;95,77 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;5 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;21 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;23 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;5 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;21 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;23 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;5 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;21 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;23 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;5 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;21 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;23 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;21 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;23 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;100 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;109 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;91 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;95 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIII;107 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIII;91 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIII;91 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIV;105 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIV;90 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIV;91 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;90 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;91 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;90 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;91 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,17 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,79 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,33 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;98,9 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,79 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;98,9 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,79 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;98,9 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;95,79 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;103 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;82 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;75 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;101 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;82 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;71 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;99 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;81 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;71 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;81 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;71 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;81 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;71 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,06 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;94,67 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;96,12 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;98,78 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;94,67 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;98,78 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;94,67 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;98,78 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;94,67 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;6 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;9 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;20 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;6 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;9 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;20 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;6 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;9 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;20 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;9 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;20 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;9 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;20 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;100 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;100 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;105 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;91 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;93 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIV;103 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIV;91 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIV;93 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QI;91 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QI;93 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;90 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;93 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;90 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;93 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,1 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;98,9 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;98,9 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;99 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;83 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;73 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;97 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;83 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;73 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;83 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;73 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;82 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;73 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;82 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;73 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;97,98 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;98,8 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;98,8 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;6 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;8 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;20 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;6 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;8 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;20 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;8 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;20 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;8 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;20 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;8 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;20 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;100 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 14 Murcia, Región de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;14.719 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;14.334 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;14.803 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the first trimester;2022QI;13.988 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the first trimester;2021QI;13.696 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the first trimester;2020QI;13.609 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the second trimester;2022QII;13.410 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the second trimester;2021QII;13.163 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the second trimester;2020QII;13.140 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;13.055 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;12.850 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;12.817 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;12.713 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;12.540 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;12.512 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,03 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,55 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;91,93 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,11 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;91,83 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;88,77 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,69 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,65 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,58 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,37 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87,48 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,52 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;14.108 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;12.698 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;13.392 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;12.092 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;12.827 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;11.589 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;12.486 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;11.302 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;12.152 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;11.019 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;94,92 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;95,23 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;90,92 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;91,27 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;88,5 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;89,01 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;86,14 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;86,78 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;611 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;1.636 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;596 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;1.604 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;583 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;1.574 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;569 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;1.548 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;561 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;1.521 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;97,55 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,04 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;95,42 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;96,21 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;93,13 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;94,62 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;91,82 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;92,97 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;14.673 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;14.342 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;14.120 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the first trimester;2022QII;13.946 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the first trimester;2021QII;13.690 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the first trimester;2020QII;13.567 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIII;13.504 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIII;13.289 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIII;13.189 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;13.101 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;12.921 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;12.845 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;12.536 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;12.472 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,05 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,45 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,08 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,03 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,66 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,41 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,29 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,09 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,97 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,41 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;88,33 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;14.078 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;12.717 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;10.727 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;13.366 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;12.096 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;10.242 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;12.932 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;11.722 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;9.927 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;12.548 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;11.382 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;9.658 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;11.036 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;9.355 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;94,94 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;95,12 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;95,48 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;91,86 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;92,18 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;92,54 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;89,13 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;89,5 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;90,03 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;86,78 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;87,21 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;595 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;1.625 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;3.393 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;580 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;1.594 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;3.325 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;572 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;1.567 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;3.262 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;553 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;1.539 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;3.187 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;1.500 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;3.117 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;97,48 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;98,09 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;96,13 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;96,43 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;96,14 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;92,94 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;94,71 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;93,93 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;92,31 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;91,87 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;14.761 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;14.530 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;14.245 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIII;14.068 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIII;13.870 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIII;13.693 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIV;13.554 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIV;13.387 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIV;13.245 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;12.939 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;12.829 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;12.622 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;12.519 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,31 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,46 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,12 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,82 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,13 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,98 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,05 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,06 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,87 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,88 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;14.272 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;13.920 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;12.635 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;13.586 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;13.271 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;12.111 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;13.086 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;12.798 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;11.697 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;12.360 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;11.313 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;12.049 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;11.028 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;95,19 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;95,34 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;95,85 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;91,69 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;91,94 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;92,58 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;88,79 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;89,54 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;86,56 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;87,28 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;489 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;610 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;1.610 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;482 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;599 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;1.582 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;468 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;589 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;1.548 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;579 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;1.516 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;573 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;1.491 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;98,57 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;98,2 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,26 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;95,71 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;96,56 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;96,15 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;94,92 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;94,16 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;93,93 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;92,61 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;14.686 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;14.648 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;14.376 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIV;14.029 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIV;14.017 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIV;13.741 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the second trimester;2022QI;13.461 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the second trimester;2021QI;13.255 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;13.002 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;12.829 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;12.704 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;12.573 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,53 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,69 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,58 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,9 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,2 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,76 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,24 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,73 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,46 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;14.237 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;14.033 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;12.592 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;13.593 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;13.419 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;11.993 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;12.878 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;11.539 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;12.433 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;11.144 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;12.144 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;10.913 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;95,48 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;95,62 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;95,24 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;91,77 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;91,64 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;88,6 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;88,5 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;86,54 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;86,67 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;449 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;615 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;1.784 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;436 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;598 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;1.748 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;583 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;1.716 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;569 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;1.685 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;560 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;1.660 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;97,1 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;97,24 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;97,98 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;94,8 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;96,19 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;92,52 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;94,45 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;91,06 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;93,05 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;10.364 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;10.218 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;10.475 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QI;9.665 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QI;9.611 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QI;9.367 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QII;9.156 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QII;9.138 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QII;8.949 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.828 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;8.845 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;8.655 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;8.520 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;8.563 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;8.383 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,26 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,06 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;89,42 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;88,34 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;89,43 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;85,43 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;85,18 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;86,56 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;82,63 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;82,21 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;83,8 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;80,03 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;10.042 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;9.462 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;9.357 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;8.882 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;8.857 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;8.430 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;8.542 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;8.161 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;8.240 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;7.900 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;93,18 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;93,87 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;88,2 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;89,09 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;85,06 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;86,25 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;82,06 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;83,49 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;322 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;756 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;308 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;729 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;299 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;708 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;286 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;684 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;280 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;663 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;95,65 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;96,43 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;92,86 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;93,65 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;88,82 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;90,48 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;86,96 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;87,7 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;10.305 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;10.216 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;9.981 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QII;9.647 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QII;9.625 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QII;9.477 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIII;9.233 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIII;9.246 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIII;9.123 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;8.865 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;8.910 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;8.810 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;8.554 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;8.473 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,61 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,21 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;94,95 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;89,6 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;90,51 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,4 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,03 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;87,22 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,27 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;83,73 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,89 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;10.005 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;9.468 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;8.069 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;9.359 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;8.899 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;7.621 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;8.953 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;8.546 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;7.322 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;8.599 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;8.231 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;7.070 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;7.908 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;6.792 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;93,54 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;93,99 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;94,45 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;89,49 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;90,26 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;90,74 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;85,95 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;86,93 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;87,62 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;83,52 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;84,17 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;300 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;748 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;1.912 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;288 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;726 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;1.856 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;280 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;700 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;1.801 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;266 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;679 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;1.740 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;646 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;1.681 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;96 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,06 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;97,07 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;93,33 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;93,58 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;94,19 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;88,67 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;90,78 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;91 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;86,36 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;87,92 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;10.353 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;10.278 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;10.114 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIII;9.692 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIII;9.647 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIII;9.593 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIV;9.223 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIV;9.197 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIV;9.179 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;8.782 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;8.798 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;8.493 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;8.515 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,62 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;93,86 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,85 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,09 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;89,48 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,76 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;85,44 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,99 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;82,63 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,19 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;10.126 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;10.009 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;9.375 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;9.471 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;9.389 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;8.879 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;9.012 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;8.947 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;8.493 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;8.540 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;8.138 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;8.256 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;7.873 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;93,53 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;93,81 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;94,71 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;89 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;89,39 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;90,59 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;85,32 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;86,81 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;82,49 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;83,98 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;227 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;269 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;739 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;221 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;258 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;714 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;211 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;250 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;686 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;242 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;660 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;237 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;642 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;97,36 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;95,91 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;96,62 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;92,95 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;92,94 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;92,83 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;89,96 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;89,31 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;88,1 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;86,87 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;10.262 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;10.346 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;10.182 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIV;9.649 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIV;9.749 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIV;9.580 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QI;9.224 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QI;9.130 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;8.820 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;8.750 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.547 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;8.508 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,03 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,23 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,09 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;89,16 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,67 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;85,25 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;85,94 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;82,61 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;83,56 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;10.064 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;10.023 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;9.419 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;9.462 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;9.442 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;8.844 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;8.931 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;8.422 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;8.540 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;8.062 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;8.275 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;7.845 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;94,02 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;94,2 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;93,9 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;89,11 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;89,42 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;85,2 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;85,59 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;82,56 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;83,29 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;198 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;323 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;763 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;187 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;307 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;736 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;293 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;708 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;280 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;688 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;272 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;663 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;94,44 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;95,05 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;96,46 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;90,71 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;92,79 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;86,69 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;90,17 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;84,21 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;86,89 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.621 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.510 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.576 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QI;1.605 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QI;1.494 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QI;1.532 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QII;1.570 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QII;1.459 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QII;1.507 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.558 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.448 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.493 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.542 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.435 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.477 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,01 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,94 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;97,21 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,85 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,62 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,62 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;96,11 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,89 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,73 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;95,13 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;95,03 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;93,72 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;1.545 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;1.220 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;1.529 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;1.207 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;1.497 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;1.178 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;1.486 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;1.169 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;1.470 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;1.157 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,96 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,93 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;96,89 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;96,56 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;96,18 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;95,82 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;95,15 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;94,84 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;76 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;290 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;76 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;287 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;73 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;281 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;72 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;279 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;72 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;278 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,97 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;96,05 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;96,9 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;94,74 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;96,21 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;94,74 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;95,86 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.569 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.487 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.517 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QII;1.533 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QII;1.451 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QII;1.491 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.521 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.439 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.481 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.507 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.421 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.464 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;1.407 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;1.445 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,71 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,58 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,29 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,94 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,77 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,63 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;96,05 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,56 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,51 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,62 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;95,25 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;1.470 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;1.197 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;977 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;1.436 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;1.167 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;957 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;1.424 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;1.156 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;949 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;1.412 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;1.141 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;943 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;1.127 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;931 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;97,69 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;97,49 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;97,95 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;96,87 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;96,57 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;97,13 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;96,05 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;95,32 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;96,52 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;94,15 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;95,29 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;99 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;290 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;540 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;97 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;284 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;534 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;97 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;283 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;532 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;95 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;280 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;521 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;280 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;514 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;97,98 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,93 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,89 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;97,98 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;97,59 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,52 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;95,96 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;96,55 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;96,48 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;96,55 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;95,19 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.607 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.573 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.537 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.591 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.559 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.519 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.568 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.544 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.503 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;1.524 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;1.485 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;1.514 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;1.471 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,11 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,83 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;97,57 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;98,16 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97,79 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;96,88 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;96,62 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;96,25 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;95,71 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;1.524 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;1.470 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;1.270 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;1.509 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;1.456 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;1.252 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;1.487 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;1.442 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;1.240 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;1.422 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;1.225 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;1.412 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;1.215 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,02 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99,05 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,58 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;97,57 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;98,1 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;97,64 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;96,73 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;96,46 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;96,05 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;95,67 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;83 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;103 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;267 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;82 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;103 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;267 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;81 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;102 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;263 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;102 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;260 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;102 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;256 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;98,8 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;97,59 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;99,03 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;98,5 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;99,03 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;97,38 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;99,03 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;95,88 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.612 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.569 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.548 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.590 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.552 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.531 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QI;1.540 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QI;1.512 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;1.515 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;1.489 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.503 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.483 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,64 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,92 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,9 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,15 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,67 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;96,56 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;96,19 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;95,79 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;95,8 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;1.523 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;1.478 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;1.219 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;1.502 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;1.461 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;1.208 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;1.449 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;1.192 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;1.425 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;1.174 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;1.414 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;1.168 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;98,62 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;98,85 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,1 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,04 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;97,79 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;96,41 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;96,31 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;95,67 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;95,82 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;89 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;91 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;329 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;88 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;91 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;323 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;91 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;320 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;90 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;315 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;89 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;315 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;98,88 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;98,18 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;97,26 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;98,9 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;95,74 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;97,8 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;95,74 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.480 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.366 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.503 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QI;2.465 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QI;2.352 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QI;2.463 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QII;2.432 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QII;2.328 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QII;2.438 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.418 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.319 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.424 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.400 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.305 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.408 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,4 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,41 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;98,4 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;98,06 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;98,39 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;97,4 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;97,5 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;98,01 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;96,84 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;96,77 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;97,42 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;96,2 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;2.299 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;1.846 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;2.285 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;1.834 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;2.253 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;1.813 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;2.239 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;1.804 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;2.223 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;1.794 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,39 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,35 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;98 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;98,21 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;97,39 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;97,72 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;96,69 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;97,18 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;181 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;520 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;180 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;518 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;179 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;515 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;179 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;515 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;177 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;511 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;99,45 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,62 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;98,9 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;99,04 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;98,9 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;99,04 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;97,79 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;98,27 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.535 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.401 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.387 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QII;2.503 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QII;2.377 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QII;2.364 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.488 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.367 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.351 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.467 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.354 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.338 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;2.339 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;2.321 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,74 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,04 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;98,15 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;98,58 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,49 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;97,32 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;98,04 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;97,95 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;97,42 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;97,24 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;2.362 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;1.881 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;1.517 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;2.331 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;1.860 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;1.500 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;2.316 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;1.850 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;1.493 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;2.298 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;1.840 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;1.483 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;1.831 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;1.470 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,69 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,88 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,88 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;98,05 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;98,35 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,42 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;97,29 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;97,82 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;97,76 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;97,34 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;96,9 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;173 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;520 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;870 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;172 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;517 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;864 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;172 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;517 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;858 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;169 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;514 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;855 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;508 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;851 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;99,42 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,42 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,31 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;99,42 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;99,42 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,62 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;97,69 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;98,85 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;98,28 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;97,69 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;97,82 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.534 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.437 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.364 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.519 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.422 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.352 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.497 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.405 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.335 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;2.392 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;2.319 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;2.374 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;2.306 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,41 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,38 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,49 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;98,54 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;98,69 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;98,77 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;98,15 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;98,1 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;97,41 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;97,55 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;2.376 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;2.225 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;1.831 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;2.361 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;2.210 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;1.822 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;2.342 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;2.193 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;1.807 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;2.182 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;1.794 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;2.165 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;1.784 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,37 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99,33 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,51 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;98,57 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;98,56 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;98,69 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;98,07 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;97,98 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;97,3 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;97,43 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;158 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;212 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;533 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;158 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;212 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;530 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;155 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;212 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;528 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;210 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;525 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;209 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;522 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,44 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;98,1 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;99,06 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;99,06 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;98,5 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;98,58 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;97,94 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.540 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.471 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.404 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.518 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.455 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.389 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QI;2.437 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QI;2.373 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;2.407 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;2.350 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.395 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.342 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,13 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,35 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,38 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,62 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;98,71 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;97,41 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;97,75 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;96,92 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;97,42 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;2.401 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;2.297 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;1.792 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;2.380 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;2.281 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;1.780 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;2.264 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;1.765 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;2.234 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;1.748 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;2.222 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;1.740 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,13 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,3 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,33 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,56 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;98,49 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;97,26 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;97,54 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;96,73 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;97,1 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;139 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;174 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;612 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;138 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;174 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;609 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;173 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;608 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;173 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;602 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;173 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;602 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;99,28 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,51 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;99,43 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;99,35 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;99,43 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;98,37 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;99,43 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;98,37 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;172 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;162 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;170 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QI;172 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QI;161 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QI;169 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QII;171 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QII;160 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QII;168 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;170 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;160 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;168 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;170 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;159 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;168 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,38 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;99,41 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;99,42 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;98,77 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;98,82 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;98,84 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;98,77 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;98,82 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;98,84 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;98,15 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;98,82 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;146 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;113 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;146 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;112 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;145 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;111 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;144 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;111 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;144 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;111 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,12 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;99,32 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;98,23 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;98,63 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;98,23 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;98,63 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;98,23 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;26 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;49 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;26 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;49 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;26 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;49 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;26 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;49 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;26 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;48 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;97,96 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;179 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;161 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;155 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QII;178 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QII;160 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QII;155 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIII;177 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIII;160 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIII;155 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;177 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;159 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;155 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;159 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;155 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;99,44 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,38 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;98,88 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;99,38 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;98,88 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;98,76 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;98,76 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;163 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;115 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;106 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;162 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;114 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;106 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;161 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;114 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;106 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;161 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;114 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;106 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;114 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;106 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;99,39 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;99,13 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;98,77 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;99,13 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;98,77 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;99,13 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;99,13 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;16 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;46 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;49 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;16 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;46 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;49 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;16 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;46 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;49 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;16 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;45 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;49 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;45 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;49 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;97,83 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;97,83 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;179 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;162 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;149 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIII;178 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIII;162 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIII;149 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIV;178 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIV;161 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIV;149 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;161 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;149 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;161 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;149 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,44 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;99,44 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;99,38 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;99,38 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;99,38 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;164 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;143 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;103 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;163 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;143 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;103 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;163 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;143 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;103 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;143 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;103 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;143 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;103 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,39 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;99,39 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;15 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;19 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;46 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;15 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;19 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;46 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;15 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;18 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;46 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;18 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;46 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;18 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;46 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;94,74 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;94,74 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;94,74 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;184 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;181 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;163 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIV;184 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIV;180 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIV;163 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QI;180 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QI;163 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;180 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;163 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;179 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;163 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,45 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;99,45 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;99,45 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;98,9 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;167 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;160 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;108 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;167 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;160 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;108 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;160 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;108 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;160 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;108 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;159 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;108 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;99,38 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;17 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;21 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;55 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;17 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;20 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;55 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;20 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;55 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;20 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;55 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;20 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;55 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;95,24 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;95,24 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;95,24 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;95,24 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;100 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;82 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;78 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;79 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QI;81 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QI;78 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QI;78 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QII;81 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QII;78 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QII;78 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;81 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;78 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;77 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;81 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;78 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;76 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,78 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;98,73 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;98,78 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;98,73 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;98,78 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;97,47 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;98,78 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;96,2 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;76 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;57 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;75 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;57 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;75 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;57 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;75 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;57 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;75 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;57 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,68 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;98,68 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;98,68 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;98,68 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;6 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;21 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;6 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;21 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;6 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;21 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;6 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;21 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;6 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;21 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;85 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;77 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;80 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QII;85 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QII;77 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QII;80 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIII;85 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIII;77 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIII;79 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;85 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;77 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;78 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;77 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;78 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,75 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;97,5 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;97,5 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;78 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;56 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;58 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;78 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;56 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;58 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;78 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;56 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;57 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;78 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;56 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;56 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;56 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;56 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,28 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;96,55 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;96,55 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;7 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;21 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;22 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;7 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;21 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;22 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;7 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;21 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;22 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;7 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;21 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;22 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;21 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;22 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;88 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;80 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;81 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIII;88 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIII;80 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIII;80 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIV;88 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIV;80 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIV;79 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;80 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;78 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;80 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;78 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,77 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97,53 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;96,3 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;96,3 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;82 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;73 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;56 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;82 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;73 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;55 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;82 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;73 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;54 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;73 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;53 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;73 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;53 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,21 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;96,43 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;94,64 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;94,64 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;6 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;7 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;25 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;6 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;7 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;25 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;6 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;7 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;25 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;7 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;25 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;7 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;25 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;88 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;81 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;79 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIV;88 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIV;81 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIV;78 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QI;80 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QI;77 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;80 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;77 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;80 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;77 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,73 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,77 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,47 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;98,77 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;97,47 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;98,77 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;97,47 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;82 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;75 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;54 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;82 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;75 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;53 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;74 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;52 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;74 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;52 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;74 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;52 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;98,15 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,67 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;96,3 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;98,67 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;96,3 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;98,67 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;96,3 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;6 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;6 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;25 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;6 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;6 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;25 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;6 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;25 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;6 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;25 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;6 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;25 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;100 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 15 Navarra, Comunidad Foral de;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;52.663 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;52.092 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;53.710 16 País Vasco;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the first trimester;2022QI;50.218 16 País Vasco;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the first trimester;2021QI;49.844 16 País Vasco;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the first trimester;2020QI;49.748 16 País Vasco;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the second trimester;2022QII;48.060 16 País Vasco;Total ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the second trimester;2021QII;48.115 16 País Vasco;Total ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the second trimester;2020QII;48.213 16 País Vasco;Total ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;46.612 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;46.816 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;46.921 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;45.496 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;45.714 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;45.757 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,36 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,68 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,62 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,26 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,37 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,77 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,51 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,87 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,36 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,39 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87,76 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,19 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;50.203 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;44.307 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;47.836 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;42.259 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;45.737 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;40.689 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;44.339 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;39.529 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;43.261 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;38.572 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;95,29 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;95,38 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;91,1 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;91,83 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;88,32 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;89,22 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;86,17 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;87,06 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;2.460 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;7.785 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;2.382 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;7.585 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;2.323 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;7.426 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;2.273 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;7.287 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;2.235 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;7.142 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;96,83 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;97,43 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;94,43 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;95,39 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;92,4 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;93,6 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;90,85 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;91,74 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;52.362 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;51.939 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;51.683 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the first trimester;2022QII;49.779 16 País Vasco;Total ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the first trimester;2021QII;49.824 16 País Vasco;Total ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the first trimester;2020QII;49.912 16 País Vasco;Total ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIII;48.079 16 País Vasco;Total ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIII;48.278 16 País Vasco;Total ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIII;48.431 16 País Vasco;Total ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;46.783 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;46.993 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;47.117 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;45.447 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;45.624 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 16 País Vasco;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,07 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,93 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,57 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,82 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,95 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,71 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,35 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,48 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,17 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,5 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;88,28 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;49.995 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;44.068 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;39.296 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;47.478 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;42.124 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;37.731 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;45.825 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;40.719 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;36.550 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;44.572 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;39.587 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;35.514 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;38.210 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;34.351 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;94,97 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;95,59 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;96,02 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;91,66 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;92,4 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;93,01 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;89,15 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;89,83 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;90,38 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;86,71 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;87,42 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;2.367 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;7.871 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;12.387 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;2.301 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;7.700 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;12.181 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;2.254 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;7.559 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;11.881 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;2.211 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;7.406 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;11.603 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;7.237 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;11.273 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 16 País Vasco;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;97,21 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,83 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,34 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;95,23 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;96,04 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;95,92 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;93,41 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;94,09 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;93,67 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;91,95 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;91,01 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;52.117 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;52.233 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;51.841 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIII;49.822 16 País Vasco;Total ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIII;50.065 16 País Vasco;Total ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIII;49.894 16 País Vasco;Total ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIV;48.231 16 País Vasco;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIV;48.496 16 País Vasco;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIV;48.298 16 País Vasco;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;46.770 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;46.693 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;45.440 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;45.621 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,6 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,85 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,24 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,54 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,85 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,17 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,54 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,07 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,99 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;50.640 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;50.094 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;43.904 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;48.377 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;47.967 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;42.130 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;46.818 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;46.440 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;40.687 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;44.760 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;39.285 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;43.464 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;38.352 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;95,53 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;95,75 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;95,96 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;92,45 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;92,71 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;92,67 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;89,35 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;89,48 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;86,76 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;87,35 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;1.477 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;2.139 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;7.937 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;1.445 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;2.098 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;7.764 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;1.413 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;2.056 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;7.611 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;2.010 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;7.408 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;1.976 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;7.269 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;97,83 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;98,08 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;97,82 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;95,67 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;96,12 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;95,89 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;93,97 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;93,34 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;92,38 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;91,58 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;51.823 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;52.164 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;51.957 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIV;49.887 16 País Vasco;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIV;50.215 16 País Vasco;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIV;49.941 16 País Vasco;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the second trimester;2022QI;48.268 16 País Vasco;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the second trimester;2021QI;48.118 16 País Vasco;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;46.559 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;46.781 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;45.327 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;45.660 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,26 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,26 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,12 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,53 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,61 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,26 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,04 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,89 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,88 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;50.550 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;49.618 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;43.299 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;48.642 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;47.733 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;41.454 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;45.852 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;39.845 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;44.210 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;38.656 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;43.032 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;37.685 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;96,23 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;96,2 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;95,74 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;92,41 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;92,02 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;89,1 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;89,28 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;86,73 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;87,03 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;1.273 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;2.546 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;8.658 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;1.245 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;2.482 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;8.487 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;2.416 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;8.273 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;2.349 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;8.125 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;2.295 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;7.975 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;97,8 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;97,49 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;98,02 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;94,89 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;95,55 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;92,26 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;93,84 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;90,14 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;92,11 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;37.458 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;37.426 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;38.159 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QI;35.179 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QI;35.331 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QI;34.492 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QII;33.241 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QII;33.780 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QII;33.123 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;31.926 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;32.609 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;31.983 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;30.928 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;31.628 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;30.942 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,92 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,4 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;90,39 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;88,74 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;90,26 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;86,8 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;85,23 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;87,13 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;83,82 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;82,57 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,51 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;81,09 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;36.026 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;33.410 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;33.821 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;31.486 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;31.933 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;30.066 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;30.660 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;29.005 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;29.689 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;28.135 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;93,88 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;94,24 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;88,64 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;89,99 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;85,11 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;86,82 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;82,41 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;84,21 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;1.432 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;4.016 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;1.358 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;3.845 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;1.308 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;3.714 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;1.266 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;3.604 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;1.239 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;3.493 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;94,83 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;95,74 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;91,34 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;92,48 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;88,41 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;89,74 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;86,52 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;86,98 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;37.041 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;37.231 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;36.858 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QII;34.669 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QII;35.287 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QII;35.231 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIII;33.097 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIII;33.861 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIII;33.883 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;31.923 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;32.716 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;32.683 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;31.341 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;31.371 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 16 País Vasco;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,6 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,78 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,59 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;89,35 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;90,95 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,93 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,18 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;87,87 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,67 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;84,18 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,11 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;35.711 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;33.229 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;29.286 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;33.396 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;31.429 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;27.818 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;31.868 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;30.117 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;26.715 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;30.730 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;29.089 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;25.753 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;27.840 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;24.707 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;93,52 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;94,58 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;94,99 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;89,24 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;90,63 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;91,22 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;86,05 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;87,54 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;87,94 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;83,78 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;84,36 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;1.330 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;4.002 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;7.572 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;1.273 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;3.858 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;7.413 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;1.229 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;3.744 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;7.168 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;1.193 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;3.627 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;6.930 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;3.501 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;6.664 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;95,71 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;96,4 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;97,9 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;92,41 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;93,55 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;94,66 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;89,7 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;90,63 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;91,52 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;87,48 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;88,01 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;36.673 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;37.206 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;37.088 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIII;34.512 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIII;35.170 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIII;35.279 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIV;33.074 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIV;33.760 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIV;33.805 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;32.219 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;32.380 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;30.997 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;31.429 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;94,11 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;94,53 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,12 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,19 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;90,74 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,15 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;86,6 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,31 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;83,31 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,74 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;35.807 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;36.114 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;32.973 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;33.678 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;34.112 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;31.303 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;32.267 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;32.735 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;29.956 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;31.225 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;28.687 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;30.033 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;27.841 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;94,05 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;94,46 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;94,94 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;90,11 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;90,64 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;90,85 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;86,46 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;87 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;83,16 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;84,44 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;866 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;1.092 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;4.115 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;834 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;1.058 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;3.976 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;807 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;1.025 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;3.849 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;994 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;3.693 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;964 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;3.588 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;96,3 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;96,89 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;96,62 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;93,19 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;93,86 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;93,54 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;91,03 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;89,74 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;88,28 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;87,19 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;36.491 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;37.188 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;37.181 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIV;34.678 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIV;35.382 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIV;35.281 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QI;33.611 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QI;33.634 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;32.066 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;32.435 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;30.947 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;31.437 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,03 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,14 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,89 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;90,38 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,46 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;86,23 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,24 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;83,22 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,55 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;35.772 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;35.676 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;32.848 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;33.983 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;33.931 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;31.094 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;32.218 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;29.620 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;30.734 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;28.538 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;29.661 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;27.654 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;95 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;95,11 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;94,66 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;90,31 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;90,17 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;86,15 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;86,88 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;83,14 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;84,19 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;719 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;1.512 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;4.333 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;695 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;1.451 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;4.187 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;1.393 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;4.014 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;1.332 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;3.897 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;1.286 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;3.783 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;96,66 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;95,97 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;96,63 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;92,13 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;92,64 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;88,1 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;89,94 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;85,05 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;87,31 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;5.709 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;5.565 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;5.864 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QI;5.629 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QI;5.490 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QI;5.686 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QII;5.516 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QII;5.393 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QII;5.601 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.444 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;5.327 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.521 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.382 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.268 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.463 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,6 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,65 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,96 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,62 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,91 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,52 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,36 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,72 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,15 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;94,27 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,66 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;93,16 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;5.390 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;4.327 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;5.310 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;4.262 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;5.198 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;4.179 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;5.129 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;4.126 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;5.073 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;4.082 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;98,52 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,5 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;96,44 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;96,58 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;95,16 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;95,35 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;94,12 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;94,34 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;319 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;1.238 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;319 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;1.228 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;318 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;1.214 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;315 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;1.201 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;309 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;1.186 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,19 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;99,69 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,06 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;98,75 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;97,01 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;96,87 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;95,8 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;5.749 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;5.583 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;5.552 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QII;5.637 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QII;5.493 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QII;5.479 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.567 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.440 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.415 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.497 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.364 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.365 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;5.274 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;5.277 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,05 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,39 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,69 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,83 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,44 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,53 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,62 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;96,08 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,63 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,47 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;95,05 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;5.441 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;4.289 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;3.666 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;5.334 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;4.212 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;3.614 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;5.265 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;4.169 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;3.582 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;5.198 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;4.111 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;3.553 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;4.042 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;3.495 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,03 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,2 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,58 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;96,77 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;97,2 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;97,71 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;95,53 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;95,85 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;96,92 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;94,24 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;95,34 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;308 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;1.294 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;1.886 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;303 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;1.281 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;1.865 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;302 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;1.271 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;1.833 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;299 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;1.253 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;1.812 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;1.232 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;1.782 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;98,38 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,89 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;98,05 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;98,22 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;97,19 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;97,08 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;96,83 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;96,08 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;95,21 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;94,49 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5.761 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.738 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.616 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.690 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.674 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.546 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.605 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.596 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.486 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;5.494 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;5.396 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;5.441 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;5.332 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,77 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,88 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,75 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;97,29 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;97,53 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97,69 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,75 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;96,08 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;94,82 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,94 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;5.575 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;5.444 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;4.338 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;5.504 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;5.380 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;4.285 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;5.421 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;5.307 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;4.237 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;5.210 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;4.165 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;5.157 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;4.119 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,73 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,82 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,78 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;97,24 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;97,48 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;97,67 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;95,7 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;96,01 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;94,73 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;94,95 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;186 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;294 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;1.278 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;186 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;294 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;1.261 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;184 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;289 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;1.249 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;284 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;1.231 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;284 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;1.213 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,67 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;98,92 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;98,3 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;97,73 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;96,6 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;96,32 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;96,6 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;94,91 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.716 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;5.667 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;5.610 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.648 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIV;5.587 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIV;5.550 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QI;5.492 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QI;5.468 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;5.409 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;5.401 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.342 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.334 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,81 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,59 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,93 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,91 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,47 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,45 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;96,27 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;94,27 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;95,08 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;5.559 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;5.345 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;4.219 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;5.493 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;5.266 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;4.171 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;5.175 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;4.105 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;5.093 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;4.051 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;5.031 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;4.000 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;98,81 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;98,52 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;98,86 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;96,82 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;97,3 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;95,29 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;96,02 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;94,13 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;94,81 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;157 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;322 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;1.391 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;155 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;321 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;1.379 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;317 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;1.363 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;316 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;1.350 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;311 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;1.334 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;98,73 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;99,69 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,14 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;98,45 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;97,99 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;98,14 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;97,05 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;96,58 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;95,9 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.711 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;8.347 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;8.880 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QI;8.629 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QI;8.271 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QI;8.768 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QII;8.523 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QII;8.194 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QII;8.689 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.464 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;8.135 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;8.625 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;8.412 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;8.080 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;8.565 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,06 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,09 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;98,74 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,84 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;98,17 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;97,85 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;97,16 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;97,46 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;97,13 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;96,57 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;96,8 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;96,45 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;8.084 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;6.078 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;8.006 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;6.021 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;7.908 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;5.958 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;7.853 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;5.914 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;7.805 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;5.877 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,04 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,06 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;97,82 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;98,03 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;97,14 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;97,3 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;96,55 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;96,69 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;627 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;2.269 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;623 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;2.250 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;615 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;2.236 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;611 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;2.221 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;607 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;2.203 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;99,36 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;99,16 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;98,09 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;98,55 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;97,45 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;97,88 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;96,81 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;97,09 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;8.782 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;8.384 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;8.501 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QII;8.684 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QII;8.306 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QII;8.432 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIII;8.628 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIII;8.242 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIII;8.371 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;8.578 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;8.184 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;8.312 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;8.107 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;8.221 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 16 País Vasco;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,88 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,07 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,19 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;98,25 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;98,31 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,47 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;97,68 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;97,61 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;97,78 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;96,7 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;96,71 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;8.131 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;6.070 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;5.791 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;8.037 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;6.006 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;5.747 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;7.982 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;5.958 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;5.706 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;7.935 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;5.917 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;5.666 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;5.862 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;5.609 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,84 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,95 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,24 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;98,17 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;98,15 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,53 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;97,59 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;97,48 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;97,84 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;96,57 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;96,86 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;651 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;2.314 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;2.710 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;647 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;2.300 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;2.685 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;646 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;2.284 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;2.665 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;643 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;2.267 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;2.646 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;2.245 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;2.612 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;99,39 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,39 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,08 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;99,23 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;98,7 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,34 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;98,77 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;97,97 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;97,64 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;97,02 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;96,38 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;8.907 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;8.537 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;8.407 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIII;8.846 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIII;8.471 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIII;8.346 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIV;8.779 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIV;8.398 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIV;8.289 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;8.319 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;8.201 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;8.265 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;8.148 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,32 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,23 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,27 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;98,56 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;98,37 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;98,6 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;97,45 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;97,55 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;96,81 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;96,92 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;8.529 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;7.869 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;6.107 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;8.468 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;7.810 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;6.060 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;8.404 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;7.741 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;6.017 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;7.672 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;5.958 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;7.622 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;5.921 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,28 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99,25 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,23 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;98,53 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;98,37 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;98,53 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;97,5 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;97,56 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;96,86 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;96,95 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;378 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;668 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;2.300 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;378 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;661 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;2.286 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;375 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;657 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;2.272 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;647 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;2.243 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;643 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;2.227 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;98,95 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,39 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;99,21 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;98,35 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;98,78 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;96,86 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;97,52 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;96,26 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;96,83 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;8.828 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;8.543 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;8.422 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIV;8.775 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIV;8.486 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIV;8.370 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QI;8.410 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QI;8.278 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;8.330 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;8.210 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.285 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;8.156 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,4 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,33 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,38 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,44 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;98,29 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;97,51 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;97,48 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;96,98 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;96,84 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;8.475 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;7.918 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;5.777 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;8.423 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;7.863 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;5.738 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;7.791 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;5.671 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;7.716 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;5.621 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;7.674 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;5.586 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,39 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,31 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,32 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,4 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;98,17 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;97,45 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;97,3 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;96,92 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;96,69 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;353 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;625 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;2.645 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;352 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;623 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;2.632 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;619 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;2.607 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;614 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;2.589 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;611 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;2.570 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;99,72 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;99,68 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,51 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;99,04 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;98,56 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;98,24 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;97,88 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;97,76 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;97,16 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;551 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;518 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;548 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QI;549 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QI;516 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QI;544 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QII;548 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QII;513 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QII;542 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;546 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;511 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;537 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;542 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;506 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;536 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,64 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,61 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;99,27 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;99,46 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;99,03 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;98,91 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;99,09 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;98,65 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;97,99 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;98,37 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;97,68 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;97,81 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;491 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;350 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;489 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;348 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;488 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;345 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;487 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;344 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;484 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;339 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,59 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,43 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;99,39 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;98,57 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;99,19 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;98,29 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;98,57 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;96,86 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;60 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;168 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;60 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;168 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;60 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;168 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;59 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;167 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;58 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;167 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;98,33 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;99,4 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;96,67 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;99,4 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;553 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;513 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;530 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QII;552 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QII;510 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QII;528 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIII;550 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIII;508 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIII;523 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;548 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;503 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;522 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;501 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;520 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 16 País Vasco;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;99,82 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,42 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,62 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;99,46 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;99,03 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,68 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;99,1 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;98,05 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;98,49 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;97,66 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;98,11 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;502 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;340 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;389 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;501 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;337 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;388 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;500 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;336 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;385 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;499 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;332 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;384 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;330 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;382 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;99,8 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;99,12 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,74 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;99,6 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;98,82 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,97 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;99,4 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;97,65 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;98,71 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;97,06 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;98,2 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;51 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;173 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;141 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;51 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;173 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;140 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;50 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;172 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;138 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;49 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;171 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;138 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;171 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;138 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,29 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;98,04 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;99,42 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;97,87 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;96,08 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;98,84 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;97,87 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;98,84 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;97,87 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;539 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;518 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;500 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIII;537 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIII;517 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIII;494 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIV;536 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIV;510 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIV;493 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;508 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;491 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;507 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;488 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,63 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,81 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,8 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;99,44 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;98,46 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;98,6 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;98,07 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;98,2 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;97,88 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;97,6 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;506 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;458 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;342 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;504 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;457 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;338 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;503 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;450 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;337 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;448 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;335 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;447 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;332 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,6 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99,78 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,83 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;99,41 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;98,25 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;98,54 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;97,82 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;97,95 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;97,6 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;97,08 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;33 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;60 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;158 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;33 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;60 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;156 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;33 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;60 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;156 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;60 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;156 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;60 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;156 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,73 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;98,73 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;98,73 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;98,73 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;544 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;534 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;509 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIV;542 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIV;529 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIV;509 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QI;526 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QI;507 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;525 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;505 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;524 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;503 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,63 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,06 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;100 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,5 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;99,61 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;98,31 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;99,21 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;98,13 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;98,82 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;512 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;468 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;315 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;511 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;463 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;315 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;460 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;313 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;459 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;311 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;458 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;310 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,8 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;98,93 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,29 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;99,37 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;98,08 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;98,73 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;97,86 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;98,41 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;32 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;66 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;194 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;31 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;66 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;194 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;66 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;194 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;66 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;194 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;66 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;193 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;96,88 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;99,48 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;234 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;236 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;259 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QI;232 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QI;236 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QI;258 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QII;232 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QII;235 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QII;258 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;232 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;234 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;255 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;232 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;232 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;251 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,15 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;100 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;99,61 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;99,15 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;99,58 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;99,61 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;99,15 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;99,15 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;98,46 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;99,15 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;98,31 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;96,91 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;212 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;142 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;210 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;142 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;210 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;141 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;210 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;140 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;210 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;139 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,06 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;100 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;99,06 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;99,3 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;99,06 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;98,59 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;99,06 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;97,89 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;22 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;94 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;22 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;94 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;22 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;94 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;22 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;94 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;22 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;93 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;98,94 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;237 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;228 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;242 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QII;237 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QII;228 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QII;242 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIII;237 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIII;227 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIII;239 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;237 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;226 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;235 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;224 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;235 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 16 País Vasco;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;100 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;100 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;99,56 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,76 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;100 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;99,12 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;97,11 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;98,25 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;97,11 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;210 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;140 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;164 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;210 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;140 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;164 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;210 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;139 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;162 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;210 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;138 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;158 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;136 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;158 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;100 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;99,29 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,78 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;100 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;98,57 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;96,34 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;97,14 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;96,34 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;27 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;88 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;78 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;27 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;88 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;78 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;27 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;88 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;77 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;27 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;88 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;77 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;88 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;77 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;98,72 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;98,72 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;98,72 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;237 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;234 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;230 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIII;237 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIII;233 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIII;229 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIV;237 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIV;232 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIV;225 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;230 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;225 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;230 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;224 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;100 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,57 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,57 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;100 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;99,15 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97,83 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;98,29 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;97,83 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;98,29 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;97,39 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;223 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;209 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;144 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;223 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;208 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;144 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;223 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;207 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;140 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;205 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;140 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;205 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;139 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;100 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;99,52 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;100 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;99,04 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;97,22 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;98,09 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;97,22 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;98,09 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;96,53 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;14 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;25 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;86 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;14 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;25 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;85 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;14 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;25 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;85 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;25 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;85 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;25 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;85 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,84 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;98,84 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;98,84 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;98,84 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;244 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;232 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;235 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIV;244 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIV;231 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIV;231 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QI;229 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QI;231 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;229 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;230 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;229 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;230 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,57 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,3 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,71 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;98,3 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;98,71 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;97,87 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;98,71 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;97,87 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;232 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;211 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;140 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;232 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;210 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;136 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;208 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;136 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;208 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;135 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;208 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;135 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,53 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;97,14 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,58 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;97,14 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;98,58 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;96,43 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;98,58 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;96,43 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;12 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;21 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;95 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;12 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;21 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;95 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;21 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;95 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;21 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;95 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;21 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;95 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;100 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 16 País Vasco;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.360 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;8.229 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;8.653 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the first trimester;2022QI;7.982 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the first trimester;2021QI;7.822 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the first trimester;2020QI;7.856 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the second trimester;2022QII;7.678 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the second trimester;2021QII;7.595 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the second trimester;2020QII;7.629 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;7.441 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;7.390 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;7.413 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;7.277 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;7.254 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;7.211 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,48 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,05 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;90,79 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,84 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,3 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;88,17 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,01 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,8 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,67 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,05 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,15 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,34 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;7.781 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;7.262 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;7.420 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;6.885 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;7.138 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;6.675 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;6.916 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;6.490 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;6.762 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;6.376 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;95,36 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;94,81 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;91,74 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;91,92 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;88,88 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;89,37 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;86,9 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;87,8 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;579 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;967 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;562 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;937 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;540 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;920 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;525 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;900 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;515 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;878 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;97,06 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;96,9 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;93,26 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;95,14 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;90,67 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;93,07 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;88,95 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;90,8 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;8.375 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;8.140 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;8.115 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the first trimester;2022QII;7.987 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the first trimester;2021QII;7.840 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the first trimester;2020QII;7.838 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIII;7.708 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIII;7.604 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIII;7.595 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;7.507 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;7.432 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;7.378 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;7.231 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;7.123 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 17 Rioja, La;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,37 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,31 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,59 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,04 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,42 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,59 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,64 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,3 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,92 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,83 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87,78 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;7.829 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;6.935 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;6.386 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;7.459 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;6.658 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;6.142 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;7.197 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;6.449 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;5.931 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;7.007 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;6.302 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;5.753 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;6.127 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;5.552 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;95,27 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;96,01 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;96,18 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;91,93 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;92,99 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;92,88 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;89,5 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;90,87 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;90,09 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;88,35 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;86,94 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;546 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;1.205 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;1.729 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;528 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;1.182 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;1.696 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;511 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;1.155 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;1.664 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;500 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;1.130 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;1.625 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;1.104 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;1.571 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;96,7 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;98,09 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,09 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;93,59 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;95,85 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;96,24 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;91,58 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;93,78 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;93,98 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;91,62 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;90,86 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;8.401 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;8.266 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;8.260 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIII;8.002 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIII;7.883 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIII;7.905 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIV;7.732 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIV;7.647 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIV;7.631 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;7.421 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;7.348 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;7.240 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;7.212 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,25 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,37 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,7 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,04 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,51 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,38 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,78 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,96 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,59 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,31 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;7.920 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;7.903 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;7.345 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;7.538 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;7.529 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;7.006 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;7.277 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;7.301 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;6.747 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;7.078 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;6.490 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;6.907 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;6.368 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;95,18 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;95,27 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;95,38 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;91,88 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;92,38 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;91,86 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;89,56 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;88,36 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;87,4 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;86,7 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;481 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;363 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;915 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;464 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;354 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;899 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;455 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;346 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;884 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;343 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;858 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;333 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;844 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;96,47 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;97,52 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,25 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;94,59 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;95,32 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;96,61 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;94,49 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;93,77 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;91,74 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;92,24 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;8.336 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;8.243 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;8.271 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.988 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIV;7.908 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIV;7.884 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the second trimester;2022QI;7.643 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the second trimester;2021QI;7.562 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;7.415 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;7.389 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;7.227 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;7.226 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,83 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,94 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,32 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,72 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,43 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,96 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,34 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,67 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,37 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;7.913 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;7.660 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;7.065 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;7.572 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;7.336 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;6.703 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;7.085 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;6.419 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;6.882 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;6.264 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;6.707 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;6.120 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;95,69 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;95,77 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;94,88 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;92,49 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;90,86 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;89,84 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;88,66 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;87,56 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;86,62 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;423 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;583 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;1.206 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;416 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;572 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;1.181 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;558 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;1.143 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;533 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;1.125 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;520 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;1.106 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;98,35 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;98,11 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;97,93 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;95,71 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;94,78 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;91,42 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;93,28 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;89,19 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;91,71 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.141 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.166 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.381 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QI;5.776 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QI;5.780 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QI;5.634 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QII;5.521 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QII;5.580 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QII;5.440 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.307 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;5.396 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.251 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.161 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.271 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.069 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,06 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,74 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;88,29 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;89,9 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;90,5 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;85,25 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;86,42 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;87,51 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;82,29 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,04 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,48 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;79,44 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;5.744 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;5.698 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;5.394 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;5.333 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;5.155 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;5.144 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;4.954 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;4.977 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;4.816 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;4.867 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;93,91 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;93,59 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;89,75 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;90,28 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;86,25 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;87,35 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;83,84 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;85,42 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;397 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;468 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;382 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;447 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;366 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;436 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;353 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;419 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;345 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;404 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;96,22 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;95,51 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;92,19 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;93,16 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;88,92 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;89,53 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;86,9 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;86,32 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;6.109 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.083 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.031 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QII;5.770 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QII;5.811 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QII;5.783 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.514 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.595 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.564 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.330 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.438 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.362 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;5.253 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;5.126 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,45 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,53 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,89 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;90,26 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;91,98 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,26 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,25 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,4 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,91 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,36 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,99 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;5.739 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;5.416 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;5.038 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;5.415 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;5.161 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;4.813 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;5.173 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;4.969 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;4.618 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;4.997 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;4.830 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;4.451 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;4.669 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;4.259 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;94,35 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;95,29 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;95,53 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;90,14 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;91,75 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;91,66 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;87,07 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;89,18 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;88,35 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;86,21 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;84,54 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;370 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;667 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;993 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;355 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;650 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;970 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;341 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;626 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;946 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;333 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;608 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;911 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;584 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;867 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;95,95 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,45 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;97,68 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;92,16 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;93,85 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;95,27 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;90 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;91,15 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;91,74 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;87,56 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;87,31 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.143 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.137 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.168 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.767 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.777 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.837 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.515 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.560 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.582 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;5.356 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;5.319 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;5.194 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;5.197 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,88 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;94,13 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,63 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,78 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;90,6 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,5 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,27 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,24 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,63 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,26 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;5.819 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;5.936 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;5.729 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;5.458 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;5.585 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;5.408 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;5.213 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;5.375 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;5.164 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;5.174 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;4.920 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;5.021 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;4.807 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;93,8 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;94,09 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;94,4 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;89,59 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;90,55 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;90,14 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;87,16 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;85,88 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;84,59 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;83,91 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;324 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;201 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;439 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;309 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;192 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;429 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;302 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;185 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;418 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;182 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;399 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;173 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;390 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;95,37 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;95,52 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;97,72 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;93,21 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;92,04 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;95,22 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;90,55 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;90,89 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;86,07 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;88,84 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.084 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.082 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.171 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.765 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIV;5.768 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIV;5.803 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QI;5.522 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QI;5.501 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;5.326 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;5.345 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.154 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.194 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,76 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,84 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,04 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;90,79 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,14 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,57 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;86,61 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,74 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,17 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;5.810 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;5.682 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;5.576 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;5.496 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;5.379 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;5.227 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;5.147 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;4.951 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;4.969 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;4.806 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;4.805 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;4.671 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;94,6 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;94,67 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;93,74 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;90,58 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;88,79 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;87,45 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;86,19 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;84,57 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;83,77 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;274 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;400 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;595 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;269 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;389 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;576 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;375 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;550 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;357 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;539 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;349 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;523 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;98,18 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;97,25 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;96,81 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;93,75 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;92,44 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;89,25 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;90,59 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;87,25 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;87,9 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;926 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;821 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;939 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QI;919 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QI;811 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QI;903 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QII;892 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QII;800 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QII;884 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;879 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;788 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;866 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;869 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;778 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;854 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,24 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,78 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,17 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,33 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,44 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,14 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,92 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,98 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,23 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,84 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,76 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,95 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;841 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;635 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;836 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;628 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;813 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;619 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;801 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;607 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;792 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;604 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,41 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,9 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;96,67 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;97,48 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;95,24 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;95,59 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;94,17 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;95,12 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;85 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;186 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;83 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;183 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;79 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;181 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;78 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;181 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;77 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;174 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;97,65 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,39 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;92,94 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;97,31 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;91,76 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;97,31 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;90,59 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;93,55 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;940 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;825 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;847 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QII;916 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QII;811 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QII;832 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIII;901 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIII;802 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIII;817 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;891 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;789 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;811 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;778 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;802 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,45 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,3 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,23 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,85 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,21 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,46 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,79 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,64 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,75 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,3 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,69 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;861 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;623 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;547 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;837 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;611 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;536 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;824 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;602 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;525 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;816 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;596 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;520 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;586 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;515 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;97,21 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,07 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;97,99 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;95,7 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;96,63 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;95,98 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;94,77 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;95,67 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;95,06 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;94,06 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;94,15 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;79 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;202 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;300 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;79 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;200 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;296 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;77 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;200 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;292 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;75 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;193 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;291 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;192 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;287 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;99,01 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,67 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;97,47 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;99,01 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;97,33 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;94,94 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;95,54 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;97 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;95,05 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;95,67 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;920 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;880 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;853 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIII;906 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIII;868 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIII;837 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIV;899 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIV;854 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIV;828 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;837 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;817 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;825 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;809 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,48 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,64 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,12 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;97,72 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;97,05 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97,07 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,11 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,78 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,75 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,84 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;853 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;814 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;678 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;840 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;802 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;665 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;834 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;789 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;657 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;772 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;648 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;761 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;644 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,48 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,53 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,08 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;97,77 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;96,93 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;96,9 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;94,84 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;95,58 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;93,49 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;94,99 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;67 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;66 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;175 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;66 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;66 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;172 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;65 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;65 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;171 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;65 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;169 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;64 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;165 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;98,51 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,29 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;97,01 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;98,48 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;97,71 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;98,48 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;96,57 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;96,97 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;94,29 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;909 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;874 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;821 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIV;890 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIV;862 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIV;813 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QI;849 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QI;803 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;830 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;795 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;823 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;787 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,91 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,63 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,03 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;97,14 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,81 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,97 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;96,83 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;94,16 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;95,86 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;844 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;791 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;602 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;826 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;779 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;597 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;766 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;593 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;751 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;588 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;744 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;581 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;97,87 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;98,48 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,17 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;96,84 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;98,5 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;94,94 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;97,67 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;94,06 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;96,51 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;65 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;83 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;219 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;64 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;83 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;216 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;83 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;210 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;79 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;207 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;79 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;206 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;98,46 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;98,63 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;95,89 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;95,18 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;94,52 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;95,18 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;94,06 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.220 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.169 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.255 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QI;1.214 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QI;1.159 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QI;1.241 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QII;1.192 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QII;1.143 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QII;1.227 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.182 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.134 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.219 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.174 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.133 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.212 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,51 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,14 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;98,88 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,7 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,78 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;97,77 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;96,89 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;97,01 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;97,13 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;96,23 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;96,92 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;96,57 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;1.130 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;882 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;1.124 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;878 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;1.104 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;866 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;1.095 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;860 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;1.088 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;859 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,47 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,55 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;97,7 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;98,19 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;96,9 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;97,51 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;96,28 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;97,39 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;90 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;287 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;90 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;281 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;88 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;277 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;87 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;274 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;86 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;274 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;97,91 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;97,78 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;96,52 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;96,67 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;95,47 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;95,56 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;95,47 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.251 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.163 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.162 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QII;1.226 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QII;1.149 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QII;1.148 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.218 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.138 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.140 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.211 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.136 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.132 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;1.131 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;1.122 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,8 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,8 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;97,36 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,85 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,11 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;96,8 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;97,68 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;97,42 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;97,25 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;96,56 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;1.161 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;853 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;748 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;1.139 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;843 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;740 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;1.132 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;835 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;735 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;1.126 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;833 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;730 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;829 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;726 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,11 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;98,83 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,93 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;97,5 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;97,89 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;98,26 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;96,99 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;97,66 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;97,59 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;97,19 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;97,06 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;90 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;310 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;414 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;87 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;306 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;408 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;86 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;303 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;405 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;85 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;303 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;402 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;302 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;396 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;96,67 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;98,71 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,55 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;95,56 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;97,74 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;97,83 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;94,44 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;97,74 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;97,1 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;97,42 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;95,65 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.262 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.177 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.167 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.253 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.166 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.160 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.242 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.161 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.151 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;1.156 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;1.143 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;1.149 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;1.137 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;99,29 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;99,07 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,4 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;98,42 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;98,64 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;98,63 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;98,22 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;97,94 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;97,62 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;97,43 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;1.179 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;1.091 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;892 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;1.171 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;1.080 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;887 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;1.161 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;1.075 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;881 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;1.070 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;878 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;1.063 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;873 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;99,32 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,99 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,44 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;98,47 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;98,53 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;98,77 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;98,08 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;98,43 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;97,43 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;97,87 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;83 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;86 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;275 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;82 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;86 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;273 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;81 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;86 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;270 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;86 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;265 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;86 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;264 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;98,8 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;99,27 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;97,59 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;98,18 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;96,36 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;96 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.263 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.215 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.205 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.253 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.206 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.195 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QI;1.200 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QI;1.186 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;1.187 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;1.177 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.178 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.173 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;99,21 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,26 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,17 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,77 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;98,42 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;97,7 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;97,68 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;96,95 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;97,34 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;1.186 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;1.123 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;837 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;1.177 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;1.114 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;830 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;1.108 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;827 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;1.098 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;822 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;1.094 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;820 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;99,24 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,2 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,16 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,66 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;98,81 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;97,77 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;98,21 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;97,42 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;97,97 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;77 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;92 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;368 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;76 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;92 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;365 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;92 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;359 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;89 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;355 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;84 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;353 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;98,7 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;99,18 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;97,55 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;96,74 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;96,47 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;91,3 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;95,92 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;53 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;58 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;60 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QI;53 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QI;57 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QI;60 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QII;53 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QII;57 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QII;60 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;53 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;57 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;60 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;53 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;57 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;60 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;100 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,28 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;100 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;100 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;98,28 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;100 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;100 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;98,28 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;100 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;100 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;98,28 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;100 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;48 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;37 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;48 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;36 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;48 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;36 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;48 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;36 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;48 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;36 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;100 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;97,3 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;100 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;97,3 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;100 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;97,3 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;100 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;97,3 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;5 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;21 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;5 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;21 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;5 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;21 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;5 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;21 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;5 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;21 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;100 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;54 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;52 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;58 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QII;54 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QII;52 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QII;58 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIII;54 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIII;52 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIII;58 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;54 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;52 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;57 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;52 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;57 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;100 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;100 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;98,28 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;100 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;98,28 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;50 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;31 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;42 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;50 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;31 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;42 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;50 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;31 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;42 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;50 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;31 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;41 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;31 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;41 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;100 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;100 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;97,62 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;100 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;97,62 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;4 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;21 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;16 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;4 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;21 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;16 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;4 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;21 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;16 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;4 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;21 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;16 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;21 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;16 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;100 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;55 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;54 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;55 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIII;55 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIII;54 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIII;54 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIV;55 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIV;54 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIV;53 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;54 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;52 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;54 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;52 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;100 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,18 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;100 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;100 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,36 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;100 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,55 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;100 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,55 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;51 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;46 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;35 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;51 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;46 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;35 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;51 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;46 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;34 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;46 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;33 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;46 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;33 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;100 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;100 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;100 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;97,14 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;100 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;94,29 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;100 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;94,29 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;4 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;8 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;20 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;4 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;8 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;19 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;4 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;8 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;19 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;8 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;19 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;8 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;19 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;95 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;95 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;95 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;95 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;57 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;54 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;58 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIV;57 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIV;54 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIV;57 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QI;54 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QI;56 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;54 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;56 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;54 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;56 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;100 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,28 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;100 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,55 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;100 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;96,55 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;100 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;96,55 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;52 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;47 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;40 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;52 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;47 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;39 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;47 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;38 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;47 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;38 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;47 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;38 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;100 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;97,5 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;100 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;95 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;100 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;95 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;100 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;95 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;5 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;7 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;18 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;5 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;7 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;18 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;7 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;18 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;7 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;18 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;7 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;18 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;100 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;20 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;15 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;18 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QI;20 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QI;15 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QI;18 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QII;20 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QII;15 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QII;18 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;20 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;15 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;17 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;20 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;15 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;16 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;100 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;100 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;100 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;100 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;100 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;100 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;100 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;100 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,44 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;100 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;100 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,89 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;18 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;10 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;18 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;10 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;18 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;10 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;18 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;10 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;18 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;10 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;100 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;100 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;100 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;100 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;100 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;100 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;100 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;100 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;2 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;5 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;2 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;5 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;2 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;5 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;2 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;5 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;2 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;5 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;100 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;21 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;17 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;17 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QII;21 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QII;17 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QII;17 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIII;21 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIII;17 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIII;16 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;21 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;17 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;16 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;17 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;16 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 17 Rioja, La;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;100 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;100 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;100 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,12 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;100 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;100 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,12 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;100 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,12 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;18 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;12 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;11 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;18 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;12 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;11 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;18 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;12 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;11 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;18 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;12 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;11 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;12 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;11 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;100 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;100 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;100 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;100 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;100 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;100 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;100 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;100 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;3 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;5 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;6 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;3 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;5 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;6 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;3 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;5 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;5 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;3 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;5 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;5 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;5 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;5 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;83,33 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;83,33 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;83,33 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;21 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;18 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;17 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIII;21 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIII;18 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIII;17 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIV;21 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIV;18 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIV;17 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;18 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;17 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;18 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;17 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;100 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;100 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;100 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;100 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;100 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;100 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;100 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;100 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;100 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;18 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;16 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;11 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;18 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;16 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;11 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;18 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;16 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;11 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;16 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;11 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;16 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;11 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;100 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;100 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;100 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;100 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;100 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;100 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;100 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;100 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;3 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;2 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;6 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;3 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;2 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;6 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;3 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;2 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;6 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;2 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;6 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;2 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;6 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;100 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;100 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;23 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;18 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;16 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIV;23 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIV;18 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIV;16 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QI;18 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QI;16 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;18 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;16 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;18 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;16 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;100 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;100 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;100 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;100 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;100 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;100 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;100 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;100 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;21 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;17 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;10 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;21 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;17 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;10 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;17 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;10 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;17 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;10 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;17 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;10 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;100 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;100 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;100 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;100 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;100 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;100 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;100 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;2 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;1 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;6 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;2 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;1 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;6 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;1 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;6 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;1 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;6 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;1 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;6 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;100 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 17 Rioja, La;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.504 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.500 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.543 18 Ceuta;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the first trimester;2022QI;1.425 18 Ceuta;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the first trimester;2021QI;1.409 18 Ceuta;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the first trimester;2020QI;1.379 18 Ceuta;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the second trimester;2022QII;1.346 18 Ceuta;Total ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the second trimester;2021QII;1.350 18 Ceuta;Total ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the second trimester;2020QII;1.343 18 Ceuta;Total ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.291 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.310 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.297 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.243 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.258 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.262 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,75 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,93 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;89,37 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;89,49 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;90 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;87,04 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;85,84 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;87,33 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;84,06 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;82,65 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;83,87 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;81,79 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;1.444 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;1.329 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;1.369 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;1.242 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;1.295 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;1.185 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;1.241 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;1.151 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;1.195 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;1.105 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;94,81 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;93,45 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;89,68 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;89,16 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;85,94 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;86,61 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;82,76 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;83,15 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;60 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;171 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;56 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;167 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;51 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;165 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;50 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;159 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;48 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;153 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;93,33 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;97,66 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;85 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;96,49 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;83,33 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;92,98 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;80 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;89,47 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.517 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.482 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.480 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the first trimester;2022QII;1.424 18 Ceuta;Total ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the first trimester;2021QII;1.408 18 Ceuta;Total ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the first trimester;2020QII;1.431 18 Ceuta;Total ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.356 18 Ceuta;Total ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.361 18 Ceuta;Total ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.372 18 Ceuta;Total ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.296 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.304 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.331 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;1.252 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;1.265 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 18 Ceuta;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,87 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,01 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,69 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;89,39 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;91,84 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,7 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;85,43 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;87,99 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,93 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;84,48 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,47 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;1.466 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;1.329 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;1.232 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;1.377 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;1.257 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;1.184 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;1.310 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;1.216 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;1.132 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;1.251 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;1.165 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;1.096 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;1.120 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;1.038 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;93,93 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;94,58 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;96,1 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;89,36 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;91,5 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;91,88 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;85,33 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;87,66 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;88,96 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;84,27 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;84,25 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;51 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;153 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;248 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;47 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;151 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;247 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;46 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;145 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;240 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;45 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;139 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;235 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;132 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;227 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 18 Ceuta;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;92,16 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;98,69 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,6 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;90,2 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;94,77 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;96,77 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;88,24 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;90,85 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;94,76 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;86,27 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;91,53 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.496 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.497 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.486 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.410 18 Ceuta;Total ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.426 18 Ceuta;Total ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.414 18 Ceuta;Total ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.337 18 Ceuta;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.355 18 Ceuta;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.367 18 Ceuta;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;1.300 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;1.298 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;1.245 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;1.264 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;94,25 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,26 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,15 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,37 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;90,51 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,99 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;86,84 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,35 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;83,17 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,06 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;1.484 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;1.434 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;1.303 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;1.398 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;1.365 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;1.236 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;1.325 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;1.297 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;1.194 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;1.247 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;1.130 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;1.193 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;1.098 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;94,2 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;95,19 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;94,86 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;89,29 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;90,45 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;91,63 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;86,96 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;86,72 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;83,19 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;84,27 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;12 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;63 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;183 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;12 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;61 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;178 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;12 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;58 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;173 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;53 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;168 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;52 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;166 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;96,83 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;97,27 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;92,06 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;94,54 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;84,13 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;91,8 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;82,54 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;90,71 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.486 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.503 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.489 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.399 18 Ceuta;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.418 18 Ceuta;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.430 18 Ceuta;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the second trimester;2022QI;1.355 18 Ceuta;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the second trimester;2021QI;1.351 18 Ceuta;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;1.289 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;1.306 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.239 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.270 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,15 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,34 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,04 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;90,15 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,73 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;85,76 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,71 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;82,44 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,29 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;1.480 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;1.418 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;1.316 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;1.393 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;1.335 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;1.261 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;1.279 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;1.187 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;1.216 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;1.144 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;1.169 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;1.113 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;94,12 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;94,15 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;95,82 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;90,2 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;90,2 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;85,75 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;86,93 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;82,44 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;84,57 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;6 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;85 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;173 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;6 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;83 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;169 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;76 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;164 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;73 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;162 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;70 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;157 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;97,65 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;97,69 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;89,41 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;94,8 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;85,88 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;93,64 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;82,35 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;90,75 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.175 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.179 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.222 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QI;1.097 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QI;1.092 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QI;1.067 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QII;1.026 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QII;1.038 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QII;1.033 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;976 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.000 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;988 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;932 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;949 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;955 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,36 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;92,62 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,32 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,32 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;88,04 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,53 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;83,06 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;84,82 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;80,85 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;79,32 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;80,49 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;78,15 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;1.136 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;1.081 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;1.062 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;997 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;995 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;945 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;946 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;913 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;904 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;868 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;93,49 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;92,23 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;87,59 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;87,42 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;83,27 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;84,46 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;79,58 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;80,3 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;39 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;98 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;35 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;95 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;31 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;93 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;30 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;87 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;28 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;81 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;89,74 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;96,94 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;79,49 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;94,9 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;76,92 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;88,78 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;71,79 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;82,65 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.187 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.165 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.172 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QII;1.101 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QII;1.095 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QII;1.127 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.040 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.048 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.072 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;985 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;995 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.031 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;945 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;969 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 18 Ceuta;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,75 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,99 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,16 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;87,62 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;89,96 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,47 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;82,98 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;85,41 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,97 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;81,12 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;82,68 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;1.152 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;1.075 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;1.010 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;1.070 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;1.007 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;966 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;1.010 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;966 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;918 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;956 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;919 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;882 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;876 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;826 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;92,88 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;93,67 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;95,64 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;87,67 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;89,86 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;90,89 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;82,99 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;85,49 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;87,33 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;81,49 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;81,78 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;35 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;90 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;162 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;31 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;88 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;161 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;30 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;82 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;154 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;29 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;76 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;149 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;69 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;143 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;88,57 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,78 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;99,38 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;85,71 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;91,11 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;95,06 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;82,86 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;84,44 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;91,98 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;76,67 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;88,27 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.157 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.166 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.160 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.081 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.098 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.094 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.016 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.034 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.048 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;982 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;982 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;934 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;951 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,43 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;94,17 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,31 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;87,81 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;88,68 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,34 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;84,22 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;84,66 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;80,1 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;81,98 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;1.151 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;1.128 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;1.052 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;1.075 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;1.062 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;991 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;1.010 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;1.001 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;950 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;954 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;888 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;906 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;859 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;93,4 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;94,15 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;94,2 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;87,75 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;88,74 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;90,3 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;84,57 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;84,41 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;80,32 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;81,65 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;6 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;38 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;108 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;6 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;36 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;103 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;6 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;33 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;98 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;28 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;94 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;28 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;92 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;94,74 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;95,37 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;86,84 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;90,74 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;73,68 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;87,04 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;73,68 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;85,19 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.145 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.176 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.162 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.064 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.096 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.107 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QI;1.034 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QI;1.032 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;975 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;992 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;928 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;958 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,93 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,2 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,27 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;87,93 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;88,81 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;82,91 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;85,37 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;78,91 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;82,44 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;1.144 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;1.113 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;1.062 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;1.063 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;1.035 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;1.011 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;980 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;940 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;924 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;902 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;880 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;873 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;92,92 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;92,99 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;95,2 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;88,05 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;88,51 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;83,02 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;84,93 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;79,07 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;82,2 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;1 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;63 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;1 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;61 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;96 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;54 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;92 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;51 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;90 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;48 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;85 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;96,83 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;96 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;85,71 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;92 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;80,95 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;90 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;76,19 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;85 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;141 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;145 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;139 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QI;140 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QI;143 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QI;134 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QII;134 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QII;140 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QII;133 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;130 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;138 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;132 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;127 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;137 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;131 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99,29 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,62 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,4 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,04 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,55 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,68 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,2 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,17 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,96 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,07 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,48 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;94,24 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;132 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;117 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;131 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;116 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;126 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;113 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;122 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;111 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;119 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;110 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,24 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,15 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;95,45 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;96,58 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;92,42 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;94,87 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;90,15 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;94,02 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;9 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;28 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;9 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;27 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;8 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;27 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;8 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;27 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;8 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;27 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;96,43 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;88,89 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;96,43 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;88,89 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;96,43 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;88,89 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;96,43 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;134 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;130 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;129 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QII;129 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QII;129 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QII;127 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIII;124 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIII;129 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIII;125 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;122 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;125 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;125 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;123 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;122 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,27 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;99,23 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,45 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,54 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;99,23 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,9 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,04 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;96,15 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,9 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,62 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,57 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;128 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;110 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;92 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;123 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;109 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;90 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;118 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;109 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;88 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;116 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;105 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;88 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;103 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;87 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;96,09 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;99,09 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;97,83 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;92,19 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;99,09 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;95,65 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;90,63 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;95,45 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;95,65 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;93,64 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;94,57 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;6 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;20 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;37 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;6 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;20 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;37 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;6 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;20 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;37 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;6 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;20 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;37 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;20 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;35 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;94,59 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;143 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;133 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;146 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIII;135 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIII;130 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIII;142 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIV;131 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIV;124 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIV;142 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;122 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;140 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;118 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;139 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;94,41 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,74 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,26 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,61 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,23 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97,26 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,73 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,89 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,72 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;95,21 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;140 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;124 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;116 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;132 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;121 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;112 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;128 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;115 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;112 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;113 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;111 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;109 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;110 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;94,29 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;97,58 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;96,55 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;91,43 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;92,74 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;96,55 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;91,13 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;95,69 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;87,9 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;94,83 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;3 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;9 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;30 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;3 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;9 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;30 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;3 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;9 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;30 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;9 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;29 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;9 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;29 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;96,67 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;96,67 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;146 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;138 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;145 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIV;143 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIV;134 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIV;142 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QI;133 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QI;140 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;127 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;138 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;125 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;136 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,95 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,1 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,93 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,38 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,55 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,03 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,17 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,58 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,79 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;145 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;130 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;116 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;142 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;126 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;113 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;125 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;112 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;119 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;110 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;117 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;108 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;97,93 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;96,92 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;97,41 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;96,15 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;96,55 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;91,54 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;94,83 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;90 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;93,1 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;1 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;8 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;29 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;1 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;8 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;29 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;8 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;28 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;8 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;28 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;8 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;28 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;96,55 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;96,55 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;96,55 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;175 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;166 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;174 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QI;175 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QI;164 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QI;170 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QII;173 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QII;162 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QII;169 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;172 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;162 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;169 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;171 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;162 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;168 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;100 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,8 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;97,7 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;98,86 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,59 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;97,13 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;98,29 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;97,59 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;97,13 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;97,71 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;97,59 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;96,55 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;163 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;122 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;163 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;120 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;161 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;118 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;160 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;118 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;159 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;118 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;100 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;98,36 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;98,77 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;96,72 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;98,16 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;96,72 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;97,55 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;96,72 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;12 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;44 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;12 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;44 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;12 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;44 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;12 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;44 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;12 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;44 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;100 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;100 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;100 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;100 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;183 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;176 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;169 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QII;181 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QII;173 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QII;167 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIII;179 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIII;173 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIII;165 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;176 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;173 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;165 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;173 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;164 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 18 Ceuta;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,91 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,3 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,82 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;97,81 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;98,3 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,63 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;96,17 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;98,3 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;97,63 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;98,3 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;97,04 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;173 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;134 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;120 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;171 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;131 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;118 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;169 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;131 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;116 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;166 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;131 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;116 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;131 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;115 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;98,84 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;97,76 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;98,33 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;97,69 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;97,76 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;96,67 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;95,95 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;97,76 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;96,67 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;97,76 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;95,83 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;10 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;42 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;49 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;10 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;42 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;49 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;10 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;42 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;49 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;10 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;42 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;49 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;42 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;49 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;100 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;182 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;186 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;169 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIII;180 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIII;186 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIII;167 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIV;176 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIV;185 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIV;166 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;184 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;165 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;181 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;163 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,9 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,82 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,7 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;99,46 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;98,22 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;98,92 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;97,63 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;97,31 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;96,45 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;179 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;171 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;125 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;177 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;171 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;123 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;173 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;170 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;122 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;169 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;121 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;167 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;119 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;98,88 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;98,4 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;96,65 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;99,42 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;97,6 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;98,83 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;96,8 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;97,66 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;95,2 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;3 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;15 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;44 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;3 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;15 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;44 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;3 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;15 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;44 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;15 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;44 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;14 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;44 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;100 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;93,33 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;100 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;181 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;176 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;170 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIV;178 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIV;175 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIV;169 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QI;175 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QI;167 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;174 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;164 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;173 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;164 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,34 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;99,43 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;99,41 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;99,43 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;98,24 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;98,86 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;96,47 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;98,3 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;96,47 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;177 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;162 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;127 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;174 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;161 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;126 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;161 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;124 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;160 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;121 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;159 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;121 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;98,31 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;99,38 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;99,21 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;99,38 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;97,64 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;98,77 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;95,28 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;98,15 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;95,28 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;4 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;14 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;43 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;4 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;14 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;43 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;14 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;43 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;14 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;43 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;14 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;43 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;100 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;10 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;8 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;5 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QI;10 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QI;8 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QI;5 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QII;10 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QII;8 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QII;5 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;10 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;8 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;5 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;10 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;8 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;5 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;100 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;100 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;100 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;100 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;100 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;100 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;100 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;100 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;100 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;100 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;100 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;100 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;10 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;7 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;10 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;7 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;10 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;7 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;10 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;7 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;10 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;7 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;100 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;100 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;100 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;100 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;100 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;100 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;100 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;100 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;0 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;1 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;0 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;1 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;0 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;1 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;0 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;1 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;0 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;1 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;.. 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;.. 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;.. 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;0 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;0 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;100 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;11 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;9 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;7 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QII;11 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QII;9 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QII;7 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIII;11 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIII;9 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIII;7 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;11 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;9 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;7 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;9 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;7 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 18 Ceuta;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;100 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;100 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;100 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;100 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;100 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;100 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;100 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;100 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;100 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;11 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;8 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;7 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;11 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;8 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;7 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;11 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;8 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;7 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;11 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;8 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;7 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;8 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;7 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;100 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;100 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;100 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;100 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;100 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;100 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;100 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;100 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;0 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;1 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;0 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;0 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;1 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;0 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;0 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;1 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;0 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;0 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;1 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;0 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;1 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;0 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;.. 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;.. 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;.. 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;.. 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;0 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;.. 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;0 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;.. 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;.. 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;11 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;9 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;8 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIII;11 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIII;9 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIII;8 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIV;11 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIV;9 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIV;8 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;9 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;8 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;9 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;8 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;100 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;100 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;100 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;100 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;100 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;100 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;100 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;100 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;100 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;11 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;8 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;8 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;11 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;8 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;8 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;11 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;8 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;8 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;8 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;8 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;8 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;8 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;100 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;100 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;100 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;100 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;100 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;100 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;100 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;100 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;0 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;1 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;0 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;0 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;1 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;0 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;0 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;1 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;0 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;1 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;0 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;1 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;0 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;0 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;.. 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;0 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;.. 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;0 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;.. 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;.. 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;.. 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;12 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;10 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;10 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIV;12 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIV;10 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIV;10 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QI;10 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QI;10 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;10 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;10 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;10 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;10 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;100 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;100 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;100 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;100 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;100 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;100 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;100 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;100 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;12 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;10 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;9 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;12 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;10 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;9 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;10 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;9 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;10 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;9 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;10 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;9 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;100 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;100 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;100 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;100 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;100 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;100 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;100 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;0 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;0 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;1 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;0 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;0 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;1 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;0 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;1 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;0 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;1 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;0 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;1 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;0 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;.. 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;0 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;.. 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;.. 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;.. 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;0 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;100 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;3 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;2 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;3 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QI;3 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QI;2 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QI;3 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QII;3 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QII;2 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QII;3 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;3 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;2 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;3 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;3 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;2 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;3 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;100 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;100 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;100 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;100 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;100 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;100 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;100 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;100 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;100 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;100 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;100 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;100 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;3 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;2 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;3 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;2 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;3 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;2 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;3 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;2 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;3 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;2 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;100 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;100 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;100 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;100 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;100 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;100 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;100 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;100 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;0 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;0 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;0 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;0 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;0 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;0 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;0 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;0 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;0 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;0 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;.. 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;.. 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;.. 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;.. 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;.. 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;.. 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;0 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;.. 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;0 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;.. 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;2 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;2 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;3 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QII;2 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QII;2 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QII;3 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIII;2 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIII;2 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIII;3 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;2 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;2 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;3 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;2 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;3 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 18 Ceuta;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;100 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;100 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;100 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;100 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;100 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;100 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;100 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;100 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;100 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;2 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;2 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;3 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;2 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;2 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;3 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;2 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;2 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;3 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;2 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;2 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;3 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;2 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;3 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;100 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;100 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;100 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;100 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;100 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;100 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;100 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;100 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;0 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;0 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;0 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;0 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;0 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;0 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;0 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;0 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;0 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;0 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;0 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;0 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;0 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;0 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;.. 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;.. 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;.. 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;.. 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;.. 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;.. 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;0 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;.. 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;.. 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;0 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;.. 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;.. 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;.. 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;.. 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIII;3 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIII;3 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIII;3 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIV;3 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIV;3 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIV;3 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;3 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;3 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;3 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;3 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;100 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;100 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;100 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;100 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;100 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;100 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;100 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;100 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;100 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;3 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;3 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;2 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;3 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;3 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;2 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;3 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;3 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;2 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;3 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;2 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;3 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;2 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;100 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;100 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;100 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;100 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;100 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;100 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;100 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;100 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;0 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;0 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;1 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;0 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;0 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;1 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;0 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;0 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;1 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;0 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;1 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;0 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;1 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;0 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;.. 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;0 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;.. 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;0 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;.. 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;.. 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;100 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;.. 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;100 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIV;2 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIV;3 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIV;2 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QI;3 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QI;2 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;3 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;2 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;3 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;2 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;100 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;100 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;100 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;100 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;100 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;100 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;100 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;100 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;2 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;3 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;2 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;2 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;3 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;2 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;3 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;2 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;3 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;2 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;3 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;2 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;100 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;100 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;100 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;100 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;100 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;100 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;100 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;0 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;0 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;0 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;0 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;0 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;0 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;0 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;0 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;0 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;0 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;0 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;0 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;0 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;.. 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;.. 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;0 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;.. 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;.. 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;.. 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;.. 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;.. 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;.. 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;0 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;.. 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 18 Ceuta;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.535 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.485 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.691 19 Melilla;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the first trimester;2022QI;1.409 19 Melilla;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the first trimester;2021QI;1.387 19 Melilla;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the first trimester;2020QI;1.465 19 Melilla;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the second trimester;2022QII;1.319 19 Melilla;Total ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the second trimester;2021QII;1.317 19 Melilla;Total ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the second trimester;2020QII;1.342 19 Melilla;Total ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.254 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.252 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.266 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.211 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.201 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.211 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;Total ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;91,79 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,4 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;86,64 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;85,93 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;88,69 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;79,36 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;81,69 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;84,31 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;74,87 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;78,89 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;80,88 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;71,61 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;1.462 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;1.280 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;1.341 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;1.185 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;1.258 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;1.122 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;1.198 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;1.061 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;1.155 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;1.016 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;91,72 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;92,58 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;86,05 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;87,66 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;81,94 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;82,89 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;79 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;79,38 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;73 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;205 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;68 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;202 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;61 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;195 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;56 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;191 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;56 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;185 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;93,15 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;98,54 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;83,56 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;95,12 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;76,71 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;93,17 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;76,71 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;90,24 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;Total ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.517 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.501 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.570 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the first trimester;2022QII;1.406 19 Melilla;Total ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the first trimester;2021QII;1.400 19 Melilla;Total ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the first trimester;2020QII;1.421 19 Melilla;Total ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.323 19 Melilla;Total ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.325 19 Melilla;Total ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.335 19 Melilla;Total ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.273 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.268 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.273 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2022QI;1.199 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2021QI;1.224 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 19 Melilla;Total ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,68 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,27 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;90,51 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;87,21 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;88,27 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;85,03 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;83,92 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;84,48 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;81,08 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;79,88 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;77,96 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;Total ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;1.461 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;1.304 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;1.308 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;1.355 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;1.210 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;1.162 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;1.276 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;1.139 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;1.083 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;1.226 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;1.087 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;1.027 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;1.029 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;982 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 19 Melilla;Total ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;92,74 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;92,79 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;88,84 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;87,34 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;87,35 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;82,8 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;83,92 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;83,36 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;78,52 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;78,91 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;75,08 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;Total ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;56 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;197 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;262 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;51 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;190 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;259 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;47 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;186 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;252 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;47 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;181 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;246 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;170 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;242 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 19 Melilla;Total ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;91,07 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;96,45 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,85 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;83,93 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;94,42 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;96,18 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;83,93 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;91,88 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;93,89 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;86,29 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;92,37 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;Total ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.500 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.489 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.484 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.397 19 Melilla;Total ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.403 19 Melilla;Total ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.380 19 Melilla;Total ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.331 19 Melilla;Total ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.336 19 Melilla;Total ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.306 19 Melilla;Total ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;1.257 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;1.255 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2022QII;1.206 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2021QII;1.209 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;Total ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,13 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;94,22 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,99 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;88,73 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;89,72 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;88,01 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;84,42 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;84,57 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;80,99 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;81,47 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;1.483 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;1.426 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;1.295 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;1.383 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;1.342 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;1.194 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;1.317 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;1.277 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;1.126 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;1.203 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;1.079 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;1.155 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;1.039 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;93,26 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;94,11 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;92,2 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;88,81 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;89,55 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;86,95 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;84,36 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;83,32 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;81 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;80,23 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;17 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;63 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;189 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;14 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;61 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;186 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;14 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;59 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;180 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;54 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;176 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;51 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;170 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;82,35 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;96,83 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,41 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;82,35 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;93,65 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;95,24 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;85,71 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;93,12 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;80,95 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;89,95 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;Total ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.493 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.485 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.483 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.404 19 Melilla;Total ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.405 19 Melilla;Total ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.388 19 Melilla;Total ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the second trimester;2022QI;1.315 19 Melilla;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the second trimester;2021QI;1.327 19 Melilla;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;1.254 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;1.272 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.201 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.216 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;Total ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,04 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,61 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,59 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;88,55 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,48 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;84,44 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;85,77 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;80,88 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;82 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;1.479 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;1.376 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;1.299 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;1.390 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;1.301 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;1.209 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;1.217 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;1.151 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;1.166 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;1.101 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;1.116 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;1.048 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;93,98 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;94,55 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;93,07 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;88,44 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;88,61 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;84,74 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;84,76 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;81,1 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;80,68 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;14 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;109 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;184 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;14 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;104 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;179 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;98 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;176 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;88 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;171 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;85 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;168 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;95,41 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;97,28 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;89,91 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;95,65 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;80,73 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;92,93 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;77,98 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;91,3 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;Total ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.133 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.120 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.324 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2022QI;1.018 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2021QI;1.028 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the first trimester;2020QI;1.106 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QII;942 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QII;967 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QII;986 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;887 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;907 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;913 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIV;847 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIV;865 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIV;863 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;89,85 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;91,79 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;83,53 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;83,14 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;86,34 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;74,47 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;78,29 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;80,98 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;68,96 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;74,76 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;77,23 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;65,18 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;1.079 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;996 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;968 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;907 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;898 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;852 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;847 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;796 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;807 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;759 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;89,71 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;91,06 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;83,23 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;85,54 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;78,5 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;79,92 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;74,79 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;76,2 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;54 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;124 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;50 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;121 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;44 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;115 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;40 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;111 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;40 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;106 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;92,59 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;97,58 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;81,48 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;92,74 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;74,07 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;89,52 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;74,07 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;85,48 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.125 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.142 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.232 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QII;1.026 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QII;1.049 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QII;1.086 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QIII;956 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QIII;980 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.001 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;909 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;931 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;944 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2022QI;867 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2021QI;900 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 19 Melilla;From 1 to 5;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;91,2 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;91,86 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;88,15 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;84,98 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;85,81 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;81,25 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;80,8 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;81,52 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;76,62 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;75,92 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;73,05 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;1.089 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;1.021 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;1.060 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;994 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;934 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;916 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;928 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;869 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;837 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;881 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;825 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;784 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;771 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;743 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;91,28 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;91,48 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;86,42 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;85,22 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;85,11 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;78,96 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;80,9 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;80,8 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;73,96 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;75,51 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;70,09 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;36 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;121 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;172 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;32 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;115 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;170 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;28 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;111 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;164 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;28 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;106 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;160 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;96 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;157 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;88,89 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;95,04 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;98,84 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;77,78 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;91,74 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;95,35 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;77,78 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;87,6 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;93,02 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;79,34 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;91,28 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.119 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.127 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.134 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.025 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.046 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.032 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIV;961 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIV;988 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIV;962 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;915 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;915 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QII;868 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QII;875 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,6 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;92,81 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;91,01 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;85,88 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;87,67 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;84,83 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;81,19 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;80,69 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;77,02 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;77,16 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;1.108 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;1.081 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;1.022 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;1.017 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;1.002 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;922 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;953 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;946 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;856 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;878 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;812 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;834 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;778 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;91,79 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;92,69 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;90,22 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;86,01 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;87,51 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;83,76 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;81,22 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;79,45 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;77,15 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;76,13 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;11 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;46 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;112 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;8 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;44 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;110 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;8 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;42 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;106 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;37 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;103 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;34 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;97 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;72,73 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;95,65 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;98,21 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;72,73 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;91,3 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;94,64 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;80,43 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;91,96 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;73,91 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;86,61 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.110 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.126 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.128 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.024 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.054 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.037 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2022QI;969 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2021QI;980 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;916 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;932 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QIII;870 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QIII;881 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,25 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,61 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;91,93 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;86,06 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;86,88 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;81,35 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;82,62 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;77,26 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;78,1 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;1.102 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;1.046 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;1.017 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;1.016 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;978 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;930 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;898 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;875 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;855 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;832 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;812 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;784 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;92,2 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;93,5 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;91,45 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;85,85 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;86,04 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;81,74 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;81,81 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;77,63 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;77,09 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;8 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;80 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;111 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;8 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;76 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;107 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;71 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;105 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;61 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;100 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;58 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;97 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;95 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;96,4 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;88,75 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;94,59 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;76,25 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;90,09 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;72,5 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;87,39 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 1 to 5;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;195 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;173 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;184 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2022QI;186 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2021QI;172 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the first trimester;2020QI;178 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QII;180 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QII;167 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QII;176 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;173 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;166 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;174 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIV;170 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIV;160 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIV;170 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,38 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,42 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,74 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,31 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,53 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,65 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,72 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,95 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,57 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,18 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,49 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,39 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;187 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;138 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;178 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;137 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;173 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;133 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;167 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;132 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;164 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;126 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;95,19 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;99,28 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;92,51 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;96,38 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;89,3 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;95,65 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;87,7 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;91,3 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;8 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;35 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;8 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;35 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;7 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;34 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;6 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;34 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;6 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;34 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;100 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;87,5 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;97,14 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;75 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;97,14 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;75 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;97,14 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;202 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;170 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;171 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QII;196 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QII;166 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QII;170 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QIII;189 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QIII;162 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QIII;170 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;186 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;158 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;166 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2022QI;154 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2021QI;163 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,03 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,65 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,42 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,56 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,29 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;99,42 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,08 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,94 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;97,08 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,59 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;95,32 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;192 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;138 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;124 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;187 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;134 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;123 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;180 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;130 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;123 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;177 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;126 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;121 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;122 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;119 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;97,4 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;97,1 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,19 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;93,75 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;94,2 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;99,19 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;92,19 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;91,3 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;97,58 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;88,41 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;95,97 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;10 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;32 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;47 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;9 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;32 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;47 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;9 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;32 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;47 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;9 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;32 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;45 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;32 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;44 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;90 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;90 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;90 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;95,74 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;93,62 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;195 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;177 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;180 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QIII;190 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QIII;174 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QIII;179 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIV;188 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIV;168 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIV;175 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;164 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;174 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QII;162 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QII;169 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,44 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,31 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,44 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,41 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,92 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97,22 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,66 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;96,67 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,53 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,89 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;193 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;173 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;143 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;188 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;170 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;142 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;186 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;164 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;140 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;160 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;140 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;158 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;135 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;97,41 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,27 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;99,3 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;96,37 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;94,8 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;97,9 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;92,49 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;97,9 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;91,33 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;94,41 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;2 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;4 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;37 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;2 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;4 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;37 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;2 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;4 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;35 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;4 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;34 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;4 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;34 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;94,59 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;91,89 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;91,89 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;196 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;171 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;168 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIV;193 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIV;166 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIV;164 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2022QI;161 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2021QI;163 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;157 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;160 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QIII;151 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QIII;157 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,47 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,08 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,62 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,15 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,02 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,81 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,24 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,3 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,45 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;194 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;157 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;138 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;191 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;153 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;135 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;149 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;135 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;145 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;132 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;139 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;129 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;98,45 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;97,45 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;97,83 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;94,9 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;97,83 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;92,36 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;95,65 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;88,54 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;93,48 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;2 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;14 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;30 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;2 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;13 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;29 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;12 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;28 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;12 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;28 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;12 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;28 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;92,86 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;96,67 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;85,71 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;93,33 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;85,71 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;93,33 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;85,71 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;93,33 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 6 to 9 employees ;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;201 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;187 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;176 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2022QI;199 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2021QI;182 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the first trimester;2020QI;174 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QII;191 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QII;178 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QII;173 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;188 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;174 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;172 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIV;188 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIV;171 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIV;171 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;99 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,33 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;98,86 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,02 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,19 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;98,3 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,53 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,05 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;97,73 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,53 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,44 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;97,16 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;190 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;142 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;189 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;137 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;181 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;133 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;178 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;129 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;178 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;127 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;99,47 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;96,48 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;95,26 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;93,66 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;93,68 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;90,85 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;93,68 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;89,44 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;11 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;45 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;10 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;45 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;10 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;45 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;10 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;45 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;10 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;44 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;100 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;90,91 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;90,91 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;90,91 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;90,91 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;97,78 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;185 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;183 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;161 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QII;179 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QII;179 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QII;159 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QIII;173 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QIII;177 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QIII;158 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;173 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;173 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;157 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2022QI;172 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2021QI;155 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 19 Melilla;From 10 to 99;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,76 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,81 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,76 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,51 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,72 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;98,14 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,51 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,54 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;97,52 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,99 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;96,27 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;175 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;140 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;119 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;169 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;137 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;118 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;163 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;135 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;118 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;163 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;131 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;117 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;131 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;115 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;96,57 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;97,86 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;99,16 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;93,14 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;96,43 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;99,16 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;93,14 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;93,57 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;98,32 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;93,57 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;96,64 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;10 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;43 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;42 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;10 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;42 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;41 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;10 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;42 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;40 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;10 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;42 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;40 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;41 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;40 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;100 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;100 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;97,67 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;97,62 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;100 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;97,67 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;95,24 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;100 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;97,67 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;95,24 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;95,35 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;95,24 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;180 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;181 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;164 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QIII;176 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QIII;179 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QIII;163 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIV;176 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIV;176 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIV;163 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;174 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;160 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QII;172 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QII;159 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,78 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,9 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;99,39 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;97,78 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;97,24 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;99,39 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;96,13 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;97,56 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;95,03 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;96,95 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;177 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;168 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;126 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;173 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;166 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;126 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;173 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;163 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;126 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;161 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;123 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;159 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;122 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;97,74 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;98,81 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;97,74 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;97,02 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;100 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;95,83 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;97,62 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;94,64 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;96,83 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;3 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;13 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;38 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;3 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;13 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;37 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;3 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;13 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;37 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;13 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;37 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;13 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;37 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;100 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;100 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;97,37 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;100 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;97,37 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;100 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;97,37 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;100 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;97,37 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;181 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;184 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;182 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIV;181 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIV;181 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIV;182 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2022QI;181 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2021QI;179 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;177 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;175 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QIII;176 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QIII;173 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,37 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;100 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;98,37 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;98,35 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;96,2 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;96,15 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;95,65 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;95,05 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;177 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;169 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;139 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;177 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;166 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;139 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;166 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;136 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;162 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;132 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;161 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;130 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;98,22 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;98,22 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;97,84 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;95,86 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;94,96 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;95,27 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;93,53 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;4 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;15 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;43 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;4 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;15 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;43 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;15 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;43 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;15 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;43 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;15 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;43 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;100 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;100 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;100 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;100 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;100 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;100 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;100 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;100 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;100 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;100 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;100 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;100 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;From 10 to 99;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;4 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;3 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;6 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2022QI;4 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2021QI;3 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the first trimester;2020QI;6 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QII;4 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QII;3 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QII;6 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;4 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;3 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;6 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIV;4 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIV;3 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIV;6 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;100 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;100 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;100 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;100 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;100 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;100 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;100 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;100 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;100 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;100 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;100 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;100 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;4 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;2 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;4 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;2 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;4 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;2 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;4 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;2 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;4 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;2 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;100 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;100 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;100 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;100 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;100 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;100 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;100 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;100 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;0 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;1 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;0 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;1 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;0 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;1 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;0 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;1 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;0 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;1 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;.. 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;100 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;.. 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;100 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;.. 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;100 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;0 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;100 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;0 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;100 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;3 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;4 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;4 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QII;3 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QII;4 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QII;4 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QIII;3 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QIII;4 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QIII;4 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;3 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;4 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;4 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2022QI;4 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2021QI;4 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 19 Melilla;from 100 to 249;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;100 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;100 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;100 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;100 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;100 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;100 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;100 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;100 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;100 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;3 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;3 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;3 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;3 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;3 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;3 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;3 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;3 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;3 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;3 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;3 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;3 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;3 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;3 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;100 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;100 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;100 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;100 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;100 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;100 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;100 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;100 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;0 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;1 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;1 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;0 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;1 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;1 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;0 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;1 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;1 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;0 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;1 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;1 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;1 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;1 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;.. 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;100 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;100 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;.. 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;100 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;100 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;0 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;100 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;100 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;0 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;100 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;100 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;100 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;100 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QIII;5 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QIII;2 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QIII;5 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIV;5 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIV;2 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIV;5 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;2 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;5 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QII;2 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QII;5 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;100 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;100 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;100 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;100 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;100 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;100 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;100 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;100 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;100 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;4 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;2 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;3 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;4 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;2 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;3 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;4 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;2 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;3 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;2 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;3 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;2 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;3 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;100 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;100 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;100 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;100 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;100 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;100 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;100 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;100 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;1 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;0 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;2 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;1 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;0 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;2 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;1 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;0 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;2 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;0 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;2 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;0 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;2 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;100 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;.. 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;100 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;100 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;.. 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;100 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;100 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;.. 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;100 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;.. 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;100 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;.. 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;100 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIV;5 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIV;3 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIV;3 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2022QI;3 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2021QI;3 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;3 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;3 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QIII;3 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QIII;3 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;100 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;100 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;100 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;100 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;100 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;100 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;100 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;100 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;5 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;3 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;3 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;5 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;3 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;3 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;3 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;3 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;3 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;3 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;3 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;3 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;100 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;100 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;100 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;100 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;100 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;100 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;100 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;0 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;0 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;0 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;0 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;0 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;0 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;0 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;0 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;0 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;0 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;0 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;0 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;0 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;.. 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;.. 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;0 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;.. 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;.. 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;.. 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;.. 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;.. 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;.. 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;0 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;.. 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;from 100 to 249;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;2 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;2 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;1 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2022QI;2 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2021QI;2 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the first trimester;2020QI;1 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QII;2 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QII;2 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QII;1 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;2 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;2 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;1 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIV;2 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIV;2 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIV;1 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2022QI;100 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2021QI;100 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Number at the start of the quarter;2020QI;100 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;100 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;100 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;100 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;100 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;100 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;100 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;100 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;100 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;100 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;100 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;100 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;100 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;2 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;2 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2022QI;2 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2021QI;2 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QII;2 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QII;2 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;2 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;2 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIV;2 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIV;2 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2022QI;100 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2021QI;100 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;100 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;100 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;100 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;100 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;100 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;100 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;100 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;100 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;0 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;0 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2022QI;0 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2021QI;0 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QII;0 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QII;0 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;0 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;0 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIV;0 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIV;0 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2022QI;.. 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2021QI;.. 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;.. 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;.. 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QII;.. 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QII;.. 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;0 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;.. 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;0 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;.. 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;De 250 o más;Cohort January 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;2 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;2 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;2 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QII;2 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QII;2 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QII;2 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QIII;2 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QIII;2 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QIII;2 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;2 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;2 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;2 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2022QI;2 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2021QI;2 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QII;100 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QII;100 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QII;100 19 Melilla;De 250 o más;Cohort April 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;100 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;100 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;100 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;100 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;100 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;100 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;100 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;100 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;100 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;100 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;100 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;De 250 o más;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;2 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;2 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;2 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QII;2 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QII;2 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QII;2 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QIII;2 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QIII;2 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QIII;2 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;2 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;2 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;2 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2022QI;2 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2021QI;2 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QII;100 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QII;100 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QII;100 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;100 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;100 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;100 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;100 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;100 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;100 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;100 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;100 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;100 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;100 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;100 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;De 250 o más;Cohort April 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;0 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;0 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;0 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QII;0 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QII;0 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QII;0 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QIII;0 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QIII;0 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QIII;0 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;0 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;0 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;0 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2022QI;0 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2021QI;0 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QII;.. 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QII;.. 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QII;.. 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;.. 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;.. 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;.. 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;0 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;.. 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;.. 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;0 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;.. 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;.. 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;.. 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;.. 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;De 250 o más;Cohort April 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QIII;1 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QIII;2 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QIII;1 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIV;1 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIV;2 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIV;1 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;2 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;1 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QII;2 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QII;1 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;100 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;100 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;100 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;100 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;100 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;100 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;100 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;100 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;100 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;100 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;1 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;2 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;1 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QIII;1 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QIII;2 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QIII;1 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIV;1 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIV;2 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIV;1 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;2 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;1 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QII;2 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QII;1 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QIII;100 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QIII;100 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QIII;100 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;100 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;100 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;100 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;100 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;100 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;100 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;100 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;100 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;100 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;100 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;0 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;0 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;0 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QIII;0 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QIII;0 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QIII;0 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIV;0 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIV;0 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIV;0 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;0 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;0 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QII;0 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QII;0 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QIII;0 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QIII;.. 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QIII;.. 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;0 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;.. 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;.. 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;0 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;.. 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;.. 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2022QI;.. 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2021QI;.. 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;.. 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;.. 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;De 250 o más;Cohort July 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIV;1 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIV;1 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIV;2 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2022QI;1 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2021QI;2 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the second trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;1 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;2 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QIII;1 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QIII;2 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;100 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;100 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;100 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;100 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;100 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;100 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;100 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;100 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;100 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;1 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;1 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;2 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIV;1 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIV;1 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIV;2 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2022QI;1 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2021QI;2 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;1 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;2 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QIII;1 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QIII;2 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIV;100 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIV;100 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIV;100 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIV;100 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIV;100 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIV;100 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2022QI;100 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2021QI;100 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QII;100 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QII;100 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QIII;100 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QIII;100 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Sin ERTE;Percentage of survivals in the fourth semester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;0 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;0 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;0 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIV;0 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIV;0 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIV;0 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2022QI;0 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2021QI;0 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the second trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;0 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;0 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QIII;0 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QIII;0 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Survival in the third trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIV;0 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIV;.. 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIV;.. 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Number at the start of the quarter;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIV;0 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIV;.. 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIV;.. 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the first trimester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2022QI;.. 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2021QI;.. 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the second semester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QII;.. 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QII;.. 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the third semester;2020QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QIII;0 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2022QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QIII;.. 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2021QI;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIV;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QIII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QII;"" 19 Melilla;De 250 o más;Cohort October 1;Con ERTE;Percentage of survivals in the fourth semester;2020QI;""